UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
FORM 10-Q
Q☒QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF
THE SECURITIES EXCHANGE ACT OF 1934
For the quarterly period ended September 30, 20172020
OR
o☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF
THE SECURITIES EXCHANGE ACT OF 1934
For the transition period from to
Commission File Number: 001-14428
RENAISSANCERE HOLDINGS LTD.
(Exact Name Of Registrant As Specified In Its Charter)
|
| | | | |
| Bermuda | 98-014-197498-0141974 |
(State or Other Jurisdiction of Incorporation or Organization) | (I.R.S. Employer
Identification Number)
|
Renaissance House, 12 Crow Lane, Pembroke, Bermuda HM 19 |
| |
Renaissance House, 12 Crow Lane
Pembroke, Bermuda
| HM 19 |
(Address of Principal Executive Offices) | (Zip (Address of Principal Executive Offices) (Zip Code) |
(441) 295-4513
(Registrant’s telephone number, including area code)
Not Applicable
(Former name, former address and former fiscal year, if changed since last report)
Securities registered pursuant to Section 12(b) of the Act:
| | | | | | | | |
| Title of each class | Trading
symbol(s) | Name of each exchange on which registered |
| Common Shares, Par Value $1.00 per share | RNR | New York Stock Exchange |
| Series E 5.375% Preference Shares, Par Value $1.00 per share | RNR PRE | New York Stock Exchange |
| Depositary Shares, each representing a 1/1,000th interest in a Series F 5.750% Preference Share, Par Value $1.00 per share | RNR PRF | New York Stock Exchange |
Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. Yes Q☒ No o☐
Indicate by check mark whether the registrant has submitted electronically and posted on its corporate web site, if any, every Interactive Data File required to be submitted and posted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit and post such files). Yes Q☒ No o
☐
Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company, or an emerging growth company. See the definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company,” and “emerging growth company” in Rule 12b-2 of the Exchange Act.
Large accelerated filer Q☒, Accelerated filer o☐, Non-accelerated filer o (do not check if a smaller reporting company)☐, Smaller reporting company o☐, Emerging growth company o☐
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. o☐
Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act).
Yes o☐ No Q
☒
The number of Common Shares, par value US $1.00 per share, outstanding at October 27, 201723, 2020 was 40,029,116.
RENAISSANCERE HOLDINGS LTD.
TABLE OF CONTENTS
| | | | | | | | |
| | Page |
| | |
| | |
| |
| ITEM 1. | | |
| | |
| | |
| | Page |
| | |
| | |
ITEM 1. | | |
| | |
| | |
| | |
| | |
| | |
| | |
| ITEM 2. | | |
| ITEM 3. | | |
| ITEM 4. | | |
| | |
| |
| ITEM 1. | | |
| ITEM 1A. | | |
| ITEM 2. | | |
| ITEM 3. | | |
| ITEM 4. | | |
| ITEM 5. | | |
| ITEM 6. | | |
| | |
| |
NOTE ON FORWARD-LOOKING STATEMENTS
This Quarterly Report on Form 10-Q (this “Form 10-Q”) of RenaissanceRe Holdings Ltd. (the “Company” or “RenaissanceRe”) contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended (the “Securities Act”), and Section 21E of the Securities Exchange Act of 1934, as amended (the “Exchange Act”). Forward-looking statements are necessarily based on estimates and assumptions that are inherently subject to significant business, economic and competitive uncertainties and contingencies, many of which, with respect to future business decisions, are subject to change. These uncertainties and contingencies can affect actual results and could cause actual results to differ materially from those expressed in any forward-looking statements made by, or on behalf of, us. In particular, statements using words such as “may”, “should”, “estimate”, “expect”, “anticipate”, “intend”, “believe”, “predict”, “potential”,“may,” “should,” “estimate,” “expect,” “anticipate,” “intend,” “believe,” “predict,” “potential,” or words of similar import generally involve forward-looking statements. For example, we may include certain forward-looking statements in “Management’s Discussion and Analysis of Financial Condition and Results of Operations” with regard to trends in results, prices, volumes, operations, investment results, margins, combined ratios, fees, reserves, market conditions, risk management and exchange rates. This Form 10-Q also contains forward-looking statements with respect to our business and industry, such as those relating to our strategy and management objectives, market standing and product volumes, competition and new entrants in our industry, industry capital, insured losses from loss events, government initiatives and regulatory matters affecting the reinsurance and insurance industries.
The inclusion of forward-looking statements in this report should not be considered as a representation by us or any other person that our current objectives or plans will be achieved. Numerous factors could cause our actual results to differ materially from those addressed by the forward-looking statements, including the following:
•the uncertainty of the continuing impact of the COVID-19 pandemic and measures taken in response thereto;
•the effect of legislative, regulatory, judicial or social influences related to the COVID-19 pandemic on our financial performance, including the emergence of unexpected or un-modeled insurance or reinsurance losses and our ability to conduct our business;
•the impact and potential future impacts of the COVID-19 pandemic on the value of our investments and our access to capital in the future or the pricing or terms of available financing;
•the effect that measures taken to mitigate the COVID-19 pandemic have on our operations and those of our counterparties;
•the frequency and severity of catastrophic and other events we cover;
•the effectiveness of our claims and claim expense reserving process;
•the effect of climate change on our business, including the trend towards increasingly frequent and severe climate events;
•our ability to maintain our financial strength ratings;
•the effect of climate change on our business;emerging claims and coverage issues;
•collection on claimed retrocessional coverage, and new retrocessional reinsurance being available on acceptable terms and providing the coverage that we intended to obtain;
the effects of United States (“U.S.”) business tax reform proposals;
adverse tax developments, including potential changes to the taxation of inter-company or related party transactions, or changes to the tax treatment of our shareholders or investors in our joint ventures or other entities we manage;
the effect of emerging claims and coverage issues;
continued soft reinsurance underwriting market conditions;
•our reliance on a small and decreasing number of reinsurance brokers and other distribution services for the preponderance of our revenue;
•our exposure to credit loss from counterparties in the normal course of business;
•the effect of continued challenging economic conditions throughout the world;
•the performance of our investment portfolio;
•a contention by the United States (the “U.S.”) Internal Revenue Service (the “IRS”) that Renaissance Reinsurance Ltd. (“Renaissance Reinsurance”), or any of our other Bermuda subsidiaries, is subject to taxation in the U.S.;
•the performanceeffects of U.S. tax reform legislation and possible future tax reform legislation and regulations, including changes to the tax treatment of our investment portfolio;shareholders or investors in our joint ventures or other entities we manage;
losses we could face from terrorism, political unrest or war;
•the effect of cybersecurity risks, including technology breaches or failure, on our business;
our ability to successfully implement our business strategies and initiatives;
our ability to retain our key senior officers and to attract or retain the executives and employees necessary to manage our business;
our ability to determine the impairments taken on our investments;
the effects of inflation;
the ability of our ceding companies and delegated authority counterparties to accurately assess the risks they underwrite;
the effect of operational risks, including system or human failures;
our ability to effectively manage capital on behalf of investors in joint ventures or other entities we manage;
foreign currency exchange rate fluctuations;
our ability to raise capital if necessary;
our ability to comply with covenants in our debt agreements;
changes to the regulatory systems under which we operate, including as a result of increased global regulation of the insurance and reinsurance industry;
changes in Bermuda laws and regulations and the political environment in Bermuda;
our dependence on the ability of our operating subsidiaries to declare and pay dividends;
•the success of any of our strategic investments or acquisitions, including our ability to manage our operations as our product and geographical diversity increases;
•our ability to retain our key senior officers and to attract or retain the executives and employees necessary to manage our business;
•our ability to effectively manage capital on behalf of investors in joint ventures or other entities we manage;
•foreign currency exchange rate fluctuations;
•soft reinsurance underwriting market conditions;
•changes in the method for determining the London Inter-bank Offered Rate (“LIBOR”) and the potential replacement of LIBOR;
•losses we could face from terrorism, political unrest or war;
•our ability to successfully implement our business strategies and initiatives;
•our ability to determine any impairments taken on our investments;
•the effects of inflation;
•the ability of our ceding companies and delegated authority counterparties to accurately assess the risks they underwrite;
•the effect of operational risks, including system or human failures;
•our ability to raise capital if necessary;
•our ability to comply with covenants in our debt agreements;
•changes to the regulatory systems under which we operate, including as a result of increased global regulation of the insurance and reinsurance industries;
•changes in Bermuda laws and regulations and the political environment in Bermuda;
•our dependence on the ability of our operating subsidiaries to declare and pay dividends;
•aspects of our corporate structure that may discourage third-party takeovers and other transactions;
•difficulties investors may have in servicing process or enforcing judgments against us in the U.S.;
•the cyclical nature of the reinsurance and insurance industries;
•adverse legislative developments that reduce the size of the private markets we serve or impede their future growth;
other political, regulatory or industry initiatives adversely impacting us;•consolidation of competitors, customers and insurance and reinsurance brokers;
risks related to Solvency II;
•the effect on our business of the highly competitive nature of our industry, including the effect of new entrants to, competing products for and consolidation in the (re)insurance industry;
consolidation of competitors, customers•other political, regulatory or industry initiatives adversely impacting us;
•our ability to comply with applicable sanctions and insurance and reinsurance brokers;foreign corrupt practices laws;
•increasing barriers to free trade and the free flow of capital;
•international restrictions on the writing of reinsurance by foreign companies and government intervention in the natural catastrophe market;
•the effect of Organisation for Economic Co-operation and Development (the “OECD”) or European Union (“EU”) measures to increase our taxes and reporting requirements;
the effect of the vote by the U.K. to leave the EU;
•changes in regulatory regimes and accounting rules that may impact financial results irrespective of business operations; and
•our need to make many estimates and judgments in the preparation of our financial statements.statements; and
•the effect of the exit by the United Kingdom (the “U.K.”) from the EU.
As a consequence, our future financial condition and results may differ from those expressed in any forward-looking statements made by or on behalf of us. The factors listed above, which are discussed in more detail in our filings with the U.S. Securities and Exchange Commission (“SEC”), including our Annual Report on Form 10-K (“Form 10-K”) for the year ended December 31, 2016,2019, Part II, Item 1A of this Quarterly Report on Form 10-Q and our prospectus supplement dated June 4, 2020, should not be construed as exhaustive. The effects of the events and circumstances described in the risk factors contained in this Form 10-Q may have the effect of heightening many of the risks contained in our Form 10-K. Forward-looking statements speak only as of the date they are made, and we undertake no obligation to revise or update forward-looking statements to reflect new information, events or circumstances after the date hereof or to reflect the occurrence of unanticipated events.
PART I FINANCIAL INFORMATION
ITEM 1. FINANCIAL STATEMENTS
INDEX TO CONSOLIDATED FINANCIAL STATEMENTS
RenaissanceRe Holdings Ltd. and Subsidiaries
Consolidated Balance Sheets
(in thousands of United States Dollars, except share and per share amounts)
| | | | | | | | | | | |
| September 30,
2020 | | December 31,
2019 |
| Assets | (Unaudited) | | (Audited) |
| Fixed maturity investments trading, at fair value – amortized cost $13,070,757 at September 30, 2020 (December 31, 2019 – $11,067,414) | $ | 13,391,318 | | | $ | 11,171,655 | |
| | | |
| Short term investments, at fair value | 5,158,961 | | | 4,566,277 | |
| Equity investments trading, at fair value | 547,381 | | | 436,931 | |
| Other investments, at fair value | 1,122,683 | | | 1,087,377 | |
| Investments in other ventures, under equity method | 98,990 | | | 106,549 | |
| Total investments | 20,319,333 | | | 17,368,789 | |
| Cash and cash equivalents | 1,287,378 | | | 1,379,068 | |
| Premiums receivable | 3,337,120 | | | 2,599,896 | |
| Prepaid reinsurance premiums | 1,082,270 | | | 767,781 | |
| Reinsurance recoverable | 2,883,808 | | | 2,791,297 | |
| Accrued investment income | 71,947 | | | 72,461 | |
| Deferred acquisition costs and value of business acquired | 697,346 | | | 663,991 | |
| Receivable for investments sold | 752,936 | | | 78,369 | |
| Other assets | 306,265 | | | 346,216 | |
| Goodwill and other intangible assets | 257,437 | | | 262,226 | |
| | | |
| Total assets | $ | 30,995,840 | | | $ | 26,330,094 | |
| Liabilities, Noncontrolling Interests and Shareholders’ Equity | | | |
| Liabilities | | | |
| Reserve for claims and claim expenses | $ | 9,900,615 | | | $ | 9,384,349 | |
| Unearned premiums | 3,276,156 | | | 2,530,975 | |
| Debt | 1,135,740 | | | 1,384,105 | |
| Reinsurance balances payable | 3,915,804 | | | 2,830,691 | |
| Payable for investments purchased | 1,597,893 | | | 225,275 | |
| Other liabilities | 391,494 | | | 932,024 | |
| | | |
| Total liabilities | 20,217,702 | | | 17,287,419 | |
| Commitments and Contingencies | | | |
| Redeemable noncontrolling interests | 3,387,317 | | | 3,071,308 | |
| Shareholders’ Equity | | | |
| Preference shares: $1.00 par value – 11,010,000 shares issued and outstanding at September 30, 2020 (December 31, 2019 – 16,010,000) | 525,000 | | | 650,000 | |
| Common shares: $1.00 par value – 50,810,043 shares issued and outstanding at September 30, 2020 (December 31, 2019 – 44,148,116) | 50,810 | | | 44,148 | |
| Additional paid-in capital | 1,615,328 | | | 568,277 | |
| Accumulated other comprehensive loss | (2,083) | | | (1,939) | |
| Retained earnings | 5,201,766 | | | 4,710,881 | |
| Total shareholders’ equity attributable to RenaissanceRe | 7,390,821 | | | 5,971,367 | |
| | | |
| | | |
| Total liabilities, noncontrolling interests and shareholders’ equity | $ | 30,995,840 | | | $ | 26,330,094 | |
|
| | | | | | | |
| | September 30,
2017 | | December 31,
2016 |
| Assets | (Unaudited) | | (Audited) |
Fixed maturity investments trading, at fair value – amortized cost $7,061,487
at September 30, 2017 (December 31, 2016 – $6,920,690) | $ | 7,092,969 |
| | $ | 6,891,244 |
|
| Short term investments, at fair value | 1,497,262 |
| | 1,368,379 |
|
| Equity investments trading, at fair value | 402,035 |
| | 383,313 |
|
| Other investments, at fair value | 548,492 |
| | 549,805 |
|
| Investments in other ventures, under equity method | 101,420 |
| | 124,227 |
|
| Total investments | 9,642,178 |
| | 9,316,968 |
|
| Cash and cash equivalents | 581,576 |
| | 421,157 |
|
| Premiums receivable | 1,521,266 |
| | 987,323 |
|
| Prepaid reinsurance premiums | 635,756 |
| | 441,260 |
|
| Reinsurance recoverable | 1,588,304 |
| | 279,564 |
|
| Accrued investment income | 38,366 |
| | 38,076 |
|
| Deferred acquisition costs | 434,914 |
| | 335,325 |
|
| Receivable for investments sold | 193,758 |
| | 105,841 |
|
| Other assets | 164,019 |
| | 175,382 |
|
| Goodwill and other intangible assets | 244,787 |
| | 251,186 |
|
| Total assets | $ | 15,044,924 |
| | $ | 12,352,082 |
|
| Liabilities, Noncontrolling Interests and Shareholders’ Equity | | | |
| Liabilities | | | |
| Reserve for claims and claim expenses | $ | 5,192,313 |
| | $ | 2,848,294 |
|
| Unearned premiums | 1,713,069 |
| | 1,231,573 |
|
| Debt | 989,245 |
| | 948,663 |
|
| Reinsurance balances payable | 1,034,454 |
| | 673,983 |
|
| Payable for investments purchased | 377,543 |
| | 305,714 |
|
| Other liabilities | 301,559 |
| | 301,684 |
|
| Total liabilities | 9,608,183 |
| | 6,309,911 |
|
| Commitments and Contingencies |
|
| |
|
|
| Redeemable noncontrolling interests | 1,033,729 |
| | 1,175,594 |
|
| Shareholders’ Equity | | | |
| Preference shares: $1.00 par value – 16,000,000 shares issued and outstanding at September 30, 2017 (December 31, 2016 – 16,000,000) | 400,000 |
| | 400,000 |
|
| Common shares: $1.00 par value – 40,029,116 shares issued and outstanding at September 30, 2017 (December 31, 2016 – 41,187,413) | 40,029 |
| | 41,187 |
|
| Additional paid-in capital | 32,852 |
| | 216,558 |
|
| Accumulated other comprehensive income | 161 |
| | 1,133 |
|
| Retained earnings | 3,929,970 |
| | 4,207,699 |
|
| Total shareholders’ equity attributable to RenaissanceRe | 4,403,012 |
| | 4,866,577 |
|
| Total liabilities, noncontrolling interests and shareholders’ equity | $ | 15,044,924 |
| | $ | 12,352,082 |
|
See accompanying notes to the consolidated financial statements
RenaissanceRe Holdings Ltd. and Subsidiaries
Consolidated Statements of Operations
For the three and nine months endedSeptember 30, 20172020 and 20162019
(in thousands of United States Dollars, except per share amounts) (Unaudited) | | | | Three months ended | | Nine months ended | | Three months ended | | Nine months ended |
| | September 30,
2017 | | September 30,
2016 | | September 30,
2017 | | September 30,
2016 | | September 30,
2020 | | September 30,
2019 | | September 30,
2020 | | September 30,
2019 |
| Revenues | | | | | | | | Revenues | | | | | | | |
| Gross premiums written | $ | 640,269 |
| | $ | 430,224 |
| | $ | 2,389,774 |
| | $ | 2,051,485 |
| Gross premiums written | $ | 1,143,058 | | | $ | 861,068 | | | $ | 4,870,651 | | | $ | 3,902,271 | |
| Net premiums written | $ | 483,221 |
| | $ | 284,222 |
| | $ | 1,583,102 |
| | $ | 1,315,813 |
| Net premiums written | $ | 899,411 | | | $ | 704,130 | | | $ | 3,350,022 | | | $ | 2,656,126 | |
| Decrease (increase) in unearned premiums | 64,571 |
| | 62,299 |
| | (287,000 | ) | | (264,284 | ) | Decrease (increase) in unearned premiums | 100,772 | | | 202,618 | | | (426,645) | | | (287,848) | |
| Net premiums earned | 547,792 |
| | 346,521 |
| | 1,296,102 |
| | 1,051,529 |
| Net premiums earned | 1,000,183 | | | 906,748 | | | 2,923,377 | | | 2,368,278 | |
| Net investment income | 40,257 |
| | 51,423 |
| | 148,745 |
| | 134,410 |
| Net investment income | 83,543 | | | 111,387 | | | 272,321 | | | 312,069 | |
| Net foreign exchange (losses) gains | (156 | ) | | (5,986 | ) | | 11,118 |
| | (8,368 | ) | |
| Equity in earnings (losses) of other ventures | 1,794 |
| | (11,630 | ) | | 5,830 |
| | (3,997 | ) | |
| Other income | 2,996 |
| | 2,268 |
| | 7,053 |
| | 9,001 |
| |
| Net foreign exchange gains (losses) | | Net foreign exchange gains (losses) | 17,426 | | | (8,275) | | | 4,503 | | | (1,812) | |
| Equity in earnings of other ventures | | Equity in earnings of other ventures | 5,457 | | | 5,877 | | | 19,062 | | | 17,350 | |
| Other income (loss) | | Other income (loss) | 1,476 | | | 1,016 | | | (4,161) | | | 5,109 | |
| Net realized and unrealized gains on investments | 42,052 |
| | 59,870 |
| | 143,538 |
| | 191,295 |
| Net realized and unrealized gains on investments | 224,208 | | | 34,395 | | | 561,891 | | | 395,655 | |
| | Total revenues | 634,735 |
| | 442,466 |
| | 1,612,386 |
| | 1,373,870 |
| Total revenues | 1,332,293 | | | 1,051,148 | | | 3,776,993 | | | 3,096,649 | |
| Expenses | | | | | | | | Expenses | | | | | | | |
| Net claims and claim expenses incurred | 1,221,696 |
| | 112,575 |
| | 1,557,364 |
| | 406,930 |
| Net claims and claim expenses incurred | 942,030 | | | 654,520 | | | 2,023,256 | | | 1,334,928 | |
| Acquisition expenses | 76,761 |
| | 80,580 |
| | 248,294 |
| | 215,177 |
| Acquisition expenses | 215,180 | | | 202,181 | | | 659,394 | | | 553,614 | |
| Operational expenses | 42,537 |
| | 40,493 |
| | 131,586 |
| | 147,801 |
| Operational expenses | 49,045 | | | 53,415 | | | 165,583 | | | 158,162 | |
| Corporate expenses | 4,413 |
| | 11,537 |
| | 14,335 |
| | 25,514 |
| Corporate expenses | 48,050 | | | 13,844 | | | 75,939 | | | 76,480 | |
| Interest expense | 11,799 |
| | 10,536 |
| | 32,416 |
| | 31,610 |
| Interest expense | 11,843 | | | 15,580 | | | 38,612 | | | 42,868 | |
| Total expenses | 1,357,206 |
| | 255,721 |
| | 1,983,995 |
| | 827,032 |
| Total expenses | 1,266,148 | | | 939,540 | | | 2,962,784 | | | 2,166,052 | |
| (Loss) income before taxes | (722,471 | ) | | 186,745 |
| | (371,609 | ) | | 546,838 |
| |
| Income before taxes | | Income before taxes | 66,145 | | | 111,608 | | | 814,209 | | | 930,597 | |
| Income tax benefit (expense) | 18,977 |
| | 1,316 |
| | 14,739 |
| | (8,040 | ) | Income tax benefit (expense) | 8,244 | | | (3,664) | | | (12,785) | | | (20,670) | |
| Net (loss) income | (703,494 | ) | | 188,061 |
| | (356,870 | ) | | 538,798 |
| |
| Net loss (income) attributable to redeemable noncontrolling interests | 204,277 |
| | (35,641 | ) | | 132,338 |
| | (110,867 | ) | |
| Net (loss) income attributable to RenaissanceRe | (499,217 | ) | | 152,420 |
| | (224,532 | ) | | 427,931 |
| |
| | Net income | | Net income | 74,389 | | | 107,944 | | | 801,424 | | | 909,927 | |
| Net income attributable to redeemable noncontrolling interests | | Net income attributable to redeemable noncontrolling interests | (19,301) | | | (62,057) | | | (236,120) | | | (204,091) | |
| Net income attributable to RenaissanceRe | | Net income attributable to RenaissanceRe | 55,088 | | | 45,887 | | | 565,304 | | | 705,836 | |
| Dividends on preference shares | (5,595 | ) | | (5,595 | ) | | (16,786 | ) | | (16,786 | ) | Dividends on preference shares | (7,289) | | | (9,189) | | | (23,634) | | | (27,567) | |
| Net (loss) income (attributable) available to RenaissanceRe common shareholders | $ | (504,812 | ) | | $ | 146,825 |
| | $ | (241,318 | ) | | $ | 411,145 |
| |
| Net (loss) income (attributable) available to RenaissanceRe common shareholders per common share – basic | $ | (12.75 | ) | | $ | 3.58 |
| | $ | (6.04 | ) | | $ | 9.77 |
| |
| Net (loss) income (attributable) available to RenaissanceRe common shareholders per common share – diluted | $ | (12.75 | ) | | $ | 3.56 |
| | $ | (6.04 | ) | | $ | 9.71 |
| |
| Net income available to RenaissanceRe common shareholders | | Net income available to RenaissanceRe common shareholders | $ | 47,799 | | | $ | 36,698 | | | $ | 541,670 | | | $ | 678,269 | |
| | Net income available to RenaissanceRe common shareholders per common share – basic | | Net income available to RenaissanceRe common shareholders per common share – basic | $ | 0.94 | | | $ | 0.83 | | | $ | 11.60 | | | $ | 15.58 | |
| | Net income available to RenaissanceRe common shareholders per common share – diluted | | Net income available to RenaissanceRe common shareholders per common share – diluted | $ | 0.94 | | | $ | 0.83 | | | $ | 11.58 | | | $ | 15.57 | |
| Dividends per common share | $ | 0.32 |
| | $ | 0.31 |
| | $ | 0.96 |
| | $ | 0.93 |
| Dividends per common share | $ | 0.35 | | | $ | 0.34 | | | $ | 1.05 | | | $ | 1.02 | |
See accompanying notes to the consolidated financial statements
RenaissanceRe Holdings Ltd. and Subsidiaries
Consolidated Statements of Comprehensive (Loss) Income
For the three and nine months endedSeptember 30, 20172020 and 20162019
(in thousands of United States Dollars) (Unaudited)
| | | | | | | | | | | | | | | | | | | | | | | |
| Three months ended | | Nine months ended |
| September 30,
2020 | | September 30,
2019 | | September 30,
2020 | | September 30,
2019 |
| Comprehensive income | | | | | | | |
| Net income | $ | 74,389 | | | $ | 107,944 | | | $ | 801,424 | | | $ | 909,927 | |
| Change in net unrealized losses on investments, net of tax | 2,186 | | | 608 | | | 41 | | | 1,880 | |
| Foreign currency translation adjustments, net of tax | (1,203) | | | 8,249 | | | (185) | | | 4,541 | |
| | | | | | | |
| Comprehensive income | 75,372 | | | 116,801 | | | 801,280 | | | 916,348 | |
| Net income attributable to redeemable noncontrolling interests | (19,301) | | | (62,057) | | | (236,120) | | | (204,091) | |
| | | | | | | |
| Comprehensive income attributable to redeemable noncontrolling interests | (19,301) | | | (62,057) | | | (236,120) | | | (204,091) | |
| Comprehensive income attributable to RenaissanceRe | $ | 56,071 | | | $ | 54,744 | | | $ | 565,160 | | | $ | 712,257 | |
| | | | | | | |
| | | | | | | |
| | | | | | | |
| | | | | | | |
| | | | | | | |
|
| | | | | | | | | | | | | | | |
| | Three months ended | | Nine months ended |
| | September 30,
2017 | | September 30,
2016 | | September 30,
2017 | | September 30,
2016 |
| Comprehensive (loss) income | | | | | | | |
| Net (loss) income | $ | (703,494 | ) | | $ | 188,061 |
| | $ | (356,870 | ) | | $ | 538,798 |
|
| Change in net unrealized gains on investments | 300 |
| | 284 |
| | (972 | ) | | 513 |
|
| Comprehensive (loss) income | (703,194 | ) | | 188,345 |
| | (357,842 | ) | | 539,311 |
|
| Net loss (income) attributable to redeemable noncontrolling interests | 204,277 |
| | (35,641 | ) | | 132,338 |
| | (110,867 | ) |
| Comprehensive loss (income) attributable to redeemable noncontrolling interests | 204,277 |
| | (35,641 | ) | | 132,338 |
| | (110,867 | ) |
| Comprehensive (loss) income attributable to RenaissanceRe | $ | (498,917 | ) | | $ | 152,704 |
| | $ | (225,504 | ) | | $ | 428,444 |
|
See accompanying notes to the consolidated financial statements
RenaissanceRe Holdings Ltd. and Subsidiaries
Consolidated Statements of Changes in Shareholders’ Equity
For the three and nine months endedSeptember 30, 20172020 and 20162019
(in thousands of United States Dollars) (Unaudited)
| | | | | | | | | | | | | | | | | | | | | | | |
| Three months ended | | Nine months ended |
| September 30,
2020 | | September 30,
2019 | | September 30,
2020 | | September 30,
2019 |
| Preference shares | | | | | | | |
| Beginning balance | $ | 525,000 | | | $ | 650,000 | | | $ | 650,000 | | | $ | 650,000 | |
| | | | | | | |
| Repurchase of shares | 0 | | | 0 | | | (125,000) | | | 0 | |
| Ending balance | 525,000 | | | 650,000 | | | 525,000 | | | 650,000 | |
| Common shares | | | | | | | |
| Beginning balance | 50,811 | | | 44,162 | | | 44,148 | | | 42,207 | |
| Issuance of shares | 0 | | | 0 | | | 6,777 | | | 1,739 | |
| Repurchase of shares | 0 | | | 0 | | | (406) | | | 0 | |
| Exercise of options and issuance of restricted stock awards | (1) | | | (10) | | | 291 | | | 206 | |
| Ending balance | 50,810 | | | 44,152 | | | 50,810 | | | 44,152 | |
| Additional paid-in capital | | | | | | | |
| Beginning balance | 1,602,738 | | | 552,210 | | | 568,277 | | | 296,099 | |
| Issuance of shares | (42) | | | 0 | | | 1,088,730 | | | 248,259 | |
| Repurchase of shares | 0 | | | 0 | | | (62,215) | | | 0 | |
| | | | | | | |
| Change in redeemable noncontrolling interests | 0 | | | (145) | | | (353) | | | (361) | |
| Exercise of options and issuance of restricted stock awards | 12,632 | | | 8,101 | | | 20,889 | | | 16,169 | |
| Ending balance | 1,615,328 | | | 560,166 | | | 1,615,328 | | | 560,166 | |
| Accumulated other comprehensive (loss) income | | | | | | | |
| Beginning balance | (3,066) | | | (3,869) | | | (1,939) | | | (1,433) | |
| Change in net unrealized losses on investments, net of tax | 2,186 | | | 608 | | | 41 | | | 1,880 | |
| Foreign currency translation adjustments, net of tax | (1,203) | | | 8,249 | | | (185) | | | 4,541 | |
| | | | | | | |
| Ending balance | (2,083) | | | 4,988 | | | (2,083) | | | 4,988 | |
| Retained earnings | | | | | | | |
| Beginning balance | 5,171,689 | | | 4,670,339 | | | 4,710,881 | | | 4,058,207 | |
| | | | | | | |
| Net income | 74,389 | | | 107,944 | | | 801,424 | | | 909,927 | |
| Net income attributable to redeemable noncontrolling interests | (19,301) | | | (62,057) | | | (236,120) | | | (204,091) | |
| | | | | | | |
| Dividends on common shares | (17,722) | | | (15,108) | | | (50,785) | | | (44,547) | |
| Dividends on preference shares | (7,289) | | | (9,189) | | | (23,634) | | | (27,567) | |
| Ending balance | 5,201,766 | | | 4,691,929 | | | 5,201,766 | | | 4,691,929 | |
| | | | | | | |
| Total shareholders’ equity | $ | 7,390,821 | | | $ | 5,951,235 | | | $ | 7,390,821 | | | $ | 5,951,235 | |
|
| | | | | | | |
| | Nine months ended |
| | September 30,
2017 | | September 30,
2016 |
| Preference shares | | | |
| Balance – January 1 | $ | 400,000 |
| | $ | 400,000 |
|
| Balance – September 30 | 400,000 |
| | 400,000 |
|
| Common shares | | | |
| Balance – January 1 | 41,187 |
| | 43,701 |
|
| Repurchase of shares | (1,322 | ) | | (2,741 | ) |
| Exercise of options and issuance of restricted stock awards | 164 |
| | 196 |
|
| Balance – September 30 | 40,029 |
| | 41,156 |
|
| Additional paid-in capital | | | |
| Balance – January 1 | 216,558 |
| | 507,674 |
|
| Repurchase of shares | (187,269 | ) | | (306,693 | ) |
| Change in redeemable noncontrolling interests | (307 | ) | | (1,040 | ) |
| Exercise of options and issuance of restricted stock awards | 3,870 |
| | 13,112 |
|
| Balance – September 30 | 32,852 |
| | 213,053 |
|
| Accumulated other comprehensive income | | | |
| Balance – January 1 | 1,133 |
| | 2,108 |
|
| Change in net unrealized gains on investments | (972 | ) | | 513 |
|
| Balance – September 30 | 161 |
| | 2,621 |
|
| Retained earnings | | | |
| Balance – January 1 | 4,207,699 |
| | 3,778,701 |
|
| Cumulative effect of adoption of ASU 2016-09 (Note 2) | 2,213 |
| | — |
|
| Net (loss) income | (356,870 | ) | | 538,798 |
|
| Net loss (income) attributable (available) to redeemable noncontrolling interests | 132,338 |
| | (110,867 | ) |
| Dividends on common shares | (38,624 | ) | | (38,886 | ) |
| Dividends on preference shares | (16,786 | ) | | (16,786 | ) |
| Balance – September 30 | 3,929,970 |
| | 4,150,960 |
|
| Total shareholders’ equity | $ | 4,403,012 |
| | $ | 4,807,790 |
|
See accompanying notes to the consolidated financial statements
RenaissanceRe Holdings Ltd. and Subsidiaries
Consolidated Statements of Cash Flows
For the nine months endedSeptember 30, 20172020 and 20162019
(in thousands of United States Dollars) (Unaudited)
| | | | | | | | | | | |
| Nine months ended |
| September 30,
2020 | | September 30,
2019 |
| Cash flows provided by operating activities | | | |
| Net income | $ | 801,424 | | | $ | 909,927 | |
| Adjustments to reconcile net income to net cash provided by operating activities | | | |
| Amortization, accretion and depreciation | (1,922) | | | (27,239) | |
| Equity in undistributed earnings of other ventures | (907) | | | 1,754 | |
| Net realized and unrealized gains on investments | (561,891) | | | (395,655) | |
| | | |
| | | |
| | | |
| Loss on sale of RenaissanceRe UK | 30,242 | | | 0 | |
| Change in: | | | |
| Premiums receivable | (736,070) | | | (625,031) | |
| Prepaid reinsurance premiums | (314,489) | | | (216,064) | |
| Reinsurance recoverable | (96,159) | | | 482,663 | |
| Deferred acquisition costs | (33,383) | | | 74,409 | |
| Reserve for claims and claim expenses | 675,092 | | | 118,650 | |
| Unearned premiums | 745,506 | | | 487,903 | |
| Reinsurance balances payable | 1,089,733 | | | 738,442 | |
| Other | (267,397) | | | (285,327) | |
| Net cash provided by operating activities | 1,329,779 | | | 1,264,432 | |
| Cash flows used in investing activities | | | |
| Proceeds from sales and maturities of fixed maturity investments trading | 11,564,999 | | | 12,835,916 | |
| Purchases of fixed maturity investments trading | (13,114,732) | | | (13,403,711) | |
| | | |
| | | |
| Net sales (purchases) of equity investments trading | 1,842 | | | (6,937) | |
| Net purchases of short term investments | (549,218) | | | (1,362,151) | |
| Net purchases of other investments | (101,302) | | | (130,476) | |
| Net purchases of investments in other ventures | (2,407) | | | (2,341) | |
| Return of investment from investment in other ventures | 9,255 | | | 11,250 | |
| Net purchase of other assets | 0 | | | (4,108) | |
| Net proceeds from sale of RenaissanceRe UK | 136,744 | | | 0 | |
| Net purchase of TMR | 0 | | | (276,206) | |
| | | |
| Net cash used in investing activities | (2,054,819) | | | (2,338,764) | |
| Cash flows provided by financing activities | | | |
| Dividends paid – RenaissanceRe common shares | (50,785) | | | (44,547) | |
| Dividends paid – preference shares | (23,634) | | | (27,567) | |
| RenaissanceRe common share issuance, net of expenses | 1,095,507 | | | 0 | |
| RenaissanceRe common share repurchases | (62,621) | | | 0 | |
| Issuance of debt, net of expenses | 0 | | | 396,411 | |
| Repayment of debt | (250,000) | | | 0 | |
| | | |
| Redemption of 6.08% Series C preference shares | (125,000) | | | 0 | |
| | | |
| | | |
| Net third-party redeemable noncontrolling interest share transactions | 59,104 | | | 515,952 | |
| Taxes paid on withholding shares | (10,264) | | | (7,229) | |
| | | |
| Net cash provided by financing activities | 632,307 | | | 833,020 | |
| Effect of exchange rate changes on foreign currency cash | 1,043 | | | 4,641 | |
| Net decrease in cash and cash equivalents | (91,690) | | | (236,671) | |
| | | |
| Cash and cash equivalents, beginning of period | 1,379,068 | | | 1,107,922 | |
| Cash and cash equivalents, end of period | $ | 1,287,378 | | | $ | 871,251 | |
|
| | | | | | | |
| | Nine months ended |
| | September 30,
2017 | | September 30,
2016 |
| Cash flows provided by operating activities | | | |
| Net (loss) income | $ | (356,870 | ) | | $ | 538,798 |
|
| Adjustments to reconcile net (loss) income to net cash provided by operating activities | | | |
| Amortization, accretion and depreciation | 18,586 |
| | 18,343 |
|
| Equity in undistributed losses of other ventures | 19,559 |
| | 10,173 |
|
| Net realized and unrealized gains on investments | (143,538 | ) | | (191,295 | ) |
| Net unrealized (gains) losses included in net investment income | (2,686 | ) | | 17,608 |
|
| Change in: | | | |
| Premiums receivable | (533,943 | ) | | (403,322 | ) |
| Prepaid reinsurance premiums | (194,496 | ) | | (280,750 | ) |
| Reinsurance recoverable | (1,308,740 | ) | | (106,243 | ) |
| Deferred acquisition costs | (99,589 | ) | | (152,461 | ) |
| Reserve for claims and claim expenses | 2,344,019 |
| | 94,054 |
|
| Unearned premiums | 481,496 |
| | 545,034 |
|
| Reinsurance balances payable | 360,471 |
| | 250,686 |
|
| Other | 37,433 |
| | 39,740 |
|
| Net cash provided by operating activities | 621,702 |
| | 380,365 |
|
| Cash flows (used in) provided by investing activities | | | |
| Proceeds from sales and maturities of fixed maturity investments trading | 7,663,002 |
| | 6,509,019 |
|
| Purchases of fixed maturity investments trading | (7,798,285 | ) | | (6,744,838 | ) |
| Proceeds from sales and maturities of fixed maturity investments available for sale | — |
| | 5,931 |
|
| Net sales of equity investments trading | 61,571 |
| | 183,112 |
|
| Net (purchases) sales of short term investments | (146,326 | ) | | 128,869 |
|
| Net sales (purchases) of other investments | 5,181 |
| | (56,765 | ) |
| Net sales of other assets | — |
| | 400 |
|
| Net cash (used in) provided by investing activities | (214,857 | ) | | 25,728 |
|
| Cash flows used in financing activities | | | |
| Dividends paid – RenaissanceRe common shares | (38,624 | ) | | (38,886 | ) |
| Dividends paid – preference shares | (16,786 | ) | | (16,786 | ) |
| RenaissanceRe common share repurchases | (188,591 | ) | | (309,434 | ) |
| Issuance of debt, net of expenses | 295,866 |
| | — |
|
| Repayment of debt | (250,000 | ) | | — |
|
| Net third party redeemable noncontrolling interest share transactions | (44,193 | ) | | (45,496 | ) |
| Taxes paid on withholding shares | (13,694 | ) | | (10,362 | ) |
| Net cash used in financing activities | (256,022 | ) | | (420,964 | ) |
| Effect of exchange rate changes on foreign currency cash | 9,596 |
| | 1,316 |
|
| Net increase (decrease) in cash and cash equivalents | 160,419 |
| | (13,555 | ) |
| Cash and cash equivalents, beginning of period | 421,157 |
| | 506,885 |
|
| Cash and cash equivalents, end of period | $ | 581,576 |
| | $ | 493,330 |
|
See accompanying notes to the consolidated financial statements
RENAISSANCERE HOLDINGS LTD. AND SUBSIDIARIES
NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS
September 30, 20172020
(unless otherwise noted, amounts in tables expressed in thousands of United States (“U.S.”) dollars,
except shares, per share amounts and percentages) (Unaudited)
NOTE 1.ORGANIZATION
This report on Form 10-Q should be read in conjunction with the RenaissanceRe’s Annual Report on Form 10-K (“Form 10-K”) for the fiscal year ended December 31, 2016.
2019. RenaissanceRe was formed under the laws of Bermuda on June 7, 1993 and is a global provider of reinsurance and insurance that specializes in matching well-structured risks with efficient sources of capital.1993. Together with its wholly owned and majority-owned subsidiaries and DaVinciRe (as defined below),joint ventures, the Company provides property, casualty and specialty reinsurance and certain insurance solutions to customers, principally through intermediaries. The Company has offices in Bermuda, Ireland, Singapore, the United Kingdom, and the United States.its customers.
•Renaissance Reinsurance Ltd. (“Renaissance Reinsurance”), a Bermuda-domiciled reinsurance company, is the Company’s principal reinsurance subsidiary and provides property, casualty and specialty reinsurance coverages to insurers and reinsurers on a worldwide basis. Effective October 1, 2016, each of Renaissance Reinsurance Specialty Risks Ltd. and Platinum Underwriters Bermuda, Ltd. merged into Renaissance Reinsurance, with Renaissance Reinsurance being the sole surviving entity.
•Renaissance Reinsurance U.S. Inc. (“Renaissance Reinsurance U.S.”) is a reinsurance company domiciled in the state of Maryland that provides property, casualty and specialty reinsurance coverages to insurers and reinsurers, primarily in the Americas.
•RenaissanceRe Underwriting Managers U.S. LLC, a specialty reinsurance agency domiciled in the state of Connecticut, provides specialty treaty reinsurance solutions on both a quota share and excess of loss basis; and writes business on behalf of RenaissanceRe Specialty U.S. Ltd. (“RenaissanceRe Specialty U.S.”), a Bermuda-domiciled reinsurer, which operates subject to U.S. federal income tax, and RenaissanceRe Syndicate 1458 (“Syndicate 1458”).
•Syndicate 1458 is the Company’s Lloyd’s syndicate. RenaissanceRe Corporate Capital (UK) Limited, (“RenaissanceRe CCL”), a wholly owned subsidiary of RenaissanceRe, is Syndicate 1458’s sole corporate member andmember. RenaissanceRe Syndicate Management Ltd. (“RSML”), a wholly owned subsidiary of RenaissanceRe, is the managing agent for Syndicate 1458.
•On March 22, 2019, the Company’s wholly owned subsidiary, RenaissanceRe Specialty Holdings (UK) Limited (“RenaissanceRe Specialty Holdings”), completed its previously announced purchase of all of the share capital of RenaissanceRe Europe AG (formerly known as Tokio Millennium Re AG) (“RenaissanceRe Europe”), RenaissanceRe (UK) Limited (formerly known as Tokio Millennium Re (UK) Limited) (“RenaissanceRe UK”), and their respective subsidiaries (collectively, “TMR”) pursuant to a Stock Purchase Agreement by and among the Company, Tokio Marine & Nichido Fire Insurance Co. Ltd. (“Tokio”) and, with respect to certain sections only, Tokio Marine Holdings, Inc. entered into on October 30, 2018 (the “TMR Stock Purchase Agreement”). See “Note 3. Acquisition of Tokio Millennium Re” in the Company’s “Notes to the Consolidated Financial Statements” included in the Company’s Form 10-K for the year ended December 31, 2019 for additional information regarding the acquisition of TMR.
•RenaissanceRe Europe, a Swiss-domiciled reinsurance company, which has branches in Australia, Bermuda, the U.K. and the U.S., provides property, casualty and specialty reinsurance coverages to insurers and reinsurers on a worldwide basis.
•RenaissanceRe UK, a U.K.-domiciled reinsurance company in run-off, provided property, casualty and specialty reinsurance coverages on a worldwide basis. RenaissanceRe UK was placed into run-off effective July 1, 2015, from which date all new and renewal business was written by the U.K. branch of RenaissanceRe Europe. On August 18, 2020, the Company completed the sale of RenaissanceRe UK to an investment vehicle managed by AXA Liabilities Managers, an affiliate of AXA XL.
•The Company also manages property, casualty and specialty reinsurance business written on behalf of joint ventures, which principally include Top Layer Reinsurance Ltd. (“Top Layer Re”), recorded under the equity method of accounting, and DaVinci Reinsurance Ltd. (“DaVinci”). Because the Company owns a noncontrolling equityeconomic interest in, but controls a majority of the outstanding voting power of, DaVinci’s parent, DaVinciRe Holdings Ltd. (“DaVinciRe”), the results of DaVinci and DaVinciRe are consolidated in the
Company’s consolidated financial statements and all significant intercompany transactions have been eliminated. Redeemable noncontrolling interest - DaVinciRe represents the interests of external parties with respect to the net income and shareholders’ equity of DaVinciRe. Renaissance Underwriting Managers, Ltd. (“RUM”), a wholly owned subsidiary of RenaissanceRe, acts as exclusive underwriting manager for these joint ventures in return for fee-based income and profit participation.
•RenaissanceRe Medici Fund Ltd. (“Medici”) is an exempted fund,company, incorporated under the laws of Bermuda.Bermuda and registered as an institutional fund. Medici’s objective is to seek to invest substantially all of its assets in various insurance basedinsurance-based investment instruments that have returns primarily tied to property catastrophe risk. Third-party investors have subscribed for a portion of the participating, non-voting common shares of Medici. Because the Company owns a noncontrolling equityeconomic interest in, but controls a majority of the outstanding voting power of Medici’sMedici, through its wholly-owned parent, RenaissanceRe Fund Holdings Ltd. (“Fund Holdings”), the results of Medici and Fund Holdings are consolidated in the Company’s consolidated financial statements and all significant inter-company transactions have been eliminated. Redeemable noncontrolling interest -
Medici represents the interests of external parties with respect to the net income and shareholders’ equity of Medici.
Effective January 1, 2013, the Company formed and launched a managed joint venture, •Upsilon RFO Re Ltd., formerly known as Upsilon Reinsurance II Ltd. (“Upsilon RFO”), a Bermuda domiciled special purpose insurer (“SPI”), is a managed joint venture formed by the Company principally to provide additional capacity to the worldwide aggregate and per-occurrence primary and retrocessional property catastrophe excess of loss market. Upsilon RFO is considered a variable interest entity (“VIE”) and the Company is considered the primary beneficiary. As a result, Upsilon RFO is consolidated by the Company and all significant inter-company transactions have been eliminated.
Effective November 13, 2014, the Company incorporated •RenaissanceRe Upsilon Fund Ltd. (“Upsilon Fund”), an exempted Bermuda segregated accounts company. Upsiloncompany registered as a Class A Professional Fund, was formed by the Company to provide a fund structure through which third-party investors can invest in reinsurance risk managed by the Company. As a segregated accounts company, Upsilon Fund is permitted to establish segregated accounts to invest in and hold identified pools of assets and liabilities. Each pool of assets and liabilities in each segregated account is structured to be ring-fenced from any claims from the creditors of Upsilon Fund’s general account and from the creditors of other segregated accounts within Upsilon Fund. Third-party investors purchase redeemable, non-voting preference shares linked to specific segregated accounts of Upsilon Fund and own 100% of these shares. Upsilon Fund is an investment company and is considered a VIE. The Company is not considered the primary beneficiary of Upsilon Fund and, as a result, the Company does not consolidate the financial position and results of operations of Upsilon Fund.
Effective November 7, 2016, •The Company formed Vermeer Reinsurance Ltd. (“Vermeer”), an exempted Bermuda reinsurer, with PGGM, a Dutch pension fund manager. Vermeer provides capacity focused on risk remote layers in the U.S. property catastrophe market. Vermeer is managed by RUM in return for a management fee. The Company maintains a majority voting control of Vermeer, while PGGM retains economic benefits. Vermeer is considered a VIE, as it has voting rights that are not proportional to its participating rights and the Company is the primary beneficiary. As a result, the Company consolidates Vermeer and all significant inter-company transactions have been eliminated. The Company does not currently expect its voting or economic interest in Vermeer to fluctuate.
•Fibonacci Reinsurance Ltd. ("Fibonacci Re"), a Bermuda-domiciled SPI, was formed to provideprovides collateralized capacity to Renaissance Reinsurance and its affiliates. Fibonacci Re raisedraises capital from third-party investors and the Company, via private placements of participating notes which are listed on the Bermuda Stock Exchange. Fibonacci Re is considered a VIE. The Company is not considered the primary beneficiary of Fibonacci Re and, as a result, the Company does not consolidate the financial position and results of operations of Fibonacci Re.
•The Company and Reinsurance Group of America, Incorporated closed an initiative (“Langhorne”) to source third-party capital to support reinsurers targeting large in-force life and annuity blocks. Langhorne Holdings LLC (“Langhorne Holdings”) is a company that owns and manages certain reinsurance entities within Langhorne. Langhorne Partners LLC (“Langhorne Partners”) is the general partner for Langhorne and the entity which manages the third-parties investing in Langhorne
Holdings. The Company concluded that Langhorne Holdings meets the definition of a VIE. The Company is not the primary beneficiary of Langhorne Holdings and as a result, the Company does not consolidate the financial position or results of operations of Langhorne Holdings. The Company concluded that Langhorne Partners is not a VIE. The Company will account for its investments in Langhorne Holdings and Langhorne Partners under the equity method of accounting, one quarter in arrears.
•Mona Lisa Re Ltd. (“Mona Lisa Re”), a Bermuda domiciled SPI, provides reinsurance capacity to subsidiaries of RenaissanceRe, namely Renaissance Reinsurance and DaVinci, through reinsurance agreements which are collateralized and funded by Mona Lisa Re through the issuance of one or more series of principal-at-risk variable rate notes. The Company concluded that Mona Lisa Re meets the definition of a VIE as it does not have sufficient equity capital to finance its activities. The Company evaluated its relationship with Mona Lisa Re and concluded it is not the primary beneficiary of Mona Lisa Re as it does not have power over the activities that most significantly impact the economic performance of Mona Lisa Re. As a result, the financial position and results of operations of Mona Lisa Re are not consolidated by the Company.
•As a result of the acquisition of TMR, the Company manages Shima Reinsurance Ltd. (“Shima Re”), Norwood Re Ltd. (“Norwood Re”) and Blizzard Re Ltd. (together, the “TMR managed third-party capital vehicles”), which provide third-party investors with access to reinsurance risk. Following the closing of the acquisition, the retrocessionaires providing reinsurance to TMR on certain TMR managed third-party capital vehicles’ legacy portfolios of in-force and expired contracts were replaced. The TMR managed third-party capital vehicles no longer write new business.
NOTE 2.SIGNIFICANT ACCOUNTING POLICIES
There have been no material changes to the Company’s significant accounting policies as described in its Form 10-K for the year ended December 31, 2016,2019, except as noteddescribed below.
BASIS OF PRESENTATION
These consolidated financial statements have been prepared on the basis of accounting principles generally accepted in the United StatesU.S. (“GAAP”) for interim financial information and in conformity with the instructions to Form 10-Q and Article 10 of Regulation S-X. Accordingly, they do not include all of the information and footnotes required by GAAP for complete consolidated financial statements. In the opinion of management, these unaudited consolidated financial statements reflect all adjustments (consisting of normal recurring accruals) considered necessary for a fair presentation of the Company’s financial position and results of operations as at the end of and for the periods presented. All significant intercompany accounts and transactions have been eliminated from these statements.
Certain comparative information has been reclassified to conform to the current presentation. Because of the seasonality of the Company’s business, the results of operations and cash flows for any interim period will not necessarily be indicative of the results of operations and cash flows for the full fiscal year or subsequent quarters.
USE OF ESTIMATES IN FINANCIAL STATEMENTS
The preparation of consolidated financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported and disclosed amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the consolidated financial statements and the reported amounts of revenues and expenses during the reporting period. Actual results could differ materially from those estimates. The major estimates reflected in the Company’s consolidated financial statements include, but are not limited to, the reserve for claims and claim expenses; reinsurance
recoverables, including allowances for reinsurance recoverables deemed uncollectible; estimates of written and earned premiums; fair value, including the fair value of investments, financial instruments and derivatives; impairment charges; deferred acquisition costs and the value of business acquired and the Company’s deferred tax valuation allowance.
RECENTLY ADOPTED ACCOUNTING PRONOUNCEMENTS
Improvements to Employee Share-Based Payment AccountingINVESTMENTS
In March 2016, the FASB issued ASU No. 2016-09, Improvements to Employee Share-Based Payment Accounting (“ASU 2016-09”). ASU 2016-09 was issued to simplify several aspects of the accounting for share-based payment transactions, including the income tax consequences, classification of awards as either equity or liabilities, and the classification of taxes paid on the statements of cash flows. ASU 2016-09 became effective for the Company in annual and interim periods beginning after December 15, 2016. The cumulative effect of the adoption of ASU 2016-09 was a $2.2 million increase to opening retained earnings as of January 1, 2017.Other Investments
RECENTLY ISSUED ACCOUNTING PRONOUNCEMENTS NOT YET ADOPTED
Revenue from Contracts with Customers
In May 2014, the FASB issued ASU No. 2014-09, Revenue from Contracts with Customers (“ASU 2014-09”). ASU 2014-09 provides comprehensive guidance on the recognition of revenue from customers arising from the transfer of goods and services. The core principle of the guidance is that an entity should recognize revenue to depict the transfer of promised goods or services to customers in an amount that reflects the consideration to which the entity expects to be entitled in exchange for those goods or services. ASU 2014-09 also provides guidance on accounting for certain contract costs and will also require new disclosures. ASU 2014-09 was to be effective for public business entities in annual and interim periods beginning after December 15, 2016, however in July 2015, the FASB decided to defer by one year the effective dates of ASU 2014-09, and as a result, ASU 2014-09 will be effective for public business entities in annual and interim periods beginning after December 15, 2017. Early adoption is permitted. ASU 2014-09 notably excludes the accounting for insurance contracts, leases, financial instruments and guarantees. The Company is currently evaluating the impact of this guidance, withaccounts for its implementation efforts primarily focused on other income (loss) on its consolidated statements of operations. The adoption of ASU 2014-09 is not expected to have a material impact on the Company’s consolidated statements of operations and financial position.
Leases
In February 2016, the FASB issued ASU No. 2016-02, Leases (“ASU 2016-02”). ASU 2016-02 requires lessees to recognize lease assets and lease liabilities on the balance sheet for those leases classified as operating leases under previous guidance. ASU 2016-02 is effective for public business entities for annual and interim periods beginning after December 15, 2018. Early application is permitted. The Company is currently evaluating the impact of this guidance; however, it is not expected to have a material impact on the Company’s consolidated statements of operations and financial position.
Recognition and Measurement of Financial Assets and Financial Liabilities
In January 2016, the FASB issued ASU No. 2016-01, Recognition and Measurement of Financial Assets and Financial Liabilities (“ASU 2016-01”). ASU 2016-01 requires equity investments (except those accounted for under the equity method of accounting or those that result in the consolidation of the investee) to be measured at fair value in accordance with changesFASB ASC Topic Financial Instruments with interest, dividend income, income distributions included in net investment income and realized and unrealized gains and losses included in net realized and unrealized gains (losses) on investments. The fair value recognized in net income, simplifiesof certain of the impairment assessment ofCompany’s fund investments, which principally include private equity investments, without readily determinable values by requiring a qualitative assessment to identify impairment, eliminatessenior secured bank loan funds and hedge funds, is recorded on its balance sheet in other investments, and is generally established on the requirement to disclose the methods and significant assumptions used to estimate the fair value for financial instruments measured at amortized cost, requires the usebasis of the exit price notion when measuringnet valuation criteria established by the managers of such investments, if applicable. The net valuation criteria established by the managers of such investments is established in accordance with the governing documents of such investments. Certain of the Company’s fund managers, fund administrators, or both, are unable to provide final fund valuations as of the Company’s current reporting date. The typical reporting lag experienced by the Company to receive a final net asset value report is one month for hedge funds and senior secured bank loan funds and three months for private equity investments, although, in the past, in respect of certain of the Company’s private equity investments, the Company has on occasion experienced delays of up to six months at year end, as the private equity investments typically complete their respective year-end audits before releasing their final net asset value statements.
In circumstances where there is a reporting lag between the current period end reporting date and the reporting date of the latest fund valuation, the Company estimates the fair value of financial instrumentsthese funds by starting with the most recently available prior month or quarter-end fund valuations, adjusting these valuations for disclosure purposes, requires separate presentationactual capital calls, redemptions or distributions, as well as the impact of changes in foreign currency exchange rates, and then estimating the return for the current period. In circumstances in which the Company estimates the return for the current period, all information available to the Company is utilized. This principally includes preliminary estimates reported to the Company by its fund managers, obtaining the valuation of underlying portfolio investments where such underlying investments are publicly traded and therefore have a readily observable price, using information that is available to the Company with respect to the underlying investments, reviewing various indices for similar investments or asset classes, as well as estimating returns based on the results of similar types of investments for which the Company has obtained reported results, or other comprehensive incomevaluation methods, where possible. Actual final fund valuations may differ, perhaps materially so, from the Company’s estimates and these differences are recorded in the Company’s statement of operations in the portion ofperiod in which they are reported to the totalCompany as a change in estimate.
The Company’s other investments also include investments in catastrophe bonds which are recorded at fair value and the fair value of a liability resulting from a change in the instrument-specific credit risk when the organization has elected to measure the liabilities in accordance with the fair value option, requires the separate presentation of financial assets and financial liabilities by measurement category and form ofis based on broker or underwriter bid indications.
financial asset on the balance sheet or the accompanying notes to the financial statements and clarifies that the reporting organization should evaluate the need for a valuation allowance on a deferred tax asset related to available for sale securities in combination with the organization’s other deferred tax assets. ASU 2016-01 is effective for public business entities in annual and interim periods beginning after December 15, 2017. Earlier adoption is generally not permitted, except for certain specific provisions of ASU 2016-01. The Company is currently evaluating the impact of this guidance; however, it is not expected to have a material impact on the Company’s consolidated statements of operations and financial position.RECENTLY ADOPTED ACCOUNTING PRONOUNCEMENTS
Measurement of Credit Losses on Financial Instruments
In June 2016, the FASB issued ASU No. 2016-13, Measurement of Credit Losses on Financial Instruments (“ASU 2016-13”). ASU 2016-13 modifies the recognition of credit losses by replacing the incurred loss impairment methodology with a methodology that reflects expected credit losses and requires consideration of a broader range of reasonable and supportable information to inform credit loss estimates. ASU 2016-13 is applicable to financial assets such as loans, debt securities, trade receivables, off-balance sheet credit exposures, reinsurance receivables, and other financial assets that have the contractual right to receive cash. The measurement of expected credit losses is based on relevant information about past events, including historical experience, current conditions, and reasonable and supportable forecasts that affect the collectibilitycollectability of the reported amount. The Company's invested assets are measured at fair value through net income, and therefore those invested assets wouldwere not be impacted by the adoption of ASU 2016-13. The Company has other financial assets, such as reinsurance recoverables, that could bewere not materially impacted by the adoption of ASU 2016-13. ASU 2016-13 is effective for public business entities that are SEC filers for annual and interim periods beginning after December 15, 2019.2019, accordingly, the Company adopted ASU 2016-13 effective January 1, 2020. The Company is currently evaluating the impactadoption of this guidance; however, it isASU 2016-13 did not expected to have a material impact on the Company’s consolidated statements of operations and financial position.
Classification of Certain Cash Receipts and Cash PaymentsDisclosure Framework - Changes to the Disclosure Requirements for Fair Value Measurement
In August 2016,2018, the FASB issued ASU No. 2016-15, Classification2018-13, Disclosure Framework - Changes to the Disclosure Requirements for Fair Value Measurement (“ASU 2018-13”). The ASU 2018-13 modifies the disclosure requirements of Certain Cash Receipts and Cash Payments (“ASU 2016-15”). ASU 2016-15 clarifiesfair value measurements as part of the classificationdisclosure framework project with the objective to improve the effectiveness of receipts and paymentsdisclosures in the statementnotes to the financial statements. ASU 2018-13 allows for removal of cash flows.the amount and reasons for transfer between Level 1 and Level 2 of the fair value hierarchy; the policy for transfers between levels; and the valuation processes for Level 3 fair value measurements. ASU 2016-15 provides guidance related to (1) settlement and payment of zero coupon debt instruments, (2) contingent consideration, (3) proceeds from settlement of insurance claims, (4) proceeds from settlement of corporate and bank owned life insurance policies, (5) distributions from equity method investees, (6) cash receipts from beneficial interests obtained by a transferor, and (7) general guidelines for cash receipts and payments that have more than one aspect of classification. ASU 2016-152018-13 is effective for public businessall entities for annual periodsfiscal years beginning after December 15, 2018,2019 and interim periods within annual periods beginning after December 15, 2019. Early adoptionthose fiscal years, accordingly, the Company adopted ASU 2018-13 effective January 1, 2020. Since ASU 2018-13 is permitted. The Company is currently evaluating the impact of this guidance; however,disclosure-related only, it isdid not expected to have a material impact on the Company’s consolidated statements of cash flows.
Intra-Entity Transfers of Assets Other Than Inventory
In October 2016, the FASB issued ASU No. 2016-16, Intra-Entity Transfers of Assets Other Than Inventory (“ASU 2016-16”). ASU 2016-16 requires entities to recognize the income tax consequences of intra-entity transfers of assets other than inventory when the transfers occur; this is a change from current guidance which prohibits the recognition of current and deferred income taxes until the underlying assets have been sold to outside entities. ASU 2016-16 is effective for public business entities for annual and interim periods beginning after December 15, 2018. Early adoption is permitted. The Company is currently evaluating the impact of this guidance; however, it is not expected to have a material impact on the Company’s consolidated statements of operations and financial position.
Simplifying the Test for Goodwill Impairment
In January 2017, the FASB issued ASU No. 2017-04, Simplifying the Test for Goodwill Impairment (“ASU 2017-04”). Among other things, ASU 2017-04 requires the following: (1) the elimination of step 2two of the goodwill impairment test; entities will no longer utilize the implied fair value of their assets and liabilities for purposes of testing goodwill for impairment, (2) the quantitative portion of the goodwill impairment test will be performed by comparing the fair value of a reporting unit with its carrying amount; an impairment charge is to be recognized for the excess of carrying amount over fair value, but only to the extent of the amount of
goodwill allocated to that reporting unit, and (3) foreign currency translation adjustments are not to be allocated to a reporting unit from an entity’s accumulated other comprehensive income;income (loss); the reporting unit’s carrying amount should include only the currently translated balances of the assets and liabilities assigned to the reporting unit. ASU 2017-04 is effective for public business entities that are SEC filers for annual periods, or any interim goodwill impairment tests in annual periods, beginning after December 15, 2019.2019, accordingly, the Company adopted ASU 2017-04 effective January 1, 2020. The adoption of ASU 2017-04 did not have a material impact on the Company’s consolidated statements of operations and financial position.
RECENTLY ISSUED ACCOUNTING PRONOUNCEMENTS NOT YET ADOPTED
Simplifying the Accounting for Income Taxes
In December 2019, the FASB issued ASU No. 2019-12, Simplifying the Accounting for Income Taxes (”ASU 2019-12”). Among other things, ASU 2019-12 eliminates certain exceptions for recognizing deferred taxes for investments, performing intraperiod tax allocation and calculating income taxes in interim periods. ASU 2019-12 also clarifies the accounting for transactions that result in a step-up in the tax basis of goodwill. ASU 2019-12 is effective for public business entities for fiscal years, and interim periods within those fiscal years, beginning after December 15, 2020. Early adoption is permitted for interim or annual goodwill impairment tests performed on testing dates after January 1, 2017.permitted. The Company is currently evaluating the impact of this guidance; however, it is not expected to have a material impact on the Company’s consolidated statements of operations and financial position.
NOTE 3.INVESTMENTS
Fixed Maturity Investments Trading
The following table summarizes the fair value of fixed maturity investments trading: |
| | | | | | | | | |
| | | | | | |
| | | September 30,
2017 | | December 31,
2016 | |
| | U.S. treasuries | $ | 2,956,952 |
| | $ | 2,617,894 |
| |
| | Agencies | 41,109 |
| | 90,972 |
| |
| | Municipal | 521,220 |
| | 519,069 |
| |
| | Non-U.S. government (Sovereign debt) | 177,855 |
| | 333,224 |
| |
| | Non-U.S. government-backed corporate | 121,892 |
| | 133,300 |
| |
| | Corporate | 2,028,750 |
| | 1,877,243 |
| |
| | Agency mortgage-backed | 499,310 |
| | 462,493 |
| |
| | Non-agency mortgage-backed | 299,530 |
| | 258,944 |
| |
| | Commercial mortgage-backed | 263,029 |
| | 409,747 |
| |
| | Asset-backed | 183,322 |
| | 188,358 |
| |
| | Total fixed maturity investments trading | $ | 7,092,969 |
| | $ | 6,891,244 |
| |
| | | | | | |
| | | | | | | | | | | | | | | | | |
| | | | | |
| | September 30,
2020 | | December 31,
2019 | |
| U.S. treasuries | $ | 4,350,971 | | | $ | 4,467,345 | | |
| Agencies | 437,681 | | | 343,031 | | |
| | | | | |
| Non-U.S. government | 568,960 | | | 497,392 | | |
| | | | | |
| Non-U.S. government-backed corporate | 401,449 | | | 321,356 | | |
| Corporate | 4,655,765 | | | 3,075,660 | | |
| Agency mortgage-backed | 1,086,474 | | | 1,148,499 | | |
| Non-agency mortgage-backed | 293,953 | | | 294,604 | | |
| Commercial mortgage-backed | 788,995 | | | 468,698 | | |
| Asset-backed | 807,070 | | | 555,070 | | |
| Total fixed maturity investments trading | $ | 13,391,318 | | | $ | 11,171,655 | | |
| | | | | |
Contractual maturities of fixed maturity investments trading are described in the following table. Expected maturities will differ from contractual maturities because borrowers may have the right to call or prepay obligations with or without call or prepayment penalties. |
| | | | | | | | | |
| | | | | | |
| | September 30, 2017 | Amortized Cost | | Fair Value | |
| | Due in less than one year | $ | 366,988 |
| | $ | 367,091 |
| |
| | Due after one through five years | 4,326,788 |
| | 4,324,948 |
| |
| | Due after five through ten years | 985,535 |
| | 1,001,975 |
| |
| | Due after ten years | 151,964 |
| | 153,764 |
| |
| | Mortgage-backed | 1,047,676 |
| | 1,061,869 |
| |
| | Asset-backed | 182,536 |
| | 183,322 |
| |
| | Total | $ | 7,061,487 |
| | $ | 7,092,969 |
| |
| | | | | | |
| | | | | | | | | | | | | | | | | | | | | | | | | |
| | | | | | | | | | | | | |
| | | | | | | |
| September 30, 2020 | Amortized
Cost | | Fair Value | | | | | | | | | |
| Due in less than one year | $ | 617,235 | | | $ | 621,610 | | | | | | | | | | |
| Due after one through five years | 5,622,660 | | | 5,749,128 | | | | | | | | | | |
| Due after five through ten years | 3,247,152 | | | 3,374,898 | | | | | | | | | | |
| Due after ten years | 650,611 | | | 669,190 | | | | | | | | | | |
| Mortgage-backed | 2,124,561 | | | 2,169,422 | | | | | | | | | | |
| Asset-backed | 808,538 | | | 807,070 | | | | | | | | | | |
| Total | $ | 13,070,757 | | | $ | 13,391,318 | | | | | | | | | | |
| | | | | | | | | | | | | |
Equity Investments Trading
The following table summarizes the fair value of equity investments trading: |
| | | | | | | | | |
| | | | | | |
| | | September 30,
2017 | | December 31,
2016 | |
| | Financials | $ | 275,373 |
| | $ | 275,065 |
| |
| | Communications and technology | 45,592 |
| | 36,770 |
| |
| | Industrial, utilities and energy | 32,922 |
| | 30,303 |
| |
| | Consumer | 22,613 |
| | 20,501 |
| |
| | Healthcare | 21,113 |
| | 17,245 |
| |
| | Basic materials | 4,422 |
| | 3,429 |
| |
| | Total | $ | 402,035 |
| | $ | 383,313 |
| |
| | | | | | |
| | | | | | | | | | | | | | | | | |
| | | | | |
| | September 30,
2020 | | December 31,
2019 | |
| Financials | $ | 323,516 | | | $ | 248,189 | | |
| Communications and technology | 108,782 | | | 79,206 | | |
| Consumer | 41,442 | | | 35,987 | | |
| Industrial, utilities and energy | 33,968 | | | 38,583 | | |
| Healthcare | 33,314 | | | 29,510 | | |
| Basic materials | 6,359 | | | 5,456 | | |
| Total | $ | 547,381 | | | $ | 436,931 | | |
| | | | | |
Pledged Investments
At September 30, 2017, $3.32020, $6.7 billion of cash and investments at fair value were on deposit with, or in trust accounts for the benefit of, various counterparties, including with respect to the Company’s letter of credit facilities (December(December 31, 20162019 - $2.7$7.0 billion). Of this amount, $1.4$1.6 billion is on deposit with, or in trust accounts for the benefit of, U.S. state regulatory authorities (December(December 31, 20162019 - $842.6 million)$2.0 billion).
Reverse Repurchase Agreements
At September 30, 2017,2020, the Company held $477.5$103.4 million (December (December 31, 20162019 - $78.7 million)$57.6 million) of reverse repurchase agreements. These loans are fully collateralized, are generally outstanding for a short period of time and are presented on a gross basis as part of short term investments on the Company’s consolidated balance sheets. The required collateral for these loans typically includes high-quality, readily marketable instruments at a minimum amount of 102% of the loan principal. Upon maturity, the Company receives principal and interest income.
Net Investment Income
The components of net investment income are as follows: |
| | | | | | | | | | | | | | | | | |
| | | | | | | | | | |
| | | Three months ended | | Nine months ended | |
| | | September 30,
2017 | | September 30,
2016 | | September 30,
2017 | | September 30,
2016 | |
| | Fixed maturity investments | $ | 45,305 |
| | $ | 39,959 |
| | $ | 133,080 |
| | $ | 122,056 |
| |
| | Short term investments | 2,771 |
| | 1,174 |
| | 7,476 |
| | 3,401 |
| |
| | Equity investments | 930 |
| | 797 |
| | 2,630 |
| | 3,325 |
| |
| | Other investments | | | | | | | | |
| | Private equity investments | 6,371 |
| | 4,572 |
| | 20,784 |
| | (430 | ) | |
| | Other | (11,491 | ) | | 8,765 |
| | (4,520 | ) | | 17,109 |
| |
| | Cash and cash equivalents | 352 |
| | 246 |
| | 836 |
| | 584 |
| |
| | | 44,238 |
| | 55,513 |
| | 160,286 |
| | 146,045 |
| |
| | Investment expenses | (3,981 | ) | | (4,090 | ) | | (11,541 | ) | | (11,635 | ) | |
| | Net investment income | $ | 40,257 |
| | $ | 51,423 |
| | $ | 148,745 |
| | $ | 134,410 |
| |
| | | | | | | | | | |
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
| | | | | | | | | |
| | Three months ended | | Nine months ended | |
| | September 30,
2020 | | September 30,
2019 | | September 30,
2020 | | September 30,
2019 | |
| Fixed maturity investments | $ | 68,022 | | | $ | 82,977 | | | $ | 211,303 | | | $ | 232,566 | | |
| Short term investments | 1,611 | | | 15,061 | | | 19,752 | | | 44,712 | | |
| Equity investments | 1,559 | | | 1,326 | | | 4,776 | | | 3,269 | | |
| Other investments | | | | | | | | |
| Catastrophe bonds | 13,626 | | | 12,812 | | | 41,284 | | | 33,284 | | |
| Other | 2,598 | | | 2,672 | | | 5,334 | | | 6,226 | | |
| Cash and cash equivalents | 441 | | | 1,978 | | | 2,782 | | | 5,801 | | |
| | 87,857 | | | 116,826 | | | 285,231 | | | 325,858 | | |
| Investment expenses | (4,314) | | | (5,439) | | | (12,910) | | | (13,789) | | |
| Net investment income | $ | 83,543 | | | $ | 111,387 | | | $ | 272,321 | | | $ | 312,069 | | |
| | | | | | | | | |
Net Realized and Unrealized Gains on Investments
Net realized and unrealized gains on investments are as follows:
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
| | | | | | | | | |
| | Three months ended | | Nine months ended | |
| | September 30,
2020 | | September 30,
2019 | | September 30,
2020 | | September 30,
2019 | |
| | | | | | | | | |
| | | | | | | | | |
| Net realized gains on fixed maturity investments trading | $ | 55,665 | | | $ | 30,101 | | | $ | 219,001 | | | $ | 52,826 | | |
| Net unrealized gains on fixed maturity investments trading | 16,316 | | | 17,226 | | | 193,649 | | | 243,139 | | |
| Net realized and unrealized gains on fixed maturity investments trading | 71,981 | | | 47,327 | | | 412,650 | | | 295,965 | | |
| Net realized and unrealized gains on investments-related derivatives | 2,033 | | | 11,134 | | | 59,586 | | | 62,103 | | |
| Net realized gains (losses) on equity investments trading | 16,624 | | | (72) | | | 1,999 | | | 30,666 | | |
| Net unrealized gains (losses) on equity investments trading | 107,332 | | | (26,451) | | | 109,291 | | | 7,852 | | |
| Net realized and unrealized gains (losses) on equity investments trading | 123,956 | | | (26,523) | | | 111,290 | | | 38,518 | | |
| Net realized and unrealized gains (losses) on other investments - catastrophe bonds | 12,611 | | | 9,242 | | | 2,711 | | | (4,870) | | |
| Net realized and unrealized gains (losses) on other investments - other | 13,627 | | | (6,785) | | | (24,346) | | | 3,939 | | |
| Net realized and unrealized gains on investments | $ | 224,208 | | | $ | 34,395 | | | $ | 561,891 | | | $ | 395,655 | | |
| | | | | | | | | |
| | | | | | | | | |
| | | | | | | | | |
| | | | | | | | | |
|
| | | | | | | | | | | | | | | | | |
| | | | | | | | | | |
| | | Three months ended | | Nine months ended | |
| | | September 30,
2017 | | September 30,
2016 | | September 30,
2017 | | September 30,
2016 | |
| | Gross realized gains | $ | 16,343 |
| | $ | 20,383 |
| | $ | 43,053 |
| | $ | 60,794 |
| |
| | Gross realized losses | (6,126 | ) | | (3,363 | ) | | (29,902 | ) | | (25,832 | ) | |
| | Net realized gains on fixed maturity investments | 10,217 |
| | 17,020 |
| | 13,151 |
| | 34,962 |
| |
| | Net unrealized gains (losses) on fixed maturity investments trading | 5,545 |
| | (4,235 | ) | | 48,940 |
| | 125,501 |
| |
| | Net realized and unrealized (losses) gains on investments-related derivatives | (4,020 | ) | | 1,727 |
| | (4,344 | ) | | (26,873 | ) | |
| | Net realized gains on equity investments trading | 13,675 |
| | 127 |
| | 49,736 |
| | 14,038 |
| |
| | Net unrealized gains (losses) on equity investments trading | 16,635 |
| | 45,231 |
| | 36,055 |
| | 43,667 |
| |
| | Net realized and unrealized gains on investments | $ | 42,052 |
| | $ | 59,870 |
| | $ | 143,538 |
| | $ | 191,295 |
| |
| | | | | | | | | | |
NOTE 4.FAIR VALUE MEASUREMENTS
The use of fair value to measure certain assets and liabilities with resulting unrealized gains or losses is pervasive within the Company’s consolidated financial statements. Fair value is defined under accounting guidance currently applicable to the Company to be the price that would be received upon the sale of an asset or paid to transfer a liability in an orderly transaction between open market participants at the measurement date. The Company recognizes the change in unrealized gains and losses arising from changes in fair value in its consolidated statements of operations.
FASB ASC Topic Fair Value Measurements and Disclosures prescribes a fair value hierarchy that prioritizes the inputs to the respective valuation techniques used to measure fair value. The hierarchy gives the highest priority to unadjusted quoted prices in active markets for identical assets or liabilities (Level 1) and the lowest priority to valuation techniques that use at least one significant input that is unobservable (Level 3). The three levels of the fair value hierarchy are described below:
•Fair values determined by Level 1 inputs utilize unadjusted quoted prices obtained from active markets for identical assets or liabilities for which the Company has access. The fair value is determined by multiplying the quoted price by the quantity held by the Company;
•Fair values determined by Level 2 inputs utilize inputs other than quoted prices included in Level 1 that are observable for the asset or liability, either directly or indirectly. Level 2 inputs include quoted prices for similar assets and liabilities in active markets, and inputs other than quoted prices that are observable for the asset or liability, such as interest rates and yield curves that are observable at commonly quoted intervals, broker quotes and certain pricing indices; and
•Level 3 inputs are based all or in part on significant unobservable inputs for the asset or liability, and include situations where there is little, if any, market activity for the asset or liability. In these cases, significant management assumptions can be used to establish management’s best estimate of the assumptions used by other market participants in determining the fair value of the asset or liability.
In certain cases, the inputs used to measure fair value may fall into different levels of the fair value hierarchy. In such cases, the level in the fair value hierarchy within which the fair value measurement in its entirety falls has been determined based on the lowest level input that is significant to the fair value measurement of the asset or liability. The Company’s assessment of the significance of a particular input to the fair value measurement in its entirety requires judgment, and the Company considers factors specific to the asset or liability.
In order to determine if a market is active or inactive for a security, the Company considers a number of factors, including, but not limited to, the spread between what a seller is asking for a security and what a buyer is bidding for the same security, the volume of trading activity for the security in question, the price of the security compared to its par value (for fixed maturity investments), and other factors that may be indicative of market activity.
There have been no material changes in the Company’s valuation techniques, nor have there been any transfers between Level 1 and Level 2, or Level 2 and Level 3 during the period represented by these consolidated financial statements.
Below is a summary of the assets and liabilities that are measured at fair value on a recurring basis and also represents the carrying amount on the Company’s consolidated balance sheets:
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
| | | | | | | | | |
| At September 30, 2020 | Total | | Quoted
Prices in Active
Markets for
Identical
Assets
(Level 1) | | Significant
Other
Observable
Inputs
(Level 2) | | Significant
Unobservable
Inputs
(Level 3) | |
| Fixed maturity investments | | | | | | | | |
| U.S. treasuries | $ | 4,350,971 | | | $ | 4,350,971 | | | $ | 0 | | | $ | 0 | | |
| Agencies | 437,681 | | | 0 | | | 437,681 | | | 0 | | |
| | | | | | | | | |
| Non-U.S. government | 568,960 | | | 0 | | | 568,960 | | | 0 | | |
| | | | | | | | | |
| Non-U.S. government-backed corporate | 401,449 | | | 0 | | | 401,449 | | | 0 | | |
| Corporate | 4,655,765 | | | 0 | | | 4,655,765 | | | 0 | | |
| Agency mortgage-backed | 1,086,474 | | | 0 | | | 1,086,474 | | | 0 | | |
| Non-agency mortgage-backed | 293,953 | | | 0 | | | 293,953 | | | 0 | | |
| Commercial mortgage-backed | 788,995 | | | 0 | | | 788,995 | | | 0 | | |
| Asset-backed | 807,070 | | | 0 | | | 807,070 | | | 0 | | |
| Total fixed maturity investments | 13,391,318 | | | 4,350,971 | | | 9,040,347 | | | 0 | | |
| Short term investments | 5,158,961 | | | 0 | | | 5,158,961 | | | 0 | | |
| Equity investments trading | 547,381 | | | 547,381 | | | 0 | | | 0 | | |
| Other investments | | | | | | | | |
| Catastrophe bonds | 816,971 | | | 0 | | | 816,971 | | | 0 | | |
| Private equity investments (1) | 274,810 | | | 0 | | | 0 | | | 74,959 | | |
| Senior secured bank loan funds (1) | 20,933 | | | 0 | | | 0 | | | 0 | | |
| | | | | | | | | |
| Hedge funds (1) | 9,969 | | | 0 | | | 0 | | | 0 | | |
| | | | | | | | | |
| Total other investments | 1,122,683 | | | 0 | | | 816,971 | | | 74,959 | | |
| Other assets and (liabilities) | | | | | | | | |
| Assumed and ceded (re)insurance contracts (2) | (6,608) | | | 0 | | | 0 | | | (6,608) | | |
| Derivatives (3) | (1,473) | | | 1,232 | | | (2,705) | | | 0 | | |
| | | | | | | | | |
| Total other assets and (liabilities) | (8,081) | | | 1,232 | | | (2,705) | | | (6,608) | | |
| | $ | 20,212,262 | | | $ | 4,899,584 | | | $ | 15,013,574 | | | $ | 68,351 | | |
| | | | | | | | | |
(1) Certain investments that are measured at fair value using the net asset value per share (or its equivalent) practical expedient have not been classified in the fair value hierarchy. The fair value amounts presented in this table are intended to permit reconciliation of the fair value hierarchy to the amounts presented in the consolidated balance sheet.
(2) Included in assumed and ceded (re)insurance contracts at September 30, 2020 was $2.2 million of other assets and $8.8 million of other liabilities.
(3) See “Note 13. Derivative Instruments” for additional information related to the fair value, by type of contract, of derivatives entered into by the Company.
|
| | | | | | | | | | | | | | | | | |
| | | | | | | | | | |
| | At September 30, 2017 | Total | | Quoted Prices in Active Markets for Identical Assets (Level 1) | | Significant Other Observable Inputs (Level 2) | | Significant Unobservable Inputs (Level 3) | |
| | Fixed maturity investments | | | | | | | | |
| | U.S. treasuries | $ | 2,956,952 |
| | $ | 2,956,952 |
| | $ | — |
| | $ | — |
| |
| | Agencies | 41,109 |
| | — |
| | 41,109 |
| | — |
| |
| | Municipal | 521,220 |
| | — |
| | 521,220 |
| | — |
| |
| | Non-U.S. government (Sovereign debt) | 177,855 |
| | — |
| | 177,855 |
| | — |
| |
| | Non-U.S. government-backed corporate | 121,892 |
| | — |
| | 121,892 |
| | — |
| |
| | Corporate | 2,028,750 |
| | — |
| | 2,028,750 |
| | — |
| |
| | Agency mortgage-backed | 499,310 |
| | — |
| | 499,310 |
| | — |
| |
| | Non-agency mortgage-backed | 299,530 |
| | — |
| | 299,530 |
| | — |
| |
| | Commercial mortgage-backed | 263,029 |
| | — |
| | 263,029 |
| | — |
| |
| | Asset-backed | 183,322 |
| | — |
| | 183,322 |
| | — |
| |
| | Total fixed maturity investments | 7,092,969 |
| | 2,956,952 |
| | 4,136,017 |
| | — |
| |
| | Short term investments | 1,497,262 |
| | — |
| | 1,497,262 |
| | — |
| |
| | Equity investments trading | 402,035 |
| | 402,035 |
| | — |
| | — |
| |
| | Other investments | | | | | | | | |
| | Catastrophe bonds | 332,044 |
| | — |
| | 332,044 |
| | — |
| |
| | Private equity partnerships (1) | 196,280 |
| | — |
| | — |
| | — |
| |
| | Senior secured bank loan funds (1) | 19,572 |
| | — |
| | — |
| | — |
| |
| | Hedge funds (1) | 596 |
| | — |
| | — |
| | — |
| |
| | Total other investments | 548,492 |
| | — |
| | 332,044 |
| | — |
| |
| | Other assets and (liabilities) | | | | | | | | |
| | Assumed and ceded (re)insurance contracts (2) | (3,493 | ) | | — |
| | — |
| | (3,493 | ) | |
| | Derivatives (3) | 1,944 |
| | (114 | ) | | 2,058 |
| | — |
| |
| | Other | (8,777 | ) | | — |
| | (8,777 | ) | | — |
| |
| | Total other assets and (liabilities) | (10,326 | ) | | (114 | ) | | (6,719 | ) | | (3,493 | ) | |
| | | $ | 9,530,432 |
| | $ | 3,358,873 |
| | $ | 5,958,604 |
| | $ | (3,493 | ) | |
| | | | | | | | | | |
| |
(1) | Certain investments that are measured at fair value using the net asset value per share (or its equivalent) practical expedient have not been classified in the fair value hierarchy. The fair value amounts presented in this table are intended to permit reconciliation of the fair value hierarchy to the amounts presented in the consolidated balance sheet. |
| |
(2) | Included in assumed and ceded (re)insurance contracts at September 30, 2017 was $1.8 million and $5.3 million of other assets and other liabilities, respectively. |
| |
(3) | See “Note 13. Derivative Instruments” for additional information related to the fair value by type of contract, of derivatives entered into by the Company. |
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
| | | | | | | | | |
| At December 31, 2019 | Total | | Quoted
Prices in Active
Markets for
Identical
Assets
(Level 1) | | Significant
Other
Observable
Inputs
(Level 2) | | Significant
Unobservable
Inputs
(Level 3) | |
| Fixed maturity investments | | | | | | | | |
| U.S. treasuries | $ | 4,467,345 | | | $ | 4,467,345 | | | $ | 0 | | | $ | 0 | | |
| Agencies | 343,031 | | | 0 | | | 343,031 | | | 0 | | |
| | | | | | | | | |
| Non-U.S. government | 497,392 | | | 0 | | | 497,392 | | | 0 | | |
| | | | | | | | | |
| Non-U.S. government-backed corporate | 321,356 | | | 0 | | | 321,356 | | | 0 | | |
| Corporate | 3,075,660 | | | 0 | | | 3,075,660 | | | 0 | | |
| Agency mortgage-backed | 1,148,499 | | | 0 | | | 1,148,499 | | | 0 | | |
| Non-agency mortgage-backed | 294,604 | | | 0 | | | 294,604 | | | 0 | | |
| Commercial mortgage-backed | 468,698 | | | 0 | | | 468,698 | | | 0 | | |
| Asset-backed | 555,070 | | | 0 | | | 555,070 | | | 0 | | |
| Total fixed maturity investments | 11,171,655 | | | 4,467,345 | | | 6,704,310 | | | 0 | | |
| Short term investments | 4,566,277 | | | 0 | | | 4,566,277 | | | 0 | | |
| Equity investments trading | 436,931 | | | 436,931 | | | 0 | | | 0 | | |
| Other investments | | | | | | | | |
| Catastrophe bonds | 781,641 | | | 0 | | | 781,641 | | | 0 | | |
| Private equity investments (1) | 271,047 | | | 0 | | | 0 | | | 74,634 | | |
| Senior secured bank loan funds (1) | 22,598 | | | 0 | | | 0 | | | 0 | | |
| | | | | | | | | |
| Hedge funds (1) | 12,091 | | | 0 | | | 0 | | | 0 | | |
| | | | | | | | | |
| Total other investments | 1,087,377 | | | 0 | | | 781,641 | | | 74,634 | | |
| Other assets and (liabilities) | | | | | | | | |
| Assumed and ceded (re)insurance contracts (2) | 4,731 | | | 0 | | | 0 | | | 4,731 | | |
| Derivatives (3) | 16,937 | | | (1,020) | | | 17,957 | | | 0 | | |
| | | | | | | | | |
| Total other assets and (liabilities) | 21,668 | | | (1,020) | | | 17,957 | | | 4,731 | | |
| | $ | 17,283,908 | | | $ | 4,903,256 | | | $ | 12,070,185 | | | $ | 79,365 | | |
| | | | | | | | | |
(1) Certain investments that are measured at fair value using the net asset value per share (or its equivalent) practical expedient have not been classified in the fair value hierarchy. The fair value amounts presented in this table are intended to permit reconciliation of the fair value hierarchy to the amounts presented in the consolidated balance sheet.
(2) Included in assumed and ceded (re)insurance contracts at December 31, 2019 was $32.9 million of other assets and $28.2 million of other liabilities.
(3) See “Note 13. Derivative Instruments” for additional information related to the fair value, by type of contract, of derivatives entered into by the Company.
|
| | | | | | | | | | | | | | | | | |
| | | | | | | | | | |
| | At December 31, 2016 | Total | | Quoted Prices in Active Markets for Identical Assets (Level 1) | | Significant Other Observable Inputs (Level 2) | | Significant Unobservable Inputs (Level 3) | |
| | Fixed maturity investments | | | | | | | | |
| | U.S. treasuries | $ | 2,617,894 |
| | $ | 2,617,894 |
| | $ | — |
| | $ | — |
| |
| | Agencies | 90,972 |
| | — |
| | 90,972 |
| | — |
| |
| | Municipal | 519,069 |
| | — |
| | 519,069 |
| | — |
| |
| | Non-U.S. government (Sovereign debt) | 333,224 |
| | — |
| | 333,224 |
| | — |
| |
| | Non-U.S. government-backed corporate | 133,300 |
| | — |
| | 133,300 |
| | — |
| |
| | Corporate | 1,877,243 |
| | — |
| | 1,877,243 |
| | — |
| |
| | Agency mortgage-backed | 462,493 |
| | — |
| | 462,493 |
| | — |
| |
| | Non-agency mortgage-backed | 258,944 |
| | — |
| | 258,944 |
| | — |
| |
| | Commercial mortgage-backed | 409,747 |
| | — |
| | 409,747 |
| | — |
| |
| | Asset-backed | 188,358 |
| | — |
| | 188,358 |
| | — |
| |
| | Total fixed maturity investments | 6,891,244 |
| | 2,617,894 |
| | 4,273,350 |
| | — |
| |
| | Short term investments | 1,368,379 |
| | — |
| | 1,368,379 |
| | — |
| |
| | Equity investments trading | 383,313 |
| | 383,313 |
| | — |
| | — |
| |
| | Other investments | | | | | | | | |
| | Catastrophe bonds | 335,209 |
| | — |
| | 335,209 |
| | — |
| |
| | Private equity partnerships (1) | 191,061 |
| | — |
| | — |
| | — |
| |
| | Senior secured bank loan funds (1) | 22,040 |
| | — |
| | — |
| | — |
| |
| | Hedge funds (1) | 1,495 |
| | — |
| | — |
| | — |
| |
| | Total other investments | 549,805 |
| | — |
| | 335,209 |
| | — |
| |
| | Other assets and (liabilities) | | | | | | | | |
| | Assumed and ceded (re)insurance contracts (2) | (13,004 | ) | | — |
| | — |
| | (13,004 | ) | |
| | Derivatives (3) | (8,922 | ) | | (646 | ) | | (8,276 | ) | | — |
| |
| | Other | (13,105 | ) | | — |
| | (13,105 | ) | | — |
| |
| | Total other assets and (liabilities) | (35,031 | ) | | (646 | ) | | (21,381 | ) | | (13,004 | ) | |
| | | $ | 9,157,710 |
| | $ | 3,000,561 |
| | $ | 5,955,557 |
| | $ | (13,004 | ) | |
| | | | | | | | | | |
| |
(1) | Certain investments that are measured at fair value using the net asset value per share (or its equivalent) practical expedient have not been classified in the fair value hierarchy. The fair value amounts presented in this table are intended to permit reconciliation of the fair value hierarchy to the amounts presented in the consolidated balance sheet. |
| |
(2) | Included in assumed and ceded (re)insurance contracts at December 31, 2016 was $4.4 million and $17.4 million of other assets and other liabilities, respectively. |
| |
(3) | See “Note 13. Derivative Instruments” for additional information related to the fair value by type of contract, of derivatives entered into by the Company. |
Level 1 and Level 2 Assets and Liabilities Measured at Fair Value
Fixed Maturity Investments
Fixed maturity investments included in Level 1 consist of the Company’s investments in U.S. treasuries. Fixed maturity investments included in Level 2 are agencies, municipal, non-U.S. government, non-U.S. government-backed corporate, corporate, agency mortgage-backed, non-agency mortgage-backed, commercial mortgage-backed and asset-backed.
The Company’s fixed maturity investments are primarily priced using pricing services, such as index providers and pricing vendors, as well as broker quotations. In general, the pricing vendors provide pricing for a high volume of liquid securities that are actively traded. For securities that do not trade on an
exchange, the pricing services generally utilize market data and other observable inputs in matrix pricing models to determine month end prices. Observable inputs include benchmark yields, reported trades,
broker-dealer quotes, issuer spreads, bids, offers, reference data and industry and economic events. Index pricing generally relies on market traders as the primary source for pricing; however, models are also utilized to provide prices for all index eligible securities. The models use a variety of observable inputs such as benchmark yields, transactional data, dealer runs, broker-dealer quotes and corporate actions. Prices are generally verified using third-party data. Securities which are priced by an index provider are generally included in the index.
In general, broker-dealers value securities through their trading desks based on observable inputs. The methodologies include mapping securities based on trade data, bids or offers, observed spreads, and performance on newly issued securities. Broker-dealers also determine valuations by observing secondary trading of similar securities. Prices obtained from broker quotations are considered non-binding, however they are based on observable inputs and by observing secondary trading of similar securities obtained from active, non-distressed markets.
The Company considers these broker quotations to be Level 2 inputs as they are corroborated with other market observable inputs. The techniques generally used to determine the fair value of the Company’s fixed maturity investments are detailed below by asset class.
U.S. treasuriesTreasuries
Level 1 - At September 30, 2017,2020, the Company’s U.S. treasuries fixed maturity investments were primarily priced by pricing services and had a weighted average effective yield to maturity of 1.6%0.3% and a weighted average credit quality of AA (December(December 31, 20162019 - 1.4%1.7% and AA, respectively). When pricing these securities, the pricing services utilize daily data from many real time market sources, including active broker dealers.broker-dealers. Certain data sources are regularly reviewed for accuracy to attempt to ensure the most reliable price source is used for each issue and maturity date.
Agencies
Level 2 - At September 30, 2017,2020, the Company’s agency fixed maturity investments had a weighted average effective yield to maturity of 1.6%0.8% and a weighted average credit quality of AA (December(December 31, 20162019 - 2.0%2.1% and AA, respectively). The issuers of the Company’s agency fixed maturity investments primarily consist of the Federal National Mortgage Association, the Federal Home Loan Mortgage Corporation and other agencies. Fixed maturity investments included in agencies are primarily priced by pricing services. When evaluating these securities, the pricing services gather information from market sources and integrate other observations from markets and sector news. Evaluations are updated by obtaining broker dealerbroker-dealer quotes and other market information including actual trade volumes, when available. The fair value of each security is individually computed using analytical models which incorporate option adjusted spreads and other daily interest rate data.
Municipal
Level 2 - At September 30, 2017, the Company’s municipal fixed maturity investments had a weighted average effective yield of 1.9% and a weighted average credit quality of AA (December 31, 2016 - 2.4% and AA, respectively). The Company’s municipal fixed maturity investments are primarily priced by pricing services. When evaluating these securities, the pricing services gather information regarding the security from third-party sources such as trustees, paying agents or issuers. Evaluations are updated by obtaining broker dealer quotes and other market information including actual trade volumes, when available. The pricing services also consider the specific terms and conditions of the securities, including any specific features which may influence risk. In certain instances, securities are individually evaluated using a spread over widely accepted market benchmarks.
Non-U.S. government (Sovereign debt)Government
Level 2 - At September 30, 2017,2020, the Company’s non-U.S. government fixed maturity investments had a weighted average effective yield to maturity of 1.7%0.7% and a weighted average credit quality of AAA (December 31, 20162019 - 1.6% and AAA,AA, respectively). The issuers of securities in this sector are non-U.S. governments and their respective agencies as well as supranational organizations. Securities held in these sectors are primarily
priced by pricing services that employ proprietary discounted cash flow models to value the securities. Key quantitative inputs for these models are daily observed benchmark curves for treasury, swap and high issuance credits. The pricing services then apply a credit spread for each security which is developed by in-depth and real time market analysis. For securities in which trade volume is low, the pricing services utilize data from more frequently traded securities with similar attributes. These models may also be supplemented by daily market and credit research for international markets.
Non-U.S. government-backed corporateGovernment-backed Corporate
Level 2 - At September 30, 2017,2020, the Company’s non-U.S. government-backed corporate fixed maturity investments had a weighted average effective yield to maturity of 1.9%0.9% and a weighted average credit quality of AA (December(December 31, 20162019 - 1.5%2.0% and AAA,AA, respectively). Non-U.S. government-backed corporate fixed maturity investments are primarily priced by pricing services that employ proprietary discounted cash flow models to value the securities. Key quantitative inputs for these models are daily observed benchmark curves for
treasury, swap and high issuancequality credits. The pricing services then apply a credit spread to the respective curve for each security which is developed by in-depth and real time market analysis. For securities in which trade volume is low, the pricing services utilize data from more frequently traded securities with similar attributes. These models may also be supplemented by daily market and credit research for international markets.
Corporate
Level 2 - At September 30, 2017,2020, the Company’s corporate fixed maturity investments principally consisted of U.S. and international corporations and had a weighted average effective yield to maturity of 3.5%2.4% and a weighted average credit quality of BBB (December(December 31, 20162019 - 3.7%3.0% and BBB, respectively). The Company’s corporate fixed maturity investments are primarily priced by pricing services. When evaluating these securities, the pricing services gather information from market sources regarding the issuer of the security and obtain credit data, as well as other observations, from markets and sector news. Evaluations are updated by obtaining broker dealerbroker-dealer quotes and other market information including actual trade volumes, when available. The pricing services also consider the specific terms and conditions of the securities, including any specific features which may influence risk. In certain instances, securities are individually evaluated using a spread which is added to the U.S. treasury curve or a security specific swap curve as appropriate.
Agency mortgage-backedMortgage-backed
Level 2 - At September 30, 2017,2020, the Company’s agency mortgage-backed fixed maturity investments included agency residential mortgage-backed securities with a weighted average effective yield to maturity of 2.9%1.0%, a weighted average credit quality of AA and a weighted average life of 6.33.7 years (December(December 31, 20162019 - 2.9%2.5%, AA and 6.94.9 years, respectively). The Company’s agency mortgage-backed fixed maturity investments are primarily priced by pricing services using a mortgage pool specific model which utilizes daily inputs from the active to be announcedto-be-announced market which is very liquid, as well as the U.S. treasury market. The model also utilizes additional information, such as the weighted average maturity, weighted average coupon and other available pool level data which is provided by the sponsoring agency. Valuations are also corroborated with daily active market quotes.
Non-agency mortgage-backedMortgage-backed
Level 2 - The Company’s non-agency mortgage-backed fixed maturity investments include non-agency prime, non-agency Alt-A and other non-agency residential mortgage-backed and non-agency Alt-A fixed maturity investments. The Company has no fixed maturity investments that were classified as sub-prime at the time of purchase held in its fixed maturity investments portfolio.securities. At September 30, 2017,2020, the Company’s non-agency prime residential mortgage-backed fixed maturity investments had a weighted average effective yield to maturity of 3.8%2.3%, a weighted average credit quality of BBB and a weighted average life of 4.1 years (December 31, 2019 - 3.3%, BBB and 4.8 years, respectively). The Company’s non-agency Alt-A residential mortgage-backed fixed maturity investments held at September 30, 2020 had a weighted average yield to maturity of 3.5%, a weighted average credit quality of non-investment grade and a weighted average life of 5.05.7 years (December(December 31, 20162019 - 4.3%, BBB and 5.1 years, respectively). The Company’s non-agency Alt-A fixed maturity investments held at September 30, 2017 had a weighted average effective yield of 3.7%, a weighted average credit quality of non-investment grade and a weighted average life of 6.2 years (December 31, 2016 - 5.2%3.8%, non-investment grade and 6.06.3 years, respectively). Securities held in these sectors are primarily priced by pricing services using an option adjusted spread model or other relevant models, which principally utilize inputs including
benchmark yields, available trade information or broker quotes, and issuer spreads. The pricing services also review collateral prepayment speeds, loss severity and delinquencies among other collateral performance indicators for the securities valuation, when applicable.
Commercial mortgage-backedMortgage-backed
Level 2 - At September 30, 2017,2020, the Company’s commercial mortgage-backed fixed maturity investments had a weighted average effective yield to maturity of 3.1%1.6%, a weighted average credit quality of AAA, and a weighted average life of 4.55.2 years (December(December 31, 20162019 - 2.6%, AAA and 3.95.7 years, respectively). Securities held in these sectors are primarily priced by pricing services. The pricing services apply dealer quotes and other available trade information such as bids and offers, prepayment speeds which may be adjusted for the underlying collateral or current price data, the U.S. treasury curve and swap curve as well as cash settlement. The pricing services discount the expected cash flows for each security held in this sector using a spread adjusted benchmark yield based on the characteristics of the security.
Asset-backed
Level 2 - At September 30, 2017,2020, the Company’s asset-backed fixed maturity investments had a weighted average effective yield to maturity of 2.4%2.0%, a weighted average credit quality of AAA and a weighted average life of 2.83.5 years (December(December 31, 20162019 - 2.3%3.3%, AAA and 2.63.2 years, respectively). The underlying collateral for the Company’s asset-backed fixed maturity investments primarily consists of bank loans, student loans, credit card receivables, auto loans and other receivables. Securities held in these sectors are primarily priced by pricing services. The pricing services apply dealer quotes and other available trade information such as bids and offers, prepayment speeds which may be adjusted for the underlying collateral or current price data, the U.S. treasury curve and swap curve as well as cash settlement. The pricing services determine the expected cash flows for each security held in this sector using historical prepayment and default projections for the underlying collateral and current market data. In addition, a spread is applied to the relevant benchmark and used to discount the cash flows noted above to determine the fair value of the securities held in this sector.
Short Term Investments
Level 2 - At September 30, 2017,2020, the Company’s short term investments had a weighted average effective yield to maturity of 1.1%0.1% and a weighted average credit quality of AAA (December(December 31, 20162019 - 0.7%1.6% and AAA, respectively). The fair value of the Company’s portfolio of short term investments is generally determined using amortized cost which approximates fair value and, in certain cases, in a manner similar to the Company’s fixed maturity investments noted above.
Equity Investments, Classified as Trading
Level 1 - The fair value of the Company’s portfolio of equity investments, classified as trading is primarily priced by pricing services, reflecting the closing price quoted for the final trading day of the period. When pricing these securities, the pricing services utilize daily data from many real time market sources, including applicable securities exchanges. All data sources are regularly reviewed for accuracy to attempt to ensure the most reliable price source was used for each security.
Other investmentsInvestments
Catastrophe bondsBonds
Level 2 - The Company’s other investments include investments in catastrophe bonds which are recorded at fair value based on broker or underwriter bid indications.
Other assetsAssets and liabilitiesLiabilities
Derivatives
Level 1 and Level 2 - Other assets and liabilities include certain derivatives entered into by the Company. The fair value of these transactions includes certain exchange traded futures contracts which are considered Level 1, and foreign currency contracts and certain credit derivatives, determined using
standard industry valuation models and considered Level 2, as the inputs to the valuation model are based on observable market inputs. For credit derivatives, these inputs include credit spreads, credit ratings of the underlying referenced security, the risk free rate and the contract term. For foreign currency contracts, these inputs include spot rates and interest rate curves.
Other
Level 2 - The liabilities measured at fair value and included in Level 2 at September 30, 2017 of $8.8 million are comprised of cash settled restricted stock units (“CSRSU”) that form part of the Company’s compensation program. The fair value of the Company’s CSRSUs is determined using observable exchange traded prices for the Company’s common shares.
Level 3 Assets and Liabilities Measured at Fair Value
Below is a summary of quantitative information regarding the significant observable and unobservable inputs (Level 3) used in determining the fair value of assets and liabilities measured at fair value on a recurring basis:
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
| | | | | | | | | | | | | |
| At September 30, 2020 | Fair Value
(Level 3) | | Valuation Technique | | Unobservable
Inputs | | Low | | High | | Weighted Average or Actual | |
| Other investments | | | | | | | | | | | | |
| Private equity investment | $ | 74,959 | | | Internal valuation model | | Discount rate | | n/a | | n/a | | 8.0% | |
| | | | | | | | | | | | | |
| | | | | | Liquidity discount | | n/a | | n/a | | 15.0 | % | |
| Total other investments | 74,959 | | | | | | | | | | | | |
| Other assets and (liabilities) | | | | | | | | | | | | |
| Assumed and ceded (re)insurance contracts | (934) | | | Internal valuation model | | Bond price | | n/a | | n/a | | $ | 92.24 | | |
| | | | | | Liquidity discount | | n/a | | n/a | | 1.3 | % | |
| Assumed and ceded (re)insurance contracts | (7,842) | | | Internal valuation model | | Net undiscounted cash flows | | n/a | | n/a | | $ | 12,133 | |
| | | | | | Expected loss ratio | | n/a | | n/a | | 26.2 | % | |
| | | | | | | | | | | | | |
| | | | | | | | | | | | | |
| | | | | | Discount rate | | n/a | | n/a | | 0.3 | % | |
| Assumed and ceded (re)insurance contracts | 2,168 | | | Internal valuation model | | Expected loss ratio | | n/a | | n/a | | 0.0 | % | |
| | | | | | | | | | | | | |
| | | | | | | | | | | | | |
| Total other assets and (liabilities) | (6,608) | | | | | | | | | | | | |
| Total assets and (liabilities) measured at fair value on a recurring basis using Level 3 inputs | $ | 68,351 | | | | | | | | | | | | |
| | | | | | | | | | | | | |
|
| | | | | | | | | | | | | | | | | | | | | |
| | | | | | | | | | | | | | |
| | At September 30, 2017 | Fair Value (Level 3) | | Valuation Technique | | Unobservable (U) and Observable (O) Inputs | | Low | | High | | Weighted Average or Actual | |
| | Other assets and (liabilities) | | | | | | | | | | | | |
| | Assumed and ceded (re)insurance contracts | $ | 582 |
| | Internal valuation model | | Bond price (U) | | $ | 101.28 |
| | $ | 109.27 |
| | $ | 105.64 |
| |
| | | | | | | Liquidity discount (U) | | n/a |
| | n/a |
| | 1.3 | % | |
| | Assumed and ceded (re)insurance contracts | (4,075 | ) | | Internal valuation model | | Net undiscounted cash flows (U) | | n/a |
| | n/a |
| | $ | (4,733 | ) | |
| | | | | | | Expected loss ratio (U) | | n/a |
| | n/a |
| | 24.3 | % | |
| | | | | | | Net acquisition expense ratio (O) | | n/a |
| | n/a |
| | 13.4 | % | |
| | | | | | | Contract period (O) | | 2.0 years |
| | 4.7 years |
| | 4.1 years |
| |
| | | | | | | Discount rate (U) | | n/a |
| | n/a |
| | 1.9 | % | |
| | Total other assets and (liabilities) | $ | (3,493 | ) | | | | | | | | | | | |
| | | | | | | | | | | | | | |
Fixed Maturity | | | | | | | | | | | | | | | | | | | | | | | | | |
| | | | | | | | | |
| | | | Other
investments | | Other assets
and
(liabilities) | | Total | |
| Balance - July 1, 2020 | | | $ | 71,450 | | | $ | (6,711) | | | $ | 64,739 | | |
| Total realized and unrealized losses | | | | | | | | |
| Included in net realized and unrealized gains on investments | | | 4,044 | | | 0 | | | 4,044 | | |
| Included in other income (loss) | | | 0 | | | 575 | | | 575 | | |
| Total foreign exchange losses | | | 13 | | | 0 | | | 13 | | |
| Purchases | | | 0 | | | (472) | | | (472) | | |
| Sales | | | (548) | | | 0 | | | (548) | | |
| | | | | | | | | |
| | | | | | | | | |
| | | | | | | | | |
| | | | | | | | | |
| Balance - September 30, 2020 | | | $ | 74,959 | | | $ | (6,608) | | | $ | 68,351 | | |
| | | | | | | | | |
| | | | | | | | | |
| | | | | | | | | |
| | | | | | | | | |
| | | | | | | | | |
| | | | Other
investments | | Other assets
and
(liabilities) | | Total | |
| Balance - January 1, 2020 | | | $ | 74,634 | | | $ | 4,731 | | | $ | 79,365 | | |
| Total realized and unrealized losses | | | | | | | | |
| Included in net realized and unrealized gains on investments | | | (10,492) | | | 0 | | | (10,492) | | |
| Included in other income (loss) | | | 0 | | | (4,035) | | | (4,035) | | |
| Total foreign exchange losses | | | (8) | | | 0 | | | (8) | | |
| Purchases | | | 20,962 | | | (1,565) | | | 19,397 | | |
| Sales | | | (10,137) | | | 0 | | | (10,137) | | |
| Settlements | | | 0 | | | (5,739) | | | (5,739) | | |
| | | | | | | | | |
| | | | | | | | | |
| | | | | | | | | |
| Balance - September 30, 2020 | | | $ | 74,959 | | | $ | (6,608) | | | $ | 68,351 | | |
| | | | | | | | | |
| | | | | | | | | |
| | | | | | | | | |
| | | | | | | | | | | | | | | | | | | | | | | | | |
| | | | | | | | | |
| | | | Other
investments | | Other assets and (liabilities) | | Total | |
| Balance - July 1, 2019 | | | $ | 74,810 | | | $ | 7,942 | | | $ | 82,752 | | |
| Total realized and unrealized losses | | | | | | | | |
| Included in net realized and unrealized gains on investments | | | (592) | | | 0 | | | (592) | | |
| Included in other income (loss) | | | 0 | | | (1,188) | | | (1,188) | | |
| Total foreign exchange losses | | | (8) | | | 0 | | | (8) | | |
| Purchases | | | 0 | | | (535) | | | (535) | | |
| | | | | | | | | |
| | | | | | | | | |
| | | | | | | | | |
| | | | | | | | | |
| Balance - September 30, 2019 | | | $ | 74,210 | | | $ | 6,219 | | | $ | 80,429 | | |
| | | | | | | | | |
| | | | | | | | | |
| | | | | | | | | |
| | | | | | | | | |
| | | | | | | | | |
| | | | Other
investments | | Other assets and (liabilities) | | Total | |
| Balance - January 1, 2019 | | | $ | 54,545 | | | $ | (8,359) | | | $ | 46,186 | | |
| Total realized and unrealized gains (losses) | | | | | | | | |
| Included in net realized and unrealized gains on investments | | | 1,790 | | | | | 1,790 | | |
| Included in other income (loss) | | | | | (1,030) | | | (1,030) | | |
| Total foreign exchange losses | | | (16) | | | 0 | | | (16) | | |
| Purchases | | | 17,891 | | | (4,382) | | | 13,509 | | |
| | | | | | | | | |
| Settlements | | | 0 | | | 20 | | | 20 | | |
| Amounts acquired (1) | | | 0 | | | 19,970 | | | 19,970 | | |
| | | | | | | | | |
| Balance - September 30, 2019 | | | $ | 74,210 | | | $ | 6,219 | | | $ | 80,429 | | |
| | | | | | | | | |
| | | | | | | | | |
| | | | | | | | | |
(1) Represents the fair value of the other assets acquired from TMR, measured at fair value on a recurring basis using Level 3 inputs at March 22, 2019. See “Note 3. Acquisition of Tokio Millennium Re” in the Company’s “Notes to the Consolidated Financial Statements” included in the Company’s Form 10-K for the year ended December 31, 2019 for additional information related to the acquisition of TMR.
Other Investments
CorporatePrivate Equity Investments
Level 3 - Previously,At September 30, 2020, the Company’s corporate fixed maturityother investments included an investment in$75.0 million of private equity investments which are recorded at fair value, with the preferred equityfair value obtained through the use of an insurance holding company.internal valuation models. The Company measured the fair value of this investmentthese investments using multiples of net tangible book value of the underlying entity. The significant unobservable inputs used in the fair value measurement of these investments are liquidity discount rates applied to each of the net tangible book value multiples used in the internal valuation models, and discount rates applied to the expected cash flows of the underlying entity in various scenarios. These unobservable inputs in isolation can cause significant increases or decreases in fair value. Generally, an increase in the liquidity discount rate or discount rates would result in a discounted cash flow model and ultimately sold this investment duringdecrease in the year ended December 31, 2016.fair value of these private equity investments.
Other assetsAssets and liabilitiesLiabilities
Assumed and ceded (re)Ceded (Re)insurance contractsContracts
Level 3 - At September 30, 2017,2020, the Company had a $0.6$0.9 million net assetliability related to an assumed reinsurance contract accounted for at fair value, with the fair value obtained through the use of an internal valuation model. The inputs to the internal valuation model are principally based on indicative pricing obtained from independent brokers and pricing vendors for similarly structured marketable securities. The most significant unobservable inputs include prices for similar marketable securities and a liquidity premium. The Company considers the prices for similar securities to be unobservable, as there is little, if any market activity for these similar assets. In addition, the Company has estimated a liquidity premium that would be required if the Company attempted to effectively exit its position by executing a short sale of these securities. Generally, an increase in the prices for similar marketable securities or a decrease in the liquidity
premium would result in an increase in the expected profit and ultimate fair value of this assumed reinsurance contract.
Level 3 - At September 30, 2017,2020, the Company had a $4.1$7.8 million net liability related to assumed and ceded (re)insurance contracts accounted for at fair value, with the fair value obtained through the use of an internal valuation model. The inputs to the internal valuation model are principally based on proprietary data as observable market inputs are generally not available. The most significant unobservable inputs include the assumed and ceded expected net cash flows related to the contracts, including the expected premium, acquisition expenses and losses; the expected loss ratio and the relevant discount rate used to present value the net cash flows. The contract period and acquisition expense ratio are considered an observable input as each is defined in the contract. The negative acquisition expense ratio used to determine the fair value of the contracts at September 30, 2017 is the result of override commissions on the contracts being higher than the gross acquisition expenses. Generally, an increase in the net expected cash flows and expected term of the contract and a decrease in the discount rate, expected loss ratio or acquisition expense ratio, would result in an increase in the expected profit and ultimate fair value of these assumed and ceded (re)insurance contracts.
Below isLevel 3 - At September 30, 2020, the Company had a reconciliation of the beginning$2.2 million net asset related to assumed and ending balances,ceded (re)insurance contracts accounted for the periods shown, of assets and liabilities measured at fair value, with the fair value obtained through the use of internal valuation models. The inputs to the models are primarily based on the unexpired period of risk and an evaluation of the probability of loss. The fair value of the contracts are sensitive to loss-triggering events. In the event of a recurring basis using Level 3 inputs. Interestloss, the Company would adjust the fair value of the contract to account for a recovery or liability in accordance with the contract terms and dividend incomethe estimate of exposure under the contract. The inputs for the contracts are included in net investment incomebased on management’s evaluation and are excluded from the reconciliation. |
| | | | | |
| | | | |
| | | Other assets and (liabilities) | |
| | Balance - July 1, 2017 | $ | (9,502 | ) | |
| | Total realized and unrealized gains | | |
| | Included in other income | 135 |
| |
| | Purchases | (63 | ) | |
| | Settlements | 5,937 |
| |
| | Balance - September 30, 2017 | $ | (3,493 | ) | |
| | | | |
| | | | |
| | | | |
| | | Other assets and (liabilities) | |
| | Balance - January 1, 2017 | $ | (13,004 | ) | |
| | Total realized and unrealized gains | | |
| | Included in other income | 3,525 |
| |
| | Purchases | 49 |
| |
| | Settlements | 5,937 |
| |
| | Balance - September 30, 2017 | $ | (3,493 | ) | |
| | | | |
|
| | | | | | | | | | | | | |
| | | | | | | | |
| | | Fair Value Measurements Using Significant Unobservable Inputs (Level 3) | |
| | | Fixed maturity investments trading | | Other assets and (liabilities) | | Total | |
| | Balance - July 1, 2016 | $ | — |
| | $ | (2,680 | ) | | $ | (2,680 | ) | |
| | Total realized and unrealized gains | | | | | | |
| | Included in other income | — |
| | 795 |
| | 795 |
| |
| | Purchases | — |
| | (10,127 | ) | | (10,127 | ) | |
| | Balance - September 30, 2016 | $ | — |
| | $ | (12,012 | ) | | $ | (12,012 | ) | |
| | | | | | | | |
| | | | | | | | |
| | | | | | | | |
| | | Fair Value Measurements Using Significant Unobservable Inputs (Level 3) | |
| | | Fixed maturity investments trading | | Other assets and (liabilities) | | Total | |
| | Balance - January 1, 2016 | $ | 7,618 |
| | $ | (5,899 | ) | | $ | 1,719 |
| |
| | Total realized and unrealized (losses) gains | | | | | | |
| | Included in net investment income | (118 | ) | | — |
| | (118 | ) | |
| | Included in other income | — |
| | 4,587 |
| | 4,587 |
| |
| | Purchases | — |
| | (10,700 | ) | | (10,700 | ) | |
| | Settlements | (7,500 | ) | | — |
| | (7,500 | ) | |
| | Balance - September 30, 2016 | $ | — |
| | $ | (12,012 | ) | | $ | (12,012 | ) | |
| | | | | | | | |
unobservable.
Financial Instruments Disclosed, But Not Carried, at Fair Value
The Company uses various financial instruments in the normal course of its business. The Company’s insurance contracts are excluded from the fair value of financial instruments accounting guidance, unless the Company elects the fair value option, and therefore, are not included in the amounts discussed herein. The carrying values of cash and cash equivalents, accrued investment income, receivables for investments sold, certain other assets, payables for investments purchased, certain other liabilities, and other financial instruments not included herein approximated their fair values.
Debt
Included on the Company’s consolidated balance sheet at September 30, 20172020 were debt obligations of $989.2 million (December$1.1 billion (December 31, 20162019 - $948.7 million)$1.4 billion). At September 30, 2017,2020, the fair value of the Company’s debt obligations was $1,034.2 million (December$1.3 billion (December 31, 20162019 – $964.8 million)$1.5 billion).
The fair value of the Company’s debt obligations is determined using indicative market pricing obtained from third-party service providers, which the Company considers Level 2 in the fair value hierarchy. There have been no changes during the period in the Company’s valuation technique used to determine the fair value of the Company’s debt obligations. Refer to “Note 7. Debt and Credit Facilities” for additional information related to the Company’s debt obligations.
The Fair Value Option for Financial Assets and Financial Liabilities
The Company has elected to account for certain financial assets and financial liabilities at fair value using the guidance under FASB ASC Topic Financial Instruments as the Company believes it represents the most meaningful measurement basis for these assets and liabilities. Below is a summary of the balances the Company has elected to account for at fair value: |
| | | | | | | | | |
| | | | | | |
| | | September 30,
2017 | | December 31,
2016 | |
| | Other investments | $ | 548,492 |
| | $ | 549,805 |
| |
| | Other assets | $ | 2,383 |
| | $ | 4,379 |
| |
| | Other liabilities | $ | 5,876 |
| | $ | 17,383 |
| |
| | | | | | |
| | | | | | | | | | | | | | | | | |
| | | | | |
| | September 30,
2020 | | December 31,
2019 | |
| Other investments | $ | 1,122,683 | | | $ | 1,087,377 | | |
| Other assets | $ | 11,508 | | | $ | 32,944 | | |
| Other liabilities | $ | 18,116 | | | $ | 28,213 | | |
| | | | | |
Included in net investment incomerealized and unrealized gains on investments for the three and nine months endedSeptember 30, 20172020 were net unrealized gains of $26.4 million and losses of $9.8$18.1 million, and gains of $2.7 million respectively,
related to the changes in fair value of other investments (2016(2019 – net unrealized gains of $9.4$5.1 million and $6.1 million)$7.3 million, respectively). Included in other (loss) income for the three and nine months ended September 30, 20172020 were net unrealized gains of $Nil$NaN and $Nil$NaN related to the changes in the fair value of other assets and liabilities (2016(2019 - $Nil$NaN and $Nil)$NaN, respectively).
Measuring the Fair Value of Other Investments Using Net Asset Valuations
The table below shows the Company’s portfolio of other investments measured using net asset valuations as a practical expedient: |
| | | | | | | | | | | | | | | |
| | | | | | | | | | | | |
| | At September 30, 2017 | Fair Value | | Unfunded
Commitments | | Redemption Frequency | | Redemption
Notice Period (Minimum Days) | | Redemption
Notice Period (Maximum Days) | |
| | Private equity partnerships | $ | 196,280 |
| | $ | 300,482 |
| | See below | | See below | | See below | |
| | Senior secured bank loan funds | 19,572 |
| | 23,758 |
| | See below | | See below | | See below | |
| | Hedge funds | 596 |
| | — |
| | See below | | See below | | See below | |
| | Total other investments measured using net asset valuations | $ | 216,448 |
| | $ | 324,240 |
| | | | | | | |
| | | | | | | | | | | | |
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
| | | | | | | | | | | |
| At September 30, 2020 | Fair Value | | Unfunded
Commitments | | Redemption Frequency | | Redemption
Notice Period (Minimum Days) | | Redemption
Notice Period (Maximum Days) | |
| Private equity investments | $ | 199,851 | | | $ | 686,588 | | | See below | | See below | | See below | |
| Senior secured bank loan funds | 20,933 | | | 8,185 | | | See below | | See below | | See below | |
| Hedge funds | 9,969 | | | 0 | | | See below | | See below | | See below | |
| | | | | | | | | | | |
| Total other investments measured using net asset valuations | $ | 230,753 | | | $ | 694,773 | | | | | | | | |
| | | | | | | | | | | |
Private equity partnerships – TheEquity Investments
A significant portion of the Company’s investments in private equity partnerships includedinvestments include alternative asset limited partnerships (or similar corporate structures) that invest in certain private equity asset classes including U.S. and global leveraged buyouts, mezzanine investments, distressed securities, real estate, and oil, gas and power. The Company generally has no right to redeem its interest in any of these private equity
partnerships investments in advance of dissolution of the applicable private equity partnership.investment. Instead, the nature of these investments is that distributions are received by the Company in connection with the liquidation of the underlying assets of the respective private equity partnership.investment. It is estimated that the majority of the underlying assets of the limited partnerships would liquidate over 7 to 10 years from inception of the respective limited partnership.
Senior secured bank loan funds – Secured Bank Loan Funds
At September 30, 2017,2020, the Company had $19.6$20.9 million invested in closed end funds which invest primarily in loans. The Company has no right to redeem its investment in these funds. It is estimated that the majority of the underlying assets in these closed end funds would begin to liquidate over 4 to 5 years from inception of the applicable fund.
Hedge funds – TheFunds
At September 30, 2020, the Company investshad $10.0 million of investments in hedge funds that pursue multiple strategies. The Company’s investments in hedge funds at September 30, 2017 were $0.6 million of so called “side pocket” investmentsare primarily focused on global credit opportunities which are notgenerally redeemable at the option of the shareholder. The Company will retain its interest in the side pocket investments until the underlying investments attributable to such side pockets are liquidated, realized or deemed realized at the discretion of the fund manager.
NOTE 5.REINSURANCE
The Company purchases reinsurance and other protection to manage its risk portfolio and to reduce its exposure to large losses. The Company currently has in place contracts that provide for recovery of a portion of certain claims and claim expenses, generally in excess of various retentions or on a proportional basis. In addition to loss recoveries, certain of the Company’s ceded reinsurance contracts provide for payments of additional premiums, for reinstatement premiums and for lost no-claims bonuses, which are incurred when losses are ceded to the respective reinsurance contracts. The Company remains liable to the extent that any reinsurance companyreinsurer fails to meet its obligations.
The following table sets forth the effect of reinsurance and retrocessional activity on premiums written and earned and on net claims and claim expenses incurred:
|
| | | | | | | | | | | | | | | | | |
| | | | | | | | | | |
| | | Three months ended | | Nine months ended | |
| | | September 30,
2017 | | September 30,
2016 | | September 30,
2017 | | September 30,
2016 | |
| | Premiums written | | | | | | | | |
| | Direct | $ | 64,040 |
| | $ | 53,488 |
| | $ | 205,253 |
| | $ | 154,205 |
| |
| | Assumed | 576,229 |
| | 376,736 |
| | 2,184,521 |
| | 1,897,280 |
| |
| | Ceded | (157,048 | ) | | (146,002 | ) | | (806,672 | ) | | (735,672 | ) | |
| | Net premiums written | $ | 483,221 |
| | $ | 284,222 |
| | $ | 1,583,102 |
| | $ | 1,315,813 |
| |
| | Premiums earned | | | | | | | | |
| | Direct | $ | 61,908 |
| | $ | 43,097 |
| | $ | 176,433 |
| | $ | 114,173 |
| |
| | Assumed | 712,499 |
| | 471,097 |
| | 1,731,845 |
| | 1,392,278 |
| |
| | Ceded | (226,615 | ) | | (167,673 | ) | | (612,176 | ) | | (454,922 | ) | |
| | Net premiums earned | $ | 547,792 |
| | $ | 346,521 |
| | $ | 1,296,102 |
| | $ | 1,051,529 |
| |
| | Claims and claim expenses | | | | | | | | |
| | Gross claims and claim expenses incurred | $ | 2,482,510 |
| | $ | 153,846 |
| | $ | 2,924,217 |
| | $ | 540,696 |
| |
| | Claims and claim expenses recovered | (1,260,814 | ) | | (41,271 | ) | | (1,366,853 | ) | | (133,766 | ) | |
| | Net claims and claim expenses incurred | $ | 1,221,696 |
| | $ | 112,575 |
| | $ | 1,557,364 |
| | $ | 406,930 |
| |
| | | | | | | | | | |
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
| | | | | | | | | |
| | Three months ended | | Nine months ended | |
| | September 30,
2020 | | September 30,
2019 | | September 30,
2020 | | September 30,
2019 | |
| Premiums written | | | | | | | | |
| Direct | $ | 138,208 | | | $ | 108,478 | | | $ | 463,462 | | | $ | 318,984 | | |
| Assumed | 1,004,850 | | | 752,590 | | | 4,407,189 | | | 3,583,287 | | |
| Ceded | (243,647) | | | (156,938) | | | (1,520,629) | | | (1,246,145) | | |
| Net premiums written | $ | 899,411 | | | $ | 704,130 | | | $ | 3,350,022 | | | $ | 2,656,126 | | |
| Premiums earned | | | | | | | | |
| Direct | $ | 128,621 | | | $ | 103,446 | | | $ | 401,177 | | | $ | 283,898 | | |
| Assumed | 1,301,871 | | | 1,146,831 | | | 3,732,961 | | | 3,114,408 | | |
| Ceded | (430,309) | | | (343,529) | | | (1,210,761) | | | (1,030,028) | | |
| Net premiums earned | $ | 1,000,183 | | | $ | 906,748 | | | $ | 2,923,377 | | | $ | 2,368,278 | | |
| Claims and claim expenses | | | | | | | | |
| Gross claims and claim expenses incurred | $ | 1,192,132 | | | $ | 714,714 | | | $ | 2,587,073 | | | $ | 1,804,889 | | |
| Claims and claim expenses recovered | (250,102) | | | (60,194) | | | (563,817) | | | (469,961) | | |
| Net claims and claim expenses incurred | $ | 942,030 | | | $ | 654,520 | | | $ | 2,023,256 | | | $ | 1,334,928 | | |
| | | | | | | | | |
The Company adopted ASU 2016-13 effective January 1, 2020. In assessing an allowance for reinsurance assets, which includes reinsurance balances receivable and reinsurance recoverables, the Company considers historical information, financial strength of reinsurers, collateralization amounts, and ratings to determine the appropriateness of the allowance. In assessing future default for reinsurance assets, the Company evaluates the valuation allowance under the probability of default and loss given default method. The Company utilizes its internal capital and risk models which uses counterparty ratings from major rating agencies, as well as assessing the current market conditions for the likelihood of default. Historically, the Company has not experienced material credit losses from reinsurance assets. The adoption of ASU 2016-13 did not have a material impact on the Company’s consolidated statements of operations and financial position. At September 30, 2020, the Company’s reinsurance recoverable balance was $2.9 billion (December 31, 2019 - $2.8 billion). Of the Company’s reinsurance recoverable balance at September 30, 2020, 49.5% is fully collateralized by our reinsurers, 49.3% is recoverable from reinsurers rated A- or higher by major rating agencies and 1.2% is recoverable from reinsurers rated lower than A- by major rating agencies (December 31, 2019 - 57.5%, 41.0% and 1.5%, respectively). The reinsurers with the three largest balances accounted for 15.8%, 9.8% and 6.9%, respectively, of the Company’s reinsurance recoverable balance at September 30, 2020 (December 31, 2019 - 12.7%, 7.2% and 7.0%, respectively). The valuation allowance recorded against reinsurance recoverable was $10.2 million at September 30, 2020 (December 31, 2019 - $7.3 million). The three largest company-specific components of the valuation allowance represented 16.0%, 7.4% and 5.7%, respectively, of the Company’s total valuation allowance at September 30, 2020 (December 31, 2019 - 18.1%, 7.9% and 7.2%, respectively).
NOTE 6.RESERVE FOR CLAIMS AND CLAIM EXPENSES
The Company believes the most significant accounting judgment made by management is its estimate of claims and claim expense reserves. Claims and claim expense reserves represent estimates, including actuarial and statistical projections at a given point in time, of the ultimate settlement and administration costs for unpaid claims and claim expenses arising from the insurance and reinsurance contracts the
Company sells. The Company establishes its claims and claim expense reserves by taking claims reported to the Company by insureds and ceding companies, but which have not yet been paid (“case reserves”), adding estimates for the anticipated cost of claims incurred but not yet reported to the Company, or incurred but not enough reported to the Company (collectively referred to as “IBNR”) and, if deemed necessary, adding costs for additional case reserves which represent the Company’s estimates for claims related to
specific contracts previously reported to the Company which it believes may not be adequately estimated by the client as of that date, or adequately covered in the application of IBNR.
The following table summarizes the Company’s claims and claim expense reserves by segment, allocated between case reserves, additional case reserves and IBNR:
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
| | | | | | | | | |
| At September 30, 2020 | Case
Reserves | | Additional
Case Reserves | | IBNR | | Total | |
| Property | $ | 1,037,526 | | | $ | 1,752,260 | | | $ | 1,238,478 | | | $ | 4,028,264 | | |
| Casualty and Specialty | 1,625,554 | | | 123,001 | | | 4,123,464 | | | 5,872,019 | | |
| Other | 332 | | | 0 | | | 0 | | | 332 | | |
| Total | $ | 2,663,412 | | | $ | 1,875,261 | | | $ | 5,361,942 | | | $ | 9,900,615 | | |
| | | | | | | | | |
| At December 31, 2019 | | | | | | | | |
| Property | $ | 1,253,406 | | | $ | 1,631,223 | | | $ | 1,189,221 | | | $ | 4,073,850 | | |
| Casualty and Specialty | 1,596,426 | | | 129,720 | | | 3,583,913 | | | 5,310,059 | | |
| Other | 440 | | | 0 | | | 0 | | | 440 | | |
| Total | $ | 2,850,272 | | | $ | 1,760,943 | | | $ | 4,773,134 | | | $ | 9,384,349 | | |
| | | | | | | | | |
|
| | | | | | | | | | | | | | | | | |
| | | | | | | | | | |
| | At September 30, 2017 | Case Reserves | | Additional Case Reserves | | IBNR | | Total | |
| | Property | $ | 310,871 |
| | $ | 416,758 |
| | $ | 1,917,573 |
| | $ | 2,645,202 |
| |
| | Casualty and Specialty | 655,328 |
| | 132,755 |
| | 1,734,475 |
| | 2,522,558 |
| |
| | Other | 9,904 |
| | — |
| | 14,649 |
| | 24,553 |
| |
| | Total | $ | 976,103 |
| | $ | 549,513 |
| | $ | 3,666,697 |
| | $ | 5,192,313 |
| |
| | | | | | | | | | |
| | At December 31, 2016 | | | | | | | | |
| | Property | $ | 214,954 |
| | $ | 186,308 |
| | $ | 226,512 |
| | $ | 627,774 |
| |
| | Casualty and Specialty | 591,705 |
| | 105,419 |
| | 1,498,002 |
| | 2,195,126 |
| |
| | Other | 6,935 |
| | — |
| | 18,459 |
| | 25,394 |
| |
| | Total | $ | 813,594 |
| | $ | 291,727 |
| | $ | 1,742,973 |
| | $ | 2,848,294 |
| |
| | | | | | | | | | |
Activity in the liability for unpaid claims and claim expenses is summarized as follows:
| | | | | | | | | | | | | | | | | |
| | | | | |
| Nine months ended September 30, | 2020 | | 2019 | |
| Net reserves as of beginning of period | $ | 6,593,052 | | | $ | 3,704,050 | | |
| Net incurred related to: | | | | |
| Current year | 2,078,639 | | | 1,349,448 | | |
| Prior years | (55,383) | | | (14,520) | | |
| Total net incurred | 2,023,256 | | | 1,334,928 | | |
| Net paid related to: | | | | |
| Current year | 191,213 | | | 128,471 | | |
| Prior years | 1,293,014 | | | 563,539 | | |
| Total net paid | 1,484,227 | | | 692,010 | | |
| Foreign exchange (1) | 39,904 | | | (41,605) | | |
| Amounts disposed of (2) | (155,178) | | | 0 | | |
| | | | | |
| Amounts acquired (3) | 0 | | | 1,858,775 | | |
| Net reserves as of end of period | 7,016,807 | | | 6,164,138 | | |
| Reinsurance recoverable as of end of period | 2,883,808 | | | 2,438,299 | | |
| Gross reserves as of end of period | $ | 9,900,615 | | | $ | 8,602,437 | | |
| | | | | |
(1) Reflects the impact of the foreign exchange revaluation of the net reserve for claims and claim expenses denominated in non-U.S. dollars as at the balance sheet date.
(2) Represents the fair value of RenaissanceRe UK's reserve for claims and claim expenses, net of reinsurance recoverables, disposed of on August 18, 2020.
(3) Represents the fair value of TMR's reserve for claims and claim expenses, net of reinsurance recoverables, acquired at March 22, 2019.
|
| | | | | | | | | |
| | | | | | |
| | Nine months ended September 30, | 2017 | | 2016 | |
| | Net reserves as of January 1 | $ | 2,568,730 |
| | $ | 2,632,519 |
| |
| | Net incurred related to: | | | | |
| | Current year | 1,561,027 |
| | 483,574 |
| |
| | Prior years | (3,663 | ) | | (76,644 | ) | |
| | Total net incurred | 1,557,364 |
| | 406,930 |
| |
| | Net paid related to: | | | | |
| | Current year | 158,685 |
| | 39,971 |
| |
| | Prior years | 396,411 |
| | 391,047 |
| |
| | Total net paid | 555,096 |
| | 431,018 |
| |
| | Foreign exchange | 33,011 |
| | 11,899 |
| |
| | Net reserves as of September 30 | 3,604,009 |
| | 2,620,330 |
| |
| | Reinsurance recoverable as of September 30 | 1,588,304 |
| | 240,769 |
| |
| | Gross reserves as of September 30 | $ | 5,192,313 |
| | $ | 2,861,099 |
| |
| | | | | | |
Prior Year Development of the Reserve for Net Claims and Claim Expenses
The Company’s estimates of claims and claim expense reserves are not precise in that, among other things, they are based on predictions of future developments and estimates of future trends and other variable factors. Some, but not all, of the Company’s reserves are further subject to the uncertainty inherent in actuarial methodologies and estimates. Because a reserve estimate is simply an insurer’s estimate at a point in time of its ultimate liability, and because there are numerous factors that affect reserves and claims payments that cannot be determined with certainty in advance, the Company’s ultimate payments will vary, perhaps materially, from its estimates of reserves. If the Company determines in a subsequent period that adjustments to its previously established reserves are appropriate, such adjustments are recorded in the period in which they are identified. On a net basis, the Company’s cumulative favorable or unfavorable
development is generally reduced by offsetting changes in its reinsurance recoverables, as well as changes to loss related premiums such as reinstatement premiums and redeemable noncontrolling interest, for changes in claims and claim expenses that impact DaVinciRe, all of which generally move in the opposite direction to changes in the Company’s ultimate claims and claim expenses.
The following table details the Company’s prior year development by segment of its liability for unpaid claims and claim expenses: |
| | | | | | | | | |
| | | | | | |
| | Nine months ended September 30, | 2017 | | 2016 | |
| | | (Favorable) adverse development | | (Favorable) adverse development | |
| | Property | $ | (16,968 | ) | | $ | (37,512 | ) | |
| | Casualty and Specialty | 14,015 |
| | (38,327 | ) | |
| | Other | (710 | ) | | (805 | ) | |
| | Total favorable development of prior accident years net claims and claim expenses | $ | (3,663 | ) | | $ | (76,644 | ) | |
| | | | | | |
| | | | | | | | | | | | | | | | | |
| | | | | |
| Nine months ended September 30, | 2020 | | 2019 | |
| | (Favorable) adverse development | | (Favorable) adverse development | |
| Property | $ | (31,425) | | | $ | 5,020 | | |
| Casualty and Specialty | (23,827) | | | (19,718) | | |
| Other | (131) | | | 178 | | |
| Total net favorable development of prior accident years net claims and claim expenses | $ | (55,383) | | | $ | (14,520) | | |
| | | | | |
Changes to prior year estimated claims reserves decreased the Company’sincreased net lossincome by $3.7$55.4 million during the nine months ended September 30, 2017, (20162020 (2019 - increased the Company’s net income by $76.6$14.5 million), excluding the consideration of changes in reinstatement, adjustment or other premium changes,items, profit commissions, redeemable noncontrolling interest - DaVinciReinterests and income tax.
Property Segment
The following table detailstables detail the development of the Company’s liability for unpaid claims and claim expenses for its Property segment, allocated between large and small catastrophe net claims and claim expenses and attritional net claims and claim expenses, included in the other line item: |
| | | | | | | | | |
| | | | | | |
| | Nine months ended September 30, | 2017 | | 2016 | |
| | | (Favorable) adverse development | | (Favorable) adverse development | |
| | Catastrophe net claims and claim expenses | | | | |
| | Large catastrophe events | | | | |
| | April and May U.S. Tornadoes (2011) | $ | (4,163 | ) | | $ | (3,396 | ) | |
| | Tohoku Earthquake and Tsunami (2011) | — |
| | (5,894 | ) | |
| | New Zealand Earthquake (2010) | 5,001 |
| | 8,710 |
| |
| | New Zealand Earthquake (2011) | 5,807 |
| | — |
| |
| | Other | (3,881 | ) | | (7,435 | ) | |
| | Total large catastrophe events | 2,764 |
| | (8,015 | ) | |
| | Small catastrophe events | | | | |
| | Fort McMurray Wildfire (2016) | (6,386 | ) | | — |
| |
| | Tianjin Explosion (2015) | (4,896 | ) | | (6,163 | ) | |
| | Other | (9,293 | ) | | (23,334 | ) | |
| | Total small catastrophe events | (20,575 | ) | | (29,497 | ) | |
| | Total catastrophe net claims and claim expenses | (17,811 | ) | | (37,512 | ) | |
| | Actuarial assumption changes | 843 |
| | — |
| |
| | Total net favorable development of prior accident years net claims and claim expenses | $ | (16,968 | ) | | $ | (37,512 | ) | |
| | | | | | |
| | | | | | | | | | | |
| | | |
| Nine months ended September 30, | 2020 | |
| | (Favorable) adverse development | |
| Catastrophe net claims and claim expenses | | |
| Large catastrophe events | | |
| 2019 Large Loss Events | $ | (13,435) | | |
| 2018 Large Loss Events | (12,306) | | |
| 2017 Large Loss Events | (9,101) | | |
| | | |
| | | |
| | | |
| | | |
| Other | 11,265 | | |
| Total large catastrophe events | (23,577) | | |
| Small catastrophe events and attritional loss movements | | |
| | | |
| | | |
| Other small catastrophe events and attritional loss movements | (13,293) | | |
| Total small catastrophe events and attritional loss movements | (13,293) | | |
| Total catastrophe and attritional net claims and claim expenses | (36,870) | | |
| Actuarial assumption changes | 5,445 | | |
| Total net favorable development of prior accident years net claims and claim expenses | $ | (31,425) | | |
| | | |
The net favorable development of prior accident years net claims and claim expenses within the Company’s Property segment in the nine months ended September 30, 20172020 of $17.0$31.4 million was primarily comprised of net adverse development of $2.8 million related to large catastrophe events, net favorable development of
$20.6 million related to small catastrophe events and $0.8 million of adverse development associated with actuarial assumption changes. Included in net adverse development ofon prior accident years net claims and claim expenses fromassociated with the following large eventscatastrophe events:
•$13.4 million associated with Hurricane Dorian and Typhoon Faxai, Typhoon Hagibis and losses associated with aggregate loss contracts (collectively, the “2019 Large Loss Events”);
•$12.3 million associated with Typhoons Jebi, Mangkhut and Trami, Hurricane Florence, the wildfires in California during the third and fourth quarters of 2018, Hurricane Michael and certain losses associated with aggregate loss contracts (collectively, the ”2018 Large Loss Events”); and
•$9.1 million associated with Hurricanes Harvey, Irma and Maria, the Mexico City Earthquake, the wildfires in California during the fourth quarter of 2017 and certain losses associated with aggregate loss contracts (collectively, the “2017 Large Loss Events”).
Partially offsetting this net favorable development was net adverse development of $5.8$5.4 million related to the 2011 New Zealand Earthquake and $5.0 million related to the 2010 New Zealand Earthquake due to increases in the estimated expected losses associated with these events. Partially offsetting these events was favorable development of $4.2 million and $3.9 million related to the 2011 April and May U.S. Tornadoes and a number of other events, respectively, due to reductions in the estimated ultimate losses associated with these events. Included in net favorable development of prior accident years net claims and claims expenses from small events was a reduction in the estimated ultimate losses associated with the 2016 Fort McMurray Wildfire of $6.4 million and the 2015 Tianjin Explosion of $4.9 million. In addition, the Company’s Property segment experienced net favorable development of $9.3 million associated with a number of other small catastrophe events.actuarial assumption changes.
| | | | | | | | | | | |
| | | |
| Nine months ended September 30, | 2019 | |
| | (Favorable) adverse development | |
| Catastrophe net claims and claim expenses | | |
| Large catastrophe events | | |
| 2017 Large Loss Events | $ | (90,817) | | |
| 2018 Large Loss Events | 61,592 | | |
| Other | 23,834 | | |
| Total large catastrophe events | (5,391) | | |
| Small catastrophe events and attritional loss movements | | |
| Other small catastrophe events and attritional loss movements | 1,166 | | |
| Total small catastrophe events and attritional loss movements | 1,166 | | |
| Total catastrophe and attritional net claims and claim expenses | (4,225) | | |
| Actuarial assumption changes | 9,245 | | |
| Total net adverse development of prior accident years net claims and claim expenses | $ | 5,020 | | |
| | | |
The net favorableadverse development of prior accident years net claims and claim expenses within the Company’s Property segment in the nine months ended September 30, 20162019 of $37.5$5.0 million was principally comprised of net favorable development of $29.5$5.4 million associated withrelated to large catastrophe events, net adverse development of $1.2 million related to small catastrophe events and attritional loss movements and net adverse development of $9.2 million related to linesactuarial assumption changes. Included in net favorable development of business where the Company principally estimatesprior accident years net claims and claim expenses using traditional actuarial methods. In addition, the Company experienced net favorable development of $8.0 million from large catastrophe events due principally to a decreasewithin the Property segment was $90.8 million of net decreases in the estimated ultimate losses for the 2011 Tohoku Earthquake and the April and May 2011 Tornadoes of $5.9 million and $3.4 million, respectively, and net favorable development of $7.4 million associated with a numberthe 2017 Large Loss Events, partially offset by $61.6 million of other large catastrophe events. Partially offsetting this net favorable development of large catastrophe events was an increaseincreases in the estimated ultimate losses for the 2010 New Zealand Earthquake of $8.7 million. In addition, the Company’s Property segment experienced net favorable development due to reductions in the estimated ultimate losses from the 2015 Tianjin Explosion of $6.2 million and net favorable development of $23.3 million associated with a number of other small catastrophe events.the 2018 Large Loss Events.
Casualty and Specialty Segment
The following table details the development of the Company’s liability for unpaid claims and claim expenses for its Casualty and Specialty segment: |
| | | | | | | | | |
| | | | | | |
| | Nine months ended September 30, | 2017 | | 2016 | |
| | | (Favorable) adverse development | | (Favorable) adverse development | |
| | Actuarial methods - actual reported claims lower than expected claims | $ | (17,004 | ) | | $ | (32,209 | ) | |
| | Ogden Rate change | 33,481 |
| | — |
| |
| | Actuarial assumption changes | (2,462 | ) | | (6,118 | ) | |
| | Total adverse (favorable) development of prior accident years net claims and claim expenses | $ | 14,015 |
| | $ | (38,327 | ) | |
| | | | | | |
| | | | | | | | | | | | | | | | | |
| | | | | |
| Nine months ended September 30, | 2020 | | 2019 | |
| | (Favorable) adverse development | | (Favorable) adverse development | |
| Actuarial methods | $ | (27,944) | | | $ | (54,527) | | |
| Actuarial assumption changes | 4,117 | | | 34,809 | | |
| Total net favorable development of prior accident years net claims and claim expenses | $ | (23,827) | | | $ | (19,718) | | |
| | | | | |
The net adversefavorable development of prior accident years net claims and claim expenses within the Company’s Casualty and Specialty segment of $23.8 million in the nine months ended September 30, 2017 of $14.0 million2020 was driven by $33.5 million of adverse development associated with the change in the discount rate used to calculate lump sum awards in U.K. bodily injury cases (the “Ogden Rate”), from 2.5%, to minus 0.75%. Offsetting the adverse development due to the impact of the Ogden Rate change was $17.0 million of net favorable development in the first nine months of 2017 related to actual reported losses generally coming in lower than expected on attritional net claims and claim expenses across a number of lines of business, and $2.5partially offset by net adverse development of $4.1 million of net favorable development associated with certain actuarial assumption changes.
The net favorable development of prior accident years net claims and claim expenses within the Company’s Casualty and Specialty segment of $19.7 million in the nine months ended September 30, 20162019 was comprised of $38.3 million was driven by $32.2 million ofnet favorable development of $54.5 million related to actual reported net claims and claim expenseslosses generally coming in lower than expected on prior accident years eventsattritional net claims and $6.1claim expenses across a number of lines of business, partially offset by net adverse development of $34.8 million of favorable development associated with certain actuarial assumption changes.
NOTE 7.DEBT AND CREDIT FACILITIES
Except as noted below, thereThere have been no material changes to the Company’s debt obligations and credit facilities as described in its Form 10-K for the year ended December 31, 2016.2019, except as described below.
Debt Obligations
A summary of the Company’s debt obligations on its consolidated balance sheets is set forth below: |
| | | | | | | | | | | | | | | | | |
| | | | | | | | | | |
| | | September 30, 2017 | | December 31, 2016 | |
| | | Fair Value | | Carrying Value | | Fair Value | | Carrying Value | |
| | 3.450% Senior Notes due 2027 | $ | 296,589 |
| | $ | 295,179 |
| | $ | — |
| | $ | — |
| |
| | 3.700% Senior Notes due 2025 | 309,648 |
| | 297,225 |
| | 291,750 |
| | 296,948 |
| |
| | 5.75% Senior Notes due 2020 | 269,265 |
| | 249,188 |
| | 270,875 |
| | 248,941 |
| |
| | Series B 7.50% Senior Notes due 2017 | — |
| | — |
| | 257,500 |
| | 255,352 |
| |
| | 4.750% Senior Notes due 2025 (DaVinciRe) (1) | 158,742 |
| | 147,653 |
| | 144,675 |
| | 147,422 |
| |
| | | $ | 1,034,244 |
| | $ | 989,245 |
| | $ | 964,800 |
| | $ | 948,663 |
| |
| | | | | | | | | | |
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
| | | | | | | | | |
| | September 30, 2020 | | December 31, 2019 | |
| | Fair Value | | Carrying Value | | Fair Value | | Carrying Value | |
| 3.600% Senior Notes due 2029 | $ | 451,056 | | | $ | 392,161 | | | $ | 424,920 | | | $ | 391,475 | | |
| 3.450% Senior Notes due 2027 | 329,331 | | | 296,662 | | | 314,070 | | | 296,292 | | |
| 3.700% Senior Notes due 2025 | 316,536 | | | 298,335 | | | 318,567 | | | 298,057 | | |
| 5.75% Senior Notes due 2020 | 0 | | | 0 | | | 251,030 | | | 249,931 | | |
| | | | | | | | | |
| 4.750% Senior Notes due 2025 (DaVinciRe) (1) | 164,481 | | | 148,582 | | | 160,031 | | | 148,350 | | |
| | | | | | | | | |
| | | | | | | | | |
| Total debt | $ | 1,261,404 | | | $ | 1,135,740 | | | $ | 1,468,618 | | | $ | 1,384,105 | | |
| | | | | | | | | |
| |
(1) | RenaissanceRe owns a noncontrolling economic interest in its joint venture DaVinciRe. Because RenaissanceRe controls a majority of DaVinciRe’s outstanding voting rights, the consolidated financial statements of DaVinciRe are included in the consolidated financial statements of RenaissanceRe. However, RenaissanceRe does not guarantee or provide credit support for DaVinciRe and RenaissanceRe’s financial exposure to DaVinciRe is limited to its investment in DaVinciRe’s shares and counterparty credit risk arising from reinsurance transactions.
|
3.450%(1) RenaissanceRe owns a noncontrolling economic interest in its joint venture DaVinciRe. Because RenaissanceRe controls a majority of DaVinciRe’s outstanding voting rights, the consolidated financial statements of DaVinciRe are included in the consolidated financial statements of RenaissanceRe. However, RenaissanceRe does not guarantee or provide credit support for DaVinciRe and RenaissanceRe’s financial exposure to DaVinciRe is limited to its investment in DaVinciRe’s shares and counterparty credit risk arising from reinsurance transactions.
5.75% Senior Notes due 20272020 of RenRe North America Holdings Inc. and RenaissanceRe Finance
On June 29, 2017, RenaissanceRe Finance issued $300.0 million of its 3.450% Senior Notes due July 1, 2027, with interest on the notes payable on July 1 and January 1 of each year. The notes are fully and unconditionally guaranteed by RenaissanceRe and may be redeemed by RenaissanceRe Finance prior to maturity, subject to the payment of a “make-whole” premium if the notes are redeemed prior to April 1, 2027. The notes contain various covenants, including limitations on mergers and consolidations, and restrictions as to the disposition of, and the placing of liens on, stock of designated subsidiaries. The net proceeds from the offering of the notes are to be used for general corporate purposes.
Series B 7.50% Senior Notes due 2017 of Platinum Underwriters Finance, Inc.
On June 1, 2017,March 15, 2020, the Company repaid in full at maturity anthe aggregate principal amount of $250.0 million, plus applicable accrued interest, of its Series B 7.50%the 5.75% Senior Notes due 2017 assumed in connection with the acquisition2020 of PlatinumRenRe North America Holdings Inc. and originally issued by Platinum Underwriters Finance, Inc.
RenaissanceRe Finance.
Credit Facilities
The outstanding amounts issued or drawn under each of the Company’s significant credit facilities is set forth below: |
| | | | | |
| | | | |
| | At September 30, 2017 | Issued or Drawn | |
| | RenaissanceRe Revolving Credit Facility | $ | — |
| |
| | Uncommitted Standby Letter of Credit Facility with Wells Fargo | 99,168 |
| |
| | Uncommitted Standby Letter of Credit Facility with NAB | 4,356 |
| |
| | Bilateral Letter of Credit Facility with Citibank Europe | 192,715 |
| |
| | Funds at Lloyd’s Letter of Credit Facilities | | |
| | Renaissance Reinsurance FAL Facility | 180,000 |
| |
| | Total credit facilities in U.S. dollars | $ | 476,239 |
| |
| | | | |
| | Funds at Lloyd’s Letter of Credit Facilities | | |
| | Specialty Risks FAL Facility | £ | 10,000 |
| |
| | Total credit facilities in British Pounds | £ | 10,000 |
| |
| | | | |
| | | | | | | | | | | |
| | | |
| At September 30, 2020 | Issued or Drawn | |
| Revolving Credit Facility (1) | $ | 0 | | |
| Bilateral Letter of Credit Facilities | | |
| Secured | 330,356 | | |
| Unsecured | 346,459 | | |
| Funds at Lloyd’s Letter of Credit Facility | 290,000 | | |
| | | |
| | | |
| | $ | 966,815 | | |
| | | |
(1) At September 30, 2020, no amounts were issued or drawn under this facility.
Uncommitted, Secured Standby Letter of Credit FacilitiesFacility with Wells Fargo
Effective asJune 11, 2020, RenaissanceRe and certain of May 25, 2017,its subsidiaries and affiliates, including Renaissance Reinsurance, DaVinci, Renaissance Reinsurance U.S. and RenaissanceRe Europe entered into an amendment to its letter of credit facility with Wells Fargo Bank, of Montreal (“BMO”), Citibank Europe plc, (“CEP”), and ING Bank N.V. (“ING”) as lenders (the “Renaissance Reinsurance FAL Facility”), which provided for the issuance by the lenders of two letters of credit to support business written by Syndicate 1458 with stated amounts of $380.0 million and £90.0 million, respectively.National Association. Pursuant to the amendment, the statedmaximum amount of unsecured letters of credit that the applicants may request (outstanding on such request date) was increased from $25.0 million to $100.0 million. All other terms of the facility remained the same.
Unsecured Letter of Credit Facility with Credit Suisse
Effective June 26, 2020, RenaissanceRe Europe and RenaissanceRe entered into an amendment to its letter of credit facility with Credit Suisse (Switzerland) Ltd. Pursuant to the amendment, the maximum committed amount of the $380.0 millionunsecured letter of credit facility was reducedincreased from $125.0 million to $180.0 million and the £90.0 million letter of credit was cancelled. In addition, pursuant to the amendment, Renaissance Reinsurance may request that the Renaissance Reinsurance FAL Facility be amended to increase the stated amount of the letter of credit, or issue a new letter or credit denominated in Pounds, in an aggregate amount for all such increases or issuances not to exceed $75.0 million or the equivalent thereof.$200.0 million. All other terms and conditions of the Renaissance Reinsurance FAL Facilityfacility remained the same.
During the quarter ended March 31, 2020, the following letters of credit and facilities that were transferred to the Company in connection with the acquisition of TMR were terminated: (a) certain letters of credit for the account of RenaissanceRe Europe issued by Mizuho Bank, Ltd. pursuant to a Letter of Credit and Reimbursement Agreement, dated as of May 14, 2012, as amended, (b) certain letters of credit for the account of RenaissanceRe Europe issued by The Bank of Tokyo-Mitsubishi UFJ Ltd., Düsseldorf Branch pursuant to a Committed Revolving Standby Letter of Credit Agreement, dated as of September 29, 2017, and (c) certain letters of credit for the account of RenaissanceRe UK issued by The Bank of Tokyo-Mitsubishi UFJ, Ltd. pursuant to a Facility Letter, dated as of December 21, 2006. The parties had previously agreed that no new letters of credit would be issued under these facilities.
NOTE 8.NONCONTROLLING INTERESTS
A summary of the Company’s redeemable noncontrolling interests on its consolidated balance sheets is set forth below: |
| | | | | | | | | |
| | | | | | |
| | | September 30,
2017 | | December 31, 2016 | |
| | Redeemable noncontrolling interest - DaVinciRe | $ | 812,342 |
| | $ | 994,458 |
| |
| | Redeemable noncontrolling interest - Medici | 221,387 |
| | 181,136 |
| |
| | Redeemable noncontrolling interests | $ | 1,033,729 |
| | $ | 1,175,594 |
| |
| | | | | | |
| | | | | | | | | | | | | | | | | |
| | | | | |
| | September 30,
2020 | | December 31, 2019 | |
| Redeemable noncontrolling interest - DaVinciRe | $ | 1,594,683 | | | $ | 1,435,581 | | |
| Redeemable noncontrolling interest - Medici | 696,999 | | | 632,112 | | |
| Redeemable noncontrolling interest - Vermeer | 1,095,635 | | | 1,003,615 | | |
| Redeemable noncontrolling interests | $ | 3,387,317 | | | $ | 3,071,308 | | |
| | | | | |
| | | | | |
| | | | | |
A summary of the Company’s redeemable noncontrolling interests on its consolidated statements of operations is set forth below: |
| | | | | | | | | | | | | | | | | |
| | | | | | | | | | |
| | | Three months ended | | Nine months ended | |
| | | September 30,
2017 | | September 30,
2016 | | September 30,
2017 | | September 30,
2016 | |
| | Redeemable noncontrolling interest - DaVinciRe | $ | (195,508 | ) | | $ | 30,745 |
| | $ | (127,167 | ) | | $ | 101,997 |
| |
| | Redeemable noncontrolling interest - Medici | (8,769 | ) | | 4,896 |
| | (5,171 | ) | | 8,870 |
| |
| | Net (loss) income attributable to redeemable noncontrolling interests | $ | (204,277 | ) | | $ | 35,641 |
| | $ | (132,338 | ) | | $ | 110,867 |
| |
| | | | | | | | | | |
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
| | | | | | | | | |
| | Three months ended | | Nine months ended | |
| | September 30,
2020 | | September 30,
2019 | | September 30,
2020 | | September 30,
2019 | |
| Redeemable noncontrolling interest - DaVinciRe | $ | (26,616) | | | $ | 30,558 | | | $ | 146,664 | | | $ | 152,946 | | |
| Redeemable noncontrolling interest - Medici | 33,963 | | | 15,211 | | | 42,436 | | | 19,396 | | |
| Redeemable noncontrolling interest - Vermeer | 11,954 | | | 16,288 | | | 47,020 | | | 31,749 | | |
| Net income attributable to redeemable noncontrolling interests | $ | 19,301 | | | $ | 62,057 | | | $ | 236,120 | | | $ | 204,091 | | |
| | | | | | | | | |
Redeemable Noncontrolling Interest – DaVinciRe
In October 2001, the Company formed DaVinciRe and DaVinci with other equity investors. RenaissanceRe owns a noncontrolling economic interest in DaVinciRe; however, because RenaissanceRe controls a majority of DaVinciRe’s outstanding voting rights, the consolidated financial statements of DaVinciRe are included in the consolidated financial statements of the Company. The portion of DaVinciRe’s earnings owned by third parties is recorded in the consolidated statements of operations as net income attributable to redeemable noncontrolling interests. The Company’s noncontrolling economic ownership in DaVinciRe was 23.5%21.4% at September 30, 2017 (December2020 (December 31, 20162019 - 24.0%21.9%).
DaVinciRe shareholders are party to a shareholders agreement which provides DaVinciRe shareholders, excluding RenaissanceRe, with certain redemption rights that enable each shareholder to notify DaVinciRe of such shareholder’s desire for DaVinciRe to repurchase up to half of such shareholder’s initial aggregate number of shares held, subject to certain limitations, such as limiting the aggregate of all share repurchase requests to 25% of DaVinciRe’s capital in any given year and satisfying all applicable regulatory
requirements. If total shareholder requests exceed 25% of DaVinciRe’s capital, the number of shares repurchased will be reduced among the requesting shareholders pro-rata, based on the amounts desired to be repurchased. Shareholders desiring to have DaVinci repurchase their shares must notify DaVinciRe before March 1 of each year. The repurchase price will be based on GAAP book value as of the end of the year in which the shareholder notice is given, and the repurchase will be effective as of January 1 of the following year. The repurchase price is generally subject to a true-up for potential development on outstanding loss reserves after settlement of all claims relating to the applicable years.
20162020
DuringEffective January 2016, DaVinciRe redeemed a portion1, 2020, the Company sold an aggregate of $10.0 million of its outstanding shares from certain existing DaVinciRe shareholders, including RenaissanceRe, while new DaVinciRe shareholders purchased shares in DaVinciRe to an existing third-party investor. The Company’s noncontrolling economic ownership in DaVinciRe subsequent to this transaction was 21.4%.
2019
Effective June 1, 2019, DaVinciRe completed an equity capital raise of $349.2 million, comprised of $263.1 million from third-party investors and $86.1 million from RenaissanceRe. The net redemption asIn addition, RenaissanceRe sold an aggregate of $11.6 million of its shares in DaVinciRe to a result of these transactions was $100.0 million. In connection with the redemption, DaVinciRe retained a $10.0 million holdback.third-party investor. The Company’s noncontrolling economic ownership in DaVinciRe subsequent to these transactions was 24.0%21.9%, effective JanuaryJune 1, 2016.2019.
2017
During January 2017, DaVinciRe redeemed $75.0 million of its outstanding shares from certain existing DaVinciRe shareholders, including RenaissanceRe. In connection with the redemption, DaVinciRe retained a $7.5 million holdback. In addition, RenaissanceRe sold an aggregate of $24.0 million of its shares in DaVinciRe to an existing shareholder and a new shareholder. The Company’s noncontrolling economic ownership in DaVinciRe subsequent to these transactions was 22.6%, effective January 1, 2017. The Company expects its noncontrolling economic ownership in DaVinciRe to fluctuate over time.
During July 2017, RenaissanceRe purchased $12.0 million of DaVinciRe’s outstanding shares from an existing third-party shareholder. The Company’s noncontrolling economic ownership in DaVinciRe subsequent to these transactions was 23.5%, effective July 1, 2017.
See “Note 16. Subsequent Events” for additional information related to DaVinciRe share transactions subsequent to September 30, 2017.
The activity in redeemable noncontrolling interest – DaVinciRe is detailed in the table below: |
| | | | | | | | | | | | | | | | | |
| | | | | | | | | | |
| | | Three months ended | | Nine months ended | |
| | | September 30,
2017 | | September 30,
2016 | | September 30,
2017 | | September 30,
2016 | |
| | Beginning balance | $ | 1,019,918 |
| | $ | 953,443 |
| | $ | 994,458 |
| | $ | 930,955 |
| |
| | Redemption of shares from redeemable noncontrolling interest | (12,068 | ) | | (400 | ) | | (78,870 | ) | | (92,204 | ) | |
| | Sale of shares to redeemable noncontrolling interests | — |
| | — |
| | 23,921 |
| | 43,040 |
| |
| | Net (loss) attributable to redeemable noncontrolling interest | (195,508 | ) | | 30,745 |
| | (127,167 | ) | | 101,997 |
| |
| | Ending balance | $ | 812,342 |
| | $ | 983,788 |
| | $ | 812,342 |
| | $ | 983,788 |
| |
| | | | | | | | | | |
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
| | | | | | | | | |
| | Three months ended | | Nine months ended | |
| | September 30,
2020 | | September 30,
2019 | | September 30,
2020 | | September 30,
2019 | |
| Beginning balance | $ | 1,621,300 | | | $ | 1,431,101 | | | $ | 1,435,581 | | | $ | 1,034,946 | | |
| Redemption of shares from redeemable noncontrolling interest, net of adjustments | (1) | | | 1,018 | | | 2,447 | | | 86 | | |
| Sale of shares to redeemable noncontrolling interests | 0 | | | 0 | | | 9,991 | | | 274,699 | | |
| | | | | | | | | |
| Net (loss) income attributable to redeemable noncontrolling interest | (26,616) | | | 30,558 | | | 146,664 | | | 152,946 | | |
| | | | | | | | | |
| Ending balance | $ | 1,594,683 | | | $ | 1,462,677 | | | $ | 1,594,683 | | | $ | 1,462,677 | | |
| | | | | | | | | |
Redeemable Noncontrolling Interest - RenaissanceRe Medici Fund Ltd. (“Medici”)
Medici is an exempted company incorporated under the laws of Bermuda and itsregistered as an institutional fund. Medici’s objective is to seek to invest substantially all of its assets in various insurance-based investment instruments that have returns primarily tied to property catastrophe risk. RenaissanceRe owns a noncontrolling economic interest in Medici; however, because RenaissanceRe controls all of Medici’s outstanding voting rights, the financial statements of Medici are included in the consolidated financial statements of the Company. The portion of Medici’s earnings owned by third parties is recorded in the consolidated statements of operations as net income attributable to redeemable noncontrolling interests. Any shareholder may redeem all or any portion of its shares as of the last day of any calendar month, upon at least 30 calendar days’ prior irrevocable written notice to Medici.
20162020
During 2016,the nine months ended September 30, 2020, third-party investors subscribed for $79.5$102.9 million and redeemed $21.7$80.4 million of the participating, non-voting common shares of Medici. As a result of these net subscriptions, the Company’s noncontrolling economic ownership in Medici was 36.5%, effective December 31, 2016.11.5% at September 30, 2020.
2019
During the nine months ended September 30, 2017,2019, third-party investors subscribed for $72.7$142.9 million and redeemed $27.3$44.4 million of the participating, non-voting common shares of Medici. As a result of these net subscriptions, the Company’s noncontrolling economic ownership in Medici was 31.6%13.7% at September 30, 2017. 2019.
The Company expects its noncontrolling economic ownership in Medici to fluctuate over time.
The activity in redeemable noncontrolling interest – Medici is detailed in the table below:
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
| | | | | | | | | |
| | Three months ended | | Nine months ended | |
| | September 30,
2020 | | September 30,
2019 | | September 30,
2020 | | September 30,
2019 | |
| Beginning balance | $ | 682,118 | | | $ | 515,915 | | | $ | 632,112 | | | $ | 416,765 | | |
| Redemption of shares from redeemable noncontrolling interest, net of adjustments | (31,174) | | | (7,008) | | | (80,412) | | | (44,448) | | |
| Sale of shares to redeemable noncontrolling interests | 12,092 | | | 10,500 | | | 102,863 | | | 142,905 | | |
| Net income attributable to redeemable noncontrolling interest | 33,963 | | | 15,211 | | | 42,436 | | | 19,396 | | |
| | | | | | | | | |
| | | | | | | | | |
| Ending balance | $ | 696,999 | | | $ | 534,618 | | | $ | 696,999 | | | $ | 534,618 | | |
| | | | | | | | | |
Redeemable Noncontrolling Interest – Vermeer
Vermeer is an exempted Bermuda reinsurer that provides capacity focused on risk remote layers in the U.S. property catastrophe market. Vermeer is managed by RUM in return for a management fee. The Company maintains majority voting control of Vermeer, while the sole third-party investor, PGGM, retains all of the economic benefits. The Company concluded that Vermeer is a VIE as it has voting rights that are not proportional to its participating rights, and the Company is the primary beneficiary. As a result, the Company consolidates Vermeer and all significant inter-company transactions have been eliminated. The portion of Vermeer’s earnings owned by PGGM is recorded in the consolidated statements of operations as net income attributable to redeemable noncontrolling interests. The Company has not provided any financial or other support to Vermeer that it was not contractually required to provide.
2020
During the nine months ended September 30, 2020, PGGM subscribed for $45.0 million of the participating, non-voting common shares of Vermeer.
2019
During the nine months ended September 30, 2019, PGGM subscribed for $150.0 million of the participating, non-voting common shares of Vermeer.
The Company does not expect its noncontrolling economic ownership in Vermeer to fluctuate over time.
The activity in redeemable noncontrolling interest – Vermeer is detailed in the table below:
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
| | | | | | | | | |
| | Three months ended | | Nine months ended | |
| | September 30,
2020 | | September 30,
2019 | | September 30,
2020 | | September 30,
2019 | |
| Beginning balance | $ | 1,083,681 | | | $ | 765,450 | | | $ | 1,003,615 | | | $ | 599,989 | | |
| | | | | | | | | |
| Sale of shares to redeemable noncontrolling interest | 0 | | | 0 | | | 45,000 | | | 150,000 | | |
| | | | | | | | | |
| Net income attributable to redeemable noncontrolling interest | 11,954 | | | 16,288 | | | 47,020 | | | 31,749 | | |
| | | | | | | | | |
| Ending balance | $ | 1,095,635 | | | $ | 781,738 | | | $ | 1,095,635 | | | $ | 781,738 | | |
| | | | | | | | | |
|
| | | | | | | | | | | | | | | | | |
| | | | | | | | | | |
| | | Three months ended | | Nine months ended | |
| | | September 30,
2017 | | September 30,
2016 | | September 30,
2017 | | September 30,
2016 | |
| | Beginning balance | $ | 222,165 |
| | $ | 168,960 |
| | $ | 181,136 |
| | $ | 115,009 |
| |
| | Redemption of shares from redeemable noncontrolling interest | (1,400 | ) | | (14,389 | ) | | (27,310 | ) | | (21,729 | ) | |
| | Sale of shares to redeemable noncontrolling interests | 9,391 |
| | 21,298 |
| | 72,732 |
| | 78,615 |
| |
| | Net (loss) income attributable to redeemable noncontrolling interest | (8,769 | ) | | 4,896 |
| | (5,171 | ) | | 8,870 |
| |
| | Ending balance | $ | 221,387 |
| | $ | 180,765 |
| | $ | 221,387 |
| | $ | 180,765 |
| |
| | | | | | | | | | |
NOTE 9.VARIABLE INTEREST ENTITIES
Upsilon RFO
Effective January 1, 2013, the Company formed and launched Upsilon RFO is a managed joint venture and a Bermuda domiciled SPI that was formed by the Company principally to provide additional capacity to the worldwide aggregate and per-occurrence retrocessional property catastrophe excess of loss market.
The shareholders (other than the Class A shareholder) participate in substantially all of the profits or losses of Upsilon RFO while their shares remain outstanding. The shareholders (other than the Class A shareholder) indemnify Upsilon RFO against losses relating to insurance risk, and therefore, these shares have been accounted for as prospective reinsurance under FASB ASC Topic Financial Services - Insurance.
Upsilon RFO is considered a VIE as it has insufficient equity capital to finance its activities without additional financial support. The Company is the primary beneficiary of Upsilon RFO as it has the power over the activities that most significantly impact the economic performance of Upsilon RFO and has the obligation to absorb expected losses and the right to receive expected benefits that could be significant to Upsilon RFO, in accordance with the accounting guidance. As a result, the Company consolidates Upsilon RFO and all significant inter-company transactions have been eliminated. Other than its equity investment in Upsilon RFO, the Company has not provided financial or other support to Upsilon RFO that it was not contractually required to provide.
20162020
During 2016, Upsilon RFO returned $242.5 million of capital to its investors, including $59.8 million to the Company. In addition, during 2016, $166.6nine months ended September 30, 2020, $802.0 million of Upsilon RFO non-voting preference shares were issued to existing investors, therein, including $55.2$95.4 million to the Company. Also during the nine months ended September 30, 2020 and following the release of collateral that was previously held by cedants associated with prior years’ contracts, Upsilon RFO returned $302.0 million of capital to its investors, including $61.6 million to the Company. At December 31, 2016,September 30, 2020, the Company’s participation in the risks assumed by Upsilon RFO was 28.8%13.9%.
2017
During the nine months ended September 30, 2017, Upsilon RFO returned $84.3 million of capital to its investors, including $33.0 million to the Company. In addition, during the nine months ended September 30, 2017, $134.1 million of Upsilon RFO non-voting preference shares were issued to existing investors therein, including $9.5 million to the Company, and an existing third-party investor purchased $7.5 million of Upsilon RFO non-voting preference shares from the Company. At September 30, 2017, the Company’s participation in the risks assumed by Upsilon RFO was 10.1%.
See “Note 16. Subsequent Events” for additional information related to Upsilon RFO’s non-voting preference shares subsequent to September 30, 2017.
At September 30, 2017,2020, the Company’s consolidated balance sheet included total assets and total liabilities of Upsilon RFO of $453.8$3.5 billion and $3.5 billion, respectively (December 31, 2019 - $3.1 billion and $3.1 billion, respectively). Of the total assets and liabilities, a net amount of $291.0 million is attributable to the Company, and $453.9$1.8 billion is attributable to third-party investors.
2019
During 2019, $618.7 million of Upsilon RFO non-voting preference shares were issued to new and existing investors, including $100.0 million to the Company. In addition, Upsilon RFO returned $279.2 million of capital to its investors, including $31.0 million to the Company. At December 31, 2019, the Company’s participation in the risks assumed by Upsilon RFO was 16.5%.
Payments for certain of the shares issued during 2020 and 2019 that were received by the Company prior to January 1, 2020 and January 1, 2019, respectively, were included in other liabilities on the Company’s consolidated balance sheet at December 31, 2019 and December 31, 2018, respectively, and in other operating cash flows on the Company’s consolidated statements of cash flows for 2019 and 2018, respectively. During 2020 and 2019, in connection with the issuance of the non-voting preference shares of Upsilon RFO, other liabilities were reduced by this amount, and reinsurance balances payable were increased by an offsetting amount, with corresponding impacts to other operating cash flows and the change in reinsurance balances payable on the Company consolidated statements of cash flows for the nine months ended September 30, 2020 and the year ended December 31, 2019, respectively.
Vermeer
Vermeer is an exempted Bermuda reinsurer that provides capacity focused on risk remote layers in the U.S. property catastrophe market. Vermeer is considered a VIE as it has voting rights that are not proportional to its participating rights. The Company is the primary beneficiary of Vermeer as it has power over the activities that most significantly impact the economic performance of Vermeer and has the obligation to absorb expected losses and the right to receive expected benefits that could be significant to Vermeer, in accordance with the accounting guidance. The portion of Vermeer’s earnings owned by PGGM is recorded
in the consolidated statements of operations as net income attributable to redeemable noncontrolling interests. See “Note 8. Noncontrolling Interests” for additional information regarding Vermeer. Other than the Company’s minimal equity investment, it has not provided any financial or other support to Vermeer that it was not contractually required to provide.
At September 30, 2020, the Company’s consolidated balance sheet included total assets and total liabilities of Vermeer of $1.3 billion and $250.1 million, respectively (December 31, 20162019 - $193.0$1.0 billion and $23.2 million, and $193.0 million, respectively). In addition, the Company’s consolidated balance sheet included redeemable noncontrolling interests associated with Vermeer of $1.1 billion at September 30, 2020 (December 31, 2019 - $1.0 billion).
Mona Lisa Re Ltd. (“Mona Lisa Re”)
On March 14, 2013, Mona Lisa Re wasis licensed as a Bermuda domiciled special purpose insurerSPI to provide reinsurance capacity to subsidiaries of RenaissanceRe, namely Renaissance Reinsurance and DaVinci, through reinsurance agreements which will beare collateralized and funded by Mona Lisa Re through the issuance of one or more series of principal-at-risk variable rate notes to third-party investors.notes.
Upon issuance of a series of notes by Mona Lisa Re, all of the proceeds from the issuance wereare deposited into collateral accounts, separated by series, to fund any potential obligation under the reinsurance agreements entered into with Renaissance Reinsurance and/or DaVinci underlying such series of notes. The outstanding principal amount of each series of notes generally will be returned to holders of such notes upon the expiration of the risk period underlying such notes, unless an event occurs which causes a loss under the applicable series of notes, in which case the amount returned will be reduced by such noteholder’s pro rata share of such loss, as specified in the applicable governing documents of such notes.
In addition, holders of such notes are generally entitled to interest payments, payable quarterly, as determined by the applicable governing documents of each series of notes.
The Company concluded that Mona Lisa Re meets the definition of a VIE as it does not have sufficient equity capital to finance its activities. The Company evaluated its relationship with Mona Lisa Re and concluded it is not the primary beneficiary of Mona Lisa Re as it does not have a variable interest inpower over the activities that most significantly impact the economic performance of Mona Lisa Re. As a result, the financial position and results of operations of Mona Lisa Re are not consolidated by the Company. The Company has not provided financial or other support to
On July 6, 2018, all previously outstanding series of notes issued by Mona Lisa Re that it was not contractually requiredwere redeemed and the proceeds were returned to provide.
the holders of such notes. Effective January 10, 2020, Mona Lisa Re issued two series of principal-at-risk variable rate notes to investors for a total principal amount of $400.0 million. At September 30, 2017,2020, the total assets and total liabilities of Mona Lisa Re were $26.1$408.1 million and $26.1$408.1 million,, respectively (December 31, 20162019 - $184.2 million$6 thousand and $184.2 million,$6 thousand, respectively).
The only transactions related to Mona Lisa Re that are recorded in the Company’s consolidated financial statements are the ceded reinsurance agreements entered into by Renaissance Reinsurance and DaVinci which are accounted for as prospective reinsurance under FASB ASC Topic Financial Services - Insurance. Insurance, and the fair value of the principal-at-risk variable rate notes owned by the Company. Other than its investment in the principal-at-risk variable rate notes of Mona Lisa Re, the Company has not provided financial or other support to Mona Lisa Re that it was not contractually required to provide.
The fair value of the Company’s investment in the principal-at-risk variable rate notes of Mona Lisa Re is included in other investments. Net of third-party investors, the fair value of the Company’s investment in Mona Lisa Re was $2.8 million at September 30, 2020.
Renaissance Reinsurance and DaVinci have together entered into ceded reinsurance contracts with Mona Lisa Re with grossceded premiums cededwritten of $0.2$24.3 million and $0.2$6.7 million, respectively, during the nine months ended September 30, 2017 (20162020 (2019 - $7.4 million$NaN and $5.1 million,$NaN, respectively). In addition, Renaissance Reinsurance and DaVinci recognized ceded premiums earned related to the ceded reinsurance contracts with Mona Lisa Re of $4.0$18.2 million and $2.8$5.1 million, respectively, during the nine months ended September 30, 2017 (20162020 (2019 - $5.4 million$NaN and $3.7 million,$NaN, respectively).
Fibonacci Re
Effective November 7, 2016, Fibonacci Re, a Bermuda-domiciled SPI, was formed to provide collateralized capacity to Renaissance Reinsurance and its affiliates.
Upon issuance of a series of notes by Fibonacci Re, all of the proceeds from the issuance are deposited into collateral accounts, separated by series, to fund any potential obligation under the reinsurance agreements entered into with Renaissance Reinsurance underlying such series of notes. The outstanding principal amount of each series of notes generally willis expected to be returned to holders of such notes upon the expiration of the risk period underlying such notes, unless an event occurs which causes a loss under the applicable series of notes, in which case the amount returned willis expected to be reduced by such noteholder’s pro rata share of such loss, as specified in the applicable governing documents of such notes. In addition, holders of such notes are generally entitled to interest payments, payable quarterly, as determined by the applicable governing documents of each series of notes. RUM receives an origination and structuring fee in connection with the formation and operation of Fibonacci Re.
The Company concluded that Fibonacci Re meets the definition of a VIE as it does not have sufficient equity capital to finance its activities. The Company evaluated its relationship with Fibonacci Re and concluded it is not the primary beneficiary of Fibonacci Re as it does not have power over the activities that most significantly impact the economic performance of Fibonacci Re. As a result, the Company does not consolidate the financial position or results of operations of Fibonacci Re.
The only transactions related to Fibonacci Re that will beare recorded in the Company’s consolidated financial statements will beare the ceded reinsurance agreements entered into by Renaissance Reinsurance that are accounted for as prospective reinsurance under FASB ASC Topic Financial Services - Insurance, and the fair value of the participating notes owned by the Company. Other than its investment in the participating notes of Fibonacci Re, the Company has not provided financial or other support to Fibonacci Re that it was not contractually required to provide.
Effective with the risk periods incepting on January 1, 2017 and June 1, 2017, Fibonacci Re raised $140.0 million and $45.0 million, respectively, of capital from third-party investors and the Company, via private placements of participating notes which are listed on the Bermuda Stock Exchange. The fair value of the Company’s investment in the participating notes of Fibonacci Re is included in other investments. Net of third-party investors, the fair value of the Company’s investment in Fibonacci Re was $16.3$1.0 million at September 30, 2017.2020 (December 31, 2019 - $0.4 million).
Renaissance Reinsurance entered into ceded reinsurance contracts with Fibonacci Re with ceded premiums written of $11 thousand and ceded premiums earned of $9.4 million$11 thousand during the nine months ended September 30, 2017. In addition, Renaissance
Reinsurance recognized ceded premiums earned related to the ceded reinsurance contracts with Fibonacci Re of $6.22020 (2019 - $0.1 million duringand $0.1 million, respectively). During the nine months ended September 30, 2017.2020, Renaissance Reinsurance reduced its net claims and claim expenses ceded to Fibonacci Re by $7.5 million (2019 - ceded net claims and claim expenses of $7.5 million) and as of September 30, 2020 had a net reinsurance recoverable of $NaN from Fibonacci Re (December 31, 2019 - $7.5 million).
The Company and Reinsurance Group of America, Incorporated formed Langhorne, an initiative to source third-party capital to support reinsurers targeting large in-force life and annuity blocks. In connection with Langhorne, as of September 30, 2020 the Company has invested $2.0 million in Langhorne Holdings (December 31, 2019 - $1.7 million), a company that owns and manages certain reinsurance entities within Langhorne. In addition, as of September 30, 2020 the Company has invested $0.1 million in Langhorne Partners (December 31, 2019 - $0.1 million), the general partner for Langhorne and the entity which manages the third-party investors investing into Langhorne Holdings.
The Company concluded that Langhorne Holdings meets the definition of a VIE as the voting rights are not proportional with the obligations to absorb losses and rights to receive residual returns. The Company evaluated its relationship with Langhorne Holdings and concluded it is not the primary beneficiary of Langhorne Holdings, as it does not have power over the activities that most significantly impact the economic performance of Langhorne Holdings. As a result, the Company does not consolidate the financial position or results of operations of Langhorne Holdings. The Company separately evaluated Langhorne Partners and concluded that it was not a VIE. The Company accounts for its investments in Langhorne Holdings and Langhorne Partners under the equity method of accounting, one quarter in arrears.
The Company anticipates that its absolute investment in Langhorne will increase, perhaps materially, as in-force life and annuity blocks of businesses are written. The Company expects its absolute and relative ownership in Langhorne Partners to remain stable. Other than its current and committed future equity
investment in Langhorne, the Company has not provided financial or other support to Langhorne that it was not contractually required to provide.
Shima Re
Shima Re was acquired on March 22, 2019 in connection with the acquisition of TMR. Shima Re is a Bermuda domiciled Class 3 insurer. Shima Re is registered as a segregated accounts company and provides third-party investors with access to reinsurance risk. The maximum remaining exposure of each segregated account is fully collateralized and is funded by cash or investments as prescribed by the participant thereto. Shima Re no longer writes new business and the last in-force contract written by Shima Re expired on December 31, 2019.
Shima Re is considered a VIE as it has voting rights that are not proportional to its participating rights. The Company evaluated its relationship with Shima Re and concluded it is not the primary beneficiary of any segregated account, as it does not have power over the activities that most significantly impact the economic performance of any segregated account. As a result, the Company does not consolidate the financial position or results of operations of Shima Re or its segregated accounts. The Company has not provided any financial or other support to any segregated account of Shima Re that it was not contractually required to provide.
Norwood Re
Norwood Re is managed by a subsidiary of RenaissanceRe Europe that the Company acquired in the acquisition of TMR. Norwood Re is a Bermuda domiciled SPI registered as a segregated accounts company formed to provide solutions for reinsurance-linked asset investors. Norwood Re is wholly owned by the Norwood Re Purpose Trust. Risks assumed by the segregated accounts of Norwood Re are fronted by or ceded from only one cedant - RenaissanceRe Europe and/or its insurance affiliates. The obligations of each segregated account are funded through the issuance of non-voting preference shares to third-party investors. The maximum exposure of each segregated account is fully collateralized and is funded by cash and term deposits or investments as prescribed by the participant thereto. Norwood Re no longer writes new business, and the last in-force contract written by Norwood expired on June 30, 2020.
Norwood Re is considered a VIE as it has voting rights that are not proportional to its participating rights. The Company evaluated its relationship with Norwood Re and concluded it is not the primary beneficiary of Norwood Re and its segregated accounts, as it does not have power over the activities that most significantly impact the economic performance of Norwood Re and its segregated accounts. As a result, the Company does not consolidate the financial position or results of operations of Norwood Re and its segregated accounts. The Company has not provided any financial or other support to Norwood Re that it was not contractually required to provide.
NOTE 10.SHAREHOLDERS’ EQUITY
Dividends
The Board of Directors of RenaissanceRe declared dividends of $0.32$0.35 per common share, payable to common shareholders of record on March 15, 2017,13, 2020, June 15, 20172020 and September 15, 2017, respectively,2020, and RenaissanceRethe Company paid the dividends of $0.32 per common share to common shareholders on March 31, 2017,2020, June 30, 20172020, and September 29, 2017, respectively. 30, 2020.
The Board of Directors approved the payment of quarterly dividends on the Series C 6.08% Preference Shares, and Series E 5.375% Preference Shares and 5.750% Series F Preference Shares to preference shareholders of record in the amounts and on the quarterly record dates and dividend payment dates set forth in the prospectus supplement and Certificate of Designation for the applicable series of preference shares, unless and until further action is taken by the Board of Directors. The dividend payment dates for the preference shares will be the first day of March, June, September and December of each year (or if this date is not a business day, on the business day immediately following this date). The record dates for the preference share dividends are one day prior to the dividend payment dates. The amount of the dividend on the Series C 6.08% Preference Shares is an amount per share equal to 6.08% of the liquidation preference per annum (the equivalent to $1.52 per share per annum, or $0.38 per share per quarter). The amount of the dividend on the Series E 5.375% Preference Shares is an amount per share equal to 5.375% of the liquidation preference per annum (the equivalent to $1.34375 per share per annum, or $0.3359375 per
share per quarter). The amount of the dividend on the 5.750% Series F Preference Shares is an amount per share equal to 5.750% of the liquidation preference per annum (the equivalent to $1,437.50 per 5.750% Series F Preference Share per annum, or $359.375 per 5.750% Series F Preference Share per quarter, or $1.4375 per Depositary Share per annum, or $0.359375 per Depositary Share per quarter).
During the nine months ended September 30, 2017,2020, the Company paid $16.8$23.6 million in preference share dividends (2016(2019 - $16.8$27.6 million) and $50.8 million) and $38.6 million in common share dividends (2016(2019 - $38.9$44.5 million).
Series C 6.08% Preference Shares Redemption
The Series C 6.08% Preference Shares were redeemed on March 26, 2020 for $125.0 million). plus accrued and unpaid dividends thereon. Following the redemption, 0 Series C 6.08% Preference Shares remain outstanding.
Common Shares
On March 22, 2019, in connection with the closing of the acquisition of TMR, the Company issued 1,739,071 of its common shares to Tokio as part of the aggregate consideration payable to Tokio under the TMR Stock Purchase Agreement. See “Note 3. Acquisition of Tokio Millennium Re” in the Company’s “Notes to the Consolidated Financial Statements” included in the Company’s Form 10-K for the year ended December 31, 2019 for additional information related to the acquisition of TMR. On January 9, 2020, Tokio completed a secondary public offering of these common shares, which represented all of Tokio's remaining ownership in the Company. The Company did not receive any proceeds from Tokio’s sale of its common shares.
On June 5, 2020, the Company issued 6,325,000 of its common shares in an underwritten public offering at a public offering price of $166.00 per share. Concurrently with the public offering, the Company raised $75.0 million through the issuance of 451,807 of its common shares at a price of $166.00 per share to State Farm Mutual Automobile Insurance Company, one of the Company’s existing stockholders, in a private placement. The total net proceeds from the offerings were $1.1 billion.
Share Repurchases
The Company’s share repurchase program may be effected from time to time, depending on market conditions and other factors, through open market purchases and privately negotiated transactions. On August 2,November 10, 2017, RenaissanceRe’s Board of Directors approved a renewal of its authorized share repurchase program for an aggregate amount of up to $500.0 million.$500.0 million. Unless terminated earlier by RenaissanceRe’s Board of Directors, the program will expire when the Company has repurchased the full value of the common shares authorized. The Company’s decision to repurchase common shares will depend on, among other matters, the market price of the common shares and the capital requirements of the Company. During the ninethree months ended September 30, 2017,March 31, 2020, the Company repurchased an aggregate of 1.3 million405,682 common shares in open market transactions at an aggregate cost of $188.6$62.6 million and an average price of $142.67$154.36 per common share. Given the current economic environment and to preserve capital for both risk and opportunity, the Company suspended share repurchases in March 2020. The Company did not engage in any share repurchase activity during the second and third quarters of 2020. At September 30, 2017, $467.32020, $437.4 million remained available for repurchase under the share repurchase program.
In the near term, the Company intends to prioritize capital for deployment into its business; however, we may resume repurchases at any time when we believe it is prudent to do so and without further notice.
NOTE 11. EARNINGS PER SHARE
The following table sets forth the computation of basic and diluted earnings per common share:
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
| | | | | | | | | |
| | Three months ended | | Nine months ended | |
| (common shares in thousands) | September 30,
2020 | | September 30,
2019 | | September 30,
2020 | | September 30,
2019 | |
| Numerator: | | | | | | | | |
| Net income available to RenaissanceRe common shareholders | $ | 47,799 | | | $ | 36,698 | | | $ | 541,670 | | | $ | 678,269 | | |
| Amount allocated to participating common shareholders (1) | (582) | | | (446) | | | (6,677) | | | (8,074) | | |
| Net income allocated to RenaissanceRe common shareholders | $ | 47,217 | | | $ | 36,252 | | | $ | 534,993 | | | $ | 670,195 | | |
| Denominator: | | | | | | | | |
| Denominator for basic income per RenaissanceRe common share - weighted average common shares | 50,009 | | | 43,462 | | | 46,130 | | | 43,003 | | |
| Per common share equivalents of employee stock options and non-vested shares | 85 | | | 75 | | | 70 | | | 46 | | |
| Denominator for diluted income per RenaissanceRe common share - adjusted weighted average common shares and assumed conversions | 50,094 | | | 43,537 | | | 46,200 | | | 43,049 | | |
| Net income available to RenaissanceRe common shareholders per common share – basic | $ | 0.94 | | | $ | 0.83 | | | $ | 11.60 | | | $ | 15.58 | | |
| Net income available to RenaissanceRe common shareholders per common share – diluted | $ | 0.94 | | | $ | 0.83 | | | $ | 11.58 | | | $ | 15.57 | | |
| | | | | | | | | |
(1)Represents earnings and dividends attributable to holders of unvested shares issued pursuant to the Company's stock compensation plans.
|
| | | | | | | | | | | | | | | | | |
| | | | | | | | | | |
| | | Three months ended | | Nine months ended | |
| | (common shares in thousands) | September 30,
2017 | | September 30,
2016 | | September 30,
2017 | | September 30,
2016 | |
| | Numerator: | | | | | | | | |
| | Net (loss) income (attributable) available to RenaissanceRe common shareholders | $ | (504,812 | ) | | $ | 146,825 |
| | $ | (241,318 | ) | | $ | 411,145 |
| |
| | Amount allocated to participating common shareholders (1) | (116 | ) | | (1,770 | ) | | (344 | ) | | (4,939 | ) | |
| | Net (loss) income allocated to RenaissanceRe common shareholders | $ | (504,928 | ) | | $ | 145,055 |
| | $ | (241,662 | ) | | $ | 406,206 |
| |
| | Denominator: | | | | | | | | |
| | Denominator for basic (loss) income per RenaissanceRe common share - weighted average common shares | 39,591 |
| | 40,513 |
| | 39,979 |
| | 41,594 |
| |
| | Per common share equivalents of employee stock options and restricted shares | — |
| | 220 |
| | — |
| | 248 |
| |
| | Denominator for diluted (loss) income per RenaissanceRe common share - adjusted weighted average common shares and assumed conversions | 39,591 |
| | 40,733 |
| | 39,979 |
| | 41,842 |
| |
| | Net (loss) income (attributable) available to RenaissanceRe common shareholders per common share – basic | $ | (12.75 | ) | | $ | 3.58 |
| | $ | (6.04 | ) | | $ | 9.77 |
| |
| | Net (loss) income (attributable) available to RenaissanceRe common shareholders per common share – diluted | $ | (12.75 | ) | | $ | 3.56 |
| | $ | (6.04 | ) | | $ | 9.71 |
| |
| | | | | | | | | | |
| |
(1) | Represents earnings attributable to holders of unvested restricted shares issued pursuant to the Company’s 2001 Stock Incentive Plan, 2010 Performance-Based Equity Incentive Plan, 2016 Long-Term Incentive Plan and to the Company’s non-employee directors. |
NOTE 12.SEGMENT REPORTING
The Company’s reportable segments are defined as follows: (1) Property, which is comprised of catastrophe and other property reinsurance and insurance written on behalf of the Company’s operating subsidiaries and certain joint ventures managed by the Company’s ventures unit, and (2) Casualty and Specialty, which is comprised of casualty and specialty reinsurance and insurance written on behalf of the Company’s operating subsidiaries and certain joint ventures managed by the Company’s ventures unit. In addition to its reportable segments, the Company has an Other category, which primarily includes its strategic investments, investments unit, corporate expenses, capital servicing costs, noncontrolling interests, certain expenses related to the acquisition of Platinum,acquisitions and the remnants of its former Bermuda-based insurance operations.
The Company’s Property segment is managed by the Chief Underwriting Officer - Property and the Casualty and Specialty segment is managed by the Chief Underwriting Officer - Casualty and Specialty. EachSpecialty, each of the Chief Underwriting Officer - Property and Chief Underwriting Officer - Casualty and Specialtywhom operate under the direction of the Company’s Group Chief Underwriting Officer, who in turn reports to the Company’s President and Chief Executive Officer.
The Company does not currently manage its assets by segment; accordingly, net investment income and total assets are not allocated to the segments.
A summary of the significant components of the Company’s revenues and expenses by segment is as follows:
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
| | | | | | | | | |
| Three months ended September 30, 2020 | Property | | Casualty and Specialty | | Other | | Total | |
| Gross premiums written | $ | 427,765 | | | $ | 715,293 | | | $ | 0 | | | $ | 1,143,058 | | |
| Net premiums written | $ | 378,708 | | | $ | 520,703 | | | $ | 0 | | | $ | 899,411 | | |
| Net premiums earned | $ | 516,623 | | | $ | 483,560 | | | $ | 0 | | | $ | 1,000,183 | | |
| Net claims and claim expenses incurred | 590,958 | | | 351,052 | | | 20 | | | 942,030 | | |
| Acquisition expenses | 98,545 | | | 116,636 | | | (1) | | | 215,180 | | |
| Operational expenses | 33,672 | | | 15,319 | | | 54 | | | 49,045 | | |
| Underwriting (loss) income | $ | (206,552) | | | $ | 553 | | | $ | (73) | | | (206,072) | | |
| Net investment income | | | | | 83,543 | | | 83,543 | | |
| Net foreign exchange gains | | | | | 17,426 | | | 17,426 | | |
| Equity in earnings of other ventures | | | | | 5,457 | | | 5,457 | | |
| Other income | | | | | 1,476 | | | 1,476 | | |
| Net realized and unrealized gains on investments | | | | | 224,208 | | | 224,208 | | |
| | | | | | | | | |
| Corporate expenses | | | | | (48,050) | | | (48,050) | | |
| Interest expense | | | | | (11,843) | | | (11,843) | | |
| Income before taxes | | | | | | | 66,145 | | |
| Income tax benefit | | | | | 8,244 | | | 8,244 | | |
| | | | | | | | | |
| Net income attributable to redeemable noncontrolling interests | | | | | (19,301) | | | (19,301) | | |
| Dividends on preference shares | | | | | (7,289) | | | (7,289) | | |
| Net income available to RenaissanceRe common shareholders | | | | | | | $ | 47,799 | | |
| | | | | | | | | |
| Net claims and claim expenses incurred – current accident year | $ | 629,827 | | | $ | 366,080 | | | $ | 0 | | | $ | 995,907 | | |
| Net claims and claim expenses incurred – prior accident years | (38,869) | | | (15,028) | | | 20 | | | (53,877) | | |
| Net claims and claim expenses incurred – total | $ | 590,958 | | | $ | 351,052 | | | $ | 20 | | | $ | 942,030 | | |
| | | | | | | | | |
| Net claims and claim expense ratio – current accident year | 121.9 | % | | 75.7 | % | | | | 99.6 | % | |
| Net claims and claim expense ratio – prior accident years | (7.5) | % | | (3.1) | % | | | | (5.4) | % | |
| Net claims and claim expense ratio – calendar year | 114.4 | % | | 72.6 | % | | | | 94.2 | % | |
| Underwriting expense ratio | 25.6 | % | | 27.3 | % | | | | 26.4 | % | |
| Combined ratio | 140.0 | % | | 99.9 | % | | | | 120.6 | % | |
| | | | | | | | | |
| | | | | | | | | |
|
| | | | | | | | | | | | | | | | | |
| | | | | | | | | | |
| | Three months ended September 30, 2017 | Property | | Casualty and Specialty | | Other | | Total | |
| | Gross premiums written | $ | 325,395 |
| | $ | 314,881 |
| | $ | (7 | ) | | $ | 640,269 |
| |
| | Net premiums written | $ | 269,393 |
| | $ | 213,835 |
| | $ | (7 | ) | | $ | 483,221 |
| |
| | Net premiums earned | $ | 336,838 |
| | $ | 210,961 |
| | $ | (7 | ) | | $ | 547,792 |
| |
| | Net claims and claim expenses incurred | 1,044,418 |
| | 177,433 |
| | (155 | ) | | 1,221,696 |
| |
| | Acquisition expenses | 17,514 |
| | 59,248 |
| | (1 | ) | | 76,761 |
| |
| | Operational expenses | 25,123 |
| | 17,389 |
| | 25 |
| | 42,537 |
| |
| | Underwriting (loss) income | $ | (750,217 | ) | | $ | (43,109 | ) | | $ | 124 |
| | (793,202 | ) | |
| | Net investment income | | | | | 40,257 |
| | 40,257 |
| |
| | Net foreign exchange losses | | | | | (156 | ) | | (156 | ) | |
| | Equity in earnings of other ventures | | | | | 1,794 |
| | 1,794 |
| |
| | Other income | | | | | 2,996 |
| | 2,996 |
| |
| | Net realized and unrealized gains on investments | | | | | 42,052 |
| | 42,052 |
| |
| | Corporate expenses | | | | | (4,413 | ) | | (4,413 | ) | |
| | Interest expense | | | | | (11,799 | ) | | (11,799 | ) | |
| | Loss before taxes | | | | | | | (722,471 | ) | |
| | Income tax benefit | | | | | 18,977 |
| | 18,977 |
| |
| | Net loss attributable to redeemable noncontrolling interests | | | | | 204,277 |
| | 204,277 |
| |
| | Dividends on preference shares | | | | | (5,595 | ) | | (5,595 | ) | |
| | Net loss attributable to RenaissanceRe common shareholders | | | | | | | $ | (504,812 | ) | |
| | | | | | | | | | |
| | Net claims and claim expenses incurred – current accident year | $ | 1,036,586 |
| | $ | 172,675 |
| | $ | — |
| | $ | 1,209,261 |
| |
| | Net claims and claim expenses incurred – prior accident years | 7,832 |
| | 4,758 |
| | (155 | ) | | 12,435 |
| |
| | Net claims and claim expenses incurred – total | $ | 1,044,418 |
| | $ | 177,433 |
| | $ | (155 | ) | | $ | 1,221,696 |
| |
| | | | | | | | | | |
| | Net claims and claim expense ratio – current accident year | 307.7 | % | | 81.9 | % | | | | 220.8 | % | |
| | Net claims and claim expense ratio – prior accident years | 2.4 | % | | 2.2 | % | | | | 2.2 | % | |
| | Net claims and claim expense ratio – calendar year | 310.1 | % | | 84.1 | % | | | | 223.0 | % | |
| | Underwriting expense ratio | 12.6 | % | | 36.3 | % | | | | 21.8 | % | |
| | Combined ratio | 322.7 | % | | 120.4 | % | | | | 244.8 | % | |
| | | | | | | | | | |
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
| | | | | | | | | |
| Nine months ended September 30, 2020 | Property | | Casualty and Specialty | | Other | | Total | |
| Gross premiums written | $ | 2,690,827 | | | $ | 2,179,824 | | | $ | 0 | | | $ | 4,870,651 | | |
| Net premiums written | $ | 1,757,427 | | | $ | 1,592,595 | | | $ | 0 | | | $ | 3,350,022 | | |
| Net premiums earned | $ | 1,429,074 | | | $ | 1,494,303 | | | $ | 0 | | | $ | 2,923,377 | | |
| Net claims and claim expenses incurred | 899,860 | | | 1,123,527 | | | (131) | | | 2,023,256 | | |
| Acquisition expenses | 278,668 | | | 380,726 | | | 0 | | | 659,394 | | |
| Operational expenses | 109,335 | | | 56,195 | | | 53 | | | 165,583 | | |
| Underwriting income (loss) | $ | 141,211 | | | $ | (66,145) | | | $ | 78 | | | 75,144 | | |
| Net investment income | | | | | 272,321 | | | 272,321 | | |
| Net foreign exchange gains | | | | | 4,503 | | | 4,503 | | |
| Equity in earnings of other ventures | | | | | 19,062 | | | 19,062 | | |
| Other loss | | | | | (4,161) | | | (4,161) | | |
| Net realized and unrealized gains on investments | | | | | 561,891 | | | 561,891 | | |
| | | | | | | | | |
| Corporate expenses | | | | | (75,939) | | | (75,939) | | |
| Interest expense | | | | | (38,612) | | | (38,612) | | |
| Income before taxes | | | | | | | 814,209 | | |
| Income tax expense | | | | | (12,785) | | | (12,785) | | |
| | | | | | | | | |
| Net income attributable to redeemable noncontrolling interests | | | | | (236,120) | | | (236,120) | | |
| Dividends on preference shares | | | | | (23,634) | | | (23,634) | | |
| Net income available to RenaissanceRe common shareholders | | | | | | | $ | 541,670 | | |
| | | | | | | | | |
| Net claims and claim expenses incurred – current accident year | $ | 931,285 | | | $ | 1,147,354 | | | $ | 0 | | | $ | 2,078,639 | | |
| Net claims and claim expenses incurred – prior accident years | (31,425) | | | (23,827) | | | (131) | | | (55,383) | | |
| Net claims and claim expenses incurred – total | $ | 899,860 | | | $ | 1,123,527 | | | $ | (131) | | | $ | 2,023,256 | | |
| | | | | | | | | |
| Net claims and claim expense ratio – current accident year | 65.2 | % | | 76.8 | % | | | | 71.1 | % | |
| Net claims and claim expense ratio – prior accident years | (2.2) | % | | (1.6) | % | | | | (1.9) | % | |
| Net claims and claim expense ratio – calendar year | 63.0 | % | | 75.2 | % | | | | 69.2 | % | |
| Underwriting expense ratio | 27.1 | % | | 29.2 | % | | | | 28.2 | % | |
| Combined ratio | 90.1 | % | | 104.4 | % | | | | 97.4 | % | |
| | | | | | | | | |
|
| | | | | | | | | | | | | | | | | |
| | | | | | | | | | |
| | Nine months ended September 30, 2017 | Property | | Casualty and Specialty | | Other | | Total | |
| | Gross premiums written | $ | 1,345,271 |
| | $ | 1,044,510 |
| | $ | (7 | ) | | $ | 2,389,774 |
| |
| | Net premiums written | $ | 895,728 |
| | $ | 687,381 |
| | $ | (7 | ) | | $ | 1,583,102 |
| |
| | Net premiums earned | $ | 716,024 |
| | $ | 580,085 |
| | $ | (7 | ) | | $ | 1,296,102 |
| |
| | Net claims and claim expenses incurred | 1,116,273 |
| | 441,801 |
| | (710 | ) | | 1,557,364 |
| |
| | Acquisition expenses | 75,117 |
| | 173,179 |
| | (2 | ) | | 248,294 |
| |
| | Operational expenses | 76,841 |
| | 54,708 |
| | 37 |
| | 131,586 |
| |
| | Underwriting (loss) income | $ | (552,207 | ) | | $ | (89,603 | ) | | $ | 668 |
| | (641,142 | ) | |
| | Net investment income | | | | | 148,745 |
| | 148,745 |
| |
| | Net foreign exchange gains | | | | | 11,118 |
| | 11,118 |
| |
| | Equity in earnings of other ventures | | | | | 5,830 |
| | 5,830 |
| |
| | Other income | | | | | 7,053 |
| | 7,053 |
| |
| | Net realized and unrealized gains on investments | | | | | 143,538 |
| | 143,538 |
| |
| | Corporate expenses | | | | | (14,335 | ) | | (14,335 | ) | |
| | Interest expense | | | | | (32,416 | ) | | (32,416 | ) | |
| | Loss before taxes | | | | | | | (371,609 | ) | |
| | Income tax benefit | | | | | 14,739 |
| | 14,739 |
| |
| | Net income attributable to redeemable noncontrolling interests | | | | | 132,338 |
| | 132,338 |
| |
| | Dividends on preference shares | | | | | (16,786 | ) | | (16,786 | ) | |
| | Net loss attributable to RenaissanceRe common shareholders | | | | | | | $ | (241,318 | ) | |
| | | | | | | | | | |
| | Net claims and claim expenses incurred – current accident year | $ | 1,133,241 |
| | $ | 427,786 |
| | $ | — |
| | $ | 1,561,027 |
| |
| | Net claims and claim expenses incurred – prior accident years | (16,968 | ) | | 14,015 |
| | (710 | ) | | (3,663 | ) | |
| | Net claims and claim expenses incurred – total | $ | 1,116,273 |
| | $ | 441,801 |
| | $ | (710 | ) | | $ | 1,557,364 |
| |
| | | | | | | | | | |
| | Net claims and claim expense ratio – current accident year | 158.3 | % | | 73.7 | % | | | | 120.4 | % | |
| | Net claims and claim expense ratio – prior accident years | (2.4 | )% | | 2.5 | % | | | | (0.2 | )% | |
| | Net claims and claim expense ratio – calendar year | 155.9 | % | | 76.2 | % | | | | 120.2 | % | |
| | Underwriting expense ratio | 21.2 | % | | 39.2 | % | | | | 29.3 | % | |
| | Combined ratio | 177.1 | % | | 115.4 | % | | | | 149.5 | % | |
| | | | | | | | | | |
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
| | | | | | | | | |
| Three months ended September 30, 2019 | Property | | Casualty and Specialty | | Other | | Total | |
| Gross premiums written | $ | 314,400 | | | $ | 546,668 | | | $ | 0 | | | $ | 861,068 | | |
| Net premiums written | $ | 302,982 | | | $ | 401,148 | | | $ | 0 | | | $ | 704,130 | | |
| Net premiums earned | $ | 444,332 | | | $ | 462,416 | | | $ | 0 | | | $ | 906,748 | | |
| Net claims and claim expenses incurred | 338,260 | | | 316,099 | | | 161 | | | 654,520 | | |
| Acquisition expenses | 79,521 | | | 122,654 | | | 6 | | | 202,181 | | |
| Operational expenses | 34,238 | | | 19,198 | | | (21) | | | 53,415 | | |
| Underwriting (loss) income | $ | (7,687) | | | $ | 4,465 | | | $ | (146) | | | (3,368) | | |
| Net investment income | | | | | 111,387 | | | 111,387 | | |
| Net foreign exchange losses | | | | | (8,275) | | | (8,275) | | |
| Equity in earnings of other ventures | | | | | 5,877 | | | 5,877 | | |
| Other income | | | | | 1,016 | | | 1,016 | | |
| Net realized and unrealized gains on investments | | | | | 34,395 | | | 34,395 | | |
| | | | | | | | | |
| Corporate expenses | | | | | (13,844) | | | (13,844) | | |
| Interest expense | | | | | (15,580) | | | (15,580) | | |
| Income before taxes | | | | | | | 111,608 | | |
| Income tax expense | | | | | (3,664) | | | (3,664) | | |
| | | | | | | | | |
| Net income attributable to redeemable noncontrolling interests | | | | | (62,057) | | | (62,057) | | |
| Dividends on preference shares | | | | | (9,189) | | | (9,189) | | |
| Net income available to RenaissanceRe common shareholders | | | | | | | $ | 36,698 | | |
| | | | | | | | | |
| Net claims and claim expenses incurred – current accident year | $ | 345,880 | | | $ | 319,087 | | | $ | 0 | | | $ | 664,967 | | |
| Net claims and claim expenses incurred – prior accident years | (7,620) | | | (2,988) | | | 161 | | | (10,447) | | |
| Net claims and claim expenses incurred – total | $ | 338,260 | | | $ | 316,099 | | | $ | 161 | | | $ | 654,520 | | |
| | | | | | | | | |
| Net claims and claim expense ratio – current accident year | 77.8 | % | | 69.0 | % | | | | 73.3 | % | |
| Net claims and claim expense ratio – prior accident years | (1.7) | % | | (0.6) | % | | | | (1.1) | % | |
| Net claims and claim expense ratio – calendar year | 76.1 | % | | 68.4 | % | | | | 72.2 | % | |
| Underwriting expense ratio | 25.6 | % | | 30.6 | % | | | | 28.2 | % | |
| Combined ratio | 101.7 | % | | 99.0 | % | | | | 100.4 | % | |
| | | | | | | | | |
| | | | | | | | | |
|
| | | | | | | | | | | | | | | | | |
| | | | | | | | | | |
| | Three months ended September 30, 2016 | Property | | Casualty and Specialty | | Other | | Total | |
| | Gross premiums written | $ | 119,904 |
| | $ | 310,320 |
| | $ | — |
| | $ | 430,224 |
| |
| | Net premiums written | $ | 90,909 |
| | $ | 193,313 |
| | $ | — |
| | $ | 284,222 |
| |
| | Net premiums earned | $ | 172,661 |
| | $ | 173,860 |
| | $ | — |
| | $ | 346,521 |
| |
| | Net claims and claim expenses incurred | 23,539 |
| | 89,844 |
| | (808 | ) | | 112,575 |
| |
| | Acquisition expenses | 21,663 |
| | 58,917 |
| | — |
| | 80,580 |
| |
| | Operational expenses | 24,258 |
| | 16,217 |
| | 18 |
| | 40,493 |
| |
| | Underwriting income | $ | 103,201 |
| | $ | 8,882 |
| | $ | 790 |
| | 112,873 |
| |
| | Net investment income | | | | | 51,423 |
| | 51,423 |
| |
| | Net foreign exchange losses | | | | | (5,986 | ) | | (5,986 | ) | |
| | Equity in losses of other ventures | | | | | (11,630 | ) | | (11,630 | ) | |
| | Other income | | | | | 2,268 |
| | 2,268 |
| |
| | Net realized and unrealized gains on investments | | | | | 59,870 |
| | 59,870 |
| |
| | Corporate expenses | | | | | (11,537 | ) | | (11,537 | ) | |
| | Interest expense | | | | | (10,536 | ) | | (10,536 | ) | |
| | Income before taxes and noncontrolling interests | | | | | | | 186,745 |
| |
| | Income tax benefit | | | | | 1,316 |
| | 1,316 |
| |
| | Net income attributable to noncontrolling interests | | | | | (35,641 | ) | | (35,641 | ) | |
| | Dividends on preference shares | | | | | (5,595 | ) | | (5,595 | ) | |
| | Net income available to RenaissanceRe common shareholders | | | | | | | $ | 146,825 |
| |
| | | | | | | | | | |
| | Net claims and claim expenses incurred – current accident year | $ | 42,062 |
| | $ | 116,298 |
| | $ | — |
| | $ | 158,360 |
| |
| | Net claims and claim expenses incurred – prior accident years | (18,523 | ) | | (26,454 | ) | | (808 | ) | | (45,785 | ) | |
| | Net claims and claim expenses incurred – total | $ | 23,539 |
| | $ | 89,844 |
| | $ | (808 | ) | | $ | 112,575 |
| |
| | | | | | | | | | |
| | Net claims and claim expense ratio – current accident year | 24.4 | % | | 66.9 | % | | | | 45.7 | % | |
| | Net claims and claim expense ratio – prior accident years | (10.8 | )% | | (15.2 | )% | | | | (13.2 | )% | |
| | Net claims and claim expense ratio – calendar year | 13.6 | % | | 51.7 | % | | | | 32.5 | % | |
| | Underwriting expense ratio | 26.6 | % | | 43.2 | % | | | | 34.9 | % | |
| | Combined ratio | 40.2 | % | | 94.9 | % | | | | 67.4 | % | |
| | | | | | | | | | |
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
| | | | | | | | | |
| Nine months ended September 30, 2019 | Property | | Casualty and Specialty | | Other | | Total | |
| Gross premiums written | $ | 2,185,984 | | | $ | 1,716,287 | | | $ | 0 | | | $ | 3,902,271 | | |
| Net premiums written | $ | 1,411,327 | | | $ | 1,244,799 | | | $ | 0 | | | $ | 2,656,126 | | |
| Net premiums earned | $ | 1,160,090 | | | $ | 1,208,188 | | | $ | 0 | | | $ | 2,368,278 | | |
| Net claims and claim expenses incurred | 541,217 | | | 793,533 | | | 178 | | | 1,334,928 | | |
| Acquisition expenses | 222,971 | | | 330,829 | | | (186) | | | 553,614 | | |
| Operational expenses | 99,546 | | | 58,603 | | | 13 | | | 158,162 | | |
| Underwriting income (loss) | $ | 296,356 | | | $ | 25,223 | | | $ | (5) | | | 321,574 | | |
| Net investment income | | | | | 312,069 | | | 312,069 | | |
| Net foreign exchange losses | | | | | (1,812) | | | (1,812) | | |
| Equity in earnings of other ventures | | | | | 17,350 | | | 17,350 | | |
| Other income | | | | | 5,109 | | | 5,109 | | |
| Net realized and unrealized gains on investments | | | | | 395,655 | | | 395,655 | | |
| | | | | | | | | |
| Corporate expenses | | | | | (76,480) | | | (76,480) | | |
| Interest expense | | | | | (42,868) | | | (42,868) | | |
| Income before taxes | | | | | | | 930,597 | | |
| Income tax expense | | | | | (20,670) | | | (20,670) | | |
| Net income attributable to redeemable noncontrolling interests | | | | | (204,091) | | | (204,091) | | |
| Dividends on preference shares | | | | | (27,567) | | | (27,567) | | |
| Net income available to RenaissanceRe common shareholders | | | | | | | $ | 678,269 | | |
| | | | | | | | | |
| Net claims and claim expenses incurred – current accident year | $ | 536,197 | | | $ | 813,251 | | | $ | 0 | | | $ | 1,349,448 | | |
| Net claims and claim expenses incurred – prior accident years | 5,020 | | | (19,718) | | | 178 | | | (14,520) | | |
| Net claims and claim expenses incurred – total | $ | 541,217 | | | $ | 793,533 | | | $ | 178 | | | $ | 1,334,928 | | |
| | | | | | | | | |
| Net claims and claim expense ratio – current accident year | 46.2 | % | | 67.3 | % | | | | 57.0 | % | |
| Net claims and claim expense ratio – prior accident years | 0.5 | % | | (1.6) | % | | | | (0.6) | % | |
| Net claims and claim expense ratio – calendar year | 46.7 | % | | 65.7 | % | | | | 56.4 | % | |
| Underwriting expense ratio | 27.8 | % | | 32.2 | % | | | | 30.0 | % | |
| Combined ratio | 74.5 | % | | 97.9 | % | | | | 86.4 | % | |
| | | | | | | | | |
|
| | | | | | | | | | | | | | | | | |
| | | | | | | | | | |
| | Nine months ended September 30, 2016 | Property | | Casualty and Specialty | | Other | | Total | |
| | Gross premiums written | $ | 1,058,816 |
| | $ | 992,669 |
| | $ | — |
| | $ | 2,051,485 |
| |
| | Net premiums written | $ | 674,361 |
| | $ | 641,452 |
| | $ | — |
| | $ | 1,315,813 |
| |
| | Net premiums earned | $ | 538,953 |
| | $ | 512,576 |
| | $ | — |
| | $ | 1,051,529 |
| |
| | Net claims and claim expenses incurred | 125,618 |
| | 282,117 |
| | (805 | ) | | 406,930 |
| |
| | Acquisition expenses | 71,176 |
| | 144,001 |
| | — |
| | 215,177 |
| |
| | Operational expenses | 79,441 |
| | 68,261 |
| | 99 |
| | 147,801 |
| |
| | Underwriting income | $ | 262,718 |
| | $ | 18,197 |
| | $ | 706 |
| | 281,621 |
| |
| | Net investment income | | | | | 134,410 |
| | 134,410 |
| |
| | Net foreign exchange losses | | | | | (8,368 | ) | | (8,368 | ) | |
| | Equity in losses of other ventures | | | | | (3,997 | ) | | (3,997 | ) | |
| | Other income | | | | | 9,001 |
| | 9,001 |
| |
| | Net realized and unrealized gains on investments | | | | | 191,295 |
| | 191,295 |
| |
| | Corporate expenses | | | | | (25,514 | ) | | (25,514 | ) | |
| | Interest expense | | | | | (31,610 | ) | | (31,610 | ) | |
| | Income before taxes and noncontrolling interests | | | | | | | 546,838 |
| |
| | Income tax expense | | | | | (8,040 | ) | | (8,040 | ) | |
| | Net income attributable to noncontrolling interests | | | | | (110,867 | ) | | (110,867 | ) | |
| | Dividends on preference shares | | | | | (16,786 | ) | | (16,786 | ) | |
| | Net income available to RenaissanceRe common shareholders | | | | | | | $ | 411,145 |
| |
| | | | | | | | | | |
| | Net claims and claim expenses incurred – current accident year | $ | 163,130 |
| | $ | 320,444 |
| | $ | — |
| | $ | 483,574 |
| |
| | Net claims and claim expenses incurred – prior accident years | (37,512 | ) | | (38,327 | ) | | (805 | ) | | (76,644 | ) | |
| | Net claims and claim expenses incurred – total | $ | 125,618 |
| | $ | 282,117 |
| | $ | (805 | ) | | $ | 406,930 |
| |
| | | | | | | | | | |
| | Net claims and claim expense ratio – current accident year | 30.3 | % | | 62.5 | % | | | | 46.0 | % | |
| | Net claims and claim expense ratio – prior accident years | (7.0 | )% | | (7.5 | )% | | | | (7.3 | )% | |
| | Net claims and claim expense ratio – calendar year | 23.3 | % | | 55.0 | % | | | | 38.7 | % | |
| | Underwriting expense ratio | 28.0 | % | | 41.4 | % | | | | 34.5 | % | |
| | Combined ratio | 51.3 | % | | 96.4 | % | | | | 73.2 | % | |
| | | | | | | | | | |
NOTE 13.DERIVATIVE INSTRUMENTS
From time to time, the Company may enter into derivative instruments such as futures, options, swaps, forward contracts and other derivative contracts primarily to manage its foreign currency exposure, obtain exposure to a particular financial market, for yield enhancement, or for trading and speculation.to assume risk. The Company’s derivative instruments arecan be exchange traded or over-the-counter, with over-the-counter derivatives generally traded under International Swaps and Derivatives Association master agreements, which establish the terms of the transactions entered into with the Company’s derivative counterparties. In the event a party becomes insolvent or otherwise defaults on its obligations, a master agreement generally permits the non-defaulting party to accelerate and terminate all outstanding transactions and net the transactions’ marked-to-market values so that a single sum in a single currency will be owed by, or owed to, the non-defaulting party. Effectively, this contractual close-out netting reduces credit exposure from gross to net exposure. Where the Company has entered into master netting agreements with counterparties, or the Company has the legal and contractual right to offset positions, the derivative positions are generally netted by counterparty and are reported accordingly in other assets and other liabilities. Commencing in the second quarter of 2019, the Company elected to adopt hedge accounting for certain of its derivative instruments used as hedges of a net investment in a foreign operation.
The tables below show the gross and net amounts of recognized derivative assets and liabilities at fair value, including the location on the consolidated balance sheets of the Company’s principal derivative instruments:
|
| | | | | | | | | | | | | | | | | | | | | | | |
| | | | | | | | | | | | | | |
| | | Derivative Assets | |
| | At September 30, 2017 | Gross Amounts of Recognized Assets | | Gross Amounts Offset in the Balance Sheet | | Net Amounts of Assets Presented in the Balance Sheet | | Balance Sheet Location | | Collateral | | Net Amount | |
| | Interest rate futures | $ | 740 |
| | 614 |
| | $ | 126 |
| | Other assets | | $ | — |
| | $ | 126 |
| |
| | Interest rate swaps | 551 |
| | 277 |
| | 274 |
| | Other assets | | — |
| | 274 |
| |
| | Foreign currency forward contracts (1) | 4,758 |
| | 557 |
| | 4,201 |
| | Other assets | | — |
| | 4,201 |
| |
| | Foreign currency forward contracts (2) | 43 |
| | 14 |
| | 29 |
| | Other assets | | — |
| | 29 |
| |
| | Credit default swaps | 956 |
| | 308 |
| | 648 |
| | Other assets | | — |
| | 648 |
| |
| | Total | $ | 7,048 |
| | $ | 1,770 |
| | $ | 5,278 |
| | | | $ | — |
| | $ | 5,278 |
| |
| | | | | | | | | | | | | | |
| | | Derivative Liabilities | |
| | At September 30, 2017 | Gross Amounts of Recognized Liabilities | | Gross Amounts Offset in the Balance Sheet | | Net Amounts of Liabilities Presented in the Balance Sheet | | Balance Sheet Location | | Collateral Pledged | | Net Amount | |
| | Interest rate futures | $ | 854 |
| | 614 |
| | $ | 240 |
| | Other liabilities | | $ | 240 |
| | $ | — |
| |
| | Interest rate swaps | 280 |
| | 277 |
| | 3 |
| | Other liabilities | | 3 |
| | — |
| |
| | Foreign currency forward contracts (1) | 2,996 |
| | — |
| | 2,996 |
| | Other liabilities | | — |
| | 2,996 |
| |
| | Foreign currency forward contracts (2) | 90 |
| | 14 |
| | 76 |
| | Other liabilities | | — |
| | 76 |
| |
| | Credit default swaps | 327 |
| | 308 |
| | 19 |
| | Other liabilities | | — |
| | 19 |
| |
| | Total | $ | 4,547 |
| | $ | 1,213 |
| | $ | 3,334 |
| | | | $ | 243 |
| | $ | 3,091 |
| |
| | | | | | | | | | | | | | |
| |
(1) | Contracts used to manage foreign currency risks in underwriting and non-investment operations. |
| |
(2) | Contracts used to manage foreign currency risks in investment operations. |
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
| | | | | | | | | | | | | |
| | Derivative Assets | |
| At September 30, 2020 | Gross Amounts of Recognized Assets | | Gross Amounts Offset in the Balance Sheet | | Net Amounts of Assets Presented in the Balance Sheet | | Balance Sheet Location | | Collateral | | Net Amount | |
| Derivative instruments not designated as hedges | | | | | | | | | | | | |
| Interest rate futures | $ | 3,642 | | | $ | 2,057 | | | $ | 1,585 | | | Other assets | | $ | 0 | | | $ | 1,585 | | |
| | | | | | | | | | | | | |
| Foreign currency forward contracts (1) | 3,235 | | | 695 | | | 2,540 | | | Other assets | | 0 | | | 2,540 | | |
| Foreign currency forward contracts (2) | 1,100 | | | 413 | | | 687 | | | Other assets | | 0 | | | 687 | | |
| Credit default swaps | 76 | | | 0 | | | 76 | | | Other assets | | 0 | | | 76 | | |
| | | | | | | | | | | | | |
| | | | | | | | | | | | | |
| | | | | | | | | | | | | |
| | | | | | | | | | | | | |
| Total derivative instruments not designated as hedges | 8,053 | | | 3,165 | | | 4,888 | | | | | 0 | | | 4,888 | | |
| Derivative instruments designated as hedges | | | | | | | | | | | | |
| Foreign currency forward contracts (3) | 4,744 | | | 3,210 | | | 1,534 | | | Other assets | | 0 | | | 1,534 | | |
| | | | | | | | | | | | | |
| Total | $ | 12,797 | | | $ | 6,375 | | | $ | 6,422 | | | | | $ | 0 | | | $ | 6,422 | | |
| | | | | | | | | | | | | |
| | | | | | | | | | | | | |
| | | | | | | | | | | | | |
| | Derivative Liabilities | |
| At September 30, 2020 | Gross Amounts of Recognized Liabilities | | Gross Amounts Offset in the Balance Sheet | | Net Amounts of Liabilities Presented in the Balance Sheet | | Balance Sheet Location | | Collateral Pledged | | Net Amount | |
| Derivative instruments not designated as hedges | | | | | | | | | | | | |
| Interest rate futures | $ | 2,410 | | | $ | 2,057 | | | $ | 353 | | | Other liabilities | | $ | 353 | | | $ | 0 | | |
| Interest rate swaps | 54 | | | 0 | | | 54 | | | Other assets | | 54 | | | 0 | | |
| Foreign currency forward contracts (1) | 6,885 | | | 998 | | | 5,887 | | | Other liabilities | | 0 | | | 5,887 | | |
| Foreign currency forward contracts (2) | 1,364 | | | 413 | | | 951 | | | Other liabilities | | 0 | | | 951 | | |
| Credit default swaps | 244 | | | 0 | | | 244 | | | Other assets | | 244 | | | 0 | | |
| Total return swaps | 85 | | | 0 | | | 85 | | | Other assets | | 0 | | | 85 | | |
| | | | | | | | | | | | | |
| | | | | | | | | | | | | |
| | | | | | | | | | | | | |
| Total derivative instruments not designated as hedges | 11,042 | | | 3,468 | | | 7,574 | | | | | 651 | | | 6,923 | | |
| Derivative instruments designated as hedges | | | | | | | | | | | | |
| Foreign currency forward contracts (3) | 581 | | | 260 | | | 321 | | | Other liabilities | | 0 | | | 321 | | |
| | | | | | | | | | | | | |
| Total | $ | 11,623 | | | $ | 3,728 | | | $ | 7,895 | | | | | $ | 651 | | | $ | 7,244 | | |
| | | | | | | | | | | | | |
(1)Contracts used to manage foreign currency risks in underwriting and non-investment operations.
(2)Contracts used to manage foreign currency risks in investment operations.
(3)Contracts designated as hedges of net investments in foreign operations.
|
| | | | | | | | | | | | | | | | | | | | | | | |
| | | | | | | | | | | | | | |
| | | Derivative Assets | |
| | At December 31, 2016 | Gross Amounts of Recognized Assets | | Gross Amounts Offset in the Balance Sheet | | Net Amounts of Assets Presented in the Balance Sheet | | Balance Sheet Location | | Collateral | | Net Amount | |
| | Interest rate futures | $ | 1,384 |
| | 1,235 |
| | $ | 149 |
| | Other assets | | $ | — |
| | $ | 149 |
| |
| | Foreign currency forward contracts (1) | 774 |
| | — |
| | 774 |
| | Other assets | | — |
| | 774 |
| |
| | Foreign currency forward contracts (2) | 621 |
| | 447 |
| | 174 |
| | Other assets | | — |
| | 174 |
| |
| | Credit default swaps | 1,429 |
| | 23 |
| | 1,406 |
| | Other assets | | — |
| | 1,406 |
| |
| | Total | $ | 4,208 |
| | $ | 1,705 |
| | $ | 2,503 |
| | | | $ | — |
| | $ | 2,503 |
| |
| | | | | | | | | | | | | | |
| | | Derivative Liabilities | |
| | At December 31, 2016 | Gross Amounts of Recognized Liabilities | | Gross Amounts Offset in the Balance Sheet | | Net Amounts of Liabilities Presented in the Balance Sheet | | Balance Sheet Location | | Collateral Pledged | | Net Amount | |
| | Interest rate futures | $ | 2,030 |
| | 1,235 |
| | $ | 795 |
| | Other liabilities | | $ | 789 |
| | $ | 6 |
| |
| | Foreign currency forward contracts (1) | 10,550 |
| | 397 |
| | 10,153 |
| | Other liabilities | | — |
| | 10,153 |
| |
| | Foreign currency forward contracts (2) | 766 |
| | 447 |
| | 319 |
| | Other liabilities | | — |
| | 319 |
| |
| | Credit default swaps | 181 |
| | 23 |
| | 158 |
| | Other liabilities | | — |
| | 158 |
| |
| | Total | $ | 13,527 |
| | $ | 2,102 |
| | $ | 11,425 |
| | | | $ | 789 |
| | $ | 10,636 |
| |
| | | | | | | | | | | | | | |
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
| | | | | | | | | | | | | |
| | Derivative Assets | |
| At December 31, 2019 | Gross Amounts of Recognized Assets | | Gross Amounts Offset in the Balance Sheet | | Net Amounts of Assets Presented in the Balance Sheet | | Balance Sheet Location | | Collateral | | Net Amount | |
| Derivative instruments not designated as hedges | | | | | | | | | | | | |
| Interest rate futures | $ | 234 | | | $ | 122 | | | $ | 112 | | | Other assets | | $ | 0 | | | $ | 112 | | |
| | | | | | | | | | | | | |
| Foreign currency forward contracts (1) | 22,702 | | | 2,418 | | | 20,284 | | | Other assets | | 0 | | | 20,284 | | |
| Foreign currency forward contracts (2) | 1,082 | | | 622 | | | 460 | | | Other assets | | 0 | | | 460 | | |
| Credit default swaps | 37 | | | 0 | | | 37 | | | Other assets | | 0 | | | 37 | | |
| Total return swaps | 3,744 | | | 0 | | | 3,744 | | | Other assets | | 3,601 | | | 143 | | |
| Equity futures | 291 | | | 0 | | | 291 | | | Other assets | | 0 | | | 291 | | |
| | | | | | | | | | | | | |
| | | | | | | | | | | | | |
| Total derivative instruments not designated as hedges | 28,090 | | | 3,162 | | | 24,928 | | | | | 3,601 | | | 21,327 | | |
| Derivative instruments designated as hedges | | | | | | | | | | | | |
| Foreign currency forward contracts (3) | 64 | | | 667 | | | (603) | | | Other assets | | 0 | | | (603) | | |
| | | | | | | | | | | | | |
| Total | $ | 28,154 | | | $ | 3,829 | | | $ | 24,325 | | | | | $ | 3,601 | | | $ | 20,724 | | |
| | | | | | | | | | | | | |
| | | | | | | | | | | | | |
| | | | | | | | | | | | | |
| | Derivative Liabilities | |
| At December 31, 2019 | Gross Amounts of Recognized Liabilities | | Gross Amounts Offset in the Balance Sheet | | Net Amounts of Liabilities Presented in the Balance Sheet | | Balance Sheet Location | | Collateral Pledged | | Net Amount | |
| Derivative instruments not designated as hedges | | | | | | | | | | | | |
| Interest rate futures | $ | 1,545 | | | $ | 122 | | | $ | 1,423 | | | Other liabilities | | $ | 1,423 | | | $ | 0 | | |
| Interest rate swaps | 50 | | | 0 | | | 50 | | | Other liabilities | | 50 | | | 0 | | |
| Foreign currency forward contracts (1) | 3,808 | | | 28 | | | 3,780 | | | Other liabilities | | 0 | | | 3,780 | | |
| Foreign currency forward contracts (2) | 939 | | | 622 | | | 317 | | | Other liabilities | | 0 | | | 317 | | |
| | | | | | | | | | | | | |
| | | | | | | | | | | | | |
| | | | | | | | | | | | | |
| Total derivative instruments not designated as hedges | 6,342 | | | 772 | | | 5,570 | | | | | 1,473 | | | 4,097 | | |
| Derivative instruments designated as hedges | | | | | | | | | | | | |
| Foreign currency forward contracts (3) | 1,818 | | | 0 | | | 1,818 | | | Other liabilities | | 0 | | | 1,818 | | |
| Total | $ | 8,160 | | | $ | 772 | | | $ | 7,388 | | | | | $ | 1,473 | | | $ | 5,915 | | |
| | | | | | | | | | | | | |
| |
(1) | (1)Contracts used to manage foreign currency risks in underwriting and non-investment operations. |
| |
(2) | Contracts used to manage foreign currency risks in investment operations. |
Refer to manage foreign currency risks in underwriting and non-investment operations.
(2)Contracts used to manage foreign currency risks in investment operations.
(3)Contracts designated as hedges of net investments in foreign operations.
See “Note 3.3. Investments” for information on reverse repurchase agreements.
The location and amount of the gain (loss) recognized in the Company’s consolidated statements of operations related to its principal derivative instruments are shown in the following table:
|
| | | | | | | | | | | |
| | | | | | | | |
| | | Location of gain (loss) recognized on derivatives | | Amount of gain (loss) recognized on derivatives | |
| | Three months ended September 30, | | | 2017 | | 2016 | |
| | Interest rate futures | Net realized and unrealized gains on investments | | $ | (3,016 | ) | | $ | 1,040 |
| |
| | Interest rate swaps | Net realized and unrealized gains on investments | | 271 |
| | — |
| |
| | Foreign currency forward contracts (1) | Net foreign exchange (losses) gains | | 2,056 |
| | 5,097 |
| |
| | Foreign currency forward contracts (2) | Net foreign exchange (losses) gains | | (40 | ) | | (489 | ) | |
| | Credit default swaps | Net realized and unrealized gains on investments | | (1,275 | ) | | 687 |
| |
| | Total | | | $ | (2,004 | ) | | $ | 6,335 |
| |
| | | | | | | | |
| | | | | | | | | | | | | | | | | | | | |
| | | | | | |
| | Location of gain (loss)
recognized on derivatives | Amount of gain (loss) recognized on
derivatives | |
| Three months ended September 30, | | 2020 | | 2019 | |
| Derivative instruments not designated as hedges | | | | | |
| Interest rate futures | Net realized and unrealized gains on investments | $ | 4,985 | | | $ | 7,263 | | |
| Interest rate swaps | Net realized and unrealized gains on investments | 243 | | | 887 | | |
| Foreign currency forward contracts (1) | Net foreign exchange gains (losses) | 2,495 | | | (5,912) | | |
| Foreign currency forward contracts (2) | Net foreign exchange gains (losses) | (730) | | | 911 | | |
| Credit default swaps | Net realized and unrealized gains on investments | (87) | | | 65 | | |
| Total return swaps | Net realized and unrealized gains on investments | 1,227 | | | 1,960 | | |
| Equity futures | Net realized and unrealized gains on investments | (4,335) | | | 959 | | |
| | | | | | |
| | | | | | |
| | | | | | |
| Total derivative instruments not designated as hedges | | 3,798 | | | 6,133 | | |
| Derivative instruments designated as hedges | | | | | |
| Foreign currency forward contracts (3) | Accumulated other comprehensive loss | (1,957) | | | 3,264 | | |
| Total derivative instruments designated as hedges | | (1,957) | | | 3,264 | | |
| Total | | $ | 1,841 | | | $ | 9,397 | | |
| | | | | | |
| | | | | | |
| | | | | | |
| | Location of gain (loss)
recognized on derivatives | Amount of gain (loss) recognized on
derivatives | |
| Nine months ended September 30, | | 2020 | | 2019 | |
| Derivative instruments not designated as hedges | | | | | |
| Interest rate futures | Net realized and unrealized gains on investments | $ | 95,548 | | | $ | 35,570 | | |
| Interest rate swaps | Net realized and unrealized gains on investments | 2,852 | | | 2,071 | | |
| Foreign currency forward contracts (1) | Net foreign exchange gains (losses) | 9,073 | | | (13,086) | | |
| Foreign currency forward contracts (2) | Net foreign exchange gains (losses) | (1,943) | | | (1,370) | | |
| Credit default swaps | Net realized and unrealized gains on investments | (3,010) | | | 5,521 | | |
| Total return swaps | Net realized and unrealized gains on investments | (5,759) | | | 6,995 | | |
| Equity futures | Net realized and unrealized gains on investments | (30,045) | | | 11,946 | | |
| | | | | | |
| | | | | | |
| | | | | | |
| Total derivative instruments not designated as hedges | | 66,716 | | | 47,647 | | |
| Derivative instruments designated as hedges | | | | | |
| Foreign currency forward contracts (3) | Accumulated other comprehensive loss | 193 | | | 4,108 | | |
| Total derivative instruments designated as hedges | | 193 | | | 4,108 | | |
| Total | | $ | 66,909 | | | $ | 51,755 | | |
| | | | | | |
|
| | | | | | | | | | | |
| | | | | | | | |
| | | Location of gain (loss) recognized on derivatives | | Amount of gain (loss) recognized on derivatives | |
| | Nine months ended September 30, | | | 2017 | | 2016 | |
| | Interest rate futures | Net realized and unrealized gains on investments | | $ | (4,064 | ) | | $ | (27,775 | ) | |
| | Interest rate swaps | Net realized and unrealized gains on investments | | 271 |
| | — |
| |
| | Foreign currency forward contracts (1) | Net foreign exchange (losses) gains | | 8,339 |
| | (92 | ) | |
| | Foreign currency forward contracts (2) | Net foreign exchange (losses) gains | | (940 | ) | | (3,706 | ) | |
| | Credit default swaps | Net realized and unrealized gains on investments | | (551 | ) | | 902 |
| |
| | Total | | | $ | 3,055 |
| | $ | (30,671 | ) | |
| | | | | | | | |
(2)Contracts used to manage foreign currency risks in investment operations.
(3)Contracts designated as hedges of net investments in foreign operations.
| |
(1) | Contracts used to manage foreign currency risks in underwriting and non-investment operations. |
| |
(2) | Contracts used to manage foreign currency risks in investment operations. |
The Company is not aware of the existence of any credit-risk related contingent features that it believes would be triggered in its derivative instruments that are in a net liability position at September 30, 2017.2020.
Derivative Instruments Not Designated as Hedges
Interest Rate Derivatives
The Company uses interest rate futures and swaps within its portfolio of fixed maturity investments to manage its exposure to interest rate risk, which may result in increasing or decreasing its exposure to this risk.
Interest Rate Futures
The fair value of interest rate futures is determined using exchange traded prices. At September 30, 2017,2020, the Company had $1.1$2.2 billion of notional long positions and $399.7 million$1.1 billion of notional short positions of primarily Eurodollar and U.S. treasury and non-U.S. dollar futures contracts (December(December 31, 20162019 - $1.2$2.5 billion and $727.9 million,$1.0 billion, respectively).
Interest Rate Swaps
During the three months ended September 30, 2017, the Company entered into interest rate swaps. The fair value of interest rate swaps is determined using the relevant exchange traded price where available or a discounted cash flow model based on the terms of the contract and inputs, including, where applicable, observable yield curves. At September 30, 2017,2020, the Company had $51.3 million$NaN of notional positions paying a fixed rate and $5.3$23.5 million receiving a fixed rate denominated in U.S. dollars.
dollar swap contracts (December 31, 2019 - $27.9 million and $25.5 million, respectively).
Foreign Currency Derivatives
The Company’s functionalreporting currency is the U.S. dollar. TheIn addition, the functional currency of the Company, and the majority of the Company’s subsidiaries, is the U.S. dollar. However, the Company writes a portion of its business in currencies other than U.S. dollars and may, from time to time, experience foreign exchange gains and losses in the Company’s consolidated financial statements. All changes in exchange rates, with the exception of non-monetary assets and liabilities, are recognized in the Company’s consolidated statements of operations.
Underwriting and Non-investments Operations Related Foreign Currency Contracts
The Company’s foreign currency policy with regard to its underwriting operations is generally to holdenter into foreign currency assets, including cash, investmentsforward and receivablesoption contracts for notional values that approximate the foreign currency liabilities, including claims and claim expense reserves and reinsurance balances payable. When necessary,payable, net of any cash, investments and receivables held in the Company mayrespective foreign currency. The Company’s use of foreign currency forward and option contracts is intended to minimize the effect of fluctuating foreign currencies on the value of non-U.S. dollar denominated assets and liabilities associated with its underwriting operations. The fair value of the Company’s underwriting operations related foreign currency contracts is determined using indicative pricing obtained from counterparties or broker quotes. At September 30, 2017,2020, the Company had outstanding underwriting related foreign currency contracts of $191.1$445.4 million in notional long positions and $68.5$523.6 million in notional short positions, denominated in U.S. dollars (December(December 31, 20162019 - $184.2$722.6 million and $91.4 million,$1.2 billion, respectively).
Investment Portfolio Related Foreign Currency Forward Contracts
The Company’s investment operations are exposed to currency fluctuations through its investments in non-U.S. dollar fixed maturity investments, short term investments and other investments. From time to time, the Company may employ foreign currency forward contracts in its investment portfolio to either assume foreign currency risk or to economically hedge its exposure to currency fluctuations from these investments. The fair value of the Company’s investment portfolio related foreign currency forward contracts is determined using an interpolated rate based on closing forward market rates. At September 30, 2017,2020, the Company had outstanding investment portfolio related foreign currency contracts of $17.6$257.4 million in notional long
positions and $4.5$112.3 million in notional short positions, denominated in U.S. dollars (December(December 31, 20162019 - $26.9$195.6 million and $57.3$61.0 million,, respectively).
Credit Derivatives
The Company’s exposure to credit risk is primarily due to its fixed maturity investments, short term investments, premiums receivable and reinsurance recoverable. From time to time, the Company purchasesmay purchase credit derivatives to hedge its exposures in the insurance industry, and to assist in managing the credit risk associated with ceded reinsurance. The Company also employs credit derivatives in its investment portfolio to either assume credit risk or hedge its credit exposure.
Credit Default Swaps
The fair value of the Company’s credit derivativesdefault swaps is determined using industry valuation models, broker bid indications or internal pricing valuation techniques. The fair value of these credit derivativesdefault swaps can change based on a variety of factors including changes in credit spreads, default rates and recovery rates, the correlation of credit risk between the referenced credit and the counterparty, and market rate inputs such as interest rates. At September 30, 2017,2020, the Company had outstanding credit derivativesdefault swaps of $15.5 million$NaN in notional positions to hedge credit risk and $13.3$115.2 million in notional positions to assume credit risk, denominated in U.S. dollars (December(December 31, 20162019 - $Nil$0.5 million and $75.2$143.4 million, respectively).
Total Return Swaps
The Company uses total return swaps as a means to manage spread duration and credit exposure in its investment portfolio. The fair value of the Company’s total return swaps is determined using broker-dealer bid quotations, market-based prices from pricing vendors or valuation models. At September 30, 2020, the Company had $6.1 million of notional long positions (long credit) and $NaN of notional short positions (short credit), denominated in U.S. dollars (December 31, 2019 - $173.5 million and $NaN, respectively).
Equity Futures
The Company uses equity derivatives in its investment portfolio from time to time to either assume equity risk or hedge its equity exposure. The fair value of the Company’s equity futures is determined using market-based prices from pricing vendors. At September 30, 2020, the Company had $NaN notional long position and $NaN notional short position of equity futures, denominated in U.S. dollars (December 31, 2019 - $122.0 million and $NaN, respectively).
Derivative Instruments Designated as Hedges of Net Investments in Foreign Operations
Foreign Currency Derivatives
Hedges of Net Investments in Foreign Operations
In connection with the acquisition of TMR, the Company acquired certain entities with non-U.S. dollar functional currencies, including RenaissanceRe Europe AG, Australia Branch and RenaissanceRe Europe AG, U.K. Branch, which have an Australian dollar and Pound sterling functional currency, respectively. The Company has entered into foreign exchange forwards to hedge the Australian dollar and Pound sterling net investments in foreign operations, on an after-tax basis, from changes in the exchange rates between the U.S. dollar and the Australian dollar and between the U.S. dollar and the Pound sterling.
The Company utilizes foreign exchange forward contracts to hedge the fair value of its net investments in foreign operations. During 2020 and 2019, the Company entered into foreign exchange forward contracts that were formally designated as hedges of its investments in RenaissanceRe Europe AG, Australia Branch and RenaissanceRe Europe AG, U.K Branch. There was no ineffectiveness in these transactions.
The table below provides a summary of derivative instruments designated as hedges of net investments in foreign operations, including the weighted average U.S. dollar equivalent of foreign denominated net (liabilities) assets that were hedged and the resulting derivative (losses) gains that are recorded in foreign currency translation adjustments, net of tax, within accumulated other comprehensive (loss) income on the Company’s consolidated statements of changes in shareholders’ equity:
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
| | | | | | | | | |
| | Three months ended | | Nine months ended | |
| | September 30,
2020 | | September 30,
2019 | | September 30,
2020 | | September 30,
2019 | |
| Weighted average of U.S. dollar equivalent of foreign denominated net (liabilities) assets | $ | (59,250) | | | $ | 79,538 | | | $ | 8,777 | | | $ | 80,303 | | |
| Derivative (losses) gains (1) | $ | (1,957) | | | $ | 3,264 | | | $ | 193 | | | $ | 4,108 | | |
| | | | | | | | | |
(1) Derivative (losses) gains from derivative instruments designated as hedges of the net investment in a foreign operation are recorded in foreign currency translation adjustments, net of tax, within accumulated other comprehensive (loss) income on the Company’s consolidated statements of changes in shareholders’ equity.
NOTE 14.COMMITMENTS, CONTINGENCIES AND OTHER ITEMS
There are no material changes from the commitments, contingencies and contingenciesother items previously disclosed in the Company’s Form 10-K for the year ended December 31, 2016.2019.
Legal Proceedings
The Company and its subsidiaries are subject to lawsuits and regulatory actions in the normal course of business that do not arise from or directly relate to claims on reinsurance treaties or contracts or direct surplus lines insurance policies. In the Company’s industry, business litigation may involve allegations of underwriting or claims-handling errors or misconduct, disputes relating to the scope of, or compliance with, the terms of delegated underwriting agreements, employment claims, regulatory actions or disputes arising
from the Company’s business ventures. The Company’s operating subsidiaries are subject to claims litigation involving, among other things, disputed interpretations of policy coverages. Generally, the Company’s direct surplus lines insurance operations are subject to greater frequency and diversity of claims and claims-related litigation than its reinsurance operations and, in some jurisdictions, may be subject to direct actions by allegedly injured persons or entities seeking damages from policyholders. These lawsuits, involving or arising out of claims on policies issued by the Company’s subsidiaries which are typical to the insurance industry in general and in the normal course of business, are considered in its loss and loss expense reserves. In addition, the Company may from time to time engage in litigation or arbitration related to its claims for payment in respect of ceded reinsurance, including disputes that challenge the Company’s ability to enforce its underwriting intent. Such matters could result, directly or indirectly, in providers of protection not meeting their obligations to the Company or not doing so on a timely basis. The Company may also be subject to other disputes from time to time, relating to operational or other matters distinct from insurance or reinsurance claims. Any litigation or arbitration, or regulatory process contains an element of uncertainty, and the value of an exposure or a gain contingency related to a dispute is difficult to estimate accordingly. Currently, theestimate. The Company believes that no individual litigation or arbitration to which it is presently a party is likely to have a material adverse effect on its financial condition, business or operations.
NOTE 15. SALE OF RENAISSANCERE UK
On February 4, 2020, RenaissanceRe Specialty Holdings entered into an agreement to sell its wholly owned subsidiary, RenaissanceRe UK, a U.K. run-off company, to an investment vehicle managed by AXA Liabilities Managers, an affiliate of AXA XL. The sale received regulatory approval on July 17, 2020 and closed on August 18, 2020. The Company recognized a pre-tax loss on the sale of RenaissanceRe UK of $30.2 million, which is included in corporate expenses in the Company’s consolidated statements of operations for the three and nine months ended September 30, 2020. The loss on sale includes amounts related to prior purchase GAAP adjustments and cumulative currency translation adjustments recorded since the acquisition of RenaissanceRe UK. The financial results of RenaissanceRe UK for the period from January 1, 2020 through August 18, 2020, are recorded in the Company’s consolidated statements of operations as part of net income available to RenaissanceRe common shareholders for the three and nine months ended September 30, 2020. Prior to the sale, the underwriting activities of RenaissanceRe UK were principally all within the Company’s Casualty and Specialty segment.
NOTE 15.16. CONDENSED CONSOLIDATING FINANCIAL INFORMATION PROVIDED IN CONNECTION WITH OUTSTANDING DEBT OF SUBSIDIARIES
The following tables are provided in connection with outstanding debt of the Company’s subsidiaries and present condensed consolidating balance sheets at September 30, 20172020 and December 31, 2016,2019, condensed consolidating statements of operations and condensed consolidating statements of comprehensive (loss) income for the three and nine months ended September 30, 20172020 and 2016,2019, and condensed consolidating statements of cash flows for the nine months ended September 30, 2017. Each of RenRe North America Holdings Inc., Platinum Underwriters2020 and 2019. RenaissanceRe Finance Inc. and RenaissanceRe Finance is a 100% owned subsidiary of RenaissanceRe.RenaissanceRe and has outstanding debt securities. For additional information related to the terms of the Company’s outstanding debt securities, see “Note 9.8. Debt and Credit Facilities” in the “Notes to the Consolidated Financial Statements” in the Company’s Form 10-K for the year ended December 31, 20162019 and “Note 7. Debt and Credit Facilities” in the “Notes to the Consolidated Financial Statements” included herein.
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
Condensed Consolidating Balance Sheet
at September 30, 2020 | RenaissanceRe
Holdings Ltd.
(Parent
Guarantor) | | | | | | RenaissanceRe Finance Inc. (Subsidiary Issuer) | | Other
RenaissanceRe
Holdings Ltd.
Subsidiaries and
Eliminations
(Non-guarantor
Subsidiaries)
(1) | | Consolidating
Adjustments
(2) | | RenaissanceRe
Consolidated |
| Assets | | | | | | | | | | | | | |
| Total investments | $ | 263,640 | | | | | | | $ | 33,702 | | | $ | 20,021,991 | | | $ | 0 | | | $ | 20,319,333 | |
| Cash and cash equivalents | 10,523 | | | | | | | 11,125 | | | 1,265,730 | | | 0 | | | 1,287,378 | |
| Investments in subsidiaries | 6,493,407 | | | | | | | 1,517,062 | | | 736,150 | | | (8,746,619) | | | 0 | |
| Due from subsidiaries and affiliates | 7,984 | | | | | | | (106,263) | | | 98,284 | | | (5) | | | 0 | |
| Premiums receivable | 0 | | | | | | | 0 | | | 3,337,120 | | | 0 | | | 3,337,120 | |
| Prepaid reinsurance premiums | 0 | | | | | | | 0 | | | 1,082,270 | | | 0 | | | 1,082,270 | |
| Reinsurance recoverable | 0 | | | | | | | 0 | | | 2,883,808 | | | 0 | | | 2,883,808 | |
| Accrued investment income | 491 | | | | | | | 11 | | | 71,445 | | | 0 | | | 71,947 | |
| Deferred acquisition costs | 0 | | | | | | | 0 | | | 697,346 | | | 0 | | | 697,346 | |
| Receivable for investments sold | 0 | | | | | | | 0 | | | 752,936 | | | 0 | | | 752,936 | |
| Other assets | 924,023 | | | | | | | 13,733 | | | 400,402 | | | (1,031,893) | | | 306,265 | |
| Goodwill and other intangible assets | 113,136 | | | | | | | 0 | | | 144,301 | | | 0 | | | 257,437 | |
| | | | | | | | | | | | | |
| Total assets | $ | 7,813,204 | | | | | | | $ | 1,469,370 | | | $ | 31,491,783 | | | $ | (9,778,517) | | | $ | 30,995,840 | |
| Liabilities, Noncontrolling Interests and Shareholders’ Equity | | | | | | | | | | | | | |
| Liabilities | | | | | | | | | | | | | |
| Reserve for claims and claim expenses | $ | 0 | | | | | | | $ | 0 | | | $ | 9,900,615 | | | $ | 0 | | | $ | 9,900,615 | |
| Unearned premiums | 0 | | | | | | | 0 | | | 3,276,156 | | | 0 | | | 3,276,156 | |
| Debt | 392,161 | | | | | | | 772,300 | | | 1,003,695 | | | (1,032,416) | | | 1,135,740 | |
| | | | | | | | | | | | | |
| Reinsurance balances payable | 0 | | | | | | | 0 | | | 3,915,804 | | | 0 | | | 3,915,804 | |
| Payable for investments purchased | 9,988 | | | | | | | 2,497 | | | 1,585,408 | | | 0 | | | 1,597,893 | |
| Other liabilities | 20,234 | | | | | | | 8,228 | | | 3,359,021 | | | (2,995,989) | | | 391,494 | |
| | | | | | | | | | | | | |
| Total liabilities | 422,383 | | | | | | | 783,025 | | | 23,040,699 | | | (4,028,405) | | | 20,217,702 | |
| Redeemable noncontrolling interests | 0 | | | | | | | 0 | | | 3,387,317 | | | 0 | | | 3,387,317 | |
| Shareholders’ Equity | | | | | | | | | | | | | |
| Total shareholders’ equity | 7,390,821 | | | | | | | 686,345 | | | 5,063,767 | | | (5,750,112) | | | 7,390,821 | |
| Total liabilities, noncontrolling interests and shareholders’ equity | $ | 7,813,204 | | | | | | | $ | 1,469,370 | | | $ | 31,491,783 | | | $ | (9,778,517) | | | $ | 30,995,840 | |
|
| | | | | | | | | | | | | | | | | | | | | | | | | | | |
| Condensed Consolidating Balance Sheet at September 30, 2017 | RenaissanceRe
Holdings Ltd.
(Parent
Guarantor) | | RenRe North
America
Holdings Inc.
(Subsidiary
Issuer) | | Platinum Underwriters Finance, Inc. (Subsidiary Issuer) | | RenaissanceRe Finance, Inc. (Subsidiary Issuer) | | Other
RenaissanceRe
Holdings Ltd.
Subsidiaries and
Eliminations
(Non-guarantor
Subsidiaries)
(1) | | Consolidating
Adjustments
(2) | | RenaissanceRe
Consolidated |
| Assets | | | | | | | | | | | | | |
| Total investments | $ | 193,268 |
| | $ | 130,802 |
| | $ | — |
| | $ | 35,098 |
| | $ | 9,283,010 |
| | $ | — |
| | $ | 9,642,178 |
|
| Cash and cash equivalents | 12,370 |
| | 226 |
| | 10 |
| | 7,663 |
| | 561,307 |
| | — |
| | 581,576 |
|
| Investments in subsidiaries | 3,968,721 |
| | 37,834 |
| | — |
| | 1,152,247 |
| | — |
| | (5,158,802 | ) | | — |
|
| Due from subsidiaries and affiliates | 107,746 |
| | 91,891 |
| | — |
| | — |
| | — |
| | (199,637 | ) | | — |
|
| Premiums receivable | — |
| | — |
| | — |
| | — |
| | 1,521,266 |
| | — |
| | 1,521,266 |
|
| Prepaid reinsurance premiums | — |
| | — |
| | — |
| | — |
| | 635,756 |
| | — |
| | 635,756 |
|
| Reinsurance recoverable | — |
| | — |
| | — |
| | — |
| | 1,588,304 |
| | — |
| | 1,588,304 |
|
| Accrued investment income | 125 |
| | 197 |
| | — |
| | 59 |
| | 37,985 |
| | — |
| | 38,366 |
|
| Deferred acquisition costs | — |
| | — |
| | — |
| | — |
| | 434,914 |
| | — |
| | 434,914 |
|
| Receivable for investments sold | 9,042 |
| | 13,472 |
| | — |
| | 101 |
| | 171,143 |
| | — |
| | 193,758 |
|
| Other assets | 429,594 |
| | 36,825 |
| | — |
| | 435,815 |
| | 98,023 |
| | (836,238 | ) | | 164,019 |
|
| Goodwill and other intangible assets | 126,246 |
| | — |
| | — |
| | — |
| | 118,541 |
| | — |
| | 244,787 |
|
| Total assets | $ | 4,847,112 |
| | $ | 311,247 |
| | $ | 10 |
| | $ | 1,630,983 |
| | $ | 14,450,249 |
| | $ | (6,194,677 | ) | | $ | 15,044,924 |
|
| Liabilities, Noncontrolling Interests and Shareholders’ Equity | | | | | | | | | | | | | |
| Liabilities | | | | | | | | | | | | | |
| Reserve for claims and claim expenses | $ | — |
| | $ | — |
| | $ | — |
| | $ | — |
| | $ | 5,192,313 |
| | $ | — |
| | $ | 5,192,313 |
|
| Unearned premiums | — |
| | — |
| | — |
| | — |
| | 1,713,069 |
| | — |
| | 1,713,069 |
|
| Debt | 417,000 |
| | — |
| | — |
| | 841,592 |
| | 147,653 |
| | (417,000 | ) | | 989,245 |
|
| Amounts due to subsidiaries and affiliates | 2,950 |
| | 55 |
| | — |
| | 97,365 |
| | — |
| | (100,370 | ) | | — |
|
| Reinsurance balances payable | — |
| | — |
| | — |
| | — |
| | 1,034,454 |
| | — |
| | 1,034,454 |
|
| Payable for investments purchased | 8,989 |
| | 17,938 |
| | — |
| | — |
| | 350,616 |
| | — |
| | 377,543 |
|
| Other liabilities | 15,161 |
| | 927 |
| | — |
| | 9,926 |
| | 282,647 |
| | (7,102 | ) | | 301,559 |
|
| Total liabilities | 444,100 |
| | 18,920 |
| | — |
| | 948,883 |
| | 8,720,752 |
| | (524,472 | ) | | 9,608,183 |
|
| Redeemable noncontrolling interests | — |
| | — |
| | — |
| | — |
| | 1,033,729 |
| | — |
| | 1,033,729 |
|
| Shareholders’ Equity | | | | | | | | | | | | | |
| Total shareholders’ equity | 4,403,012 |
| | 292,327 |
| | 10 |
| | 682,100 |
| | 4,695,768 |
| | (5,670,205 | ) | | 4,403,012 |
|
| Total liabilities, noncontrolling interests and shareholders’ equity | $ | 4,847,112 |
| | $ | 311,247 |
| | $ | 10 |
| | $ | 1,630,983 |
| | $ | 14,450,249 |
| | $ | (6,194,677 | ) | | $ | 15,044,924 |
|
| |
(1) | Includes all other subsidiaries of RenaissanceRe Holdings Ltd. and eliminations. |
| |
(2) | Includes Parent Guarantor, Subsidiary Guarantor and Subsidiary Issuer consolidating adjustments. |
|
| | | | | | | | | | | | | | | | | | | | | | | | | | | |
| Condensed Consolidating Balance Sheet at December 31, 2016 | RenaissanceRe Holdings Ltd. (Parent Guarantor) | | RenRe North
America
Holdings Inc.
(Subsidiary
Issuer) | | Platinum Underwriters Finance, Inc. (Subsidiary Issuer) | | RenaissanceRe Finance, Inc. (Subsidiary Issuer) | | Other RenaissanceRe Holdings Ltd. Subsidiaries and Eliminations (Non-guarantor Subsidiaries) (1) | | Consolidating Adjustments (2) | | RenaissanceRe Consolidated |
| Assets | | | | | | | | | | | | | |
| Total investments | $ | 387,274 |
| | $ | 119,163 |
| | $ | 267,556 |
| | $ | 45,027 |
| | $ | 8,497,948 |
| | $ | — |
| | $ | 9,316,968 |
|
| Cash and cash equivalents | 7,067 |
| | 162 |
| | 6,671 |
| | 9,397 |
| | 397,860 |
| | — |
| | 421,157 |
|
| Investments in subsidiaries | 4,074,769 |
| | 34,761 |
| | 843,089 |
| | 1,165,413 |
| | — |
| | (6,118,032 | ) | | — |
|
| Due from subsidiaries and affiliates | 7,413 |
| | 91,892 |
| | — |
| | — |
| | — |
| | (99,305 | ) | | — |
|
| Premiums receivable | — |
| | — |
| | — |
| | — |
| | 987,323 |
| | — |
| | 987,323 |
|
| Prepaid reinsurance premiums | — |
| | — |
| | — |
| | — |
| | 441,260 |
| | — |
| | 441,260 |
|
| Reinsurance recoverable | — |
| | — |
| | — |
| | — |
| | 279,564 |
| | — |
| | 279,564 |
|
| Accrued investment income | 105 |
| | 289 |
| | 551 |
| | 106 |
| | 37,025 |
| | — |
| | 38,076 |
|
| Deferred acquisition costs | — |
| | — |
| | — |
| | — |
| | 335,325 |
| | — |
| | 335,325 |
|
| Receivable for investments sold | 136 |
| | 2 |
| | 99 |
| | 45 |
| | 105,559 |
| | — |
| | 105,841 |
|
| Other assets | 410,757 |
| | 37,204 |
| | 4,689 |
| | 127,572 |
| | 118,098 |
| | (522,938 | ) | | 175,382 |
|
| Goodwill and other intangible assets | 130,407 |
| | — |
| | — |
| | — |
| | 120,779 |
| | — |
| | 251,186 |
|
| Total assets | $ | 5,017,928 |
| | $ | 283,473 |
| | $ | 1,122,655 |
| | $ | 1,347,560 |
| | $ | 11,320,741 |
| | $ | (6,740,275 | ) | | $ | 12,352,082 |
|
| Liabilities, Redeemable Noncontrolling Interest and Shareholders’ Equity | | | | | | | | | | | | | |
| Liabilities | | | | | | | | | | | | | |
| Reserve for claims and claim expenses | $ | — |
| | $ | — |
| | $ | — |
| | $ | — |
| | $ | 2,848,294 |
| | $ | — |
| | $ | 2,848,294 |
|
| Unearned premiums | — |
| | — |
| | — |
| | — |
| | 1,231,573 |
| | — |
| | 1,231,573 |
|
| Debt | 117,000 |
| | — |
| | 255,352 |
| | 545,889 |
| | 147,422 |
| | (117,000 | ) | | 948,663 |
|
| Amounts due to subsidiaries and affiliates | 14,644 |
| | 42 |
| | 123 |
| | 96,061 |
| | — |
| | (110,870 | ) | | — |
|
| Reinsurance balances payable | — |
| | — |
| | — |
| | — |
| | 673,983 |
| | — |
| | 673,983 |
|
| Payable for investments purchased | — |
| | — |
| | — |
| | — |
| | 305,714 |
| | — |
| | 305,714 |
|
| Other liabilities | 19,707 |
| | 10,544 |
| | — |
| | 13,350 |
| | 270,610 |
| | (12,527 | ) | | 301,684 |
|
| Total liabilities | 151,351 |
| | 10,586 |
| | 255,475 |
| | 655,300 |
| | 5,477,596 |
| | (240,397 | ) | | 6,309,911 |
|
| Redeemable noncontrolling interests | — |
| | — |
| | — |
| | — |
| | 1,175,594 |
| | — |
| | 1,175,594 |
|
| Shareholders’ Equity | | | | | | | | | | | | | |
| Total shareholders’ equity | 4,866,577 |
| | 272,887 |
| | 867,180 |
| | 692,260 |
| | 4,667,551 |
| | (6,499,878 | ) | | 4,866,577 |
|
| Total liabilities, redeemable noncontrolling interest and shareholders’ equity | $ | 5,017,928 |
| | $ | 283,473 |
| | $ | 1,122,655 |
| | $ | 1,347,560 |
| | $ | 11,320,741 |
| | $ | (6,740,275 | ) | | $ | 12,352,082 |
|
| |
(1) | Includes all other subsidiaries of RenaissanceRe Holdings Ltd. and eliminations. |
| |
(2) | Includes Parent Guarantor and Subsidiary Issuer consolidating adjustments. |
|
| | | | | | | | | | | | | | | | | | | | | | | | | | | |
Condensed Consolidating Statement of Operations for
the three months ended September 30, 2017 | RenaissanceRe
Holdings Ltd.
(Parent
Guarantor) | | RenRe North
America
Holdings Inc.
(Subsidiary
Issuer) | | Platinum Underwriters Finance, Inc. (Subsidiary Issuer) | | RenaissanceRe Finance, Inc. (Subsidiary Issuer) | | Other
RenaissanceRe
Holdings Ltd.
Subsidiaries and
Eliminations
(Non-guarantor
Subsidiaries)
(1) | | Consolidating
Adjustments
(2) | | RenaissanceRe
Consolidated |
| Revenues | | | | | | | | | | | | | |
| Net premiums earned | $ | — |
| | $ | — |
| | $ | — |
| | $ | — |
| | $ | 547,792 |
| | $ | — |
| | $ | 547,792 |
|
| Net investment income (loss) | 5,725 |
| | 544 |
| | (3 | ) | | 1,335 |
| | 39,342 |
| | (6,686 | ) | | 40,257 |
|
| Net foreign exchange losses | — |
| | — |
| | — |
| | — |
| | (156 | ) | | — |
| | (156 | ) |
| Equity in earnings of other ventures | — |
| | — |
| | — |
| | 38 |
| | 1,756 |
| | — |
| | 1,794 |
|
| Other income | 1 |
| | — |
| | — |
| | — |
| | 2,995 |
| | — |
| | 2,996 |
|
| Net realized and unrealized gains on investments | 110 |
| | 2,186 |
| | — |
| | 51 |
| | 39,705 |
| | — |
| | 42,052 |
|
| Total revenues | 5,836 |
| | 2,730 |
| | (3 | ) | | 1,424 |
| | 631,434 |
| | (6,686 | ) | | 634,735 |
|
| Expenses | | | | | | | | | | | | | |
| Net claims and claim expenses incurred | — |
| | — |
| | — |
| | — |
| | 1,221,696 |
| | — |
| | 1,221,696 |
|
| Acquisition expenses | — |
| | — |
| | — |
| | — |
| | 76,761 |
| | — |
| | 76,761 |
|
| Operational expenses | 2,910 |
| | 17 |
| | 1 |
| | 6,266 |
| | 37,752 |
| | (4,409 | ) | | 42,537 |
|
| Corporate expenses | 4,634 |
| | — |
| | — |
| | — |
| | (221 | ) | | — |
| | 4,413 |
|
| Interest expense | 183 |
| | — |
| | — |
| | 9,258 |
| | 2,541 |
| | (183 | ) | | 11,799 |
|
| Total expenses | 7,727 |
| | 17 |
| | 1 |
| | 15,524 |
| | 1,338,529 |
| | (4,592 | ) | | 1,357,206 |
|
| (Loss) income before equity in net (loss) income of subsidiaries and taxes | (1,891 | ) | | 2,713 |
| | (4 | ) | | (14,100 | ) | | (707,095 | ) | | (2,094 | ) | | (722,471 | ) |
| (Loss) equity in net (loss) income of subsidiaries | (499,408 | ) | | 928 |
| | — |
| | (16,352 | ) | | — |
| | 514,832 |
| | — |
|
| (Loss) Income before taxes | (501,299 | ) | | 3,641 |
| | (4 | ) | | (30,452 | ) | | (707,095 | ) | | 512,738 |
| | (722,471 | ) |
| Income tax benefit (expense) | 2,082 |
| | (890 | ) | | 29 |
| | 3,307 |
| | 14,449 |
| | — |
| | 18,977 |
|
| Net (loss) income | (499,217 | ) | | 2,751 |
| | 25 |
| | (27,145 | ) | | (692,646 | ) | | 512,738 |
| | (703,494 | ) |
| Net loss attributable to redeemable noncontrolling interests | — |
| | — |
| | — |
| | — |
| | 204,277 |
| | — |
| | 204,277 |
|
| Net (loss) income attributable to RenaissanceRe | (499,217 | ) | | 2,751 |
| | 25 |
| | (27,145 | ) | | (488,369 | ) | | 512,738 |
| | (499,217 | ) |
| Dividends on preference shares | (5,595 | ) | | — |
| | — |
| | — |
| | — |
| | — |
| | (5,595 | ) |
| Net (loss) income (attributable) available attributable to RenaissanceRe common shareholders | $ | (504,812 | ) | | $ | 2,751 |
| | $ | 25 |
| | $ | (27,145 | ) | | $ | (488,369 | ) | | $ | 512,738 |
| | $ | (504,812 | ) |
| |
(1) | Includes all other subsidiaries of RenaissanceRe Holdings Ltd. and eliminations. |
| |
(2) | Includes Parent Guarantor and Subsidiary Issuer consolidating adjustments. |
|
| | | | | | | | | | | | | | | | | | | | | | | | | | | |
| Condensed Consolidating Statement of Comprehensive (Loss) Income for the three months ended September 30, 2017 | RenaissanceRe
Holdings Ltd.
(Parent
Guarantor) | | RenRe North
America
Holdings Inc.
(Subsidiary
Issuer) | | Platinum Underwriters Finance, Inc. (Subsidiary Issuer) | | RenaissanceRe Finance, Inc. (Subsidiary Issuer) | | Other
RenaissanceRe
Holdings Ltd.
Subsidiaries and
Eliminations
(Non-guarantor
Subsidiaries)
(1) | | Consolidating
Adjustments
(2) | | RenaissanceRe
Consolidated |
| Comprehensive (loss) income | | | | | | | | | | | | | |
| Net (loss) income | $ | (499,217 | ) | | $ | 2,751 |
| | $ | 25 |
| | $ | (27,145 | ) | | $ | (692,646 | ) | | $ | 512,738 |
| | $ | (703,494 | ) |
| Change in net unrealized gains on investments | — |
| | — |
| | — |
| | — |
| | 300 |
| | — |
| | 300 |
|
| Comprehensive (loss) income | (499,217 | ) | | 2,751 |
| | 25 |
| | (27,145 | ) | | (692,346 | ) | | 512,738 |
| | (703,194 | ) |
| Net loss attributable to redeemable noncontrolling interests | — |
| | — |
| | — |
| | — |
| | 204,277 |
| | — |
| | 204,277 |
|
| Comprehensive loss attributable to redeemable noncontrolling interests | — |
| | — |
| | — |
| | — |
| | 204,277 |
| | — |
| | 204,277 |
|
| Comprehensive (loss) income attributable to RenaissanceRe | $ | (499,217 | ) | | $ | 2,751 |
| | $ | 25 |
| | $ | (27,145 | ) | | $ | (488,069 | ) | | $ | 512,738 |
| | $ | (498,917 | ) |
| |
(1) | Includes all other subsidiaries of RenaissanceRe Holdings Ltd. and eliminations. |
| |
(2) | Includes Parent Guarantor and Subsidiary Issuer consolidating adjustments. |
|
| | | | | | | | | | | | | | | | | | | | | | | | | | | |
Condensed Consolidating Statement of Operations for
the nine months ended September 30, 2017 | RenaissanceRe
Holdings Ltd.
(Parent
Guarantor) | | RenRe North
America
Holdings Inc.
(Subsidiary
Issuer) | | Platinum Underwriters Finance, Inc. (Subsidiary Issuer) | | RenaissanceRe Finance, Inc. (Subsidiary Issuer) | | Other
RenaissanceRe
Holdings Ltd.
Subsidiaries and
Eliminations
(Non-guarantor
Subsidiaries)
(1) | | Consolidating
Adjustments
(2) | | RenaissanceRe
Consolidated |
| Revenues | | | | | | | | | | | | | |
| Net premiums earned | $ | — |
| | $ | — |
| | $ | — |
| | $ | — |
| | $ | 1,296,102 |
| | $ | — |
| | $ | 1,296,102 |
|
| Net investment income | 16,466 |
| | 1,436 |
| | 1,373 |
| | 1,843 |
| | 146,816 |
| | (19,189 | ) | | 148,745 |
|
| Net foreign exchange (losses) gains | (1 | ) | | — |
| | — |
| | — |
| | 11,119 |
| | — |
| | 11,118 |
|
| Equity in (losses) earnings of other ventures | — |
| | — |
| | — |
| | (412 | ) | | 6,242 |
| | — |
| | 5,830 |
|
| Other income | — |
| | — |
| | — |
| | — |
| | 7,053 |
| | — |
| | 7,053 |
|
| Net realized and unrealized gains (losses) on investments | 155 |
| | 6,528 |
| | 4,916 |
| | (217 | ) | | 132,156 |
| | — |
| | 143,538 |
|
| Total revenues | 16,620 |
| | 7,964 |
| | 6,289 |
| | 1,214 |
| | 1,599,488 |
| | (19,189 | ) | | 1,612,386 |
|
| Expenses | | | | | | | | | | | | | |
| Net claims and claim expenses incurred | — |
| | — |
| | — |
| | — |
| | 1,557,364 |
| | — |
| | 1,557,364 |
|
| Acquisition expenses | — |
| | — |
| | — |
| | — |
| | 248,294 |
| | — |
| | 248,294 |
|
| Operational expenses | 9,398 |
| | 57 |
| | 86 |
| | 20,892 |
| | 116,212 |
| | (15,059 | ) | | 131,586 |
|
| Corporate expenses | 14,640 |
| | — |
| | — |
| | — |
| | (305 | ) | | — |
| | 14,335 |
|
| Interest expense | 464 |
| | — |
| | 2,461 |
| | 22,401 |
| | 7,554 |
| | (464 | ) | | 32,416 |
|
| Total expenses | 24,502 |
| | 57 |
| | 2,547 |
| | 43,293 |
| | 1,929,119 |
| | (15,523 | ) | | 1,983,995 |
|
| (Loss) income before equity in net (loss) income of subsidiaries and taxes | (7,882 | ) | | 7,907 |
| | 3,742 |
| | (42,079 | ) | | (329,631 | ) | | (3,666 | ) | | (371,609 | ) |
| Equity in net (loss) income of subsidiaries | (219,309 | ) | | 3,234 |
| | 28,028 |
| | 20,584 |
| | — |
| | 167,463 |
| | — |
|
| (Loss) Income before taxes | (227,191 | ) | | 11,141 |
| | 31,770 |
| | (21,495 | ) | | (329,631 | ) | | 163,797 |
| | (371,609 | ) |
| Income tax benefit (expense) | 2,659 |
| | (2,572 | ) | | (1,175 | ) | | 9,281 |
| | 6,546 |
| | — |
| | 14,739 |
|
| Net (loss) income | (224,532 | ) | | 8,569 |
| | 30,595 |
| | (12,214 | ) | | (323,085 | ) | | 163,797 |
| | (356,870 | ) |
| Net loss attributable to redeemable noncontrolling interests | — |
| | — |
| | — |
| | — |
| | 132,338 |
| | — |
| | 132,338 |
|
| Net (loss) income attributable to RenaissanceRe | (224,532 | ) | | 8,569 |
| | 30,595 |
| | (12,214 | ) | | (190,747 | ) | | 163,797 |
| | (224,532 | ) |
| Dividends on preference shares | (16,786 | ) | | — |
| | — |
| | — |
| | — |
| | — |
| | (16,786 | ) |
| Net (loss) income (attributable) available to RenaissanceRe common shareholders | $ | (241,318 | ) | | $ | 8,569 |
| | $ | 30,595 |
| | $ | (12,214 | ) | | $ | (190,747 | ) | | $ | 163,797 |
| | $ | (241,318 | ) |
| |
(1) | Includes all other subsidiaries of RenaissanceRe Holdings Ltd. and eliminations. |
| |
(2) | Includes Parent Guarantor, Subsidiary Guarantor and Subsidiary Issuer consolidating adjustments. |
|
| | | | | | | | | | | | | | | | | | | | | | | | | | | |
| Condensed Consolidating Statement of Comprehensive (Loss) Income for the nine months ended September 30, 2017 | RenaissanceRe
Holdings Ltd.
(Parent
Guarantor) | | RenRe North
America
Holdings Inc.
(Subsidiary
Issuer) | | Platinum Underwriters Finance, Inc. (Subsidiary Issuer) | | RenaissanceRe Finance, Inc. (Subsidiary Issuer) | | Other
RenaissanceRe
Holdings Ltd.
Subsidiaries and
Eliminations
(Non-guarantor
Subsidiaries)
(1) | | Consolidating
Adjustments
(2) | | RenaissanceRe
Consolidated |
| Comprehensive (loss) income | | | | | | | | | | | | | |
| Net (loss) income | $ | (224,532 | ) | | $ | 8,569 |
| | $ | 30,595 |
| | $ | (12,214 | ) | | $ | (323,085 | ) | | $ | 163,797 |
| | $ | (356,870 | ) |
| Change in net unrealized gains on investments | — |
| | — |
| | — |
| | — |
| | (972 | ) | | — |
| | (972 | ) |
| Comprehensive (loss) income | (224,532 | ) | | 8,569 |
| | 30,595 |
| | (12,214 | ) | | (324,057 | ) | | 163,797 |
| | (357,842 | ) |
| Net loss attributable to redeemable noncontrolling interests | — |
| | — |
| | — |
| | — |
| | 132,338 |
| | — |
| | 132,338 |
|
| Comprehensive loss attributable to noncontrolling interests | — |
| | — |
| | — |
| | — |
| | 132,338 |
| | — |
| | 132,338 |
|
| Comprehensive (loss) income attributable to RenaissanceRe | $ | (224,532 | ) | | $ | 8,569 |
| | $ | 30,595 |
| | $ | (12,214 | ) | | $ | (191,719 | ) | | $ | 163,797 |
| | $ | (225,504 | ) |
| |
(1) | Includes all other subsidiaries of RenaissanceRe Holdings Ltd. and eliminations. |
| |
(2) | Includes Parent Guarantor, Subsidiary Guarantor and Subsidiary Issuer consolidating adjustments. |
|
| | | | | | | | | | | | | | | | | | | | | | | | | | | |
Condensed Consolidating Statement of Operations for
the three months ended September 30, 2016 | RenaissanceRe
Holdings Ltd.
(Parent
Guarantor) | | RenRe North
America
Holdings Inc.
(Subsidiary
Issuer) | | Platinum Underwriters Finance, Inc. (Subsidiary Issuer) | | RenaissanceRe Finance, Inc. (Subsidiary Issuer) | | Other
RenaissanceRe
Holdings Ltd.
Subsidiaries and
Eliminations
(Non-guarantor
Subsidiaries)
(1) | | Consolidating
Adjustments
(2) | | RenaissanceRe
Consolidated |
| Revenues | | | | | | | | | | | | | |
| Net premiums earned | $ | — |
| | $ | — |
| | $ | — |
| | $ | — |
| | $ | 346,521 |
| | $ | — |
| | $ | 346,521 |
|
| Net investment income | 5,892 |
| | 441 |
| | 795 |
| | 140 |
| | 50,406 |
| | (6,251 | ) | | 51,423 |
|
| Net foreign exchange losses | — |
| | — |
| | — |
| | — |
| | (5,986 | ) | | — |
| | (5,986 | ) |
| Equity in losses of other ventures | — |
| | — |
| | — |
| | — |
| | (11,630 | ) | | — |
| | (11,630 | ) |
| Other income | 21 |
| | — |
| | — |
| | — |
| | 2,247 |
| | — |
| | 2,268 |
|
| Net realized and unrealized (losses) gains on investments | (336 | ) | | 1,397 |
| | 2,105 |
| | — |
| | 56,704 |
| | — |
| | 59,870 |
|
| Total revenues | 5,577 |
| | 1,838 |
| | 2,900 |
| | 140 |
| | 438,262 |
| | (6,251 | ) | | 442,466 |
|
| Expenses | | | | | | | | | | | | | |
| Net claims and claim expenses incurred | — |
| | — |
| | — |
| | — |
| | 112,575 |
| | — |
| | 112,575 |
|
| Acquisition expenses | — |
| | — |
| | — |
| | — |
| | 80,580 |
| | — |
| | 80,580 |
|
| Operational expenses | (1,233 | ) | | 36 |
| | 60 |
| | 5,021 |
| | 40,018 |
| | (3,409 | ) | | 40,493 |
|
| Corporate expenses | 11,617 |
| | — |
| | — |
| | — |
| | (80 | ) | | — |
| | 11,537 |
|
| Interest expense | 140 |
| | — |
| | 1,476 |
| | 6,545 |
| | 2,515 |
| | (140 | ) | | 10,536 |
|
| Total expenses | 10,524 |
| | 36 |
| | 1,536 |
| | 11,566 |
| | 235,608 |
| | (3,549 | ) | | 255,721 |
|
| Income (loss) before equity in net income of subsidiaries and taxes | (4,947 | ) | | 1,802 |
| | 1,364 |
| | (11,426 | ) | | 202,654 |
| | (2,702 | ) | | 186,745 |
|
| Equity in net income of subsidiaries | 158,862 |
| | 1,463 |
| | (2,694 | ) | | 1,130 |
| | — |
| | (158,761 | ) | | — |
|
| Income (loss) before taxes | 153,915 |
| | 3,265 |
| | (1,330 | ) | | (10,296 | ) | | 202,654 |
| | (161,463 | ) | | 186,745 |
|
| Income tax (expense) benefit | (1,495 | ) | | (324 | ) | | (401 | ) | | 2,785 |
| | 751 |
| | — |
| | 1,316 |
|
| Net income (loss) | 152,420 |
| | 2,941 |
| | (1,731 | ) | | (7,511 | ) | | 203,405 |
| | (161,463 | ) | | 188,061 |
|
| Net income attributable to redeemable noncontrolling interests | — |
| | — |
| | — |
| | — |
| | (35,641 | ) | | — |
| | (35,641 | ) |
| Net income (loss) attributable to RenaissanceRe | 152,420 |
| | 2,941 |
| | (1,731 | ) | | (7,511 | ) | | 167,764 |
| | (161,463 | ) | | 152,420 |
|
| Dividends on preference shares | (5,595 | ) | | — |
| | — |
| | — |
| | — |
| | — |
| | (5,595 | ) |
| Net income (loss) available (attributable) to RenaissanceRe common shareholders | $ | 146,825 |
| | $ | 2,941 |
| | $ | (1,731 | ) | | $ | (7,511 | ) | | $ | 167,764 |
| | $ | (161,463 | ) | | $ | 146,825 |
|
| |
(1) | Includes all other subsidiaries of RenaissanceRe Holdings Ltd. and eliminations. |
| |
(2) | Includes Parent Guarantor and Subsidiary Issuer consolidating adjustments. |
|
| | | | | | | | | | | | | | | | | | | | | | | | | | | |
| Condensed Consolidating Statement of Comprehensive Income (Loss) for the three months ended September 30, 2016 | RenaissanceRe
Holdings Ltd.
(Parent
Guarantor) | | RenRe North
America
Holdings Inc.
(Subsidiary
Issuer) | | Platinum Underwriters Finance, Inc. (Subsidiary Issuer) | | RenaissanceRe Finance, Inc. (Subsidiary Issuer) | | Other
RenaissanceRe
Holdings Ltd.
Subsidiaries and
Eliminations
(Non-guarantor
Subsidiaries)
(1) | | Consolidating
Adjustments
(2) | | RenaissanceRe
Consolidated |
| Comprehensive income (loss) | | | | | | | | | | | | | |
| Net income (loss) | $ | 152,420 |
| | $ | 2,941 |
| | $ | (1,731 | ) | | $ | (7,511 | ) | | $ | 203,405 |
| | $ | (161,463 | ) | | $ | 188,061 |
|
| Change in net unrealized gains on investments | — |
| | — |
| | — |
| | — |
| | 284 |
| | — |
| | 284 |
|
| Comprehensive income (loss) | 152,420 |
| | 2,941 |
| | (1,731 | ) | | (7,511 | ) | | 203,689 |
| | (161,463 | ) | | 188,345 |
|
| Net income attributable to redeemable noncontrolling interests | — |
| | — |
| | — |
| | — |
| | (35,641 | ) | | — |
| | (35,641 | ) |
| Comprehensive income attributable to redeemable noncontrolling interests | — |
| | — |
| | — |
| | — |
| | (35,641 | ) | | — |
| | (35,641 | ) |
| Comprehensive income (loss) attributable to RenaissanceRe | $ | 152,420 |
| | $ | 2,941 |
| | $ | (1,731 | ) | | $ | (7,511 | ) | | $ | 168,048 |
| | $ | (161,463 | ) | | $ | 152,704 |
|
| |
(1) | Includes all other subsidiaries of RenaissanceRe Holdings Ltd. and eliminations. |
| |
(2) | Includes Parent Guarantor and Subsidiary Issuer consolidating adjustments. |
|
| | | | | | | | | | | | | | | | | | | | | | | | | | | |
| Condensed Consolidating Statement of Operations for the nine months ended September 30, 2016 | RenaissanceRe
Holdings Ltd.
(Parent
Guarantor) | | RenRe North
America
Holdings Inc.
(Subsidiary
Issuer) | | Platinum Underwriters Finance, Inc. (Subsidiary Issuer) | | RenaissanceRe Finance, Inc. (Subsidiary Issuer) | | Other
RenaissanceRe
Holdings Ltd.
Subsidiaries and
Eliminations
(Non-guarantor
Subsidiaries)
(1) | | Consolidating
Adjustments
(2) | | RenaissanceRe
Consolidated |
| Revenues | | | | | | | | | | | | | |
| Net premiums earned | $ | — |
| | $ | — |
| | $ | — |
| | $ | — |
| | $ | 1,051,529 |
| | $ | — |
| | $ | 1,051,529 |
|
| Net investment income | 18,499 |
| | 1,395 |
| | 3,074 |
| | 421 |
| | 129,038 |
| | (18,017 | ) | | 134,410 |
|
| Net foreign exchange losses | (2 | ) | | — |
| | — |
| | — |
| | (8,366 | ) | | — |
| | (8,368 | ) |
| Equity in losses of other ventures | — |
| | — |
| | — |
| | — |
| | (3,997 | ) | | — |
| | (3,997 | ) |
| Other (loss) income | (770 | ) | | — |
| | — |
| | — |
| | 9,771 |
| | — |
| | 9,001 |
|
| Net realized and unrealized gains on investments | 4,951 |
| | 3,651 |
| | 7,483 |
| | — |
| | 175,210 |
| | — |
| | 191,295 |
|
| Total revenues | 22,678 |
| | 5,046 |
| | 10,557 |
| | 421 |
| | 1,353,185 |
| | (18,017 | ) | | 1,373,870 |
|
| Expenses | | | | | | | | | | | | | |
| Net claims and claim expenses incurred | — |
| | — |
| | — |
| | — |
| | 406,930 |
| | — |
| | 406,930 |
|
| Acquisition expenses | — |
| | — |
| | — |
| | — |
| | 215,177 |
| | — |
| | 215,177 |
|
| Operational expenses | (3,038 | ) | | (61 | ) | | 176 |
| | 16,603 |
| | 145,466 |
| | (11,345 | ) | | 147,801 |
|
| Corporate expenses | 22,411 |
| | 203 |
| | — |
| | 7 |
| | 2,893 |
| | — |
| | 25,514 |
|
| Interest expense | 421 |
| | — |
| | 4,429 |
| | 19,632 |
| | 7,549 |
| | (421 | ) | | 31,610 |
|
| Total expenses | 19,794 |
| | 142 |
| | 4,605 |
| | 36,242 |
| | 778,015 |
| | (11,766 | ) | | 827,032 |
|
| Income before equity in net income of subsidiaries and taxes | 2,884 |
| | 4,904 |
| | 5,952 |
| | (35,821 | ) | | 575,170 |
| | (6,251 | ) | | 546,838 |
|
| Equity in net income of subsidiaries | 424,077 |
| | 2,996 |
| | 31,727 |
| | 42,774 |
| | — |
| | (501,574 | ) | | — |
|
| Income before taxes | 426,961 |
| | 7,900 |
| | 37,679 |
| | 6,953 |
| | 575,170 |
| | (507,825 | ) | | 546,838 |
|
| Income tax benefit (expense) | 970 |
| | (1,791 | ) | | (1,583 | ) | | 8,456 |
| | (14,092 | ) | | — |
| | (8,040 | ) |
| Net income | 427,931 |
| | 6,109 |
| | 36,096 |
| | 15,409 |
| | 561,078 |
| | (507,825 | ) | | 538,798 |
|
| Net income attributable to redeemable noncontrolling interests | — |
| | — |
| | — |
| | — |
| | (110,867 | ) | | — |
| | (110,867 | ) |
| Net income attributable to RenaissanceRe | 427,931 |
| | 6,109 |
| | 36,096 |
| | 15,409 |
| | 450,211 |
| | (507,825 | ) | | 427,931 |
|
| Dividends on preference shares | (16,786 | ) | | — |
| | — |
| | — |
| | — |
| | — |
| | (16,786 | ) |
| Net income available to RenaissanceRe common shareholders | $ | 411,145 |
| | $ | 6,109 |
| | $ | 36,096 |
| | $ | 15,409 |
| | $ | 450,211 |
| | $ | (507,825 | ) | | $ | 411,145 |
|
| |
(1) | Includes all other subsidiaries of RenaissanceRe Holdings Ltd. and eliminations. |
| |
(2) | Includes Parent Guarantor and Subsidiary Issuer consolidating adjustments. |
|
| | | | | | | | | | | | | | | | | | | | | | | | | | | |
| Condensed Consolidating Statement of Comprehensive Income for the nine months ended September 30, 2016 | RenaissanceRe
Holdings Ltd.
(Parent
Guarantor) | | RenRe North
America
Holdings Inc.
(Subsidiary
Issuer) | | Platinum Underwriters Finance, Inc. (Subsidiary Issuer) | | RenaissanceRe Finance, Inc. (Subsidiary Issuer) | | Other
RenaissanceRe
Holdings Ltd.
Subsidiaries and
Eliminations
(Non-guarantor
Subsidiaries)
(1) | | Consolidating
Adjustments
(2) | | RenaissanceRe
Consolidated |
| Comprehensive income | | | | | | | | | | | | | |
| Net income | $ | 427,931 |
| | $ | 6,109 |
| | $ | 36,096 |
| | $ | 15,409 |
| | $ | 561,078 |
| | $ | (507,825 | ) | | $ | 538,798 |
|
| Change in net unrealized gains on investments | — |
| | — |
| | — |
| | — |
| | 513 |
| | — |
| | 513 |
|
| Comprehensive income | 427,931 |
| | 6,109 |
| | 36,096 |
| | 15,409 |
| | 561,591 |
| | (507,825 | ) | | 539,311 |
|
| Net income attributable to redeemable noncontrolling interests | — |
| | — |
| | — |
| | — |
| | (110,867 | ) | | — |
| | (110,867 | ) |
| Comprehensive income attributable to redeemable noncontrolling interests | — |
| | — |
| | — |
| | — |
| | (110,867 | ) | | — |
| | (110,867 | ) |
| Comprehensive income available to RenaissanceRe | $ | 427,931 |
| | $ | 6,109 |
| | $ | 36,096 |
| | $ | 15,409 |
| | $ | 450,724 |
| | $ | (507,825 | ) | | $ | 428,444 |
|
| |
(1) | Includes all other subsidiaries of RenaissanceRe Holdings Ltd. and eliminations. |
| |
(2) | Includes Parent Guarantor and Subsidiary Issuer consolidating adjustments. |
|
| | | | | | | | | | | | | | | | | | | | | | | |
| Condensed Consolidating Statement of Cash Flows for the nine months ended September 30, 2017 | RenaissanceRe
Holdings Ltd.
(Parent
Guarantor) | | RenRe North
America
Holdings Inc.
(Subsidiary
Issuer) | | Platinum Underwriters Finance, Inc. (Subsidiary Issuer) | | RenaissanceRe Finance, Inc. (Subsidiary Issuer) | | Other
RenaissanceRe
Holdings Ltd.
Subsidiaries and
Eliminations
(Non-guarantor
Subsidiaries)
(1) | | RenaissanceRe Consolidated |
| Cash flows (used in) provided by operating activities | | | | | | | | | | | |
| Net cash (used in) provided by operating activities | $ | (6,870 | ) | | $ | (8,209 | ) | | $ | (2,262 | ) | | $ | (343,093 | ) | | $ | 982,136 |
| | $ | 621,702 |
|
| Cash flows provided by (used in) investing activities | | | | | | | | | | | |
| Proceeds from sales and maturities of fixed maturity investments trading | 106,761 |
| | 74,455 |
| | 289,741 |
| | 279,830 |
| | 6,912,215 |
| | 7,663,002 |
|
| Purchases of fixed maturity investments trading | (118,402 | ) | | (69,168 | ) | | (143,991 | ) | | (270,785 | ) | | (7,195,939 | ) | | (7,798,285 | ) |
| Net (purchases) sales of equity investments trading | — |
| | (1,708 | ) | | 85,324 |
| | — |
| | (22,045 | ) | | 61,571 |
|
| Net sales (purchases) of short term investments | 205,864 |
| | (4,495 | ) | | 41,299 |
| | (305 | ) | | (388,689 | ) | | (146,326 | ) |
| Net sales of other investments | — |
| | — |
| | — |
| | — |
| | 5,181 |
| | 5,181 |
|
| Dividends and return of capital from subsidiaries | 285,515 |
| | 9,175 |
| | — |
| | 41,866 |
| | (336,556 | ) | | — |
|
| Contributions to subsidiaries | (500,000 | ) | | — |
| | (26,649 | ) | | (9,175 | ) | | 535,824 |
| | — |
|
| Due to (from) subsidiary | 290,130 |
| | 14 |
| | (123 | ) | | 4,062 |
| | (294,083 | ) | | — |
|
| Net cash provided by (used in) investing activities | 269,868 |
| | 8,273 |
| | 245,601 |
| | 45,493 |
| | (784,092 | ) | | (214,857 | ) |
| Cash flows (used in) provided by financing activities | | | | | | | | | | | |
| Dividends paid – RenaissanceRe common shares | (38,624 | ) | | — |
| | — |
| | — |
| | — |
| | (38,624 | ) |
| Dividends paid – preference shares | (16,786 | ) | | — |
| | — |
| | — |
| | — |
| | (16,786 | ) |
| RenaissanceRe common share repurchases | (188,591 | ) | | — |
| | — |
| | — |
| | — |
| | (188,591 | ) |
| Issuance of debt, net of expenses | — |
| | — |
| | — |
| | 295,866 |
| | — |
| | 295,866 |
|
| Repayment of debt | — |
| | — |
| | (250,000 | ) | | — |
| | — |
| | (250,000 | ) |
| Net third party redeemable noncontrolling interest share transactions | — |
| | — |
| | — |
| | — |
| | (44,193 | ) | | (44,193 | ) |
| Taxes paid on withholding shares | (13,694 | ) | | — |
| | — |
| | — |
| | — |
| | (13,694 | ) |
| Net cash (used in) provided by financing activities | (257,695 | ) | | — |
| | (250,000 | ) | | 295,866 |
| | (44,193 | ) | | (256,022 | ) |
| Effect of exchange rate changes on foreign currency cash | — |
| | — |
| | — |
| | — |
| | 9,596 |
| | 9,596 |
|
| Net increase (decrease) in cash and cash equivalents | 5,303 |
| | 64 |
| | (6,661 | ) | | (1,734 | ) | | 163,447 |
| | 160,419 |
|
| Cash and cash equivalents, beginning of period | 7,067 |
| | 162 |
| | 6,671 |
| | 9,397 |
| | 397,860 |
| | 421,157 |
|
| Cash and cash equivalents, end of period | $ | 12,370 |
| | $ | 226 |
| | $ | 10 |
| | $ | 7,663 |
| | $ | 561,307 |
| | $ | 581,576 |
|
| |
(1) | Includes all other subsidiaries of RenaissanceRe Holdings Ltd. and eliminations. |
|
| | | | | | | | | | | | | | | | | | | | | | | |
| Condensed Consolidating Statement of Cash Flows for the nine months ended September 30, 2016 | RenaissanceRe
Holdings Ltd.
(Parent
Guarantor) | | RenRe North
America
Holdings Inc.
(Subsidiary
Issuer) | | Platinum Underwriters Finance, Inc. (Subsidiary Issuer) | | RenaissanceRe Finance, Inc. (Subsidiary Issuer) | | Other RenaissanceRe Holdings Ltd. Subsidiaries and Eliminations (Non-guarantor Subsidiaries) (1) | | RenaissanceRe Consolidated |
| Cash flows (used in) provided by operating activities | | | | | | | | | | | |
| Net cash (used in) provided by operating activities | $ | (7,644 | ) | | $ | 1,847 |
| | $ | (11,062 | ) | | $ | (35,171 | ) | | $ | 432,395 |
| | $ | 380,365 |
|
| Cash flows provided by (used in) investing activities | | | | | | | | | | | |
| Proceeds from sales and maturities of fixed maturity investments trading | 272,710 |
| | 62,959 |
| | 113,947 |
| | — |
| | 6,059,403 |
| | 6,509,019 |
|
| Purchases of fixed maturity investments trading | (336,345 | ) | | (115,849 | ) | | (259,165 | ) | | — |
| | (6,033,479 | ) | | (6,744,838 | ) |
| Proceeds from sales and maturities of fixed maturity investments available for sale | — |
| | — |
| | — |
| | — |
| | 5,931 |
| | 5,931 |
|
| Net (purchases) sales of equity investments trading | — |
| | (2,392 | ) | | 192,911 |
| | — |
| | (7,407 | ) | | 183,112 |
|
| Net sales (purchases) of short term investments | 122,656 |
| | 67,986 |
| | (41,881 | ) | | — |
| | (19,892 | ) | | 128,869 |
|
| Net purchases of other investments | — |
| | — |
| | — |
| | — |
| | (56,765 | ) | | (56,765 | ) |
| Net sales of other assets | — |
| | — |
| | — |
| | — |
| | 400 |
| | 400 |
|
| Dividends and return of capital from subsidiaries | 408,189 |
| | 2,900 |
| | — |
| | 9,300 |
| | (420,389 | ) | | — |
|
| Contributions to subsidiaries | (91,001 | ) | | — |
| | — |
| | — |
| | 91,001 |
| | — |
|
| Due to (from) subsidiaries | (3,497 | ) | | (22,502 | ) | | (108 | ) | | 27,724 |
| | (1,617 | ) | | — |
|
| Net cash provided by (used in) investing activities | 372,712 |
| | (6,898 | ) | | 5,704 |
| | 37,024 |
| | (382,814 | ) | | 25,728 |
|
| Cash flows used in financing activities | | | | | | | | | | | |
| Dividends paid – RenaissanceRe common shares | (38,886 | ) | | — |
| | — |
| | — |
| | — |
| | (38,886 | ) |
| Dividends paid – preference shares | (16,786 | ) | | — |
| | — |
| | — |
| | — |
| | (16,786 | ) |
| RenaissanceRe common share repurchases | (309,434 | ) | | — |
| | — |
| | — |
| | — |
| | (309,434 | ) |
| Net third party redeemable noncontrolling interest share transactions | — |
| | — |
| | — |
| | — |
| | (45,496 | ) | | (45,496 | ) |
| Taxes paid on withholding shares | — |
| | — |
| | — |
| | — |
| | (10,362 | ) | | (10,362 | ) |
| Net cash used in financing activities | (365,106 | ) | | — |
| | — |
| | — |
| | (55,858 | ) | | (420,964 | ) |
| Effect of exchange rate changes on foreign currency cash | — |
| | — |
| | — |
| | — |
| | 1,316 |
| | 1,316 |
|
| Net (decrease) increase in cash and cash equivalents | (38 | ) | | (5,051 | ) | | (5,358 | ) | | 1,853 |
| | (4,961 | ) | | (13,555 | ) |
| Cash and cash equivalents, beginning of period | 10,185 |
| | 5,908 |
| | 7,103 |
| | 677 |
| | 483,012 |
| | 506,885 |
|
| Cash and cash equivalents, end of period | $ | 10,147 |
| | $ | 857 |
| | $ | 1,745 |
| | $ | 2,530 |
| | $ | 478,051 |
| | $ | 493,330 |
|
(1)Includes all other subsidiaries of RenaissanceRe Holdings Ltd. and eliminations.
(2)Includes Parent Guarantor and Subsidiary Issuer consolidating adjustments.
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
Condensed Consolidating Balance Sheet
at December 31, 2019 | RenaissanceRe
Holdings Ltd.
(Parent
Guarantor) | | | | | | RenaissanceRe Finance Inc. (Subsidiary Issuer) | | Other
RenaissanceRe
Holdings Ltd.
Subsidiaries and
Eliminations
(Non-guarantor
Subsidiaries)
(1) | | Consolidating
Adjustments
(2) | | RenaissanceRe
Consolidated |
| Assets | | | | | | | | | | | | | |
| Total investments | $ | 190,451 | | | | | | | $ | 288,137 | | | $ | 16,890,201 | | | $ | 0 | | | $ | 17,368,789 | |
| Cash and cash equivalents | 26,460 | | | | | | | 8,731 | | | 1,343,877 | | | 0 | | | 1,379,068 | |
| Investments in subsidiaries | 5,204,260 | | | | | | | 1,426,838 | | | 48,247 | | | (6,679,345) | | | 0 | |
| Due from subsidiaries and affiliates | 10,725 | | | | | | | 0 | | | 101,579 | | | (112,304) | | | 0 | |
| Premiums receivable | 0 | | | | | | | 0 | | | 2,599,896 | | | 0 | | | 2,599,896 | |
| Prepaid reinsurance premiums | 0 | | | | | | | 0 | | | 767,781 | | | 0 | | | 767,781 | |
| Reinsurance recoverable | 0 | | | | | | | 0 | | | 2,791,297 | | | 0 | | | 2,791,297 | |
| Accrued investment income | 0 | | | | | | | 1,171 | | | 71,290 | | | 0 | | | 72,461 | |
| Deferred acquisition costs | 0 | | | | | | | 0 | | | 663,991 | | | 0 | | | 663,991 | |
| Receivable for investments sold | 173 | | | | | | | 0 | | | 78,196 | | | 0 | | | 78,369 | |
| Other assets | 847,406 | | | | | | | 12,211 | | | 312,556 | | | (825,957) | | | 346,216 | |
| Goodwill and other intangible assets | 116,212 | | | | | | | 0 | | | 146,014 | | | 0 | | | 262,226 | |
| | | | | | | | | | | | | |
| Total assets | $ | 6,395,687 | | | | | | | $ | 1,737,088 | | | $ | 25,814,925 | | | $ | (7,617,606) | | | $ | 26,330,094 | |
| Liabilities, Noncontrolling Interest and Shareholders’ Equity | | | | | | | | | | | | | |
| Liabilities | | | | | | | | | | | | | |
| Reserve for claims and claim expenses | $ | 0 | | | | | | | $ | 0 | | | $ | 9,384,349 | | | $ | 0 | | | $ | 9,384,349 | |
| Unearned premiums | 0 | | | | | | | 0 | | | 2,530,975 | | | 0 | | | 2,530,975 | |
| Debt | 391,475 | | | | | | | 970,255 | | | 148,349 | | | (125,974) | | | 1,384,105 | |
| Amounts due to subsidiaries and affiliates | 6,708 | | | | | | | 102,493 | | | 51 | | | (109,252) | | | 0 | |
| Reinsurance balances payable | 0 | | | | | | | 0 | | | 2,830,691 | | | 0 | | | 2,830,691 | |
| Payable for investments purchased | 0 | | | | | | | 0 | | | 225,275 | | | 0 | | | 225,275 | |
| Other liabilities | 26,137 | | | | | | | 14,162 | | | 899,960 | | | (8,235) | | | 932,024 | |
| | | | | | | | | | | | | |
| Total liabilities | 424,320 | | | | | | | 1,086,910 | | | 16,019,650 | | | (243,461) | | | 17,287,419 | |
| Redeemable noncontrolling interests | 0 | | | | | | | 0 | | | 3,071,308 | | | 0 | | | 3,071,308 | |
| Shareholders’ Equity | | | | | | | | | | | | | |
| Total shareholders’ equity | 5,971,367 | | | | | | | 650,178 | | | 6,723,967 | | | (7,374,145) | | | 5,971,367 | |
| Total liabilities, redeemable noncontrolling interest and shareholders’ equity | $ | 6,395,687 | | | | | | | $ | 1,737,088 | | | $ | 25,814,925 | | | $ | (7,617,606) | | | $ | 26,330,094 | |
(1)Includes all other subsidiaries of RenaissanceRe Holdings Ltd. and eliminations.
(2)Includes Parent Guarantor and Subsidiary Issuer consolidating adjustments.
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
| Condensed Consolidating Statement of Operations for the three months ended September 30, 2020 | RenaissanceRe
Holdings Ltd.
(Parent
Guarantor) | | | | | | RenaissanceRe Finance Inc. (Subsidiary Issuer) | | Other
RenaissanceRe
Holdings Ltd.
Subsidiaries and
Eliminations
(Non-guarantor
Subsidiaries)
(1) | | Consolidating
Adjustments
(2) | | RenaissanceRe
Consolidated |
| Revenues | | | | | | | | | | | | | |
| Net premiums earned | $ | 0 | | | | | | | $ | 0 | | | $ | 1,000,183 | | | $ | 0 | | | $ | 1,000,183 | |
| Net investment income | 10,199 | | | | | | | 16 | | | 84,285 | | | (10,957) | | | 83,543 | |
| Net foreign exchange gains (losses) | 4,233 | | | | | | | 0 | | | 12,731 | | | 462 | | | 17,426 | |
| Equity in earnings of other ventures | 0 | | | | | | | 1,527 | | | 3,930 | | | 0 | | | 5,457 | |
| Other (loss) income | 0 | | | | | | | 0 | | | 1,531 | | | (55) | | | 1,476 | |
| Net realized and unrealized gains on investments | 1,324 | | | | | | | (21) | | | 222,905 | | | 0 | | | 224,208 | |
| | | | | | | | | | | | | |
| Total revenues | 15,756 | | | | | | | 1,522 | | | 1,325,565 | | | (10,550) | | | 1,332,293 | |
| Expenses | | | | | | | | | | | | | |
| Net claims and claim expenses incurred | 0 | | | | | | | 0 | | | 942,030 | | | 0 | | | 942,030 | |
| Acquisition expenses | 1,025 | | | | | | | 0 | | | 214,155 | | | 0 | | | 215,180 | |
| Operational expenses | 2,335 | | | | | | | 602 | | | 46,200 | | | (92) | | | 49,045 | |
| Corporate expenses | 11,446 | | | | | | | 7 | | | 36,597 | | | 0 | | | 48,050 | |
| Interest expense | 3,829 | | | | | | | 6,993 | | | 12,009 | | | (10,988) | | | 11,843 | |
| Total expenses | 18,635 | | | | | | | 7,602 | | | 1,250,991 | | | (11,080) | | | 1,266,148 | |
| Income (loss) before equity in net income (loss) of subsidiaries and taxes | (2,879) | | | | | | | (6,080) | | | 74,574 | | | 530 | | | 66,145 | |
| Equity in net income (loss) of subsidiaries | 58,695 | | | | | | | 18,605 | | | (14,182) | | | (63,118) | | | 0 | |
| Income before taxes | 55,816 | | | | | | | 12,525 | | | 60,392 | | | (62,588) | | | 66,145 | |
| Income tax benefit (expense) | (728) | | | | | | | 6,531 | | | 2,441 | | | 0 | | | 8,244 | |
| | | | | | | | | | | | | |
| | | | | | | | | | | | | |
| Net income | 55,088 | | | | | | | 19,056 | | | 62,833 | | | (62,588) | | | 74,389 | |
| Net income attributable to redeemable noncontrolling interests | 0 | | | | | | | 0 | | | (19,301) | | | 0 | | | (19,301) | |
| Net income attributable to RenaissanceRe | 55,088 | | | | | | | 19,056 | | | 43,532 | | | (62,588) | | | 55,088 | |
| Dividends on preference shares | (7,289) | | | | | | | 0 | | | 0 | | | 0 | | | (7,289) | |
| Net income available attributable to RenaissanceRe common shareholders | $ | 47,799 | | | | | | | $ | 19,056 | | | $ | 43,532 | | | $ | (62,588) | | | $ | 47,799 | |
(1)Includes all other subsidiaries of RenaissanceRe Holdings Ltd. and eliminations.
(2)Includes Parent Guarantor and Subsidiary Issuer consolidating adjustments.
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
| Condensed Consolidating Statement of Comprehensive Income for the three months ended September 30, 2020 | RenaissanceRe
Holdings Ltd.
(Parent
Guarantor) | | | | | | RenaissanceRe Finance, Inc. (Subsidiary Issuer) | | Other
RenaissanceRe
Holdings Ltd.
Subsidiaries and
Eliminations
(Non-guarantor
Subsidiaries)
(1) | | Consolidating
Adjustments
(2) | | RenaissanceRe
Consolidated |
| Comprehensive income | | | | | | | | | | | | | |
| Net income | $ | 55,088 | | | | | | | $ | 19,056 | | | $ | 62,833 | | | $ | (62,588) | | | $ | 74,389 | |
| Change in net unrealized (losses) gains on investments, net of tax | 2,186 | | | | | | | (4,062) | | | 3,849 | | | 213 | | | 2,186 | |
| Foreign currency translation adjustments, net of tax | (1,203) | | | | | | | 0 | | | 0 | | | 0 | | | (1,203) | |
| | | | | | | | | | | | | |
| Comprehensive income | 56,071 | | | | | | | 14,994 | | | 66,682 | | | (62,375) | | | 75,372 | |
| Net income attributable to redeemable noncontrolling interests | 0 | | | | | | | 0 | | | (19,301) | | | 0 | | | (19,301) | |
| | | | | | | | | | | | | |
| Comprehensive income attributable to redeemable noncontrolling interests | 0 | | | | | | | 0 | | | (19,301) | | | 0 | | | (19,301) | |
| Comprehensive income attributable to RenaissanceRe | $ | 56,071 | | | | | | | $ | 14,994 | | | $ | 47,381 | | | $ | (62,375) | | | $ | 56,071 | |
(1)Includes all other subsidiaries of RenaissanceRe Holdings Ltd. and eliminations.
(2)Includes Parent Guarantor and Subsidiary Issuer consolidating adjustments.
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
| Condensed Consolidating Statement of Operations for the nine months ended September 30, 2020 | RenaissanceRe
Holdings Ltd.
(Parent
Guarantor) | | | | | | RenaissanceRe Finance Inc. (Subsidiary Issuer) | | Other
RenaissanceRe
Holdings Ltd.
Subsidiaries and
Eliminations
(Non-guarantor
Subsidiaries)
(1) | | Consolidating
Adjustments
(2) | | RenaissanceRe
Consolidated |
| Revenues | | | | | | | | | | | | | |
| Net premiums earned | $ | 0 | | | | | | | $ | 0 | | | $ | 2,923,377 | | | $ | 0 | | | $ | 2,923,377 | |
| Net investment income | 31,102 | | | | | | | 1,009 | | | 272,315 | | | (32,105) | | | 272,321 | |
| Net foreign exchange losses | 3,598 | | | | | | | 0 | | | 1,115 | | | (210) | | | 4,503 | |
| Equity in earnings of other ventures | 0 | | | | | | | 2,703 | | | 16,359 | | | 0 | | | 19,062 | |
| Other income (loss) | 0 | | | | | | | 0 | | | 24,996 | | | (29,157) | | | (4,161) | |
| Net realized and unrealized (losses) gains on investments | (4,759) | | | | | | | 148 | | | 566,502 | | | 0 | | | 561,891 | |
| | | | | | | | | | | | | |
| Total revenues | 29,941 | | | | | | | 3,860 | | | 3,804,664 | | | (61,472) | | | 3,776,993 | |
| Expenses | | | | | | | | | | | | | |
| Net claims and claim expenses incurred | 0 | | | | | | | 0 | | | 2,023,256 | | | 0 | | | 2,023,256 | |
| Acquisition expenses | 3,076 | | | | | | | 0 | | | 656,318 | | | 0 | | | 659,394 | |
| Operational expenses | 7,457 | | | | | | | 31,886 | | | 155,397 | | | (29,157) | | | 165,583 | |
| Corporate expenses | 28,659 | | | | | | | 7 | | | 47,273 | | | 0 | | | 75,939 | |
| Interest expense | 11,753 | | | | | | | 23,868 | | | 35,051 | | | (32,060) | | | 38,612 | |
| Total expenses | 50,945 | | | | | | | 55,761 | | | 2,917,295 | | | (61,217) | | | 2,962,784 | |
| (Loss) income before equity in net income of subsidiaries and taxes | (21,004) | | | | | | | (51,901) | | | 887,369 | | | (255) | | | 814,209 | |
| Equity in net income of subsidiaries | 586,050 | | | | | | | 78,588 | | | (4,931) | | | (659,707) | | | 0 | |
| Income before taxes | 565,046 | | | | | | | 26,687 | | | 882,438 | | | (659,962) | | | 814,209 | |
| Income tax benefit (expense) | 258 | | | | | | | 10,055 | | | (23,098) | | | 0 | | | (12,785) | |
| | | | | | | | | | | | | |
| | | | | | | | | | | | | |
| Net income | 565,304 | | | | | | | 36,742 | | | 859,340 | | | (659,962) | | | 801,424 | |
| Net income attributable to redeemable noncontrolling interests | 0 | | | | | | | 0 | | | (236,120) | | | 0 | | | (236,120) | |
| Net income attributable to RenaissanceRe | 565,304 | | | | | | | 36,742 | | | 623,220 | | | (659,962) | | | 565,304 | |
| Dividends on preference shares | (23,634) | | | | | | | 0 | | | 0 | | | 0 | | | (23,634) | |
| Net income available to RenaissanceRe common shareholders | $ | 541,670 | | | | | | | $ | 36,742 | | | $ | 623,220 | | | $ | (659,962) | | | $ | 541,670 | |
(1)Includes all other subsidiaries of RenaissanceRe Holdings Ltd. and eliminations.
(2)Includes Parent Guarantor and Subsidiary Issuer consolidating adjustments.
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
| Condensed Consolidating Statement of Comprehensive Income for the nine months ended September 30, 2020 | RenaissanceRe
Holdings Ltd.
(Parent
Guarantor) | | | | | | RenaissanceRe Finance Inc. (Subsidiary Issuer) | | Other
RenaissanceRe
Holdings Ltd.
Subsidiaries and
Eliminations
(Non-guarantor
Subsidiaries)
(1) | | Consolidating
Adjustments
(2) | | RenaissanceRe
Consolidated |
| Comprehensive income | | | | | | | | | | | | | |
| Net income | $ | 565,304 | | | | | | | $ | 36,742 | | | $ | 859,340 | | | $ | (659,962) | | | $ | 801,424 | |
| Change in net unrealized (losses) gains on investments, net of tax | 41 | | | | | | | 3,617 | | | (3,625) | | | 8 | | | 41 | |
| Foreign currency translation adjustments, net of tax | (185) | | | | | | | 0 | | | | | 0 | | | (185) | |
| | | | | | | | | | | | | |
| Comprehensive income | 565,160 | | | | | | | 40,359 | | | 855,715 | | | (659,954) | | | 801,280 | |
| Net income attributable to redeemable noncontrolling interests | 0 | | | | | | | 0 | | | (236,120) | | | 0 | | | (236,120) | |
| | | | | | | | | | | | | |
| Comprehensive income attributable to noncontrolling interests | 0 | | | | | | | 0 | | | (236,120) | | | 0 | | | (236,120) | |
| Comprehensive income attributable to RenaissanceRe | $ | 565,160 | | | | | | | $ | 40,359 | | | $ | 619,595 | | | $ | (659,954) | | | $ | 565,160 | |
(1)Includes all other subsidiaries of RenaissanceRe Holdings Ltd. and eliminations.
(2)Includes Parent Guarantor and Subsidiary Issuer consolidating adjustments.
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
| Condensed Consolidating Statement of Operations for the three months ended September 30, 2019 | RenaissanceRe
Holdings Ltd.
(Parent
Guarantor) | | | | | | RenaissanceRe Finance Inc. (Subsidiary Issuer) | | Other
RenaissanceRe
Holdings Ltd.
Subsidiaries and
Eliminations
(Non-guarantor
Subsidiaries)
(1) | | Consolidating
Adjustments
(2) | | RenaissanceRe
Consolidated |
| Revenues | | | | | | | | | | | | | |
| Net premiums earned | $ | 0 | | | | | | | $ | 0 | | | $ | 906,748 | | | $ | 0 | | | $ | 906,748 | |
| Net investment income | 10,263 | | | | | | | 1,906 | | | 111,818 | | | (12,600) | | | 111,387 | |
| Net foreign exchange (losses) gains | (14,786) | | | | | | | 0 | | | 6,511 | | | 0 | | | (8,275) | |
| Equity in earnings of other ventures | 0 | | | | | | | 1,298 | | | 4,579 | | | 0 | | | 5,877 | |
| Other income (loss) | 1,234 | | | | | | | 0 | | | (218) | | | 0 | | | 1,016 | |
| Net realized and unrealized gains on investments | 1,983 | | | | | | | 20 | | | 32,392 | | | 0 | | | 34,395 | |
| | | | | | | | | | | | | |
| Total revenues | (1,306) | | | | | | | 3,224 | | | 1,061,830 | | | (12,600) | | | 1,051,148 | |
| Expenses | | | | | | | | | | | | | |
| Net claims and claim expenses incurred | 0 | | | | | | | 0 | | | 654,520 | | | 0 | | | 654,520 | |
| Acquisition expenses | 0 | | | | | | | 0 | | | 202,181 | | | 0 | | | 202,181 | |
| Operational expenses | 2,039 | | | | | | | 9,018 | | | 34,825 | | | 7,533 | | | 53,415 | |
| Corporate expenses | 6,948 | | | | | | | 7 | | | 5,010 | | | 1,879 | | | 13,844 | |
| Interest expense | 5,708 | | | | | | | 9,257 | | | 615 | | | 0 | | | 15,580 | |
| Total expenses | 14,695 | | | | | | | 18,282 | | | 897,151 | | | 9,412 | | | 939,540 | |
| (Loss) income before equity in net income of subsidiaries and taxes | (16,001) | | | | | | | (15,058) | | | 164,679 | | | (22,012) | | | 111,608 | |
| Equity in net income of subsidiaries | 61,021 | | | | | | | 14,365 | | | 1,456 | | | (76,842) | | | 0 | |
| Income before taxes | 45,020 | | | | | | | (693) | | | 166,135 | | | (98,854) | | | 111,608 | |
| Income tax benefit (expense) | 867 | | | | | | | 1,562 | | | (6,093) | | | 0 | | | (3,664) | |
| | | | | | | | | | | | | |
| | | | | | | | | | | | | |
| Net income | 45,887 | | | | | | | 869 | | | 160,042 | | | (98,854) | | | 107,944 | |
| Net income attributable to redeemable noncontrolling interests | 0 | | | | | | | 0�� | | | (62,057) | | | 0 | | | (62,057) | |
| Net income attributable to RenaissanceRe | 45,887 | | | | | | | 869 | | | 97,985 | | | (98,854) | | | 45,887 | |
| Dividends on preference shares | (9,189) | | | | | | | 0 | | | 0 | | | 0 | | | (9,189) | |
| Net income available to RenaissanceRe common shareholders | $ | 36,698 | | | | | | | $ | 869 | | | $ | 97,985 | | | $ | (98,854) | | | $ | 36,698 | |
(1)Includes all other subsidiaries of RenaissanceRe Holdings Ltd. and eliminations.
(2) Includes Parent Guarantor and Subsidiary Issuer consolidating adjustments.
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
| Condensed Consolidating Statement of Comprehensive Income for the three months ended September 30, 2019 | RenaissanceRe
Holdings Ltd.
(Parent
Guarantor) | | | | | | RenaissanceRe Finance Inc. (Subsidiary Issuer) | | Other
RenaissanceRe
Holdings Ltd.
Subsidiaries and
Eliminations
(Non-guarantor
Subsidiaries)
(1) | | Consolidating
Adjustments
(2) | | RenaissanceRe
Consolidated |
| Comprehensive income | | | | | | | | | | | | | |
| Net income | $ | 45,887 | | | | | | | $ | 869 | | | $ | 160,042 | | | $ | (98,854) | | | $ | 107,944 | |
| Change in net unrealized losses on investments, net of tax | 0 | | | | | | | 0 | | | 608 | | | 0 | | | 608 | |
| Foreign currency translation adjustments, net of tax | 0 | | | | | | | 0 | | | 8,249 | | | 0 | | | 8,249 | |
| | | | | | | | | | | | | |
| Comprehensive income | 45,887 | | | | | | | 869 | | | 168,899 | | | (98,854) | | | 116,801 | |
| Net income attributable to redeemable noncontrolling interests | 0 | | | | | | | 0 | | | (62,057) | | | 0 | | | (62,057) | |
| | | | | | | | | | | | | |
| Comprehensive income attributable to redeemable noncontrolling interests | 0 | | | | | | | 0 | | | (62,057) | | | 0 | | | (62,057) | |
| Comprehensive income attributable to RenaissanceRe | $ | 45,887 | | | | | | | $ | 869 | | | $ | 106,842 | | | $ | (98,854) | | | $ | 54,744 | |
(1)Includes all other subsidiaries of RenaissanceRe Holdings Ltd. and eliminations.
(2) Includes Parent Guarantor and Subsidiary Issuer consolidating adjustments.
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
| Condensed Consolidating Statement of Operations for the nine months ended September 30, 2019 | RenaissanceRe
Holdings Ltd.
(Parent
Guarantor) | | | | | | RenaissanceRe
Finance Inc.
(Subsidiary
Issuer) | | Other
RenaissanceRe
Holdings Ltd.
Subsidiaries and
Eliminations
(Non-guarantor
Subsidiaries)
(1) | | Consolidating
Adjustments
(2) | | RenaissanceRe
Consolidated |
| Revenues | | | | | | | | | | | | | |
| Net premiums earned | $ | 0 | | | | | | | $ | 0 | | | $ | 2,368,278 | | | $ | 0 | | | $ | 2,368,278 | |
| Net investment income | 29,216 | | | | | | | 5,983 | | | 310,621 | | | (33,751) | | | 312,069 | |
| Net foreign exchange (losses) gains | (20,846) | | | | | | | 0 | | | 19,034 | | | 0 | | | (1,812) | |
| Equity in earnings of other ventures | 0 | | | | | | | 2,915 | | | 14,435 | | | 0 | | | 17,350 | |
| Other income | 1,234 | | | | | | | 0 | | | 3,875 | | | 0 | | | 5,109 | |
| Net realized and unrealized gains on investments | 7,501 | | | | | | | 231 | | | 387,923 | | | 0 | | | 395,655 | |
| | | | | | | | | | | | | |
| Total revenues | 17,105 | | | | | | | 9,129 | | | 3,104,166 | | | (33,751) | | | 3,096,649 | |
| Expenses | | | | | | | | | | | | | |
| Net claims and claim expenses incurred | 0 | | | | | | | 0 | | | 1,334,928 | | | 0 | | | 1,334,928 | |
| Acquisition expenses | 0 | | | | | | | 0 | | | 553,614 | | | 0 | | | 553,614 | |
| Operational expenses | 4,643 | | | | | | | 29,958 | | | 98,651 | | | 24,910 | | | 158,162 | |
| Corporate expenses | 49,618 | | | | | | | 16 | | | 21,172 | | | 5,674 | | | 76,480 | |
| Interest expense | 13,284 | | | | | | | 27,763 | | | 1,821 | | | 0 | | | 42,868 | |
| Total expenses | 67,545 | | | | | | | 57,737 | | | 2,010,186 | | | 30,584 | | | 2,166,052 | |
| (Loss) income before equity in net income of subsidiaries and taxes | (50,440) | | | | | | | (48,608) | | | 1,093,980 | | | (64,335) | | | 930,597 | |
| Equity in net income of subsidiaries | 754,634 | | | | | | | 76,552 | | | 4,001 | | | (835,187) | | | 0 | |
| Income before taxes | 704,194 | | | | | | | 27,944 | | | 1,097,981 | | | (899,522) | | | 930,597 | |
| Income tax benefit (expense) | 1,642 | | | | | | | 4,956 | | | (27,268) | | | 0 | | | (20,670) | |
| | | | | | | | | | | | | |
| | | | | | | | | | | | | |
| Net income | 705,836 | | | | | | | 32,900 | | | 1,070,713 | | | (899,522) | | | 909,927 | |
| Net income attributable to redeemable noncontrolling interests | 0 | | | | | | | 0 | | | (204,091) | | | 0 | | | (204,091) | |
| Net income attributable to RenaissanceRe | 705,836 | | | | | | | 32,900 | | | 866,622 | | | (899,522) | | | 705,836 | |
| Dividends on preference shares | (27,567) | | | | | | | 0 | | | 0 | | | 0 | | | (27,567) | |
| Net income available to RenaissanceRe common shareholders | $ | 678,269 | | | | | | | $ | 32,900 | | | $ | 866,622 | | | $ | (899,522) | | | $ | 678,269 | |
(1)Includes all other subsidiaries of RenaissanceRe Holdings Ltd. and eliminations.
(2) Includes Parent Guarantor and Subsidiary Issuer consolidating adjustments.
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
| Condensed Consolidating Statement of Comprehensive Income for the nine months ended September 30, 2019 | RenaissanceRe
Holdings Ltd.
(Parent
Guarantor) | | | | | | RenaissanceRe
Finance Inc.
(Subsidiary
Issuer) | | Other
RenaissanceRe
Holdings Ltd.
Subsidiaries and
Eliminations
(Non-guarantor
Subsidiaries)
(1) | | Consolidating
Adjustments
(2) | | RenaissanceRe
Consolidated |
| Comprehensive income | | | | | | | | | | | | | |
| Net income | $ | 705,836 | | | | | | | $ | 32,900 | | | $ | 1,070,713 | | | $ | (899,522) | | | $ | 909,927 | |
| Change in net unrealized losses on investments, net of tax | 0 | | | | | | | 0 | | | 1,880 | | | 0 | | | 1,880 | |
| Foreign currency translation adjustments, net of tax | 0 | | | | | | | 0 | | | 4,541 | | | 0 | | | 4,541 | |
| | | | | | | | | | | | | |
| Comprehensive income | 705,836 | | | | | | | 32,900 | | | 1,077,134 | | | (899,522) | | | 916,348 | |
| Net income attributable to redeemable noncontrolling interests | 0 | | | | | | | 0 | | | (204,091) | | | 0 | | | (204,091) | |
| | | | | | | | | | | | | |
| Comprehensive income attributable to noncontrolling interests | 0 | | | | | | | 0 | | | (204,091) | | | 0 | | | (204,091) | |
| Comprehensive income attributable to RenaissanceRe | $ | 705,836 | | | | | | | $ | 32,900 | | | $ | 873,043 | | | $ | (899,522) | | | $ | 712,257 | |
(1)Includes all other subsidiaries of RenaissanceRe Holdings Ltd. and eliminations.
(2)Includes Parent Guarantor and Subsidiary Issuer consolidating adjustments.
| | | | | | | | | | | | | | | | | | | | | | | | | | | |
| Condensed Consolidating Statement of Cash Flows for the nine months ended September 30, 2020 | RenaissanceRe
Holdings Ltd.
(Parent
Guarantor) | | | | | | RenaissanceRe Finance Inc. (Subsidiary Issuer) | | Other
RenaissanceRe
Holdings Ltd.
Subsidiaries and
Eliminations
(Non-guarantor
Subsidiaries)
(1) | | RenaissanceRe
Consolidated |
| Cash flows provided by (used in) operating activities | | | | | | | | | | | |
| Net cash provided by (used in) operating activities | $ | 19,787 | | | | | | | $ | (47,993) | | | $ | 1,357,985 | | | $ | 1,329,779 | |
| Cash flows (used in) provided by investing activities | | | | | | | | | | | |
| Proceeds from sales and maturities of fixed maturity investments trading | 210,973 | | | | | | | 36,302 | | | 11,317,724 | | | 11,564,999 | |
| Purchases of fixed maturity investments trading | (346,002) | | | | | | | (45,955) | | | (12,722,775) | | | (13,114,732) | |
| | | | | | | | | | | |
| | | | | | | | | | | |
| Net sales of equity investments trading | 0 | | | | | | | 0 | | | 1,842 | | | 1,842 | |
| Net sales (purchases) of short term investments | 72,479 | | | | | | | 266,199 | | | (887,896) | | | (549,218) | |
| Net purchases of other investments | 0 | | | | | | | 0 | | | (101,302) | | | (101,302) | |
| Net purchases of investments in other ventures | 0 | | | | | | | 0 | | | (2,407) | | | (2,407) | |
| Return of investment from investments in other ventures | 0 | | | | | | | 0 | | | 9,255 | | | 9,255 | |
| | | | | | | | | | | |
| Dividends and return of capital from subsidiaries | 827,626 | | | | | | | 118,026 | | | (945,652) | | | 0 | |
| Contributions to subsidiaries | (1,538,708) | | | | | | | (130,000) | | | 1,668,708 | | | 0 | |
| Due (from) to subsidiary | (85,151) | | | | | | | 55,815 | | | 29,336 | | | 0 | |
| Net proceeds from RenaissanceRe UK | 0 | | | | | | | 0 | | | 136,744 | | | 136,744 | |
| | | | | | | | | | | |
| Net cash (used in) provided by investing activities | (858,783) | | | | | | | 300,387 | | | (1,496,423) | | | (2,054,819) | |
| Cash flows provided by (used in) financing activities | | | | | | | | | | | |
| Dividends paid – RenaissanceRe common shares | (50,785) | | | | | | | 0 | | | 0 | | | (50,785) | |
| Dividends paid – preference shares | (23,634) | | | | | | | 0 | | | 0 | | | (23,634) | |
| RenaissanceRe common share issuance, net of expenses | 1,095,507 | | | | | | | 0 | | | 0 | | | 1,095,507 | |
| RenaissanceRe common share repurchases | (62,621) | | | | | | | 0 | | | 0 | | | (62,621) | |
| Redemption of 6.08% Series C preference shares | (125,000) | | | | | | | 0 | | | 0 | | | (125,000) | |
| | | | | | | | | | | |
| | | | | | | | | | | |
| | | | | | | | | | | |
| Repayment of debt | 0 | | | | | | | (250,000) | | | 0 | | | (250,000) | |
| | | | | | | | | | | |
| | | | | | | | | | | |
| Net third-party redeemable noncontrolling interest share transactions | 0 | | | | | | | 0 | | | 59,104 | | | 59,104 | |
| | | | | | | | | | | |
| Taxes paid on withholding shares | (10,264) | | | | | | | 0 | | | 0 | | | (10,264) | |
| Net cash provided by (used in) financing activities | 823,203 | | | | | | | (250,000) | | | 59,104 | | | 632,307 | |
| Effect of exchange rate changes on foreign currency cash | (144) | | | | | | | 0 | | | 1,187 | | | 1,043 | |
| Net (decrease) increase in cash and cash equivalents | (15,937) | | | | | | | 2,394 | | | (78,147) | | | (91,690) | |
| | | | | | | | | | | |
| Cash and cash equivalents, beginning of period | 26,460 | | | | | | | 8,731 | | | 1,343,877 | | | 1,379,068 | |
| Cash and cash equivalents, end of period | $ | 10,523 | | | | | | | $ | 11,125 | | | $ | 1,265,730 | | | $ | 1,287,378 | |
(1)Includes all other subsidiaries of RenaissanceRe Holdings Ltd. and eliminations.
| | | | | | | | | | | | | | | | | | | | | | | | | | | |
| Condensed Consolidating Statement of Cash Flows for the nine months ended September 30, 2019 | RenaissanceRe
Holdings Ltd.
(Parent
Guarantor) | | | | | | RenaissanceRe
Finance Inc.
(Subsidiary
Issuer) | | Other
RenaissanceRe
Holdings Ltd.
Subsidiaries
and
Eliminations
(Non-guarantor
Subsidiaries)
(1) | | RenaissanceRe
Consolidated |
| Cash flows (used in) provided by operating activities | | | | | | | | | | | |
| Net cash (used in) provided by operating activities | $ | (381,508) | | | | | | | $ | (30,943) | | | $ | 1,676,883 | | | $ | 1,264,432 | |
| Cash flows provided by (used in) investing activities | | | | | | | | | | | |
| Proceeds from sales and maturities of fixed maturity investments trading | 277,030 | | | | | | | 43,746 | | | 12,515,140 | | | 12,835,916 | |
| Purchases of fixed maturity investments trading | (66,740) | | | | | | | (15,910) | | | (13,321,061) | | | (13,403,711) | |
| | | | | | | | | | | |
| | | | | | | | | | | |
| Net sales of equity investments trading | 0 | | | | | | | 0 | | | (6,937) | | | (6,937) | |
| Net purchases of short term investments | (34,209) | | | | | | | (16,257) | | | (1,311,685) | | | (1,362,151) | |
| Net purchases of other investments | 0 | | | | | | | 0 | | | (130,476) | | | (130,476) | |
| Net purchases of investment in other venture | 0 | | | | | | | 0 | | | (2,341) | | | (2,341) | |
| Net purchases of other assets | 0 | | | | | | | 0 | | | (4,108) | | | (4,108) | |
| Return of investment from investment in other ventures | 0 | | | | | | | 0 | | | 11,250 | | | 11,250 | |
| Dividends and return of capital from subsidiaries | 855,396 | | | | | | | 13,500 | | | (868,896) | | | 0 | |
| Contributions to subsidiaries | (1,013,916) | | | | | | | 0 | | | 1,013,916 | | | 0 | |
| Due to (from) subsidiaries | 48,444 | | | | | | | (416) | | | (48,028) | | | 0 | |
| | | | | | | | | | | |
| Net purchase of TMR | 0 | | | | | | | 0 | | | (276,206) | | | (276,206) | |
| Net cash provided by (used in) investing activities | 66,005 | | | | | | | 24,663 | | | (2,429,432) | | | (2,338,764) | |
| Cash flows provided by financing activities | | | | | | | | | | | |
| Dividends paid – RenaissanceRe common shares | (44,547) | | | | | | | 0 | | | 0 | | | (44,547) | |
| Dividends paid – preference shares | (27,567) | | | | | | | 0 | | | 0 | | | (27,567) | |
| | | | | | | | | | | |
| | | | | | | | | | | |
| | | | | | | | | | | |
| | | | | | | | | | | |
| Issuance of debt, net of expenses | 396,411 | | | | | | | 0 | | | 0 | | | 396,411 | |
| Net third-party redeemable noncontrolling interest share transactions | 0 | | | | | | | 0 | | | 515,952 | | | 515,952 | |
| Taxes paid on withholding shares | (7,229) | | | | | | | 0 | | | 0 | | | (7,229) | |
| Net cash provided by financing activities | 317,068 | | | | | | | 0 | | | 515,952 | | | 833,020 | |
| Effect of exchange rate changes on foreign currency cash | 0 | | | | | | | 0 | | | 4,641 | | | 4,641 | |
| Net increase (decrease) in cash and cash equivalents | 1,565 | | | | | | | (6,280) | | | (231,956) | | | (236,671) | |
| | | | | | | | | | | |
| Cash and cash equivalents, beginning of period | 3,534 | | | | | | | 9,604 | | | 1,094,784 | | | 1,107,922 | |
| Cash and cash equivalents, end of period | $ | 5,099 | | | | | | | $ | 3,324 | | | $ | 862,828 | | | $ | 871,251 | |
(1)Includes all other subsidiaries of RenaissanceRe Holdings Ltd. and eliminations.
NOTE 16.17. SUBSEQUENT EVENTS
EffectiveHurricane Delta, a Category 2 hurricane, made landfall on the Yucatán Peninsula on October 1, 2017, DaVinciRe completed an equity capital raise of $248.6 million from third-party investors7, 2020, and RenaissanceRe. In addition, RenaissanceRe sold an aggregate of $49.7 million of its sharessubsequently in DaVinciRe to third-party shareholders. The Company’s noncontrolling economic ownershipLouisiana on October 9, 2020, causing widespread flooding and damage, including in DaVinciRe subsequent to these transactions was 22.1%, effective October 1, 2017.the region impacted by Hurricane Laura. The Company expects its noncontrolling economic ownership in DaVinciReis also monitoring Hurricane Zeta, which made landfall on October 26, 2020 on the Yucatán Peninsula and is expected to fluctuate over time.
Effective October 1, 2017, Upsilon RFO issued $46.5 million of non-voting preference shares to investors, including $17.7 million to the Company. Effective October 1, 2017, the Company’s participationmake landfall in the risks assumed by Upsilon RFO was 16.0%.U.S. on October 28, 2020. Additionally, wildfires impacting several Western U.S. states are ongoing.
CommencingThe Company is in early October 2017, devastating wildfires impacted many areasthe preliminary stage of the state of California (the “California Wildfires”). Based on the Company’s initial assessment of the California Wildfires, it is anticipated thatassessing the impact onof these events beyond the Company’s financial results will be significant and could be material. In addition, it is possible that the Company will be impacted by other events that have occurred thus far in the fourth quarter.third quarter of 2020. The Company’s assessment of the impact from the California Wildfires and such other events, which remains at a very preliminary stage, is based on, among other things, initial industry insured loss estimates, market share analysis, the application of its modeling techniques, a review of its in-force contracts and potential uncertainties relating to reinsurance recoveries. ItBased on the Company’s initial assessment of these events, it is anticipated that the impact on the Company’s financial results may be significant and could be material. However, it is difficult at this time to provide an accurate estimate of the financial impact of these events, including as a result of the preliminary nature of the information available, the preliminary nature of the information provided thus far by industry participants, the magnitude and recent occurrence of the events, and other factors.
The estimated losses for these events will be reported in the Company's fourth quarter of 2020 financial results.
| |
ITEM 2. | MANAGEMENT’S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS |
ITEM 2. MANAGEMENT’S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS
The following is a discussion and analysis of our results of operations for the three and nine months ended September 30, 20172020 and 2016, respectively. The following also includes a discussion of2019, respectively, as well as our liquidity and capital resources at September 30, 2017.2020. This discussion and analysis should be read in conjunction with the unaudited consolidated financial statements and notes thereto included in this filing and the audited consolidated financial statements and notes thereto contained in our Form 10-K for the fiscal year ended December 31, 2016. 2019.
On March 22, 2019, we acquired RenaissanceRe Europe AG (formerly known as Tokio Millennium Re AG) (“RenaissanceRe Europe”), RenaissanceRe (UK) Limited (formerly known as Tokio Millennium Re (UK) Limited) (“RenaissanceRe UK”), and their respective subsidiaries (collectively, “TMR”), and our results of operations and financial condition include TMR from the acquisition date. The three months ended June 30, 2019, was the first full period that reflected the results of TMR on the Company’s results of operations. Subsequently, on August 18, 2020, we sold RenaissanceRe UK to an investment vehicle managed by AXA Liabilities Managers, an affiliate of AXA XL. The following discussion and analysis of our results of operations for the three and nine months ended September 30, 2020 compared to the three and nine months ended September 30, 2019 should be read in that context.
Refer to “Note 3. Acquisition of Tokio Millennium Re” in our “Notes to the Consolidated Financial Statements” included in our Form 10-K for the year ended December 31, 2019 for additional information with respect to the acquisition of TMR.
This filing contains forward-looking statements that involve risks and uncertainties. Actual results may differ materially from the results described or implied by these forward-looking statements. See “Note on Forward-Looking Statements.”
In this Form 10-Q, references to “RenaissanceRe” refer to RenaissanceRe Holdings Ltd. (the parent company) and references to “we,” “us,” “our” and the “Company” refer to RenaissanceRe Holdings Ltd. together with its subsidiaries, unless the context requires otherwise.
All dollar amounts referred to in this Form 10-Q are in U.S. dollars unless otherwise indicated.
Due to rounding, numbers presented in the tables included in this Form 10-Q may not add up precisely to the totals provided.
INDEX TO MANAGEMENT’S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS
OVERVIEW
RenaissanceRe is a global provider of reinsurance and insurance. We provide property, casualty and specialty reinsurance and certain insurance solutions to customers, principally through intermediaries. Established in 1993, we have offices in Bermuda, Australia, Ireland, Singapore, Switzerland, the United Kingdom,U.K. and the United States. U.S. Our operating subsidiaries include Renaissance Reinsurance, Renaissance Reinsurance U.S. Inc. (“Renaissance Reinsurance U.S.”), RenaissanceRe Specialty U.S. Ltd. (“RenaissanceRe Specialty U.S.”), RenaissanceRe Europe, Renaissance Reinsurance of Europe Unlimited Company (“Renaissance Reinsurance of Europe”) and RenaissanceRe Syndicate 1458 (“Syndicate 1458”). We also underwrite reinsurance on behalf of joint ventures, including DaVinci Reinsurance Ltd. (“DaVinci”), Fibonacci Reinsurance Ltd. ("Fibonacci Re"), Top Layer Reinsurance Ltd. (“Top Layer Re”), Upsilon RFO Re Ltd. (“Upsilon RFO”) and Vermeer Reinsurance Ltd. (“Vermeer”). In addition, through RenaissanceRe Medici Fund Ltd. (“Medici”), we invest in various insurance-based investment instruments that have returns primarily tied to property catastrophe risk.
We aspire to be the world’s best underwriter by matching well-structured risks with efficient sources of capital and our mission is to produce superior returns for our shareholders over the long term. We seek to accomplish these goals by being a trusted, long-term partner to our customers for assessing and managing risk, delivering responsive and innovative solutions, leveraging our core capabilities of risk assessment and information management, investing in these core capabilities in order to serve our customers across themarket cycles, that have historically characterized our markets and keeping our promises. Our strategy focuses on superior risk selection, superior customer relationships and superior capital management. We provide value to our customers and joint venture partners in the form of financial security, innovative products, and responsive service. We are known as a leader in paying valid claims promptly. We principally measure our financial success through long-term growth in tangible book value per common share plus the change in accumulated dividends, which we believe is the most appropriate measure of our financial performance, and in respect of which we believe we have delivered superior performance over time.
Our core products include property, casualty and specialty reinsurance, and certain insurance products principally distributed through intermediaries, with whom we seek to cultivatehave cultivated strong long-term relationships. We believe we have been one of the world’s leading providers of propertycatastrophe reinsurance since our founding. In recent years, through the strategic execution of a number ofseveral initiatives, including organic growth and our acquisition of Platinum Underwriters Holdings, Ltd. (“Platinum”) on March 2, 2015,acquisitions, we have expanded and diversified our casualty and specialty platform and products and believe we are a leader in certain casualty and specialty lines of business. We have determined our business consists of the following reportable segments: (1) Property, which is comprised of catastrophe and other property reinsurance and insurance written on behalf of our operating subsidiaries and certain joint
ventures managed by our ventures unit, and (2) Casualty and Specialty, which is comprised of casualty and specialty reinsurance and insurance written on behalf of our operating subsidiaries and certain joint ventures managed by our ventures unit. We also pursue a number of other opportunities through our ventures unit, which has responsibility for creating and managing our joint ventures, executing customized reinsurance transactions to assume or cede risk, and managing certain strategic investments directed at classes of risk other than catastrophe reinsurance. From time to time we consider diversification into new ventures, either through organic growth, the formation of new joint ventures, or the acquisition of, or the investment in, other companies or books of business of other companies.
To best serve our clients in the places they do business, we have operating subsidiaries, branches, joint ventures and underwriting platforms around the world, including DaVinci, Fibonacci Re, Renaissance Reinsurance, Top Layer Re, Fibonacci ReUpsilon RFO and Upsilon RFOVermeer in Bermuda, Renaissance Reinsurance U.S. in the U.S., and Syndicate 1458 in the United Kingdom (the “U.K.”). In addition, we have a presenceU.K. and RenaissanceRe Europe in IrelandSwitzerland, which has branches in Australia, Bermuda, the U.K. and Singapore and from time to time explore opportunities in other jurisdictions.the U.S. We write property and casualty and specialty reinsurance through our wholly owned operating subsidiaries, joint ventures and Syndicate 1458 and certain insurance products primarily through Syndicate 1458. Although each underwriting platform may write any or all of our classes of business, our Bermuda platform has traditionally written, and continues to write, the preponderance of our property business and our U.S. platform and Syndicate 1458 write a significant portion of our casualty and specialty business. Syndicate 1458 provides us with access to Lloyd’s extensive distribution network and worldwide licenses and also writes business through delegated authority arrangements. The underwriting results of our operating subsidiaries and underwriting platforms are included in our Property and Casualty and Specialty segment results as appropriate.
Since a meaningful portion of the reinsurance and insurance we write provides protection from damages relating to natural and man-made catastrophes, our results depend to a large extent on the frequency and
severity of such catastrophic events, and the coverages we offer to customers affected by these events. We are exposed to significant losses from these catastrophic events and other exposures we cover.cover, which primarily impact our Property segment, in both the property catastrophe and other property lines of business. Accordingly, we expect a significant degree of volatility in our financial results, and our financial results may vary significantly from quarter-to-quarter and from year-to-year, based on the level of insured catastrophic losses occurring around the world. We view our increased exposure to casualty and specialty lines of business as an efficient use of capital given these risks are generally less correlated with our property lines of business. This has allowed us to bring additional capacity to our clients across a wider range of product offerings, while continuing to be good stewards of our shareholders’ capital. In the future, our casualty and specialty lines of business may represent a greater proportion of our premiums and claims and claim expenses.
We continually explore appropriate and efficient ways to address the risk needs of our clients.clients and the impact of various regulatory and legislative changes on our operations. We have created and managed, and continue to manage, multiple capital vehicles across several jurisdictions and may create additional risk bearing vehicles or enter into additional jurisdictions in the future. In addition, our differentiated strategy and capabilities position us to pursue bespoke or large solutions for clients, which may be non-recurring. This, and other factors including the timing of contract inception, could result in significant volatility of premiums in both our Property and Casualty and Specialty segments. As our product and geographical diversity increases, we may be exposed to new risks, uncertainties and sources of volatility.
Our revenues are principally derived from three sources: (1) net premiums earned from the reinsurance and insurance policies we sell; (2) net investment income and realized and unrealized gains from the investment of our capital funds and the investment of the cash we receive on the policies which we sell; and (3) fees and other income received from our joint ventures, advisory services and various other items.
Our expenses primarily consist of: (1) net claims and claim expenses incurred on the policies of reinsurance and insurance we sell; (2) acquisition costs which typically represent a percentage of the premiums we write; (3) operating expenses which primarily consist of personnel expenses, rent and other operating expenses; (4) corporate expenses which include certain executive, legal and consulting expenses, costs for research and development, transaction and integration-related expenses, and other miscellaneous costs, including those associated with operating as a publicly traded company; (5) redeemable noncontrolling interests, which represent the interests of third parties with respect to the net income of DaVinciRe Holdings Ltd. (“DaVinciRe”), Medici and Medici;Vermeer; and (6) interest and dividend costs related to our debt and preference shares. We are also subject to taxes in certain jurisdictions in which we operate. Since the majority of our income is currently earned in Bermuda, which does not have a corporate income tax, the tax impact to our operations has historically been minimal, however, inminimal. In the future, our net tax exposure may increase as our operations expand geographically, or as a result of adverse tax developments.
The underwriting results of an insurance or reinsurance company are discussed frequently by reference to its net claims and claim expense ratio, underwriting expense ratio, and combined ratio. The net claims and claim expense ratio is calculated by dividing net claims and claim expenses incurred by net premiums earned. The underwriting expense ratio is calculated by dividing underwriting expenses (acquisition expenses and operational expenses) by net premiums earned. The combined ratio is the sum of the net claims and claim expense ratio and the underwriting expense ratio. A combined ratio below 100% indicates profitable underwriting prior to the consideration of investment income. A combined ratio over 100% indicates unprofitable underwriting prior to the consideration of investment income. We also discuss our net claims and claim expense ratio on a current accident year basis and a prior accident years basis. The current accident year net claims and claim expense ratio is calculated by taking current accident year net claims and claim expenses incurred, divided by net premiums earned. The prior accident years net claims and claim expense ratio is calculated by taking prior accident years net claims and claim expenses incurred, divided by net premiums earned.
Segments
Our reportable segments are defined as follows: (1) Property, which is comprised of catastrophe and other property reinsurance and insurance written on behalf of our operating subsidiaries and certain joint ventures managed by our ventures unit, and (2) Casualty and Specialty, which is comprised of casualty and specialty reinsurance and insurance written on behalf of our operating subsidiaries and certain joint ventures managed by our ventures unit. In addition to our two reportable segments, we have an Other category, which primarily includes our strategic investments, investments unit, corporate expenses, capital servicing costs, noncontrolling interests, certain expenses related to the acquisition of Platinumacquisitions and the remnants of our former Bermuda-based insurance operations.
Ventures
We pursue a number of other opportunities through our ventures unit, which has responsibility for creating and managing our joint ventures, executing customized reinsurance transactions to assume or cede risk and managing certain investments directed at classes of risk other than catastrophe reinsurance.
New Business
From time to time we consider diversification into new ventures, either through organic growth, the formation of new joint ventures, or the acquisition of or the investment in other companies or books of business of other companies. This potential diversification includes opportunities to write targeted, additional classes of risk-exposed business, both directly for our own account and through new joint venture opportunities. We also regularly evaluate potential strategic opportunities we believe might utilize our skills, capabilities, proprietary technology and relationships to support possible expansion into further risk-related coverages, services and products. Generally, we focus on underwriting or trading risks where we believe reasonably sufficient data is available and our analytical abilities provide us with a competitive advantage, in order for us to seek to model estimated probabilities of losses and returns in respect of our then current portfolio of risks.
We regularly review potential strategic transactions that might improve our portfolio of business, enhance or focus our strategies, expand our distribution or capabilities, or provide other benefits. In evaluating potential new ventures or investments, we generally seek an attractive estimated return on equity, the ability to develop or capitalize on a competitive advantage, and opportunities which we believe will not detract from our core operations. We believe that our ability to attract investment and operational opportunities is supported by our strong reputation and financial resources, and by the capabilities and track record of our ventures unit.
SUMMARY OF CRITICAL ACCOUNTING ESTIMATES
The Company’sOur critical accounting estimates include “Claims and Claim Expense Reserves”,Reserves,” “Premiums and Related Expenses”,Expenses,” “Reinsurance Recoverables”,Recoverables,” “Fair Value Measurements and Impairments” and “Income Taxes”,Taxes,” and are discussed in Management’s Discussion and Analysis of Financial Condition and Results of Operations in our Form 10-K for the year ended December 31, 2016.2019. There have been no material changes to our critical accounting estimates as disclosed in our Form 10-K for the year ended December 31, 2016.
2019.
SUMMARY OF RESULTS OF OPERATIONS
Below is a discussion of the results of operations for the third quarter of 2017,2020, compared to the third quarter of 2016.2019.
| | | | | | | | | | | | | | | | | | | | | | | | |
| | | | | | | | |
| Three months ended September 30, | 2020 | | 2019 | | Change | | |
| (in thousands, except per share amounts and percentages) | | | | | | | |
| Statement of operations highlights | | | | | | | |
| Gross premiums written | $ | 1,143,058 | | | $ | 861,068 | | | $ | 281,990 | | | |
| Net premiums written | $ | 899,411 | | | $ | 704,130 | | | $ | 195,281 | | | |
| Net premiums earned | $ | 1,000,183 | | | $ | 906,748 | | | $ | 93,435 | | | |
| Net claims and claim expenses incurred | 942,030 | | | 654,520 | | | 287,510 | | | |
| Acquisition expenses | 215,180 | | | 202,181 | | | 12,999 | | | |
| Operational expenses | 49,045 | | | 53,415 | | | (4,370) | | | |
| Underwriting loss | $ | (206,072) | | | $ | (3,368) | | | $ | (202,704) | | | |
| | | | | | | | |
| Net investment income | $ | 83,543 | | | $ | 111,387 | | | $ | (27,844) | | | |
| Net realized and unrealized gains on investments | 224,208 | | | 34,395 | | | 189,813 | | | |
| | | | | | | | |
| | | | | | | | |
| Total investment result | $ | 307,751 | | | $ | 145,782 | | | $ | 161,969 | | | |
| | | | | | | | |
| | | | | | | | |
| | | | | | | | |
| Net income | $ | 74,389 | | | $ | 107,944 | | | $ | (33,555) | | | |
| Net income available to RenaissanceRe common shareholders | $ | 47,799 | | | $ | 36,698 | | | $ | 11,101 | | | |
| | | | | | | | |
| | | | | | | | |
| | | | | | | | |
| Net income available to RenaissanceRe common shareholders per common share – diluted | $ | 0.94 | | | $ | 0.83 | | | $ | 0.11 | | | |
| Dividends per common share | $ | 0.35 | | | $ | 0.34 | | | $ | 0.01 | | | |
| | | | | | | | |
| Key ratios | | | | | | | |
| Net claims and claim expense ratio – current accident year | 99.6 | % | | 73.3 | % | | 26.3 | % | | |
| Net claims and claim expense ratio – prior accident years | (5.4) | % | | (1.1) | % | | (4.3) | % | | |
| Net claims and claim expense ratio – calendar year | 94.2 | % | | 72.2 | % | | 22.0 | % | | |
| Underwriting expense ratio | 26.4 | % | | 28.2 | % | | (1.8) | % | | |
| Combined ratio | 120.6 | % | | 100.4 | % | | 20.2 | % | | |
| | | | | | | | |
| Return on average common equity - annualized | 2.8 | % | | 2.8 | % | | — | % | | |
| | | | | | | | |
| Book value | September 30,
2020 | | June 30,
2020 | | Change | | |
| Book value per common share | $ | 135.13 | | | $ | 134.27 | | | $ | 0.86 | | | |
| Accumulated dividends per common share | 21.73 | | | 21.38 | | | 0.35 | | | |
| Book value per common share plus accumulated dividends | $ | 156.86 | | | $ | 155.65 | | | $ | 1.21 | | | |
| Change in book value per common share plus change in accumulated dividends | 0.9 | % | | | | | | |
| | | | | | | | |
| | | | | | | | |
| | | | | | | | |
| | | | | | | | |
| | | | | | | | |
|
| | | | | | | | | | | | | |
| | | | | | | | |
| | Three months ended September 30, | 2017 | | 2016 | | Change | |
| | (in thousands, except per share amounts and percentages) | | | | | | |
| | Statement of operations highlights | | | | | | |
| | Gross premiums written | $ | 640,269 |
| | $ | 430,224 |
| | $ | 210,045 |
| |
| | Net premiums written | $ | 483,221 |
| | $ | 284,222 |
| | $ | 198,999 |
| |
| | Net premiums earned | $ | 547,792 |
| | $ | 346,521 |
| | $ | 201,271 |
| |
| | Net claims and claim expenses incurred | 1,221,696 |
| | 112,575 |
| | 1,109,121 |
| |
| | Acquisition expenses | 76,761 |
| | 80,580 |
| | (3,819 | ) | |
| | Operational expenses | 42,537 |
| | 40,493 |
| | 2,044 |
| |
| | Underwriting (loss) income | $ | (793,202 | ) | | $ | 112,873 |
| | $ | (906,075 | ) | |
| | | | | | | | |
| | Net investment income | $ | 40,257 |
| | $ | 51,423 |
| | $ | (11,166 | ) | |
| | Net realized and unrealized gains on investments | 42,052 |
| | 59,870 |
| | (17,818 | ) | |
| | Change in net unrealized gains on fixed maturity investments available for sale | — |
| | (113 | ) | | 113 |
| |
| | Total investment result | $ | 82,309 |
| | $ | 111,180 |
| | $ | (28,871 | ) | |
| | | | | | | | |
| | Net (loss) income | $ | (703,494 | ) | | $ | 188,061 |
| | $ | (891,555 | ) | |
| | Net (loss) income (attributable) available to RenaissanceRe common shareholders | $ | (504,812 | ) | | $ | 146,825 |
| | $ | (651,637 | ) | |
| | | | | | | | |
| | Net (loss) income (attributable) available to RenaissanceRe common shareholders per common share – diluted | $ | (12.75 | ) | | $ | 3.56 |
| | $ | (16.31 | ) | |
| | Dividends per common share | $ | 0.32 |
| | $ | 0.31 |
| | $ | 0.01 |
| |
| | | | | | | | |
| | Key ratios | | | | | | |
| | Net claims and claim expense ratio – current accident year | 220.8 | % | | 45.7 | % | | 175.1 | % | |
| | Net claims and claim expense ratio – prior accident years | 2.2 | % | | (13.2 | )% | | 15.4 | % | |
| | Net claims and claim expense ratio – calendar year | 223.0 | % | | 32.5 | % | | 190.5 | % | |
| | Underwriting expense ratio | 21.8 | % | | 34.9 | % | | (13.1 | )% | |
| | Combined ratio | 244.8 | % | | 67.4 | % | | 177.4 | % | |
| | | | | | | | |
| | Return on average common equity - annualized | (47.2 | )% | | 13.5 | % | | (60.7 | )% | |
| | | | | | | | |
| | Book value | September 30,
2017 | | June 30,
2017 | | Change | |
| | Book value per common share | $ | 100.00 |
| | $ | 113.08 |
| | $ | (13.08 | ) | |
| | Accumulated dividends per common share | 17.68 |
| | 17.36 |
| | 0.32 |
| |
| | Book value per common share plus accumulated dividends | $ | 117.68 |
| | $ | 130.44 |
| | $ | (12.76 | ) | |
| | Change in book value per common share plus change in accumulated dividends | (11.3 | )% | | | | | |
| | | | | | | | |
| | Balance sheet highlights | September 30,
2017 | | June 30,
2017 | | Change | |
| | Total assets | $ | 15,044,924 |
| | $ | 13,705,680 |
| | $ | 1,339,244 |
| |
| | Total shareholders’ equity attributable to RenaissanceRe | $ | 4,403,012 |
| | $ | 4,955,255 |
| | $ | (552,243 | ) | |
| | | | | | | | |
Net loss attributableincome available to RenaissanceRe common shareholders was $504.8$47.8 million in the third quarter of 2017,2020, compared to net income available to RenaissanceRe common shareholders of $146.8$36.7 million in the third quarter of 2016, a decrease2019, an increase of $651.6 million.$11.1 million. As a result of our net loss attributableincome available to RenaissanceRe common shareholders in the third quarter of 2017,2020, we generated an annualized return on average common equity of negative 47.2%2.8% and our book value per common share decreasedincreased from $113.08$134.27 at June 30, 20172020 to $100.00$135.13 at September 30, 2017, an 11.3%decrease,2020, a 0.9% increase, after considering the change in accumulated dividends paid to our common shareholders and the impact of 270 thousand common shares being repurchased in open market transactions during the third quarter of 2017, as detailed in “Part II, Item 2. Unregistered Sales of Equity Securities and Use of Proceeds”.shareholders.
The most significant eventsitems affecting our financial performance during the third quarter of 2017,2020, on a comparative basis to the third quarter of 2016,2019, include:
Hurricanes Harvey, Irma and Maria, the Mexico City Earthquake and certain losses associated with aggregate loss contracts (“Q3 2017 Aggregate Losses”)(collectively referred to as the “Q3 2017 Large Loss•Impact of Catastrophe Events”) - the Q3 2017 Large Loss Eventswe had a net negative impact on the net loss attributableincome available to RenaissanceRe common shareholders of $615.1$321.7 million resulting from Hurricane Laura, Hurricane Sally, the wildfires occurring in California, Oregon and Washington (the “Q3 2020 Wildfires”), other catastrophe events including the August 2020 derecho which impacted the U.S. Midwest, Hurricane Isaias, and Typhoon Maysak (the “Other Q3 2020 Catastrophe Events”), and loss estimates associated with aggregate loss contracts on these and other events in the third quarter of 2020 (collectively, the “Q3 2020 Large Loss Events”). This compares to a net negative impact on our underwriting resultsnet income available to RenaissanceRe common shareholders of $838.7$154.9 million adding 156.0 percentage points to our combined ratioresulting from Hurricane Dorian and Typhoon Faxai (collectively, the “Q3 2019 Catastrophe Events”) in the third quarter of 2017. See below for additional information regarding the net negative impact of the Q3 2017 Large Loss Events.
2019;Primarily as a result of the Q3 2017 Large Loss Events,•Underwriting Results - we incurred an underwriting loss of $793.2$206.1 million and had a combined ratio of 120.6% in the third quarter of 2020, compared to an underwriting loss of $3.4 million and a combined ratio of 244.8%100.4% in the third quarter of 2017, compared to generating2019. Our underwriting income of $112.9 million and a combined ratio 67.4%, respectively,loss in the third quarter of 2016. Our underwriting loss2020 was comprised of our Property segment, which incurred an underwriting loss of $750.2$206.6 million and had a combined ratio of 322.7%140.0%, and our Casualty and Specialty segment, which generated underwriting income of $0.6 million and had a combined ratio of 99.9%. In comparison, our underwriting loss in the third quarter of 2019 was comprised of our Property segment, which incurred an underwriting loss of $43.1$7.7 million, partially offset by underwriting income of $4.5 million in our Casualty and a combined ratio of 120.4%, eachSpecialty segment.
Our underwriting results in the third quarter of 2017. The2020 were principally impacted by the Q3 20172020 Large Loss Events, which resulted in $808.6a net negative impact on the underwriting result of $422.4 million of underwriting losses in our Property segment, or 252.0and added 43.4 percentage points on itsto the combined ratio, primarily in the Property segment. The third quarter of 2019 was impacted by the Q3 2019 Catastrophe Events, which resulted in a net negative impact on the underwriting result of $181.9 million and added 20.6 percentage points to the combined ratio;
•Gross Premiums Written - our gross premiums written increased by $282.0 million, or 32.7%, to $1.1 billion, in the third quarter of 2017, and $30.02020, compared to the third quarter of 2019. This was comprised of an increase of $168.6 million of underwriting losses in ourthe Casualty and Specialty segment or 14.1 percentage points on its combined ratioand an increase of $113.4 million in the third quarter of 2017. Our underwriting results are discussed in additional detail below in “Underwriting Results by Segment”;Property segment;
Net Loss Attributable to Redeemable Noncontrolling Interests - net loss attributable to redeemable noncontrolling interests in the third quarter of 2017 was $204.3 million, compared to net income attributable to redeemable noncontrolling interests of $35.6 million in the third quarter of 2016, principally due to significant underwriting losses associated with Q3 2017 Large Loss Events incurred by DaVinciRe, and a decrease in our ownership in DaVinciRe to 23.5% at September 30, 2017, compared to 24.0% at September 30, 2016;
•Investment Results - our total investment result, which includes the sum of net investment income and net realized and unrealized gains on investments, was a gain of $82.3$307.8 million in the third quarter of 2017, compared to a gain of $111.2 million in the third quarter of 2016, a decrease of $28.9 million. The decrease in our total investment result was principally driven by unrealized losses in our other investment portfolio, specifically our catastrophe bond portfolio, which was impacted by a number of large catastrophe events occurring in the third quarter of 2017, combined with lower unrealized gains on our equity investments trading portfolio primarily due2020, compared to lower returns in the current quarter on certain larger positions; and
Equity in Earnings of Other Ventures - our equity in earnings of other ventures was $1.8$145.8 million in the third quarter of 2017, compared to a loss2019, an increase of $11.6 million$162.0 million. The primary driver of the total investment result in the third quarter of 2016, an improvement2020 was net realized and unrealized gains on investments of $13.4 million. Principally impacting this improvement$224.2 million principally within our equity and fixed maturity investments trading portfolios; and
•Net Income Attributable to Redeemable Noncontrolling Interests - our net income attributable to redeemable noncontrolling interests was the non-recurrence of equity$19.3 million in losses of other ventures during the third quarter of 2016, primarily the result of a $15.02020, compared to $62.1 million loss related to the Company’s 50% ownership in Top Layer Re. During the third quarter of 2016, Top Layer Re reduced its estimated ultimate claim and claim expenses and related reinsurance recoverable associated with the 2011 Tohoku Earthquake to $Nil as a result of favorable loss emergence, resulting2019. The decrease was primarily driven by underwriting losses in DaVinciRe, partially offset by an increase in underwritingthe net income for Top Layer Re forof Medici as compared to the third quarter of 2016. However,2019.
COVID-19 Pandemic
In late 2019 an outbreak of a novel strain of coronavirus originated in China and has since spread globally. In January 2020, the increase in underwriting income was more than offset byWorld Health Organization declared the reversaloutbreak a global health emergency, and on March 11, 2020, the World Health Organization declared the COVID-19 outbreak a pandemic. It is not yet possible to give an estimate of an unrealized foreign exchange gain relatedall of the Company’s potential reinsurance, insurance or investment exposures, or any other effects that the COVID-19 pandemic may have on our results of operations or financial condition. Due to the reserve for claimsongoing and claim expenses, which were denominated in Japanese Yen. While Top Layer Re had fully hedged its net economicrapidly evolving nature of the COVID-19 pandemic, we are continuing to evaluate the impact of the COVID-19 pandemic on our business, operations and financial condition, including our potential loss exposures.
We continue to evaluate industry trends and our potential exposure to Japanese Yen associated with thisthe ongoing COVID-19 pandemic, and expect historically significant industry losses to emerge over time as the full impact of the pandemic and its effects on the global economy are realized. A longer or more severe recession will increase the probability of losses. Potential legislative, regulatory and judicial actions are also causing
significant uncertainty with respect to policy coverage and other issues. Among other things, we continue to actively monitor information received from or reported by clients, brokers, industry actuaries, regulators, courts, and others, and to assess that information in the context of our own portfolio. Our loss since inception, becauseestimates represent our best estimate based on currently available information, and actual losses may vary materially from these estimates. Losses incurred in respect of the hedged net liability wentCOVID-19 pandemic will be reflected in the periods in which those losses are incurred.
In addition to $Nil, Top Layer Re recorded an unrealized foreign exchange loss forcoverage exposures, volatility in global financial markets, together with low or negative interest rates, reduced liquidity and a continued slowdown in global economic conditions, have adversely impacted, and may adversely affect, our investment portfolio in the third quarter of 2016. If the reserve for net claimsfuture. These conditions may also negatively impact our ability to access liquidity and claim expenses had
capital markets financing, which may not be available or may only be available on unfavorable terms.
been paid in full, rather than being reduced to $Nil, there wouldWhile we believe we have been no financial statement impactable to Top Layer Re.operate effectively with most of our employees working remotely, an extended period of remote work arrangements could strain the Company’s business continuity plans, introduce operational risk, including but not limited to cybersecurity risks, and adversely affect the Company’s ability to manage our business. For additional information see "Current Outlook" and "Part II, Item 1A, Risk Factors."
Net Negative Impact of the Q3 2017 Large Loss Events
Net negative impact from the Q3 2017 Large Loss Events includes the sum of estimates of net claims and claim expenses incurred, earned reinstatement premiums assumed and ceded, lost and earned profit commissions and redeemable noncontrolling interest. Our estimates of net negative impact are based on a review of our potential exposures, preliminary discussions with certain counterparties and catastrophe modeling techniques. MeaningfulOur actual net negative impact, both individually and in the aggregate, may vary from these estimates, perhaps materially. Changes in these estimates will be recorded in the period in which they occur.
There remains meaningful uncertainty regarding the estimates and the nature and extent of the losses from theseassociated with catastrophe events, remains, driven by the magnitude and recent occurrence of each event, the geographic areas in which the events occurred, relatively limited claims data received to date, the contingent nature of business interruption and other exposures, potential uncertainties relating to reinsurance recoveries and other factors inherent in loss estimation, among other things. We believe these estimates remain even more uncertain for the two more recent events, Hurricane Maria and the Mexico City Earthquake, because, among other things, recovery, insurance loss adjusting and exposure estimates are at earlier stages. Furthermore, seismic events such as the Mexico City Earthquake generally have longer development periods than windstorm events, which may be amplified in this instance by dynamics such as the risk of geological liquefaction and the potential for uncertainty in claims adjudication. In respect of Hurricane Maria, recovery efforts remain ongoing, with continuing power outages, infrastructure damage, communications disruptions and other issues complicating loss mitigation and estimation. Accordingly, our actual net negative impact from the events noted above, both individually and
The financial data in the aggregate, will vary from these preliminary estimates, perhaps materially. Changes in these estimates will be recorded in the period in which they occur.
See the financial datatable below forprovides additional information detailing the net negative impact of the Q3 20172020 Large Loss Events on our consolidated financial statements in the third quarter of 2017.2020.
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
| | | | | | | | | | | | | |
| Three months ended September 30, 2020 | Hurricane Laura | | Hurricane Sally | | Q3 2020 Wildfires | | Other Q3 2020 Catastrophe Events | | Aggregate Losses | | Total Q3 2020 Large Loss Events | |
| (in thousands) | | | | | | | | | | | | |
| Net claims and claims expenses incurred | $ | (123,076) | | | $ | (72,531) | | | $ | (91,107) | | | $ | (61,586) | | | $ | (120,118) | | | $ | (468,418) | | |
| Assumed reinstatement premiums earned | 18,282 | | | 5,110 | | | 17,604 | | | 7,407 | | | 5,123 | | | 53,526 | | |
| Ceded reinstatement premiums earned | (334) | | | (236) | | | — | | | — | | | — | | | (570) | | |
| Lost profit commissions | (254) | | | (418) | | | (491) | | | (549) | | | (5,179) | | | (6,891) | | |
| Net negative impact on underwriting result | (105,382) | | | (68,075) | | | (73,994) | | | (54,728) | | | (120,174) | | | (422,353) | | |
| | | | | | | | | | | | | |
| | | | | | | | | | | | | |
| Redeemable noncontrolling interest | 20,008 | | | 11,834 | | | 19,580 | | | 17,958 | | | 31,262 | | | 100,642 | | |
| Net negative impact on net income available to RenaissanceRe common shareholders | $ | (85,374) | | | $ | (56,241) | | | $ | (54,414) | | | $ | (36,770) | | | $ | (88,912) | | | $ | (321,711) | | |
| | | | | | | | | | | | | |
|
| | | | | | | | | | | | | | | | | | | | | | | | | |
| | | | | | | | | | | | | | |
| | Three months ended September 30, 2017 | Hurricane Harvey | | Hurricane Irma | | Hurricane Maria | | Mexico City Earthquake | | Q3 2017 Aggregate Losses | | Total | |
| | (in thousands, except percentages) | | | | | | | | | | | | |
| | Net claims and claim expenses incurred | $ | (275,409 | ) | | $ | (300,536 | ) | | $ | (236,478 | ) | | $ | (68,068 | ) | | $ | (128,779 | ) | | $ | (1,009,270 | ) | |
| | Reinstatement premiums earned | 65,715 |
| | 67,342 |
| | 29,138 |
| | 6,078 |
| | 1,500 |
| | 169,773 |
| |
| | Ceded reinstatement premiums earned | (9,035 | ) | | (18,190 | ) | | (1,537 | ) | | (43 | ) | | — |
| | (28,805 | ) | |
| | (Lost) earned profit commissions | (11,358 | ) | | 16,192 |
| | 13,329 |
| | 3,329 |
| | 8,146 |
| | 29,638 |
| |
| | Net negative impact on underwriting result | (230,087 | ) | | (235,192 | ) | | (195,548 | ) | | (58,704 | ) | | (119,133 | ) | | (838,664 | ) | |
| | Redeemable noncontrolling interest - DaVinciRe | 39,089 |
| | 69,152 |
| | 63,064 |
| | 14,254 |
| | 38,000 |
| | 223,559 |
| |
| | Net negative impact on net loss attributable to RenaissanceRe common shareholders | $ | (190,998 | ) | | $ | (166,040 | ) | | $ | (132,484 | ) | | $ | (44,450 | ) | | $ | (81,133 | ) | | $ | (615,105 | ) | |
| | Percentage point impact on consolidated combined ratio | 30.1 |
| | 32.9 |
| | 29.9 |
| | 9.2 |
| | 21.4 |
| | 156.0 |
| |
| | | | | | | | | | | | | | |
| | Net negative impact on Property segment underwriting result | $ | (219,976 | ) | | $ | (232,783 | ) | | $ | (178,896 | ) | | $ | (57,860 | ) | | $ | (119,133 | ) | | $ | (808,648 | ) | |
| | Net negative impact on Casualty and Specialty segment underwriting result | (10,111 | ) | | (2,409 | ) | | (16,652 | ) | | (844 | ) | | — |
| | (30,016 | ) | |
| | Net negative impact on underwriting result | $ | (230,087 | ) | | $ | (235,192 | ) | | $ | (195,548 | ) | | $ | (58,704 | ) | | $ | (119,133 | ) | | $ | (838,664 | ) | |
| | | | | | | | | | | | | | |
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
| | | | | | | | | | | | | |
| Three months ended September 30, 2020 | Hurricane Laura | | Hurricane Sally | | Q3 2020 Wildfires | | Other Q3 2020 Catastrophe Events | | Aggregate Losses | | Total Q3 2020 Large Loss Events | |
| (in thousands, except percentages) | | | | | | | | | | | | |
| Net negative impact on Property segment underwriting result | $ | (95,845) | | | $ | (68,075) | | | $ | (73,994) | | | $ | (54,728) | | | $ | (120,174) | | | $ | (412,816) | | |
| Net negative impact on Casualty and Specialty segment underwriting result | (9,537) | | | — | | | — | | | — | | | — | | | (9,537) | | |
| Net negative impact on underwriting result | $ | (105,382) | | | $ | (68,075) | | | $ | (73,994) | | | $ | (54,728) | | | $ | (120,174) | | | $ | (422,353) | | |
| Percentage point impact on consolidated combined ratio | 10.3 | | | 6.7 | | | 7.2 | | | 5.4 | | | 12.0 | | | 43.4 | | |
| | | | | | | | | | | | | |
The financial data in the table below provides additional information detailing the net negative impact of the Q3 2019 Catastrophe Events on our consolidated financial statements in the third quarter of 2019.
| | | | | | | | | | | | | | | | | | | | | | | |
| | | | | | | |
| Three months ended September 30, 2019 | Hurricane Dorian | | Typhoon Faxai | | Total Q3 2019 Catastrophe Events | |
| (in thousands) | | | | | | |
| Net claims and claims expenses incurred | $ | (60,784) | | | $ | (148,127) | | | $ | (208,911) | | |
| Assumed reinstatement premiums earned | 5,106 | | | 18,332 | | | 23,438 | | |
| Ceded reinstatement premiums earned | (364) | | | (118) | | | (482) | | |
| Earned profit commissions | 92 | | | 3,943 | | | 4,035 | | |
| Net negative impact on underwriting result | (55,950) | | | (125,970) | | | (181,920) | | |
| Redeemable noncontrolling interest | 3,659 | | | 23,335 | | | 26,994 | | |
| Net negative impact on net income available to RenaissanceRe common shareholders | $ | (52,291) | | | $ | (102,635) | | | $ | (154,926) | | |
| | | | | | | |
The financial data below provides additional information detailing the net negative impact of the Q3 2019 Catastrophe Events on our segment underwriting results and consolidated combined ratio in the third quarter of 2019.
| | | | | | | | | | | | | | | | | | | | | | | |
| | | | | | | |
| Three months ended September 30, 2019 | Hurricane Dorian | | Typhoon Faxai | | Total Q3 2019 Catastrophe Events | |
| (in thousands, except percentages) | | | | | | |
| Net negative impact on Property segment underwriting result | $ | (53,378) | | | $ | (125,540) | | | $ | (178,918) | | |
| Net negative impact on Casualty and Specialty segment underwriting result | (2,572) | | | (430) | | | (3,002) | | |
| Net negative impact on underwriting result | $ | (55,950) | | | $ | (125,970) | | | $ | (181,920) | | |
| Percentage point impact on consolidated combined ratio | 6.2 | | | 14.2 | | | 20.6 | | |
| | | | | | | |
Underwriting Results by Segment
Property
Below is a summary of the underwriting results and ratios for our Property segment: |
| | | | | | | | | | | | | |
| | | | | | | | |
| | Three months ended September 30, | 2017 | | 2016 | | Change | |
| | (in thousands, except percentages) | | | | | | |
| | Gross premiums written | $ | 325,395 |
| | $ | 119,904 |
| | $ | 205,491 |
| |
| | Net premiums written | $ | 269,393 |
| | $ | 90,909 |
| | $ | 178,484 |
| |
| | Net premiums earned | $ | 336,838 |
| | $ | 172,661 |
| | $ | 164,177 |
| |
| | Net claims and claim expenses incurred | 1,044,418 |
| | 23,539 |
| | 1,020,879 |
| |
| | Acquisition expenses | 17,514 |
| | 21,663 |
| | (4,149 | ) | |
| | Operational expenses | 25,123 |
| | 24,258 |
| | 865 |
| |
| | Underwriting (loss) income | $ | (750,217 | ) | | $ | 103,201 |
| | $ | (853,418 | ) | |
| | | | | | | | |
| | Net claims and claim expenses incurred – current accident year | $ | 1,036,586 |
| | $ | 42,062 |
| | $ | 994,524 |
| |
| | Net claims and claim expenses incurred – prior accident years | 7,832 |
| | (18,523 | ) | | 26,355 |
| |
| | Net claims and claim expenses incurred – total | $ | 1,044,418 |
| | $ | 23,539 |
| | $ | 1,020,879 |
| |
| | | | | | | | |
| | Net claims and claim expense ratio – current accident year | 307.7 | % | | 24.4 | % | | 283.3 | % | |
| | Net claims and claim expense ratio – prior accident years | 2.4 | % | | (10.8 | )% | | 13.2 | % | |
| | Net claims and claim expense ratio – calendar year | 310.1 | % | | 13.6 | % | | 296.5 | % | |
| | Underwriting expense ratio | 12.6 | % | | 26.6 | % | | (14.0 | )% | |
| | Combined ratio | 322.7 | % | | 40.2 | % | | 282.5 | % | |
| | | | | | | | |
| | | | | | | | | | | | | | | | | | | | | | | |
| | | | | | | |
| Three months ended September 30, | 2020 | | 2019 | | Change | |
| (in thousands, except percentages) | | | | | | |
| Gross premiums written | $ | 427,765 | | | $ | 314,400 | | | $ | 113,365 | | |
| Net premiums written | $ | 378,708 | | | $ | 302,982 | | | $ | 75,726 | | |
| Net premiums earned | $ | 516,623 | | | $ | 444,332 | | | $ | 72,291 | | |
| Net claims and claim expenses incurred | 590,958 | | | 338,260 | | | 252,698 | | |
| Acquisition expenses | 98,545 | | | 79,521 | | | 19,024 | | |
| Operational expenses | 33,672 | | | 34,238 | | | (566) | | |
| Underwriting loss | $ | (206,552) | | | $ | (7,687) | | | $ | (198,865) | | |
| | | | | | | |
| Net claims and claim expenses incurred – current accident year | $ | 629,827 | | | $ | 345,880 | | | $ | 283,947 | | |
| Net claims and claim expenses incurred – prior accident years | (38,869) | | | (7,620) | | | (31,249) | | |
| Net claims and claim expenses incurred – total | $ | 590,958 | | | $ | 338,260 | | | $ | 252,698 | | |
| | | | | | | |
| Net claims and claim expense ratio – current accident year | 121.9 | % | | 77.8 | % | | 44.1 | % | |
| Net claims and claim expense ratio – prior accident years | (7.5) | % | | (1.7) | % | | (5.8) | % | |
| Net claims and claim expense ratio – calendar year | 114.4 | % | | 76.1 | % | | 38.3 | % | |
| Underwriting expense ratio | 25.6 | % | | 25.6 | % | | — | % | |
| Combined ratio | 140.0 | % | | 101.7 | % | | 38.3 | % | |
| | | | | | | |
Property Gross Premiums Written –
In the third quarter of 2017,2020, our Property segment gross premiums written increased by $205.5$113.4 million, or 171.4%36.1%, to $325.4$427.8 million, compared to $119.9 million in the third quarter of 2016. Excluding the impact of $164.7 million of reinstatement premiums written in our Property segment associated with the Q3 2017 Large Loss Events, gross premiums written in our Property segment increased $40.7 million, or 34.0%, in the third quarter of 2017 compared to the third quarter of 2016.
Excluding reinstatement premiums written associated with Q3 2017 Large Loss Events, the increase in gross premiums written in our Property segment was principally driven by the other property class of business where we were able to increase our participation on a select number of transactions and enter into certain new transactions we believe have comparably attractive risk-return attributes. Gross premiums written in our other property class of business were $81.9$314.4 million in the third quarter of 2017,2019.
Gross premiums written in the catastrophe class of business were $179.7 million in the third quarter of 2020, an increase of $33.6$76.9 million, or 69.5%74.8%, compared to the third quarter of 2016. Excluding $2.52019. Gross written premiums in the third quarter of 2020 included $52.9 million of reinstatement premiums associated with the Q3 2020 Large Loss Events, as compared to $23.1 million of reinstatement premiums written in the third quarter of 2019 associated with the Q3 2019 Catastrophe Events. In addition, gross written premiums in the third quarter of 2019 included $26.4 million of negative premium adjustments related to the business of the third-party capital vehicles that the Company manages as a result of the acquisition of TMR. The negative premium adjustments were fully ceded and were reflected in ceded premiums written, resulting in no impact to the Company’s results of operations in the third quarter of 2019.
Gross premiums written in the other property class of business in the third quarter of 2017 associated with the Q3 2017 Large Loss Events, gross premiums written increased $31.1 million, or 64.3%, in the third quarter of 2017 compared to the third quarter of 2016.
Gross premiums written in our catastrophe class of business were $243.5$248.1 million in the third quarter of 2017,2020, an increase of $171.9$36.5 million, or 240.1%17.2%, compared to the third quarter of 2016. Excluding $162.2 million2019. This increase was driven by growth from existing relationships and new opportunities across a number of reinstatement premiums written in our catastrophe class of businessthe Company’s underwriting platforms, including in the third quarterdelegated authority insurance business of 2017 associated with the Q3 2017 Large Loss Events, gross premiums written in our catastrophe class of business increased $9.7 million, or 13.5%, in the third quarter of 2017 compared to the third quarter of 2016, as we were able to enter into certain new contracts following the occurrence of the Q3 2017 Large Loss Events, while continuing to exercise underwriting discipline given prevailing market terms and conditions. Certain of these contracts are for partial periods of an original exposure period.Syndicate 1458.
Our Property segment gross premiums written continue to be characterized by a large percentage of U.S. and Caribbean premium, as we have found business derived from exposures in Europe, Asia and the rest of the world to be, in general, less attractive on a risk-adjusted basis during recent periods. A significant
amount of our U.S. and Caribbean premium provides coverage against windstorms, notably U.S. Atlantic windstorms, as well as earthquakes and other natural and man-made catastrophes.
Property Ceded Premiums Written |
| | | | | | | | | | | | | |
| | | | | | | | |
| | Three months ended September 30, | 2017 | | 2016 | | Change | |
| | (in thousands) | | | | | | |
| | Ceded premiums written - Property | $ | 56,002 |
| | $ | 28,995 |
| | $ | 27,008 |
| |
| | | | | | | | |
| | | | | | | | | | | | | | | | | | | | | | | |
| | | | | | | |
| Three months ended September 30, | 2020 | | 2019 | | Change | |
| (in thousands) | | | | | | |
| Ceded premiums written - Property | $ | 49,057 | | | $ | 11,418 | | | $ | 37,639 | | |
| | | | | | | |
Ceded premiums written in our Property segment were $56.0$49.1 million in the third quarter of 2017,2020, an increase of $37.6 million, or 329.6%, compared to $29.0 millionthe third quarter of 2019. In the third quarter of 2020,
ceded premiums written included certain of the gross premiums ceded to third-party investors in the Company’s managed vehicles, primarily RenaissanceRe Upsilon Fund Ltd. (“Upsilon Fund”). Ceded premiums written in the third quarter of 2016, an increase2019 included $26.4 million negative premium adjustments related to the business of $27.0 million, principally driven by $27.4 millionthe third-party capital vehicles that the Company manages as a result of ceded reinstatement premiums written associated with the Q3 2017 Large Loss Events.acquisition of TMR, as discussed above.
Due to the potential volatility of the reinsurance contracts which we sell, we purchase reinsurance to reduce our exposure to large losses and to help manage our risk portfolio. To the extent that appropriately priced coverage is available, we anticipate continued use of retrocessional reinsurance to reduce the impact of large losses on our financial results and to manage our portfolio of risk; however, the decision to buybuying of ceded reinsurance in our Property segment is based on market opportunities and is not based on placing a specific reinsurance program each year. In addition, in future periods we may utilize the growing market for insurance-linked securities to expand our cededpurchases of retrocessional reinsurance buying if we find the pricing and terms of such coverages attractive.
Property Underwriting Results –
Our Property segment incurred an underwriting loss of $750.2$206.6 million in the third quarter of 2017,2020, compared to generatingan underwriting incomeloss of $103.2$7.7 million in the third quarter of 2016.2019. In the third quarter of 2017,2020, our Property segment generated a net claims and claim expense ratio of 310.1%114.4%, an underwriting expense ratio of 12.6%25.6% and a combined ratio of 322.7%140.0%, compared to 13.6%76.1%, 26.6%25.6% and 40.2%101.7%, respectively, in the third quarter of 2016. 2019.
Principally impacting our Property segmentthe underwriting result and combined ratio in the third quarter of 20172020 were the Q3 20172020 Large Loss Events, which resulted in ana net negative impact on the Property segment underwriting lossresult of $808.6$412.8 million and added 252.084.4 percentage points to the combined ratio.
Our Property segment experienced $7.8 million, or 2.4 percentage points, of adverse development on prior accident years net claims and claim expenses duringcombined ratio. In comparison, the third quarter of 2017, compared to $18.52019 was impacted by the Q3 2019 Catastrophe Events, which resulted in a net negative impact on the Property segment underwriting result of $178.9 million or 10.8and added 42.3 percentage points of favorable development on prior accident years net claims and claim expenses into the third quarter of 2016. The adverse development during the third quarter of 2017 was principally driven by increases in the estimated ultimate losses associated with aggregate losses from the 2016 underwriting year.
Profit Commissions and Fees |
| | | | | | | | | | | | | |
| | | | | | | | |
| | Three months ended September 30, | 2017 | | 2016 | | Change | |
| | (in thousands) | | | | | | |
| | Profit commissions and fees | $ | 32,690 |
| | $ | 19,430 |
| | $ | 13,260 |
| |
| | Decrease in underwriting expense ratio | 9.7 | % | | 11.3 | % | | (1.6 | )% | |
| | Net impact of profit commissions and fees | $ | (9,850 | ) | | $ | 31,036 |
| | $ | (40,886 | ) | |
| | | | | | | | |
We have entered into various joint ventures and specialized quota share retrocession agreements pursuant to which we cede a portion of our property book of business and earn profit commissions, as applicable, and fee income. We record these profit commissions and fees as reductions in acquisition and operating expenses, respectively, and, accordingly, these profit commissions and fees have reduced our underwriting expense ratios.
In addition, we are entitled to certain fee income and profit commissions from DaVinci. Since the results of DaVinci and its parent, DaVinciRe, are consolidated in our results of operations, the majority of these fees and profit commissions are eliminated in our consolidated financial statements and are principally reflected in redeemable noncontrolling interest – DaVinciRe. The net impact of all fees and profit commissions related to these joint ventures and specialized quota share cessions within our Property segment was an expense of $9.9 million in the third quarter of 2017, compared to income of $31.0 million in the third quartercombined ratio.
of 2016. Included in profit commissions and fees and the net impact of profit commissions and fees in the third quarter of 2017 was a true-up of profit commissions associated with DaVinci, reflecting the impact of the Q3 2017 Large Loss Events on the year-to-date results of operations of DaVinci. This was partially offset by the reversal of profit commissions previously booked on various quota share retrocession agreements, also as a result of the Q3 2017 Large Loss Events. The true-up of profit commissions associated with DaVinci was reflected in acquisition and operating expenses as appropriate, and was principally offset in net loss attributable to noncontrolling interests in our consolidated statement of operations, resulting in no net earnings impact to us from these transactions.
Casualty and Specialty Segment
Below is a summary of the underwriting results and ratios for our Casualty and Specialty segment: |
| | | | | | | | | | | | | |
| | | | | | | | |
| | Three months ended September 30, | 2017 | | 2016 | | Change | |
| | (in thousands, except percentages) | | | | | | |
| | Gross premiums written | $ | 314,881 |
| | $ | 310,320 |
| | $ | 4,561 |
| |
| | Net premiums written | $ | 213,835 |
| | $ | 193,313 |
| | $ | 20,522 |
| |
| | Net premiums earned | $ | 210,961 |
| | $ | 173,860 |
| | $ | 37,101 |
| |
| | Net claims and claim expenses incurred | 177,433 |
| | 89,844 |
| | 87,589 |
| |
| | Acquisition expenses | 59,248 |
| | 58,917 |
| | 331 |
| |
| | Operational expenses | 17,389 |
| | 16,217 |
| | 1,172 |
| |
| | Underwriting (loss) income | $ | (43,109 | ) | | $ | 8,882 |
| | $ | (51,991 | ) | |
| | | | | | | | |
| | Net claims and claim expenses incurred – current accident year | $ | 172,675 |
| | $ | 116,298 |
| | $ | 56,377 |
| |
| | Net claims and claim expenses incurred – prior accident years | 4,758 |
| | (26,454 | ) | | 31,212 |
| |
| | Net claims and claim expenses incurred – total | $ | 177,433 |
| | $ | 89,844 |
| | $ | 87,589 |
| |
| | | | | | | | |
| | Net claims and claim expense ratio – current accident year | 81.9 | % | | 66.9 | % | | 15.0 | % | |
| | Net claims and claim expense ratio – prior accident years | 2.2 | % | | (15.2 | )% | | 17.4 | % | |
| | Net claims and claim expense ratio – calendar year | 84.1 | % | | 51.7 | % | | 32.4 | % | |
| | Underwriting expense ratio | 36.3 | % | | 43.2 | % | | (6.9 | )% | |
| | Combined ratio | 120.4 | % | | 94.9 | % | | 25.5 | % | |
| | | | | | | | |
| | | | | | | | | | | | | | | | | | | | | | | |
| | | | | | | |
| Three months ended September 30, | 2020 | | 2019 | | Change | |
| (in thousands, except percentages) | | | | | | |
| Gross premiums written | $ | 715,293 | | | $ | 546,668 | | | $ | 168,625 | | |
| Net premiums written | $ | 520,703 | | | $ | 401,148 | | | $ | 119,555 | | |
| Net premiums earned | $ | 483,560 | | | $ | 462,416 | | | $ | 21,144 | | |
| Net claims and claim expenses incurred | 351,052 | | | 316,099 | | | 34,953 | | |
| Acquisition expenses | 116,636 | | | 122,654 | | | (6,018) | | |
| Operational expenses | 15,319 | | | 19,198 | | | (3,879) | | |
| Underwriting income | $ | 553 | | | $ | 4,465 | | | $ | (3,912) | | |
| | | | | | | |
| Net claims and claim expenses incurred – current accident year | $ | 366,080 | | | $ | 319,087 | | | $ | 46,993 | | |
| Net claims and claim expenses incurred – prior accident years | (15,028) | | | (2,988) | | | (12,040) | | |
| Net claims and claim expenses incurred – total | $ | 351,052 | | | $ | 316,099 | | | $ | 34,953 | | |
| | | | | | | |
| Net claims and claim expense ratio – current accident year | 75.7 | % | | 69.0 | % | | 6.7 | % | |
| Net claims and claim expense ratio – prior accident years | (3.1) | % | | (0.6) | % | | (2.5) | % | |
| Net claims and claim expense ratio – calendar year | 72.6 | % | | 68.4 | % | | 4.2 | % | |
| Underwriting expense ratio | 27.3 | % | | 30.6 | % | | (3.3) | % | |
| Combined ratio | 99.9 | % | | 99.0 | % | | 0.9 | % | |
| | | | | | | |
Casualty and Specialty Gross Premiums Written –
In the third quarter of 2017,2020, our Casualty and Specialty segment gross premiums written increased $4.6by $168.6 million, or 1.5%30.8%, to $314.9$715.3 million, compared to $310.3$546.7 million in the third quarter of 2016.2019. The $4.6 million increase was principally due to selective growth from new and existing business principallyopportunities written in the current and prior periods across various classes of business within certain of our casualty lines of business,the segment, partially offset by lower gross premiums written in our financial lines of business primarily the resultnon-renewal of a large in-force, multi-year mortgage reinsurance contract writtenportion of the business acquired in connection with the third quarteracquisition of 2016 which did not reoccur in the third quarter of 2017.TMR.
During 2016 and continuing through the third quarter of 2017, we experienced growth in a number of our casualty and specialty lines of business and will continue to seek selective growth opportunities on business we find attractive in our casualty and specialty operations through our underwriting platforms, including Bermuda, the U.S. and Syndicate 1458, although, given prevailing market conditions, we cannot assure you we will continue to do so.
Casualty and Specialty Ceded Premiums Written |
| | | | | | | | | | | | | |
| | | | | | | | |
| | Three months ended September 30, | 2017 | | 2016 | | Change | |
| | (in thousands) | | | | | | |
| | Ceded premiums written - Casualty and Specialty | $ | 101,046 |
| | $ | 117,007 |
| | $ | (15,961 | ) | |
| | | | | | | | |
| | | | | | | | | | | | | | | | | | | | | | | |
| | | | | | | |
| Three months ended September 30, | 2020 | | 2019 | | Change | |
| (in thousands) | | | | | | |
| Ceded premiums written - Casualty and Specialty | $ | 194,590 | | | $ | 145,520 | | | $ | 49,070 | | |
| | | | | | | |
Ceded premiums written in our Casualty and Specialty segment were $101.0 million in the third quarter of 2017 compared to $117.0$194.6 million in the third quarter of 2016,2020, compared to $145.5 million in the third quarter of 2019, an increase of $49.1 million. The increase was primarily a decreaseresult of $16.0 million, primarily reflecting decreased purchases ofincreased gross premiums written subject to our retrocessional reinsurance.quota share reinsurance programs.
Casualty and Specialty Underwriting Results –
Our Casualty and Specialty segment incurred angenerated underwriting lossincome of $43.1$0.6 million and had a combined ratio of 120.4% in the third quarter of 2017,2020, compared to underwriting income of $8.9$4.5 million in the third quarter of 2019. In the third quarter of 2020, our Casualty and Specialty segment generated a net claims and claim expense ratio of 72.6%, an underwriting expense ratio of 27.3% and a combined ratio of 94.9%99.9% compared to 68.4%, 30.6% and 99.0%, respectively, in the third quarter of 2016. 2019.
The increase in the Casualty and Specialty segment combinednet claims and claim expense ratio of 4.2 percentage points was principally the result of higher current accident year losses in the third quarter of 2017,2020 compared to the third quarter of 2016, was principally driven by current accident year2019. The net claims and claim expensesexpense ratio was impacted by net losses resulting from the
impact of Hurricane Laura and the purchase of an adverse development cover associated with Hurricanes Harvey, Irma and Maria andSyndicate 1458’s casualty reserves, which combined to add 3.2 percentage points. While the Mexico City Earthquake and 2.2 percentage points of adverse development on prior accident years net claims and claim expense ratio was also impacted by increased reserves in our mortgage guaranty book within our financial lines business, there was an offsetting impact to acquisition expenses partially offset byas a 6.9 percentage point decrease in theresult of reduced profit commission expense associated with this business. The underwriting expense ratio.
During the third quarter of 2017,ratio in the Casualty and Specialty segment experienced adverse development on prior accident years net claims and claim expenses of $4.8 million, or 2.2decreased 3.3 percentage points, compared to $26.5 million, or 15.2 percentage points, of favorable development on prior accident years net claims and claim expenses27.3%, in the third quarter of 2016. The adverse development during the third quarter of 2017 was principally driven by increased reported losses on a few large claims, partially offset by net favorable development on attritional net claims and claim expenses.
The 6.9 percentage point decrease in the Casualty and Specialty underwriting expense ratio in the third quarter of 2017,2020 compared to the third quarter of 2016, was2019, driven in part by alower acquisition and operating expense ratios. The decrease in profit commission expense noted above was the netprincipal driver of the decrease in acquisition ratio, combined withcosts. Operating expenses were impacted by reduced travel, marketing and office operational expenses as a $37.1 million increase in net premiumsresult of the COVID-19 pandemic.
Fee Income
| | | | | | | | | | | | | | | | | | | | | | | |
| | | | | | | |
| Three months ended September 30, | 2020 | | 2019 | | Change | |
| (in thousands) | | | | | | |
| Management fee income | | | | | | |
| Joint ventures | $ | 13,070 | | | $ | 11,434 | | | $ | 1,636 | | |
| Structured reinsurance products and other | 8,785 | | | 8,765 | | | 20 | | |
| Managed funds | 8,610 | | | 4,558 | | | 4,052 | | |
| Total management fee income | 30,465 | | | 24,757 | | | 5,708 | | |
| | | | | | | |
| Performance fee income | | | | | | |
| Joint ventures | (1,842) | | | 5,278 | | | (7,120) | | |
| Structured reinsurance products and other | (10,414) | | | 275 | | | (10,689) | | |
| Managed funds | 175 | | | 1,688 | | | (1,513) | | |
| Total performance fee income | (12,081) | | | 7,241 | | | (19,322) | | |
| Total fee income | $ | 18,384 | | | $ | 31,998 | | | $ | (13,614) | | |
| | | | | | | |
| | | | | | | |
| | | | | | | |
The table above shows total fee income earned which outpaced the $1.5 million increase in underwriting expenses
Profit Commissionsthrough third-party capital management, various joint ventures and Fees |
| | | | | | | | | | | | | |
| | | | | | | | |
| | Three months ended September 30, | 2017 | | 2016 | | Change | |
| | (in thousands, except percentages) | | | | | | |
| | Profit commissions and fees | $ | 8,409 |
| | $ | 9,483 |
| | $ | (1,074 | ) | |
| | Decrease in underwriting expense ratio | 4.0 | % | | 5.5 | % | | (1.5 | )% | |
| | | | | | | | |
We have various specialized quota sharecertain structured retrocession agreements in place pursuant to which we cedeare a portionparty. Performance fees are based on the performance of our casualtythe individual vehicles or products, and specialty bookmay be negative in a particular period if, for example, large losses occur, which can potentially result in no performance fees or the reversal of businesspreviously accrued performance fees. Joint ventures include DaVinciRe, Top Layer Re, Vermeer and earn profit commissions, as applicable,Langhorne. Managed funds include Upsilon Fund and fee income. We record these profit commissionsMedici. Structured reinsurance products and fees as reductions in acquisitionother includes certain vehicles and operating expenses, respectively, and, accordingly, these profit commissions and fees have reduced our underwriting expense ratios.reinsurance contracts which transfer risk to capital.
|
| | | | | | | | | | | | | |
| | | | | | | | |
| | Three months ended September 30, | 2017 | | 2016 | | Change | |
| | (in thousands) | | | | | | |
| | Fixed maturity investments | $ | 45,305 |
| | $ | 39,959 |
| | $ | 5,346 |
| |
| | Short term investments | 2,771 |
| | 1,174 |
| | 1,597 |
| |
| | Equity investments trading | 930 |
| | 797 |
| | 133 |
| |
| | Other investments | | | | | | |
| | Private equity investments | 6,371 |
| | 4,572 |
| | 1,799 |
| |
| | Other | (11,491 | ) | | 8,765 |
| | (20,256 | ) | |
| | Cash and cash equivalents | 352 |
| | 246 |
| | 106 |
| |
| | | 44,238 |
| | 55,513 |
| | (11,275 | ) | |
| | Investment expenses | (3,981 | ) | | (4,090 | ) | | 109 |
| |
| | Net investment income | $ | 40,257 |
| | $ | 51,423 |
| | $ | (11,166 | ) | |
| | | | | | | | |
Net investment income was $40.3 million in In the third quarter of 2017,2020, total fee income earned through third-party capital management, various joint ventures and certain structured retrocession agreements to which we are a party decreased $13.6 million, to $18.4 million, compared to $51.4$32.0 million in the third quarter of 2016, a decrease of $11.2 million, principally driven by unrealized losses in our other investment portfolio, specifically our catastrophe bond portfolio included in Other in the table above, which was impacted by a number of large catastrophe events occurring in the third quarter of 2017.
Low interest rates2019, primarily driven by lower underlying performance of our joint ventures and structured reinsurance products, primarily related to the Q3 2020 Large Loss Events, partially offset by an increase in recent years have lowered the yields at which we invest our assets relativedollar value of managed capital compared to longer-term historical levels. Recent increases in interest rates could have a longer-term positive impact on our investment income versus recent years.
Our private equity and other investment portfolios are accounted for at fair value with the change in fair value recorded in net investment income, which included net unrealized losses of $9.8 million in the third quarter of 2017, compared to unrealized gains of $9.42019. Of the $18.4 million in total fee income earned through third-party capital management in the third quarter of 20162020, $5.0 million was recorded through redeemable noncontrolling interest and $13.4 million was recorded through underwriting income as a reduction to operating expenses and acquisition expenses (2019 - $15.9 million and $16.1 million, respectively).
In addition to the fee income earned through third-party capital management, various joint ventures and certain structured retrocession agreements to which we are a party, as detailed in the table above, we also earn fee income on certain other underwriting-related activities. These fees, in the aggregate, are recorded as a reduction to operating expenses or acquisition expenses, as applicable. The total fees, as described above and including fee income earned on these other underwriting-related activities, earned by us in the third quarter of 2020 that were recorded as a reduction to operating expenses and as an increase in acquisition expenses were $30.6 million and $1.9 million, respectively, resulting in a reduction to the combined ratio of 2.9% (2019 - a reduction of $22.7 million, a reduction of $8.1 million and 3.4%, respectively).
Net Investment Income
| | | | | | | | | | | | | | | | | | | | | | | |
| | | | | | | |
| Three months ended September 30, | 2020 | | 2019 | | Change | |
| (in thousands) | | | | | | |
| Fixed maturity investments trading | $ | 68,022 | | | $ | 82,977 | | | $ | (14,955) | | |
| Short term investments | 1,611 | | | 15,061 | | | (13,450) | | |
| Equity investments trading | 1,559 | | | 1,326 | | | 233 | | |
| Other investments | | | | | | |
| Catastrophe bonds | 13,626 | | | 12,812 | | | 814 | | |
| Other | 2,598 | | | 2,672 | | | (74) | | |
| Cash and cash equivalents | 441 | | | 1,978 | | | (1,537) | | |
| | 87,857 | | | 116,826 | | | (28,969) | | |
| Investment expenses | (4,314) | | | (5,439) | | | 1,125 | | |
| Net investment income | $ | 83,543 | | | $ | 111,387 | | | $ | (27,844) | | |
| | | | | | | |
Net investment income was $83.5 million in the third quarter of 2020, compared to $111.4 million in the third quarter of 2019, a decrease of $27.8 million. Impacting our net investment income for the third quarter of 2020 were lower returns in our fixed maturity and short term investments, primarily as a result of lower yields on these investments following the decline in interest rates in early 2020.
Net Realized and Unrealized Gains on Investments
|
| | | | | | | | | | | | | |
| | | | | | | | |
| | Three months ended September 30, | 2017 | | 2016 | | Change | |
| | (in thousands) | | | | | | |
| | Gross realized gains | $ | 16,343 |
| | $ | 20,383 |
| | $ | (4,040 | ) | |
| | Gross realized losses | (6,126 | ) | | (3,363 | ) | | (2,763 | ) | |
| | Net realized gains on fixed maturity investments | 10,217 |
| | 17,020 |
| | (6,803 | ) | |
| | Net unrealized gains (losses) on fixed maturity investments trading | 5,545 |
| | (4,235 | ) | | 9,780 |
| |
| | Net realized and unrealized (losses) gains on investments-related derivatives | (4,020 | ) | | 1,727 |
| | (5,747 | ) | |
| | Net realized gains on equity investments trading | 13,675 |
| | 127 |
| | 13,548 |
| |
| | Net unrealized gains on equity investments trading | 16,635 |
| | 45,231 |
| | (28,596 | ) | |
| | Net realized and unrealized gains on investments | $ | 42,052 |
| | $ | 59,870 |
| | $ | (17,818 | ) | |
| | | | | | | | |
| | | | | | | | | | | | | | | | | | | | | | | |
| | | | | | | |
| Three months ended September 30, | 2020 | | 2019 | | Change | |
| (in thousands) | | | | | | |
| | | | | | | |
| | | | | | | |
| Net realized gains on fixed maturity investments trading | 55,665 | | | 30,101 | | | 25,564 | | |
| Net unrealized gains on fixed maturity investments trading | 16,316 | | | 17,226 | | | (910) | | |
| Net realized and unrealized gains on fixed maturity investments trading | 71,981 | | | 47,327 | | | 24,654 | | |
| Net realized and unrealized gains on investments-related derivatives | 2,033 | | | 11,134 | | | (9,101) | | |
| Net realized gains (losses) on equity investments trading | 16,624 | | | (72) | | | 16,696 | | |
| Net unrealized gains (losses) on equity investments trading | 107,332 | | | (26,451) | | | 133,783 | | |
| Net realized and unrealized gains (losses) on equity investments trading | 123,956 | | | (26,523) | | | 150,479 | | |
| Net realized and unrealized gains on other investments - catastrophe bonds | 12,611 | | | 9,242 | | | 3,369 | | |
| Net realized and unrealized gains (losses) on other investments - other | 13,627 | | | (6,785) | | | 20,412 | | |
| Net realized and unrealized gains on investments | $ | 224,208 | | | $ | 34,395 | | | $ | 189,813 | | |
| | | | | | | |
| | | | | | | |
| | | | | | | |
| | | | | | | |
Our investment portfolio strategy is structured to seek to preserveemphasize the preservation of capital and provide us with a high levelthe availability of liquidity.liquidity to meet our claims obligations and to be well diversified across market sectors. A large majority of our investments are invested in the fixed income markets and, therefore, our realized and unrealized holding gains and losses on investments are highly correlated to fluctuations in interest rates.rates and credit spreads. Therefore, everything else being constant, as interest rates or credit spreads decline, we will tend to have realized and unrealized gains from our investmentfixed maturity investments portfolio, and as interest rates and credit spreads rise, we will tend to have realized and unrealized losses from our investmentfixed maturity investments portfolio.
Net realized and unrealized gains on investments were $42.1$224.2 million in the third quarter of 2017,2020, compared to net realized and unrealized gains of $59.9$34.4 million in the third quarter of 2016, a decrease2019, an increase of $17.8$189.8 million. Included inPrincipally impacting our net realized and unrealized gains on investments are the following components:
were net realized and unrealized gains on equity investments trading, of $30.3 million in the third quarter of 2017, compared to net realizedincluding significant gains from certain positions within our strategic investment portfolio, and unrealized gains of $45.4 million in the third quarter of 2016,
a decrease of $15.0 million, driven by the weaker performance of a number of our larger equity positions during the third quarter of 2017;
net realized and unrealized gains on our portfolio of fixed maturity investments trading, of $15.8 million during primarily due to the third quarter of 2017, compared to net realized and unrealized gains of $12.8 milliondecline inthe third quarter of 2016, an increase of $3.0 million, principally driven by a slight increase in interest rates across the yield curve in the third quarter of 2017, compared to a more significant upward shift in the yield curve generating losses in the third quarter of 2016; and
net realized and unrealized losses on certain investments-related derivatives of $4.0 millioncredit spreads related to the market recovery following the disruption in global financial markets associated with the third quarter of 2017, compared to gains of $1.7 million in the third quarter of 2016, reflecting weaker performance of $5.7 million.
COVID-19 pandemic.Net Foreign Exchange LossesGains (Losses) |
| | | | | | | | | | | | | |
| | | | | | | | |
| | Three months ended September 30, | 2017 | | 2016 | | Change | |
| | (in thousands) | | | | | | |
| | Foreign exchange losses | $ | (156 | ) | | $ | (5,986 | ) | | $ | 5,830 |
| |
| | | | | | | | |
| | | | | | | | | | | | | | | | | | | | | | | |
| | | | | | | |
| Three months ended September 30, | 2020 | | 2019 | | Change | |
| (in thousands) | | | | | | |
| Net foreign exchange gains (losses) | $ | 17,426 | | | $ | (8,275) | | | $ | 25,701 | | |
| | | | | | | |
Our functional currency is the U.S. dollar. We routinely write a portion of our business in currencies other than U.S. dollars and invest a portion of our cash and investment portfolio in those currencies. In addition, and in connection with the acquisition of TMR, we acquired certain entities with non-U.S. dollar functional currencies. As a result, we may experience foreign exchange gains and losses in our consolidated financial statements. All changes in exchange rates are recognized in our consolidated statements of operations. We are primarily impacted by the foreign currency risk exposures associated with our underwriting operations, and investment portfolio, and our operations with non-U.S. dollar functional currencies, and may, from time to time, enter into foreign currency forward and option contracts to minimize the effect of fluctuating foreign currencies on the value of non-U.S. dollar denominated assets and liabilities.
Refer to “Part II, Item 7A. Quantitative and Qualitative Disclosures About Market Risk” in our Form 10-K for the year ended December 31, 2019 for additional information related to our exposure to foreign currency risk and “Note 13. Derivative Instruments” in our “Notes to the Consolidated Financial Statements” for additional information related to foreign currency forward and option contracts we have entered into.
Equity in Earnings
(Losses) of Other Ventures
|
| | | | | | | | | | | | | |
| | | | | | | | |
| | Three months ended September 30, | 2017 | | 2016 | | Change | |
| | (in thousands) | | | | | | |
| | Top Layer Re | $ | 2,722 |
| | $ | (14,951 | ) | | $ | 17,673 |
| |
| | Tower Hill Companies | (383 | ) | | 3,422 |
| | (3,805 | ) | |
| | Other | (545 | ) | | (101 | ) | | (444 | ) | |
| | Total equity in earnings (losses) of other ventures | $ | 1,794 |
| | $ | (11,630 | ) | | $ | 13,424 |
| |
| | | | | | | | |
| | | | | | | | | | | | | | | | | | | | | | | |
| | | | | | | |
| Three months ended September 30, | 2020 | | 2019 | | Change | |
| (in thousands) | | | | | | |
| Tower Hill Companies | $ | 2,379 | | | $ | 4,068 | | | $ | (1,689) | | |
| Top Layer Re | 2,120 | | | 1,943 | | | 177 | | |
| Other | 958 | | | (134) | | | 1,092 | | |
| Total equity in earnings of other ventures | $ | 5,457 | | | $ | 5,877 | | | $ | (420) | | |
| | | | | | | |
Equity in earnings (losses) of other ventures primarily represents our pro-rata share of the net income (loss) from our investments in a group of Tower Hill affiliated companies, including Bluegrass Insurance Management, LLC, Tower Hill Claims Service, LLC, Tower Hill Holdings, Inc., Tower Hill Insurance Group, LLC, Tower Hill Insurance Managers, LLC, Tower Hill Re Holdings, Inc., Tower Hill Re Ltd.Signature Insurance Holdings, Inc. and Tower Hill Signature InsuranceTomoka Re Holdings, Inc. (collectively, the “Tower Hill Companies”) and Top Layer Re, and, except for Top Layer Re, is recorded one quarter in arrears. Top Layer Re is recorded on a current quarter basis. The carrying value of these investments on our consolidated balance sheets, individually or in the aggregate, may differ from the realized value we may ultimately attain, perhaps significantly so. The other category includes our equity investments in a select group of insurance and insurance-related companies.
Equity in earnings of other ventures was $1.8 million, compared to equity in losses of other ventures of $11.6$5.5 million in the third quarter of 2016, an increase of $13.4 million. As previously described, equity in losses of other ventures during the third quarter of 2016 was primarily impacted by a $15.0 million loss related to our 50% ownership in Top Layer Re.
In addition, we recorded equity in losses of the Tower Hill Companies of $0.4 million in the third quarter of 2017,2020, compared to earnings of $3.4$5.9 million in the third quarter of 2016, a decrease of $3.8 million, principally due to an estimate of losses associated with certain catastrophe events occurring in the third quarter of 2017 impacting the profitably2019, a decrease of $0.4 million, principally driven by reduced profitability of our equity investments in the Tower Hill Companies.Companies, partially offset by improved profitability associated with a select group of insurance and insurance-related companies within the other category.
|
| | | | | | | | | | | | | |
| | | | | | | | |
| | Three months ended September 30, | 2017 | | 2016 | | Change | |
| | (in thousands) | | | | | | |
| | Assumed and ceded reinsurance contracts accounted for as derivatives and deposits | $ | 2,793 |
| | $ | 2,195 |
| | $ | 598 |
| |
| | Other items | 203 |
| | 73 |
| | 130 |
| |
| | Total other income | $ | 2,996 |
| | $ | 2,268 |
| | $ | 728 |
| |
| | | | | | | | |
| | | | | | | | | | | | | | | | | | | | | | | |
| | | | | | | |
| Three months ended September 30, | 2020 | | 2019 | | Change | |
| (in thousands) | | | | | | |
| Assumed and ceded reinsurance contracts accounted for as derivatives and deposits | $ | 1,429 | | | $ | (318) | | | $ | 1,747 | | |
| Other items | 47 | | | 1,334 | | | (1,287) | | |
| Total other income | $ | 1,476 | | | $ | 1,016 | | | $ | 460 | | |
| | | | | | | |
In the third quarter of 2017,2020, we generated other income of $3.0$1.5 million,, compared to other income of $2.3$1.0 million in the third quarter of 2016,2019, an increase of $0.7 million.$0.5 million, primarily related to our assumed and ceded reinsurance contracts accounted for as derivatives and deposits.
|
| | | | | | | | | | | | | |
| | | | | | | | |
| | Three months ended September 30, | 2017 | | 2016 | | Change | |
| | (in thousands) | | | | | | |
| | Corporate expenses | $ | 4,413 |
| | $ | 11,537 |
| | $ | (7,124 | ) | |
| | | | | | | | |
| | | | | | | | | | | | | | | | | | | | | | | |
| | | | | | | |
| Three months ended September 30, | 2020 | | 2019 | | Change | |
| (in thousands) | | | | | | |
| Corporate expenses | $ | 48,050 | | | $ | 13,844 | | | $ | 34,206 | | |
| | | | | | | |
Corporate expenses include certain executive, director, legal and consulting expenses, costs for research and development, impairment charges related to goodwill and other intangible assets, and other miscellaneous costs, including those associated with operating as a publicly traded company. company, as well as costs associated with the acquisition of TMR and the sale of RenaissanceRe UK. From time to time, we may revise the allocation of certain expenses between corporate and operating expenses to better reflect the characteristic of the underlying expense.
Corporate expenses were $4.4increased to $48.1 million in the third quarter of 2017,2020, compared to $11.5$13.8 million in the third quarter of 2016. During2019, primarily driven by the $30.2 million loss on the sale of RenaissanceRe UK on August 18, 2020, as well as related transaction and other expenses, and expenses associated with senior management departures during the third quarter of 2016 we incurred expenses associated with an executive retirement which did not repeat in2020. The loss on sale includes amounts related to prior purchase GAAP adjustments and cumulative currency translation adjustments recorded since the third quarteracquisition of 2017.RenaissanceRe UK.
Income Tax Benefit (Expense) |
| | | | | | | | | | | | | |
| | | | | | | | |
| | Three months ended September 30, | 2017 | | 2016 | | Change | |
| | (in thousands) | | | | | | |
| | Income tax benefit | $ | 18,977 |
| | $ | 1,316 |
| | $ | 17,661 |
| |
| | | | | | | | |
| | | | | | | | | | | | | | | | | | | | | | | |
| | | | | | | |
| Three months ended September 30, | 2020 | | 2019 | | Change | |
| (in thousands) | | | | | | |
| Income tax benefit (expense) | $ | 8,244 | | | $ | (3,664) | | | $ | 11,908 | | |
| | | | | | | |
We are subject to income taxes in certain jurisdictions in which we operate; however, since the majority of our income is generally earned in Bermuda, which does not have a corporate income tax, the tax impact to our operations has historically been minimal.
We recognized an income tax benefit of $19.0$8.2 million in the third quarter of 2017,2020, compared to a benefitan expense of $1.3$3.7 million in the third quarter of 2016,2019, principally driven by higher pre-tax GAAP losseslower underwriting performance and other miscellaneous items in our U.S.-based operationsthe U.S., including amounts resulting from the continued impacts of U.S. tax reform, partially offset by investment gains, primarily due to underwriting losses associated within the Q3 2017 Large Loss Events.U.S. based operations.
Net
Loss (Income)Income Attributable to Redeemable Noncontrolling Interests
|
| | | | | | | | | | | | | |
| | | | | | | | |
| | Three months ended September 30, | 2017 | | 2016 | | Change | |
| | (in thousands) | | | | | | |
| | Net loss (income) attributable to redeemable noncontrolling interests | $ | 204,277 |
| | $ | (35,641 | ) | | $ | 239,918 |
| |
| | | | | | | | |
| | | | | | | | | | | | | | | | | | | | | | | |
| | | | | | | |
| Three months ended September 30, | 2020 | | 2019 | | Change | |
| (in thousands) | | | | | | |
| Net income attributable to redeemable noncontrolling interests | $ | (19,301) | | | $ | (62,057) | | | $ | 42,756 | | |
| | | | | | | |
Our net loss (income)income attributable to redeemable noncontrolling interests was a net loss of $204.3$19.3 million in the third quarter of 2017,2020, compared to net income of $35.6$62.1 million in the third quarter of 2016,2019, a change of $239.9 million, principally due to$42.8 million. The decrease was primarily driven by underwriting losses associated with the Q3 2017 Large Loss Events incurred by DaVinciRe, and a decrease in our ownership in DaVinciRe, to 23.5% at September 30, 2017,partially offset by an increase in the net income of Medici compared to 24.0% at September 30, 2016.the third quarter of 2019.
We expect our ownership in DaVinciRe to fluctuate over time. See “Note 8. Noncontrolling Interests” and “Note 16. Subsequent Events” in our “Notes to the Consolidated Financial Statements” for additional information regarding DaVinciRe.
SUMMARY OF RESULTS OF OPERATIONS
Below is a discussion of the results of operations for the first nine months of 2017,ended September 30, 2020, compared to the first nine months of 2016.ended September 30, 2019.
| | | | | | | | | | | | | | | | | | | | | | | |
| | | | | | | |
| Nine months ended September 30, | 2020 | | 2019 | | Change | |
| (in thousands, except per share amounts and percentages) | | | | | | |
| Statement of operations highlights | | | | | | |
| Gross premiums written | $ | 4,870,651 | | | $ | 3,902,271 | | | $ | 968,380 | | |
| Net premiums written | $ | 3,350,022 | | | $ | 2,656,126 | | | $ | 693,896 | | |
| Net premiums earned | $ | 2,923,377 | | | $ | 2,368,278 | | | $ | 555,099 | | |
| Net claims and claim expenses incurred | 2,023,256 | | | 1,334,928 | | | 688,328 | | |
| Acquisition expenses | 659,394 | | | 553,614 | | | 105,780 | | |
| Operational expenses | 165,583 | | | 158,162 | | | 7,421 | | |
| Underwriting income | $ | 75,144 | | | $ | 321,574 | | | $ | (246,430) | | |
| | | | | | | |
| Net investment income | $ | 272,321 | | | $ | 312,069 | | | $ | (39,748) | | |
| Net realized and unrealized gains on investments | 561,891 | | | 395,655 | | | 166,236 | | |
| | | | | | | |
| | | | | | | |
| Total investment result | $ | 834,212 | | | $ | 707,724 | | | $ | 126,488 | | |
| | | | | | | |
| | | | | | | |
| | | | | | | |
| Net income | $ | 801,424 | | | $ | 909,927 | | | $ | (108,503) | | |
| Net income available to RenaissanceRe common shareholders | $ | 541,670 | | | $ | 678,269 | | | $ | (136,599) | | |
| | | | | | | |
| | | | | | | |
| | | | | | | |
| Net income available to RenaissanceRe common shareholders per common share – diluted | $ | 11.58 | | | $ | 15.57 | | | $ | (3.99) | | |
| Dividends per common share | $ | 1.05 | | | $ | 1.02 | | | $ | 0.03 | | |
| | | | | | | |
| Key ratios | | | | | | |
| Net claims and claim expense ratio – current accident year | 71.1 | % | | 57.0 | % | | 14.1 | % | |
| Net claims and claim expense ratio – prior accident years | (1.9) | % | | (0.6) | % | | (1.3) | % | |
| Net claims and claim expense ratio – calendar year | 69.2 | % | | 56.4 | % | | 12.8 | % | |
| Underwriting expense ratio | 28.2 | % | | 30.0 | % | | (1.8) | % | |
| Combined ratio | 97.4 | % | | 86.4 | % | | 11.0 | % | |
| | | | | | | |
| Return on average common equity - annualized | 12.0 | % | | 18.2 | % | | (6.2) | % | |
| | | | | | | |
| Book value | September 30,
2020 | | December 31,
2019 | | Change | |
| Book value per common share | $ | 135.13 | | | $ | 120.53 | | | $ | 14.60 | | |
| Accumulated dividends per common share | 21.73 | | | 20.68 | | | 1.05 | | |
| Book value per common share plus accumulated dividends | $ | 156.86 | | | $ | 141.21 | | | $ | 15.65 | | |
| Change in book value per common share plus change in accumulated dividends | 13.0 | % | | | | | |
| | | | | | | |
| | | | | | | |
| | | | | | | |
| | | | | | | |
| | | | | | | |
|
| | | | | | | | | | | | | |
| | | | | | | | |
| | Nine months ended September 30, | 2017 | | 2016 | | Change | |
| | (in thousands, except per share amounts and percentages) | | | | | | |
| | Statement of operations highlights | | | | | | |
| | Gross premiums written | $ | 2,389,774 |
| | $ | 2,051,485 |
| | $ | 338,289 |
| |
| | Net premiums written | $ | 1,583,102 |
| | $ | 1,315,813 |
| | $ | 267,289 |
| |
| | Net premiums earned | $ | 1,296,102 |
| | $ | 1,051,529 |
| | $ | 244,573 |
| |
| | Net claims and claim expenses incurred | 1,557,364 |
| | 406,930 |
| | 1,150,434 |
| |
| | Acquisition expenses | 248,294 |
| | 215,177 |
| | 33,117 |
| |
| | Operational expenses | 131,586 |
| | 147,801 |
| | (16,215 | ) | |
| | Underwriting (loss) income | $ | (641,142 | ) | | $ | 281,621 |
| | $ | (922,763 | ) | |
| | | | | | | | |
| | Net investment income | $ | 148,745 |
| | $ | 134,410 |
| | $ | 14,335 |
| |
| | Net realized and unrealized gains on investments | 143,538 |
| | 191,295 |
| | (47,757 | ) | |
| | Change in net unrealized gains on fixed maturity investments available for sale | — |
| | (472 | ) | | 472 |
| |
| | Total investment result | $ | 292,283 |
| | $ | 325,233 |
| | $ | (32,950 | ) | |
| | | | | | | | |
| | Net (loss) income | $ | (356,870 | ) | | $ | 538,798 |
| | $ | (895,668 | ) | |
| | Net (loss) income (attributable) available to RenaissanceRe common shareholders | $ | (241,318 | ) | | $ | 411,145 |
| | $ | (652,463 | ) | |
| | | | | | | | |
| | Net (loss) income (attributable) available to RenaissanceRe common shareholders per common share – diluted | $ | (6.04 | ) | | $ | 9.71 |
| | $ | (15.75 | ) | |
| | Dividends per common share | $ | 0.96 |
| | $ | 0.93 |
| | $ | 0.03 |
| |
| | | | | | | | |
| | Key ratios | | | | | | |
| | Net claims and claim expense ratio – current accident year | 120.4 | % | | 46.0 | % | | 74.4 | % | |
| | Net claims and claim expense ratio – prior accident years | (0.2 | )% | | (7.3 | )% | | 7.1 | % | |
| | Net claims and claim expense ratio – calendar year | 120.2 | % | | 38.7 | % | | 81.5 | % | |
| | Underwriting expense ratio | 29.3 | % | | 34.5 | % | | (5.2 | )% | |
| | Combined ratio | 149.5 | % | | 73.2 | % | | 76.3 | % | |
| | | | | | | | |
| | Return on average common equity - annualized | (7.4 | )% | | 12.6 | % | | (20.0 | )% | |
| | | | | | | | |
| | Book value | September 30,
2017 | | December 31,
2016 | | Change | |
| | Book value per common share | $ | 100.00 |
| | $ | 108.45 |
| | $ | (8.45 | ) | |
| | Accumulated dividends per common share | 17.68 |
| | 16.72 |
| | 0.96 |
| |
| | Book value per common share plus accumulated dividends | $ | 117.68 |
| | $ | 125.17 |
| | $ | (7.49 | ) | |
| | Change in book value per common share plus change in accumulated dividends | (6.9 | )% | | | | | |
| | | | | | | | |
| | Balance sheet highlights | September 30,
2017 | | December 31,
2016 | | Change | |
| | Total assets | $ | 15,044,924 |
| | $ | 12,352,082 |
| | $ | 2,692,842 |
| |
| | Total shareholders’ equity attributable to RenaissanceRe | $ | 4,403,012 |
| | $ | 4,866,577 |
| | $ | (463,565 | ) | |
| | | | | | | | |
Net loss attributableincome available to RenaissanceRe common shareholders was $241.3$541.7 million in the first nine months of 2017,ended September 30, 2020, compared to net income available to RenaissanceRe common shareholders of $411.1$678.3 million in the first nine months of 2016, ended September 30, 2019, a decrease of $652.5 million.$136.6 million. As a result of our net loss attributableincome available to RenaissanceRe common shareholders in the first nine months of 2017,ended September 30, 2020, we generated an annualized return on average common equity of negative 7.4%12.0% and our book value per common share decreasedincreased from $108.45$120.53 at December 31, 20162019 to $100.00$135.13 at September 30, 2017,2020, a 6.9% decrease,13.0% increase, after considering the change in accumulated dividends paid to our common shareholders, and the impact of repurchasing an aggregate of 1.3 million common shares in open market transactions during the first nine months of 2017, as detailed in “Part II, Item 2. Unregistered Sales of Equity Securities and Use of Proceeds”.shareholders.
The most significant eventsitems affecting our financial performance during the first nine months of 2017,ended September 30, 2020, on a comparative basis to the nine months ended September 30, 2019, include:
•TMR - the second quarter of 2019 was the first quarter that reflected the results of TMR in our results of operations. As such, our results of operations for the nine months ended September 30, 2020, compared to the nine months ended September 30, 2019, should be viewed in that context;
•Impact of 2016, include:
Q3 2017 Large LossCatastrophe Events- in the Q3 2017 Large Loss Eventsnine months ended September 30, 2020 we had a net negative impact on our net loss attributableincome available to RenaissanceRe common shareholders of $615.1$327.5 million resulting from Hurricane Laura, Hurricane Sally, the Q3 2020 Wildfires, Other Q3 2020 Catastrophe Events and loss estimates associated with aggregate loss contracts on these and other events in 2020 (collectively, the “2020 Large Loss Events”). This compares to a net negative impact on our underwriting resultsnet income available to RenaissanceRe common shareholders of $838.7$154.9 million adding 66.6 percentage points to our combined ratioresulting from the Q3 2019 Catastrophe Events in the first nine months ended September 30, 2019;
•Underwriting Results - we generated underwriting income of 2017. See below for additional information regarding the net negative impact of the Q3 2017 Large Loss Events.
Primarily as a result of the Q3 2017 Large Loss Events, we incurred an underwriting loss of $641.1$75.1 million and had a combined ratio of 149.5%97.4% in the first nine months of 2017,ended September 30, 2020, compared to generating underwriting income of $281.6$321.6 million and having a combined ratio of 73.2%, respectively,86.4% in the first nine months ended September 30, 2019. Our underwriting income in the nine months ended September 30, 2020 was comprised of 2016. Our$141.2 million of underwriting income in our Property segment and a $66.1 million underwriting loss in our Casualty and Specialty segment. In comparison, our underwriting income in the first nine months of 2017ended September 30, 2019 was comprised of our Property segment, which incurred angenerated underwriting lossincome of $552.2$296.4 million, and our Casualty and Specialty segment, which incurred angenerated underwriting lossincome of $89.6 million, each$25.2 million.
Included in our underwriting results in the first nine months ended September 30, 2020 was the impact of 2017. The Q3 2017the 2020 Large Loss Events, which resulted in $808.6a net negative impact on the underwriting result of $428.7 million and added 15.0 percentage points to the combined ratio, primarily in the Property segment. In comparison, the nine months ended September 30, 2019 was impacted by the Q3 2019 Catastrophe Events, which resulted in a net negative impact on the underwriting result of $181.9 million and added 7.9 percentage points to the combined ratio. Our underwriting result in the nine months ended September 30, 2020 was also negatively impacted by net claims and claim expenses associated with the COVID-19 pandemic of $123.1 million during the nine months ended September 30, 2020, primarily in the Casualty and Specialty segment. The losses primarily represent the cost of claims incurred but not yet reported, with respect to exposures such as event contingency and event-based casualty covers;
•Gross Premiums Written - our gross premiums written increased by $968.4 million, or 24.8%, to $4.9 billion, in ourthe nine months ended September 30, 2020, compared to the nine months ended September 30, 2019, with an increase of $504.8 million in the Property segment or 139.3 percentage points on its combined ratioand an increase of $463.5 million in the first nine months of 2017, and $30.0 million of underwriting losses in our Casualty and Specialty segment, or 6.4 percentage points on its combined ratiodriven by growth from existing relationships, new opportunities across a number of our underwriting platforms, rate improvements, and business acquired in the first nine months of 2016.
Our underwriting result and combined ratio in the first nine months of 2016 were impacted by the 2016 Texas Events and the Fort McMurray Wildfire, which resulted in $54.9 million of underwriting losses and added 5.6 percentage points to our combined ratio. The underwriting losses resulting from the 2016 Texas Events and the Fort McMurray Wildfire were all within our Property segment, and added 13.3 to its combined ratio. Our underwriting results are discussed in additional detail below in “Underwriting Results by Segment”;
Net Loss Attributable to Redeemable Noncontrolling Interests - our net loss attributable to redeemable noncontrolling interests was $132.3 million in the first nine months of 2017, compared to net income attributable to redeemable noncontrolling interests of $110.9 million in the first nine months of 2016. The decrease was principally due to significant underwriting losses associatedconnection with the Q3 2017 Large Loss Events incurred by DaVinciRe, and a decrease in the Company’s ownership in DaVinciRe to 23.5% at September 30, 2017, compared to 24.0% at September 30, 2016; and
acquisition of TMR;•Investment Results - our total investment result, which includes the sum of net investment income and net realized and unrealized gains on investments, was a gain of $292.3$834.2 million in the first nine months of 2017,ended September 30, 2020, compared to a gain of $325.2$707.7 million in the first nine months ended September 30, 2019, an increase of 2016.$126.5 million. Impacting the investment result were higher returns in our equity investments tradingrealized and private equity portfolios and higher net investment income due to higher average invested assets in ourunrealized gains on fixed maturity investments trading portfolio,and equity investments trading, partially offset by realized and unrealized losses on other investments;
•Net Income Attributable to Redeemable Noncontrolling Interests - our net income attributable to redeemable noncontrolling interests was $236.1 million in the nine months ended September 30, 2020, compared to $204.1 million in the nine months ended September 30, 2019. The increase was primarily driven by growth and improved performance, with higher net income from Medici and Vermeer, partially offset by lower unrealized gains in our fixed maturity investments trading portfolio driven bynet income from DaVinci, during the flattening of the yield curve during the first nine months of 2017,ended September 30, 2020 as compared to the first nine months of 2016, which experienced a pronounced downward shift in the yield curve.ended September 30, 2019; and
•Common Share Offering - on June 5, 2020, we issued 6,325,000 of our common shares in an underwritten public offering at a public offering price of $166.00 per share. Concurrently with the public offering, we raised $75.0 million through the issuance of 451,807 of our common shares at a price of $166.00 per share to State Farm Mutual Automobile Insurance Company (“State Farm”), one of our existing stockholders, in a private placement. The total net proceeds from the offerings were $1.1 billion.
Net Negative Impact of the Q3 2017 Large Loss Events
The financial data below provides additional details regardinginformation detailing the net negative impact of the Q3 20172020 Large Loss Events on our consolidated financial statements in the first nine months ended September 30, 2020.
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
| | | | | | | | | | | | | |
| Nine months ended September 30, 2020 | Hurricane Laura | | Hurricane Sally | | Q3 2020 Wildfires | | Other Q3 2020 Catastrophe Events | | Aggregate Losses | | Total 2020 Large Loss Events | |
| (in thousands) | | | | | | | | | | | | |
| Net claims and claims expenses incurred | $ | (123,076) | | | $ | (72,531) | | | $ | (91,107) | | | $ | (61,586) | | | $ | (126,563) | | | $ | (474,863) | | |
| Assumed reinstatement premiums earned | 18,282 | | | 5,110 | | | 17,604 | | | 7,407 | | | 5,256 | | | 53,659 | | |
| Ceded reinstatement premiums earned | (334) | | | (236) | | | — | | | — | | | — | | | (570) | | |
| Lost profit commissions | (254) | | | (418) | | | (491) | | | (549) | | | (5,232) | | | (6,944) | | |
| Net negative impact on underwriting result | (105,382) | | | (68,075) | | | (73,994) | | | (54,728) | | | (126,539) | | | (428,718) | | |
| | | | | | | | | | | | | |
| | | | | | | | | | | | | |
| Redeemable noncontrolling interest | 20,008 | | | 11,834 | | | 19,580 | | | 17,958 | | | 31,816 | | | 101,196 | | |
| Net negative impact on net income available to RenaissanceRe common shareholders | $ | (85,374) | | | $ | (56,241) | | | $ | (54,414) | | | $ | (36,770) | | | $ | (94,723) | | | $ | (327,522) | | |
| | | | | | | | | | | | | |
The financial data below provides additional information detailing the net negative impact of 2017.the 2020 Large Loss Events on our segment underwriting results and consolidated combined ratio in the nine months ended September 30, 2020.
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
| | | | | | | | | | | | | |
| Nine months ended September 30, 2020 | Hurricane Laura | | Hurricane Sally | | Q3 2020 Wildfires | | Other Q3 2020 Catastrophe Events | | Aggregate Losses | | Total 2020 Large Loss Events | |
| (in thousands, except percentages) | | | | | | | | | | | | |
| Net negative impact on Property segment underwriting result | $ | (95,845) | | | $ | (68,075) | | | $ | (73,994) | | | $ | (54,728) | | | $ | (126,539) | | | $ | (419,181) | | |
| Net negative impact on Casualty and Specialty segment underwriting result | (9,537) | | | — | | | — | | | — | | | — | | | (9,537) | | |
| Net negative impact on underwriting result | $ | (105,382) | | | $ | (68,075) | | | $ | (73,994) | | | $ | (54,728) | | | $ | (126,539) | | | $ | (428,718) | | |
| Percentage point impact on consolidated combined ratio | 3.6 | | | 2.3 | | | 2.5 | | | 1.8 | | | 4.3 | | | 15.0 | | |
| | | | | | | | | | | | | |
|
| | | | | | | | | | | | | | | | | | | | | | | | | |
| | | | | | | | | | | | | | |
| | Nine months ended September 30, 2017 | Hurricane Harvey | | Hurricane Irma | | Hurricane Maria | | Mexico City Earthquake | | Q3 2017 Aggregate Losses | | Total | |
| | (in thousands, except percentages) | | | | | | | | | | | | |
| | Net claims and claim expenses incurred | $ | (275,409 | ) | | $ | (300,536 | ) | | $ | (236,478 | ) | | $ | (68,068 | ) | | $ | (128,779 | ) | | $ | (1,009,270 | ) | |
| | Reinstatement premiums earned | 65,715 |
| | 67,342 |
| | 29,138 |
| | 6,078 |
| | 1,500 |
| | 169,773 |
| |
| | Ceded reinstatement premiums earned | (9,035 | ) | | (18,190 | ) | | (1,537 | ) | | (43 | ) | | — |
| | (28,805 | ) | |
| | (Lost) earned profit commissions | (11,358 | ) | | 16,192 |
| | 13,329 |
| | 3,329 |
| | 8,146 |
| | 29,638 |
| |
| | Net negative impact on underwriting result | (230,087 | ) | | (235,192 | ) | | (195,548 | ) | | (58,704 | ) | | (119,133 | ) | | (838,664 | ) | |
| | Redeemable noncontrolling interest - DaVinciRe | 39,089 |
| | 69,152 |
| | 63,064 |
| | 14,254 |
| | 38,000 |
| | 223,559 |
| |
| | Net negative impact on net loss attributable to RenaissanceRe common shareholders | $ | (190,998 | ) | | $ | (166,040 | ) | | $ | (132,484 | ) | | $ | (44,450 | ) | | $ | (81,133 | ) | | $ | (615,105 | ) | |
| | Percentage point impact on consolidated combined ratio | 16.3 |
| | 16.9 |
| | 14.4 |
| | 4.4 |
| | 9.2 |
| | 66.6 |
| |
| | | | | | | | | | | | | | |
| | Net negative impact on Property segment underwriting result | $ | (219,976 | ) | | $ | (232,783 | ) | | $ | (178,896 | ) | | $ | (57,860 | ) | | $ | (119,133 | ) | | $ | (808,648 | ) | |
| | Net negative impact on Casualty and Specialty segment underwriting result | (10,111 | ) | | (2,409 | ) | | (16,652 | ) | | (844 | ) | | — |
| | (30,016 | ) | |
| | Net negative impact on underwriting result | $ | (230,087 | ) | | $ | (235,192 | ) | | $ | (195,548 | ) | | $ | (58,704 | ) | | $ | (119,133 | ) | | $ | (838,664 | ) | |
| | | | | | | | | | | | | | |
The financial data in the table below provides additional information detailing the net negative impact of the Q3 2019 Catastrophe Events on our consolidated financial statements in the nine months ended September 30, 2019.
| | | | | | | | | | | | | | | | | | | | | | | |
| Nine months ended September 30, 2019 | Hurricane Dorian | | Typhoon Faxai | | Total Q3 2019 Catastrophe Events | |
| (in thousands) | | | | | | |
| Net claims and claims expenses incurred | $ | (60,784) | | | $ | (148,127) | | | $ | (208,911) | | |
| Assumed reinstatement premiums earned | 5,106 | | | 18,332 | | | 23,438 | | |
| Ceded reinstatement premiums earned | (364) | | | (118) | | | (482) | | |
| Earned profit commissions | 92 | | | 3,943 | | | 4,035 | | |
| Net negative impact on underwriting result | (55,950) | | | (125,970) | | | (181,920) | | |
| Redeemable noncontrolling interest | 3,659 | | | 23,335 | | | 26,994 | | |
| Net negative impact on net income available to RenaissanceRe common shareholders | $ | (52,291) | | | $ | (102,635) | | | $ | (154,926) | | |
| | | | | | | |
The financial data below provides additional information detailing the net negative impact of the Q3 2019 Catastrophe Events on our segment underwriting results and consolidated combined ratio in the nine months ended September 30, 2019.
| | | | | | | | | | | | | | | | | | | | | | | |
| Nine months ended September 30, 2019 | Hurricane Dorian | | Typhoon Faxai | | Total Q3 2019 Catastrophe Events | |
| (in thousands, except percentages) | | | | | | |
| Net negative impact on Property segment underwriting result | $ | (53,378) | | | $ | (125,540) | | | $ | (178,918) | | |
| Net negative impact on Casualty and Specialty segment underwriting result | (2,572) | | | (430) | | | (3,002) | | |
| Net negative impact on underwriting result | $ | (55,950) | | | $ | (125,970) | | | $ | (181,920) | | |
| Percentage point impact on consolidated combined ratio | 2.4 | | | 5.4 | | | 7.9 | | |
| | | | | | | |
Underwriting Results by Segment
Property Segment
Below is a summary of the underwriting results and ratios for our Property segment: |
| | | | | | | | | | | | | |
| | | | | | | | |
| | Nine months ended September 30, | 2017 | | 2016 | | Change | |
| | (in thousands, except percentages) | | | | | | |
| | Gross premiums written | $ | 1,345,271 |
| | $ | 1,058,816 |
| | $ | 286,455 |
| |
| | Net premiums written | $ | 895,728 |
| | $ | 674,361 |
| | $ | 221,367 |
| |
| | Net premiums earned | $ | 716,024 |
| | $ | 538,953 |
| | $ | 177,071 |
| |
| | Net claims and claim expenses incurred | 1,116,273 |
| | 125,618 |
| | 990,655 |
| |
| | Acquisition expenses | 75,117 |
| | 71,176 |
| | 3,941 |
| |
| | Operational expenses | 76,841 |
| | 79,441 |
| | (2,600 | ) | |
| | Underwriting (loss) income | $ | (552,207 | ) | | $ | 262,718 |
| | $ | (814,925 | ) | |
| | | | | | | | |
| | Net claims and claim expenses incurred – current accident year | $ | 1,133,241 |
| | $ | 163,130 |
| | $ | 970,111 |
| |
| | Net claims and claim expenses incurred – prior accident years | (16,968 | ) | | (37,512 | ) | | 20,544 |
| |
| | Net claims and claim expenses incurred – total | $ | 1,116,273 |
| | $ | 125,618 |
| | $ | 990,655 |
| |
| | | | | | | | |
| | Net claims and claim expense ratio – current accident year | 158.3 | % | | 30.3 | % | | 128.0 | % | |
| | Net claims and claim expense ratio – prior accident years | (2.4 | )% | | (7.0 | )% | | 4.6 | % | |
| | Net claims and claim expense ratio – calendar year | 155.9 | % | | 23.3 | % | | 132.6 | % | |
| | Underwriting expense ratio | 21.2 | % | | 28.0 | % | | (6.8 | )% | |
| | Combined ratio | 177.1 | % | | 51.3 | % | | 125.8 | % | |
| | | | | | | | |
| | | | | | | | | | | | | | | | | | | | | | | |
| | | | | | | |
| Nine months ended September 30, | 2020 | | 2019 | | Change | |
| (in thousands, except percentages) | | | | | | |
| | | | | | | |
| | | | | | | |
| | | | | | | |
| Gross premiums written | $ | 2,690,827 | | | $ | 2,185,984 | | | $ | 504,843 | | |
| Net premiums written | $ | 1,757,427 | | | $ | 1,411,327 | | | $ | 346,100 | | |
| Net premiums earned | $ | 1,429,074 | | | $ | 1,160,090 | | | $ | 268,984 | | |
| Net claims and claim expenses incurred | 899,860 | | | 541,217 | | | 358,643 | | |
| Acquisition expenses | 278,668 | | | 222,971 | | | 55,697 | | |
| Operational expenses | 109,335 | | | 99,546 | | | 9,789 | | |
| Underwriting income | $ | 141,211 | | | $ | 296,356 | | | $ | (155,145) | | |
| | | | | | | |
| Net claims and claim expenses incurred – current accident year | $ | 931,285 | | | $ | 536,197 | | | $ | 395,088 | | |
| Net claims and claim expenses incurred – prior accident years | (31,425) | | | 5,020 | | | (36,445) | | |
| Net claims and claim expenses incurred – total | $ | 899,860 | | | $ | 541,217 | | | $ | 358,643 | | |
| | | | | | | |
| Net claims and claim expense ratio – current accident year | 65.2 | % | | 46.2 | % | | 19.0 | % | |
| Net claims and claim expense ratio – prior accident years | (2.2) | % | | 0.5 | % | | (2.7) | % | |
| Net claims and claim expense ratio – calendar year | 63.0 | % | | 46.7 | % | | 16.3 | % | |
| Underwriting expense ratio | 27.1 | % | | 27.8 | % | | (0.7) | % | |
| Combined ratio | 90.1 | % | | 74.5 | % | | 15.6 | % | |
| | | | | | | |
Property Gross Premiums Written
In the first nine months of 2017,ended September 30, 2020, our Property segment gross premiums written increased by $286.5$504.8 million, or 27.1%23.1%, to $1.3$2.7 billion, compared to $1.1$2.2 billion in the first nine months of 2016. Excluding the impact of $164.7 million of reinstatement premiums written in our Property segment associated with the Q3 2017 Large Loss Events, and $12.0 million associated with the 2016 Texas Events and the Fort McMurrary Wildfire in the first nine months of 2016, gross premiums written in our Property segment increased $133.7 million, or 12.8%, in the first nine months of 2017, compared to the first nine months of 2016. We increased our participation on a select number of transactions and entered into certain new transactions we believe have comparably attractive risk-return attributes. As a result, we grew our other property and catastrophe classes of business, while continuing to exercise underwriting discipline given prevailing market terms and conditions.ended September 30, 2019.
Gross premiums written in ourthe catastrophe class of business were $1.8 billion in the nine months ended September 30, 2020, an increase of $277.0 million, or 17.9% compared to the nine months ended September 30, 2019. The increase in gross premiums written in the catastrophe class of business was primarily driven by expanded participation on existing transactions, certain new transactions, rate improvements and business acquired as a result of the acquisition of TMR.
Gross premiums written in the other property class of business were $275.8$863.2 million in the first nine months of 2017,ended September 30, 2020, an increase of $93.7$227.8 million, or 51.4%35.9%, compared to the third quarter of 2016. Excluding $2.5 million of reinstatementnine months ended September 30, 2019. The increase in gross premiums written in ourthe other property class of business inwas primarily driven by growth from existing relationships, new opportunities across a number of the first nine monthsCompany’s underwriting platforms, and business acquired as a result of 2017 associated with the Q3 2017 Large Loss Events, gross premiums written in our other property classacquisition of business increased $91.2 million, or 50.0%, in the first nine months of 2017, compared to the first nine months of 2016.TMR.
Gross premiums written in our catastrophe class of business were $1.1 billion in the first nine months of 2017, an increase of $192.8 million, or 22.0%, compared to the first nine months of 2016. Excluding $162.2 million of reinstatement premiums written in our catastrophe class of business associated with the Q3 2017 Large Loss Events in the first nine months of 2017, and $12.0 million associated with the 2016 Texas Events and the Fort McMurrary Wildfire in the first nine months of 2016, gross premiums written in our
catastrophe class of business increased $42.5 million, or 4.9%, in the first nine months of 2017, compared to the first nine months of 2016.
Property Ceded Premiums Written |
| | | | | | | | | | | | | |
| | | | | | | | |
| | Nine months ended September 30, | 2017 | | 2016 | | Change | |
| | (in thousands) | | | | | | |
| | Ceded premiums written - Property | $ | 449,543 |
| | $ | 384,455 |
| | $ | 65,088 |
| |
| | | | | | | | |
| | | | | | | | | | | | | | | | | | | | | | | |
| | | | | | | |
| Nine months ended September 30, | 2020 | | 2019 | | Change | |
| (in thousands) | | | | | | |
| Ceded premiums written - Property | $ | 933,400 | | | $ | 774,657 | | | $ | 158,743 | | |
| | | | | | | |
Ceded premiums written in our Property segment increased $65.1$158.7 million, to $449.5$933.4 million, in the first nine months of 2017,ended September 30, 2020, compared to $384.5$774.7 million in the first nine months ended September 30, 2019. The increase in ceded premiums written was principally due to certain of 2016,the gross premiums written in the catastrophe class of business noted above being ceded to third-party investors in our managed vehicles, primarily reflecting increasedUpsilon Fund and Mona Lisa Re Ltd., as well as an overall increase in ceded purchases of retrocessional reinsurance as part of the management of our risk portfolio and $27.4 million of ceded reinstatement premiums written associated with the Q3 2017 Large Loss Events.Company’s gross-to-net strategy.
Property Underwriting Results
Our Property segment incurred angenerated underwriting lossincome of $552.2$141.2 million in the first nine months of 2017,ended September 30, 2020, compared to generating underwriting income of $262.7$296.4 million in the first nine months of 2016,ended September 30, 2019, a decrease of $814.9$155.1 million. In the first nine months of 2017,ended September 30, 2020, our Property segment generated a net claims and claim expense ratio of 155.9%63.0%, an underwriting expense ratio of 21.2%27.1% and a combined ratio of 177.1%90.1%, compared to 23.3%46.7%, 28.0%27.8% and 51.3%74.5%, respectively, in the first nine months of 2016.ended September 30, 2019.
Principally impacting ourthe Property segment underwriting result and combined ratio in the first nine months of 2017ended September 30, 2020 were the Q3 20172020 Large Loss Events, which resulted in ana net negative impact on the Property segment underwriting lossresult of $808.6$428.7 million and added 139.315.0 percentage points to the combined ratio. The underwriting result and combined ratio inIn comparison, the first nine months of 2016 wereended September 30, 2019 was impacted by the 2016 TexasQ3 2019 Catastrophe Events, and the Fort McMurray Wildfire, which resulted in $54.9an net negative impact on the underwriting result of $181.9 million of underwriting losses and added 13.37.9 percentage points to our Property segmentthe combined ratio.
Our Property segment experienced favorable development on prior accident years net claims and claim expenses of $17.0 million, or 2.4 percentage points, in the first nine months of 2017, compared to $37.5 million, or 7.0 percentage points, in the first nine months of 2016. See “Note 6. Reserve for Claims and Claim Expenses” in our “Notes to the Consolidated Financial Statements” for additional information related to the development of prior accident years net claims and claim expenses.
Profit Commissions and Fees
|
| | | | | | | | | | | | | |
| | | | | | | | |
| | Nine months ended September 30, | 2017 | | 2016 | | Change | |
| | (in thousands) | | | | | | |
| | Profit commissions and fees | $ | 74,580 |
| | $ | 51,777 |
| | $ | 22,803 |
| |
| | Decrease in underwriting expense ratio | 10.4 | % | | 9.6 | % | | 0.8 | % | |
| | Net impact of profit commissions and fees | $ | 56,150 |
| | $ | 83,763 |
| | $ | (27,613 | ) | |
| | | | | | | | |
We have entered into various joint ventures and specialized quota share retrocession agreements pursuant to which we cede a portion of our property book of business and earn profit commissions, as applicable, and fee income. We record these profit commissions and fees as reductions in acquisition and operating expenses, respectively, and, accordingly, these profit commissions and fees have reduced our underwriting expense ratios.
In addition, we are entitled to certain fee income and profit commissions from DaVinci. Since the results of DaVinci and its parent, DaVinciRe, are consolidated in our results of operations, the majority of these fees and profit commissions are eliminated in our consolidated financial statements and are principally reflected in redeemable noncontrolling interest – DaVinciRe. The net impact of all fees and profit commissions related to these joint ventures and specialized quota share cessions within our Property segment was $56.2 million and $83.8 million in the first nine months of 2017 and 2016, respectively. Included in profit commissions and fees and net impact of profit commissions and fees in the third quarter of 2017 was a true-up of profit commissions associated with DaVinci reflecting the impact of the Q3 2017 Large Loss
Events on the year-to-date results of operations of DaVinci. This was partially offset by the reversal of profit commissions previously booked on various quota share retrocession agreements, also as a result of the Q3 2017 Large Loss Events. The true-up of profit commissions associated with DaVinci was reflected in acquisition and operating expenses as appropriate, and was principally offset in net loss attributable to noncontrolling interests in our consolidated statement of operations, resulting in no net earnings impact to us from these transactions.
Casualty and Specialty Segment
Below is a summary of the underwriting results and ratios for our Casualty and Specialty segment: |
| | | | | | | | | | | | | |
| | | | | | | | |
| | Nine months ended September 30, | 2017 | | 2016 | | Change | |
| | (in thousands, except percentages) | | | | | | |
| | Gross premiums written | $ | 1,044,510 |
| | $ | 992,669 |
| | $ | 51,841 |
| |
| | Net premiums written | $ | 687,381 |
| | $ | 641,452 |
| | $ | 45,929 |
| |
| | Net premiums earned | $ | 580,085 |
| | $ | 512,576 |
| | $ | 67,509 |
| |
| | Net claims and claim expenses incurred | 441,801 |
| | 282,117 |
| | 159,684 |
| |
| | Acquisition expenses | 173,179 |
| | 144,001 |
| | 29,178 |
| |
| | Operational expenses | 54,708 |
| | 68,261 |
| | (13,553 | ) | |
| | Underwriting (loss) income | $ | (89,603 | ) | | $ | 18,197 |
| | $ | (107,800 | ) | |
| | | | | | | | |
| | Net claims and claim expenses incurred – current accident year | $ | 427,786 |
| | $ | 320,444 |
| | $ | 107,342 |
| |
| | Net claims and claim expenses incurred – prior accident years | 14,015 |
| | (38,327 | ) | | 52,342 |
| |
| | Net claims and claim expenses incurred – total | $ | 441,801 |
| | $ | 282,117 |
| | $ | 159,684 |
| |
| | | | | | | | |
| | Net claims and claim expense ratio – current accident year | 73.7 | % | | 62.5 | % | | 11.2 | % | |
| | Net claims and claim expense ratio – prior accident years | 2.5 | % | | (7.5 | )% | | 10.0 | % | |
| | Net claims and claim expense ratio – calendar year | 76.2 | % | | 55.0 | % | | 21.2 | % | |
| | Underwriting expense ratio | 39.2 | % | | 41.4 | % | | (2.2 | )% | |
| | Combined ratio | 115.4 | % | | 96.4 | % | | 19.0 | % | |
| | | | | | | | |
| | | | | | | | | | | | | | | | | | | | | | | |
| | | | | | | |
| Nine months ended September 30, | 2020 | | 2019 | | Change | |
| (in thousands, except percentages) | | | | | | |
| | | | | | | |
| | | | | | | |
| | | | | | | |
| | | | | | | |
| | | | | | | |
| Gross premiums written | $ | 2,179,824 | | | $ | 1,716,287 | | | $ | 463,537 | | |
| Net premiums written | $ | 1,592,595 | | | $ | 1,244,799 | | | $ | 347,796 | | |
| Net premiums earned | $ | 1,494,303 | | | $ | 1,208,188 | | | $ | 286,115 | | |
| Net claims and claim expenses incurred | 1,123,527 | | | 793,533 | | | 329,994 | | |
| Acquisition expenses | 380,726 | | | 330,829 | | | 49,897 | | |
| Operational expenses | 56,195 | | | 58,603 | | | (2,408) | | |
| Underwriting (loss) income | $ | (66,145) | | | $ | 25,223 | | | $ | (91,368) | | |
| | | | | | | |
| Net claims and claim expenses incurred – current accident year | $ | 1,147,354 | | | $ | 813,251 | | | $ | 334,103 | | |
| Net claims and claim expenses incurred – prior accident years | (23,827) | | | (19,718) | | | (4,109) | | |
| Net claims and claim expenses incurred – total | $ | 1,123,527 | | | $ | 793,533 | | | $ | 329,994 | | |
| | | | | | | |
| Net claims and claim expense ratio – current accident year | 76.8 | % | | 67.3 | % | | 9.5 | % | |
| Net claims and claim expense ratio – prior accident years | (1.6) | % | | (1.6) | % | | — | % | |
| Net claims and claim expense ratio – calendar year | 75.2 | % | | 65.7 | % | | 9.5 | % | |
| Underwriting expense ratio | 29.2 | % | | 32.2 | % | | (3.0) | % | |
| Combined ratio | 104.4 | % | | 97.9 | % | | 6.5 | % | |
| | | | | | | |
Casualty and Specialty Gross Premiums Written
In the first nine months of 2017,ended September 30, 2020, our Casualty and Specialty segment gross premiums written increased $51.8by $463.5 million, or 5.2%27.0%, to $1,044.5 million,$2.2 billion, compared to $992.7 million$1.7 billion in the first nine months of 2016.ended September 30, 2019. The $51.8 million increase was principally due to selective growth from new and existing business and private placements within certain of our casualty lines of business, partially offset by a decrease in financial lines of business primarily as a result of a large, in-force multi-year mortgage reinsurance contractopportunities written in the first nine months of 2016, that did not reoccur in the first nine months of 2017. Financial linescurrent and prior periods across various classes of business within the segment, and more specifically, mortgage reinsurance, are prone to significant gross premiums written volatility and can be influenced by a small numberbusiness acquired in connection with the acquisition of relatively large transactions.TMR.
Casualty and Specialty Ceded Premiums Written |
| | | | | | | | | | | | | |
| | | | | | | | |
| | Nine months ended September 30, | 2017 | | 2016 | | Change | |
| | (in thousands) | | | | | | |
| | Ceded premiums written - Casualty and Specialty | $ | 357,129 |
| | $ | 351,217 |
| | $ | 5,912 |
| |
| | | | | | | | |
| | | | | | | | | | | | | | | | | | | | | | | |
| | | | | | | |
| Nine months ended September 30, | 2020 | | 2019 | | Change | |
| (in thousands) | | | | | | |
| Ceded premiums written - Casualty and Specialty | $ | 587,229 | | | $ | 471,488 | | | $ | 115,741 | | |
| | | | | | | |
Ceded premiums written in our Casualty and Specialty segment increased $5.9by $115.7 million, to $357.1$587.2 million, in the first nine months of 2017,ended September 30, 2020, compared to $351.2$471.5 million in the first nine months of 2016,ended September 30, 2019, primarily reflectingresulting from increased gross premiums written subject to our retrocessional quota share reinsurance programs, as well as an overall increase in ceded purchases of retrocessional reinsurance as part of the management of our risk portfolio in support of the growth in gross premiums written in our Casualty and Specialty segment.gross-to-net strategy.
Casualty and Specialty Underwriting Results
Our Casualty and Specialty segment incurred an underwriting loss of $89.6$66.1 million in the first nine months of 2017,ended September 30, 2020, compared to underwriting income of $18.2$25.2 million in the first nine months of 2016.ended September 30, 2019. In the first nine months of 2017,ended September 30, 2020, our Casualty and Specialty segment generated a net claims and claim expense ratio of 76.2%75.2%, an underwriting expense ratio of 39.2%29.2% and a combined ratio of 115.4%104.4%, compared to 55.0%65.7%, 41.4%32.2% and 96.4%97.9%, respectively, in the first nine months of 2016.ended
September 30, 2019. The increase in our Casualty and Specialty segment’s combined ratio was driven by a 21.2 percentage point increaseunderwriting loss in the net claims and claim expense ratio in the first nine months of 2017 to 76.2%, compared to 55.0% in the first nine months of 2016, andended September 30, 2020 was comprised of an increase in our Casualty and Specialty segment current accident year net claims and claim expenses ratio and adverse development on prior accident years net claims and claim expenses.
Current accident year net claims and claim expenses in our Casualty and Specialty segment were primarily impactedprincipally driven by net claims and claim expenses from Hurricanes Harvey, Irma and Maria, andassociated with the Mexico City Earthquake,COVID-19 pandemic of $113.7 million, which added 7.6 percentage points to the combined with higher attritional net claims and claim expenses.ratio during the nine months ended September 30, 2020.
Our Casualty and Specialty segment experienced adversenet favorable development on prior accident years net claims and claim expenses of $14.0$23.8 million, or 2.51.6 percentage points, during the first nine months of 2017,ended September 30, 2020, compared to $19.7 million, or 1.6 percentage points, respectively, in the nine months ended September 30, 2019. The net favorable development of $38.3 million, or 7.5 percentage points, in during the first nine months of 2016. The adverse development during the first nine months of 2017ended September 30, 2020 and 2019 was principally driven by $33.5 million of adverse development associated with the change in the Ogden Rate. Offsetting the adverse development due to the impact of the Ogden Rate change was $17.0 million of net favorable development in the first nine months of 2017 related to actual reported losses coming in lower than expected on attritional net claims and claim expenses across a number of lines of business and $2.5 million of net favorable development associated with actuarial assumption changes. expected.
See “Note 6. Reserve for Claims and Claim Expenses” in our “Notes to the Consolidated Financial Statements” for additional information related to the development of prior accident years net claims and claim expenses.
Profit CommissionsWhile the additional net claims and Feesclaim expenses associated with the COVID-19 pandemic that we incurred in the second and third quarters of 2020 were not significant, the Company continues to evaluate industry trends and its own potential exposure associated with the ongoing COVID-19 pandemic, and expects historically significant industry losses to emerge over time as the full impact of the pandemic and its effects on the global economy are realized. Among other things, the Company continues to actively monitor information received from or reported by clients, brokers, industry actuaries, regulators, courts, and others, and to assess that information in the context of its own portfolio. Our loss estimates represent our best estimate based on currently available information, and actual losses may vary materially from these estimates. Additionally, losses incurred in respect of the COVID-19 pandemic subsequent to September 30, 2020 will be reflected in the periods in which those losses are incurred. |
| | | | | | | | | | | | | |
| | | | | | | | |
| | Nine months ended September 30, | 2017 | | 2016 | | Change | |
| | (in thousands, except percentages) | | | | | | |
| | Profit commissions and fees | $ | 17,937 |
| | $ | 19,900 |
| | $ | (1,963 | ) | |
| | Decrease in underwriting expense ratio | 3.1 | % | | 3.9 | % | | (0.8 | )% | |
| | | | | | | | |
We have | | | | | | | | | | | | | | | | | | | | | | | |
| | | | | | | |
| Nine months ended September 30, | 2020 | | 2019 | | Change | |
| (in thousands) | | | | | | |
| Management fee income | | | | | | |
| Joint ventures | $ | 37,041 | | | $ | 30,688 | | | $ | 6,353 | | |
| Structured reinsurance products and other | 26,121 | | | 26,986 | | | (865) | | |
| Managed funds | 21,536 | | | 14,822 | | | 6,714 | | |
| Total management fee income | 84,698 | | | 72,496 | | | 12,202 | | |
| | | | | | | |
| Performance fee income | | | | | | |
| Joint ventures | 12,151 | | | 13,034 | | | (883) | | |
| Structured reinsurance products and other | 5,955 | | | 13,007 | | | (7,052) | | |
| Managed funds | 6,452 | | | 2,456 | | | 3,996 | | |
| Total performance fee income | 24,558 | | | 28,497 | | | (3,939) | | |
| Total fee income | $ | 109,256 | | | $ | 100,993 | | | $ | 8,263 | | |
| | | | | | | |
| | | | | | | |
| | | | | | | |
In the nine months ended September 30, 2020, total fee income earned through third-party capital management, various specialized quota sharejoint ventures and certain structured retrocession agreements in place pursuant to which we cedeare a portionparty increased $8.3 million, to $109.3 million, compared to $101.0 million in the nine months ended September 30, 2019, primarily driven by an increase in the dollar value of our casualtycapital being managed and specialty book of businesspartially offset by reduced underlying performance. Of the $109.3 million in total fee income earned in the nine months ended September 30, 2020 through third-party capital management, various joint ventures and certain structured retrocession agreements to which we are a party, $57.5 million was recorded through redeemable noncontrolling interest and $51.7 million was recorded through underwriting income as a reduction to operating expenses and acquisition expenses (2019 - $49.5 million and $51.5 million, respectively).
In addition to the fee income earned through third-party capital management, joint ventures and certain structured retrocession agreements to which we are a party, as detailed in the table above, we also earn profit commissions,fee income on certain other underwriting-related activities. These fees, in the aggregate, are recorded as applicable, and fee income. We record these profit commissions anda
reduction to operating expenses or acquisition expenses, as applicable. The total fees, as reductionsdescribed above and including fee income earned on certain other underwriting-related activities, earned by us in acquisition andthe nine months ended September 30, 2020 that were recorded as a reduction to operating expenses or acquisition expenses were $85.4 million and $7.5 million, respectively, resulting in a reduction to the combined ratio of 3.2% (2019 - $67.0 million, $17.5 million and accordingly, these profit commissions and fees have reduced our underwriting expense ratios.3.4%, respectively).
|
| | | | | | | | | | | | | |
| | | | | | | | |
| | Nine months ended September 30, | 2017 | | 2016 | | Change | |
| | (in thousands) | | | | | | |
| | Fixed maturity investments | $ | 133,080 |
| | $ | 122,056 |
| | $ | 11,024 |
| |
| | Short term investments | 7,476 |
| | 3,401 |
| | 4,075 |
| |
| | Equity investments trading | 2,630 |
| | 3,325 |
| | (695 | ) | |
| | Other investments | | | | |
| |
| | Private equity investments | 20,784 |
| | (430 | ) | | 21,214 |
| |
| | Other | (4,520 | ) | | 17,109 |
| | (21,629 | ) | |
| | Cash and cash equivalents | 836 |
| | 584 |
| | 252 |
| |
| | | 160,286 |
| | 146,045 |
| | 14,241 |
| |
| | Investment expenses | (11,541 | ) | | (11,635 | ) | | 94 |
| |
| | Net investment income | $ | 148,745 |
| | $ | 134,410 |
| | $ | 14,335 |
| |
| | | | | | | | |
| | | | | | | | | | | | | | | | | | | | | | | |
| | | | | | | |
| Nine months ended September 30, | 2020 | | 2019 | | Change | |
| (in thousands) | | | | | | |
| Fixed maturity investments trading | $ | 211,303 | | | $ | 232,566 | | | $ | (21,263) | | |
| Short term investments | 19,752 | | | 44,712 | | | (24,960) | | |
| Equity investments trading | 4,776 | | | 3,269 | | | 1,507 | | |
| Other investments | | | | | | |
| Catastrophe bonds | 41,284 | | | 33,284 | | | 8,000 | | |
| Other | 5,334 | | | 6,226 | | | (892) | | |
| Cash and cash equivalents | 2,782 | | | 5,801 | | | (3,019) | | |
| | 285,231 | | | 325,858 | | | (40,627) | | |
| Investment expenses | (12,910) | | | (13,789) | | | 879 | | |
| Net investment income | $ | 272,321 | | | $ | 312,069 | | | $ | (39,748) | | |
| | | | | | | |
Net investment income was $148.7$272.3 million in the first nine months of 2017,ended September 30, 2020, compared to $134.4$312.1 million in the first nine months ended September 30, 2019, a decrease of 2016, an increase of $14.3$39.7 million. Impacting our net investment income for the first nine months of 2017ended September 30, 2020 were improvedlower returns in our portfolio of private equity investments and higher net investment income in our portfolio of fixed maturity and short term investments, primarily driven by higher average invested assets,as a result of lower yields on these investments following the decline in interest rates in early 2020, partially offset by unrealized losses in our other investment portfolio, specificallyhigher returns on our catastrophe bond portfolio, which was impacted by a number of large catastrophe events occurringbonds due to growth in the third quarter of 2017.portfolio.
Our private equity and other investment portfolios are accounted for at fair value with the change in fair value recorded in net investment income, which included net unrealized gains of $2.7 million and gains of $6.1 million in the first nine months of 2017 and 2016, respectively.
Net Realized and Unrealized Gains on Investments |
| | | | | | | | | | | | | |
| | | | | | | | |
| | Nine months ended September 30, | 2017 | | 2016 | | Change | |
| | (in thousands) | | | | | | |
| | Gross realized gains | $ | 43,053 |
| | $ | 60,794 |
| | $ | (17,741 | ) | |
| | Gross realized losses | (29,902 | ) | | (25,832 | ) | | (4,070 | ) | |
| | Net realized gains on fixed maturity investments | 13,151 |
| | 34,962 |
| | (21,811 | ) | |
| | Net unrealized gains on fixed maturity investments trading | 48,940 |
| | 125,501 |
| | (76,561 | ) | |
| | Net realized and unrealized losses on investments-related derivatives | (4,344 | ) | | (26,873 | ) | | 22,529 |
| |
| | Net realized gains on equity investments trading | 49,736 |
| | 14,038 |
| | 35,698 |
| |
| | Net unrealized gains on equity investments trading | 36,055 |
| | 43,667 |
| | (7,612 | ) | |
| | Net realized and unrealized gains on investments | $ | 143,538 |
| | $ | 191,295 |
| | $ | (47,757 | ) | |
| | | | | | | | |
| | | | | | | | | | | | | | | | | | | | | | | |
| | | | | | | |
| Nine months ended September 30, | 2020 | | 2019 | | Change | |
| (in thousands) | | | | | | |
| | | | | | | |
| | | | | | | |
| Net realized gains on fixed maturity investments trading | $ | 219,001 | | | $ | 52,826 | | | $ | 166,175 | | |
| Net unrealized gains on fixed maturity investments trading | 193,649 | | | 243,139 | | | (49,490) | | |
| Net realized and unrealized gains on fixed maturity investments trading | 412,650 | | | 295,965 | | | 116,685 | | |
| Net realized and unrealized gains on investments-related derivatives | 59,586 | | | 62,103 | | | (2,517) | | |
| Net realized gains on equity investments trading | 1,999 | | | 30,666 | | | (28,667) | | |
| Net unrealized gains on equity investments trading | 109,291 | | | 7,852 | | | 101,439 | | |
| Net realized and unrealized gains on equity investments trading | 111,290 | | | 38,518 | | | 72,772 | | |
| Net realized and unrealized gains (losses) on other investments - catastrophe bonds | 2,711 | | | (4,870) | | | 7,581 | | |
| Net realized and unrealized (losses) gains on other investments - other | (24,346) | | | 3,939 | | | (28,285) | | |
| Net realized and unrealized gains on investments | $ | 561,891 | | | $ | 395,655 | | | $ | 166,236 | | |
| | | | | | | |
| | | | | | | |
| | | | | | | |
| | | | | | | |
Net realized and unrealized gains on investments were $143.5$561.9 million in the first nine months of 2017,ended September 30, 2020, compared to $191.3net realized and unrealized gains of $395.7 million in the first nine months ended September 30, 2019, a increase of 2016, a decrease of $47.8$166.2 million. Included inPrincipally impacting our net realized and unrealized gains on investments in the nine months ended September 30, 2020 were:
•net realized and unrealized gains on our fixed maturity investments trading of $62.1$412.7 million in the first nine months of 2017,ended September 30, 2020, compared to net realized and unrealized gains of $160.5$296.0 million in the first nine months ended September 30, 2019, an increase of 2016. The $98.4$116.7 million, decrease was principally driven by higher realized gains generated on the sale of fixed maturity investments, partially offset by lower unrealized gains driven by the flattening of the yield curve during the first nine months of 2017, compared to the first nine months of 2016 which experienced a pronounced downward shift in the yield curve;
on fixed maturity investments trading;•net realized and unrealized gains on equity investments trading of $85.8$111.3 million in the first nine months ended September 30, 2020, compared to gains of 2017,$38.5 million in the nine months ended September 30, 2019, an increase of $72.8 million, principally driven by a net increase in the value of our strategic investment portfolio, during the nine months ended September 30, 2020, compared to the nine months ended September 30, 2019; and
•net realized and unrealized losses on our other investments of $24.3 million in the nine months ended September 30, 2020, compared to net realized and unrealized gains of $57.7$3.9 million in the first nine months ended September 30, 2019, a decrease of 2016, an improvement of $28.1$28.3 million, principally driven by the strong performance of a number oflower returns in our private equity positions in the first nine months of 2017; and
investment portfolio.
net realized and unrealized losses on certain investments-related derivatives of $4.3 million in the first nine months of 2017, compared to losses of $26.9 million in the first nine months of 2016, an improvement of $22.5 million, primarily due to the yield curve movements noted above.
Net Foreign Exchange Gains (Losses) |
| | | | | | | | | | | | | |
| | | | | | | | |
| | Nine months ended September 30, | 2017 | | 2016 | | Change | |
| | (in thousands) | | | | | | |
| | Foreign exchange gains (losses) | $ | 11,118 |
| | $ | (8,368 | ) | | $ | 19,486 |
| |
| | | | | | | | |
| | | | | | | | | | | | | | | | | | | | | | | |
| | | | | | | |
| Nine months ended September 30, | 2020 | | 2019 | | Change | |
| (in thousands) | | | | | | |
| Net foreign exchange gains (losses) | $ | 4,503 | | | $ | (1,812) | | | $ | 6,315 | | |
| | | | | | | |
Our functional currency is the U.S. dollar. We routinely write a portion of our business in currencies other than U.S. dollars and invest a portion of our cash and investment portfolio in those currencies. In addition, and in connection with the acquisition of TMR, we acquired certain entities with non-U.S. dollar functional currencies. As a result, we may experience foreign exchange gains and losses in our consolidated financial statements. All changes in exchange rates are recognized in our consolidated statements of operations. We are primarily impacted by the foreign currency risk exposures associated with our underwriting operations, and investment portfolio, and operations with non-U.S. dollar functional currencies, and may, from time to time, enter into foreign currency forward and option contracts to minimize the effect of fluctuating foreign currencies on the value of non-U.S. dollar denominated assets and liabilities.
Equity in Earnings
(Losses) of Other Ventures
|
| | | | | | | | | | | | | |
| | | | | | | | |
| | Nine months ended September 30, | 2017 | | 2016 | | Change | |
| | (in thousands) | | | | | | |
| | Top Layer Re | $ | 7,864 |
| | $ | (10,283 | ) | | $ | 18,147 |
| |
| | Tower Hill Companies | (1,235 | ) | | 7,519 |
| | (8,754 | ) | |
| | Other | (799 | ) | | (1,233 | ) | | 434 |
| |
| | Total equity in earnings (losses) of other ventures | $ | 5,830 |
| | $ | (3,997 | ) | | $ | 9,827 |
| |
| | | | | | | | |
| | | | | | | | | | | | | | | | | | | | | | | |
| | | | | | | |
| Nine months ended September 30, | 2020 | | 2019 | | Change | |
| (in thousands) | | | | | | |
| Tower Hill Companies | $ | 7,692 | | | $ | 8,522 | | | $ | (830) | | |
| Top Layer Re | 7,036 | | | 6,550 | | | 486 | | |
| Other | 4,334 | | | 2,278 | | | 2,056 | | |
| Total equity in earnings of other ventures | $ | 19,062 | | | $ | 17,350 | | | $ | 1,712 | | |
| | | | | | | |
Equity in earnings (losses) of other ventures primarily represents our pro-rata share of the net income (loss) from our investments in Top Layer Re and the Tower Hill Companies, and, except for Top Layer Re, is recorded one quarter in arrears. The carrying value of these investments on our consolidated balance sheets, individually or in the aggregate, may differ from the realized value we may ultimately attain, perhaps significantly so.
Equity in earnings of other ventures was $5.8$19.1 million in the first nine months of 2017,ended September 30, 2020, compared to equity in losses of $4.0$17.4 million in the first nine months of 2016,ended September 30, 2019, an increase of $9.8 million. Equity in losses$1.7 million, principally driven by improved profitability of other ventures in the first nine months of 2016 was primarily impacted by a $10.3 million loss related to the Company’s 50% ownershipour equity investments in Top Layer Re described above.
In addition, we recorded equityand a select group of insurance and insurance-related companies within the other category, partially offset by reduced profitability in losses of the Tower Hill CompaniesCompanies.
Other (Loss) Income
| | | | | | | | | | | | | | | | | | | | | | | |
| | | | | | | |
| Nine months ended September 30, | 2020 | | 2019 | | Change | |
| (in thousands) | | | | | | |
| Assumed and ceded reinsurance contracts accounted for as derivatives and deposits | $ | (5,210) | | | $ | 3,547 | | | (8,757) | | |
| | | | | | | |
| Other | 1,049 | | | 1,562 | | | (513) | | |
| Total other (loss) income | $ | (4,161) | | | $ | 5,109 | | | $ | (9,270) | | |
| | | | | | | |
In the nine months ended September 30, 2020, we incurred an other loss of $1.2$4.2 million, compared to other income of $5.1 million in the first nine months of 2017, compared to earnings of $7.5 million in the first nine months of 2016,ended September 30, 2019, a decrease of $8.8 million, principally due to an estimate of losses associated with certain catastrophe events occurring in the third quarter of 2017 impacting the profitability of the Tower Hill Companies.
|
| | | | | | | | | | | | | |
| | | | | | | | |
| | Nine months ended September 30, | 2017 | | 2016 | | Change | |
| | (in thousands) | | | | | | |
| | Assumed and ceded reinsurance contracts accounted for as derivatives and deposits | $ | 7,425 |
| | $ | 9,526 |
| | (2,101 | ) | |
| | Other | (372 | ) | | (525 | ) | | 153 |
| |
| | Total other income | $ | 7,053 |
| | $ | 9,001 |
| | $ | (1,948 | ) | |
| | | | | | | | |
In the first nine months of 2017, we generated other income of $7.1 million, compared to $9.0 million in the first nine months of 2016, a decrease of $1.9$9.3 million, driven by losses on our assumed and ceded reinsurance contracts accounted for as derivatives and deposits.
|
| | | | | | | | | | | | | |
| | | | | | | | |
| | Nine months ended September 30, | 2017 | | 2016 | | Change | |
| | (in thousands) | | | | | | |
| | Corporate expenses | $ | 14,335 |
| | $ | 25,514 |
| | $ | (11,179 | ) | |
| | | | | | | | |
| | | | | | | | | | | | | | | | | | | | | | | |
| | | | | | | |
| Nine months ended September 30, | 2020 | | 2019 | | Change | |
| (in thousands) | | | | | | |
| Corporate expenses | $ | 75,939 | | | $ | 76,480 | | | $ | (541) | | |
| | | | | | | |
Corporate expenses include certain executive, director, legal and consulting expenses, costs for research and development, impairment charges related to goodwill and other intangible assets, and other miscellaneous costs, including those associated with operating as a publicly traded company. company, as well as costs associated with the acquisition of TMR and the sale of RenaissanceRe UK.
Corporate expenses decreased $11.2$0.5 million to $14.3$75.9 million, in the first nine months of 2017,ended September 30, 2020, compared to $25.5$76.5 million in the first nine months of 2016. During ended September 30, 2019. Included in corporate expenses for the first nine months ended September 30, 2020 is the $30.2 million loss on the sale of 2016 we incurredRenaissanceRe UK on August 18, 2020, as well as related transaction and other expenses, compared to $44.0 million of corporate expenses associated with an executive retirement which did not repeatthe acquisition of TMR in the first nine months of 2017.ended September 30, 2019.
Income Tax
Benefit (Expense)Expense |
| | | | | | | | | | | | | |
| | | | | | | | |
| | Nine months ended September 30, | 2017 | | 2016 | | Change | |
| | (in thousands) | | | | | | |
| | Income tax benefit (expense) | $ | 14,739 |
| | $ | (8,040 | ) | | $ | 22,779 |
| |
| | | | | | | | |
| | | | | | | | | | | | | | | | | | | | | | | |
| | | | | | | |
| Nine months ended September 30, | 2020 | | 2019 | | Change | |
| (in thousands) | | | | | | |
| Income tax expense | $ | (12,785) | | | $ | (20,670) | | | $ | 7,885 | | |
| | | | | | | |
In the first nine months of 2017,ended September 30, 2020, we recognized an income tax benefitexpense of $14.7$12.8 million, compared to an$20.7 million in the nine months ended September 30, 2019. The income tax expense of $8.0 million in the first nine months of 2016,ended September 30, 2020 was principally driven by pre-tax GAAP lossesinvestment gains in our U.S.-basedU.S. based operations, primarily due topartially offset by lower underwriting losses associated with the Q3 2017 Large Loss Events in the first nine months of 2017, compared to pre-tax GAAP incomeperformance and other miscellaneous items, also primarily in our U.S.-basedU.S. operations, in including amounts from the first nine monthscontinued impacts of 2016.U.S. tax reform.
Net Loss (Income)Income Attributable to Redeemable Noncontrolling Interests |
| | | | | | | | | | | | | |
| | | | | | | | |
| | Nine months ended September 30, | 2017 | | 2016 | | Change | |
| | (in thousands) | | | | | | |
| | Net loss (income) attributable to redeemable noncontrolling interests | $ | 132,338 |
| | $ | (110,867 | ) | | $ | 243,205 |
| |
| | | | | | | | |
| | | | | | | | | | | | | | | | | | | | | | | |
| | | | | | | |
| Nine months ended September 30, | 2020 | | 2019 | | Change | |
| (in thousands) | | | | | | |
| Net income attributable to redeemable noncontrolling interests | $ | (236,120) | | | $ | (204,091) | | | $ | (32,029) | | |
| | | | | | | |
Our net loss attributable to redeemable noncontrolling interests was $132.3 million in the first nine months of 2017, compared to net income of $110.9 million in the first nine months of 2016. The $243.2 million decrease in net income attributable to redeemable noncontrolling interests was principally due to underwriting losses associated with$236.1 million in the Q3 2017 Large Loss Events incurred by DaVinciRe and a decrease in our ownership of DaVinciRe to 23.5% atnine months ended September 30, 2017,2020, compared to 24.0% at$204.1 million in the nine months ended September 30, 2016. We expect our noncontrolling economic ownership in DaVinciRe to fluctuate over time. See “Note 8. Noncontrolling Interests”2019, a change of $32.0 million. The increase was primarily driven by growth and “Note 16. Subsequent Events” in our “Notesimproved performance, with higher net income from Medici and Vermeer, partially offset by lower net income from DaVinci, during the nine months ended September 30, 2020 as compared to the Consolidated Financial Statements” for additional information regarding DaVinciRe.nine months ended September 30, 2019.
FINANCIAL CONDITION, LIQUIDITY AND CAPITAL RESOURCES
The Company's liquidity and capital resources were not materially impacted by the COVID-19 pandemic and related volatility and slowdown in the global financial markets during the nine months ended September 30, 2020. For further discussion regarding the potential future impacts of the COVID-19 pandemic and related economic conditions on the Company's liquidity and capital resources, see "Current Outlook" and "Part II, Item 1A, Risk Factors."
Financial Condition
RenaissanceRe isAs a Bermuda-domiciled holding company, RenaissanceRe has limited operations of its own. Its assets consist primarily of investments in subsidiaries, and, weto a degree, cash and securities in amounts which fluctuate over time. We therefore rely on dividends and distributions (and other statutorily permissible payments) from our subsidiaries, and investment income and fee income to makemeet our liquidity requirements, which primarily include making principal and interest payments on our debt and to make dividend payments to our preference and common shareholders.
The payment of dividends by our subsidiaries is, under certain circumstances, limited by the applicable laws and regulations in the various jurisdictions in which our subsidiaries operate, including among others, Bermuda, the U.S., the U.K., Switzerland, Australia, Singapore and Ireland. For example,In addition, insurance laws require our insurance subsidiaries to maintain certain measures of solvency and liquidity. We believe that each of our insurance subsidiaries and branches exceeded the minimum solvency, capital and surplus requirements in their applicable jurisdictions at September 30, 2020. Certain of our subsidiaries and branches are required to file financial condition reports (“FCRs”) with their regulators, which provide details on solvency and financial performance. Where required, these FCRs will be posted on our website. The regulations governing the ability of usour and our principal operating subsidiariessubsidiaries’ ability to pay dividends and to maintain certain measures of solvency and liquidity, and requirements to file FCRs are discussed in detail in “Part II,I, Item 7. Management’s Discussion1. Business, Regulation” and Analysis of“Note 18. Statutory Requirements” in our “Notes to the Consolidated Financial Condition and Results of Operations, Liquidity and Capital Resources, Financial Condition” ofStatements” in our Form 10-K for the year ended December 31, 2016.2019.
In the aggregate, our principal operating subsidiaries have historically produced sufficient cash flows to meet their expected claims payments and operational expenses and to provide dividend payments to us. Our subsidiaries also maintain a concentration of investments in high quality liquid securities, which management believes will provide additional liquidity for extraordinary claims payments should the need arise. See “Capital Resources” section below.
However, as previously discussed, we experienced a net negative impact of $615.1 million from the Q3 2017 Large Loss Events. As we would expect following events of this magnitude, it was necessary for RenaissanceRe to contribute capital to certain of its principal operating subsidiaries to ensure they were able to maintain levels of capital adequacy and liquidity in compliance with various laws and regulations, support rating agency capital requirements, pay valid claims quickly and be adequately capitalized to pursue business opportunities as they arise. Net capital contributions by RenaissanceRe to our principal operating subsidiaries, net of dividends and return of capital received by RenaissanceRe from our principal operating subsidiaries, were $112.3 million during the first nine months of 2017. We believe RenaissanceRe and our principal operating subsidiaries continue to be adequately capitalized following the Q3 2017 Large Loss Events and these capital contributions.
In comparison, during the first nine months of 2016, dividends and return of capital by our principal operating subsidiaries to RenaissanceRe, net of capital contributions by RenaissanceRe to our principal operating subsidiaries, were $245.3 million.
Group Supervision
The Bermuda Monetary Authority (“BMA”) is our group supervisor. Under the Insurance Act 1978, amendments thereto and related regulations of Bermuda (collectively, the “Insurance Act”), we are required to maintain capital at a level equal to our enhanced capital requirement (“ECR”), which is established by reference to the Bermuda Solvency Capital Requirement (the “BSCR”) model. The BSCR is a mathematical model designed to give the BMA robust methods for determining an insurer’s capital adequacy. Underlying the BSCR is the belief that all insurers should operate on an ongoing basis with a view to maintaining their capital at a prudent level in excess of the minimum solvency margin otherwise prescribed under the Insurance Act. At September 30, 2017, we believe the statutory capital and surplus of our group exceeded the minimum amount required to be maintained under Bermuda law. Our 2016 group BSCR was filed with the BMA in advance of the May 31, 2017 filing deadline, and we exceeded the minimum amount required to be maintained under Bermuda law.
Class 3A, 3B and 4 insurers and insurance groups are also required to prepare and publish a financial condition report (“FCR”), which was introduced to the regulatory regime in 2016 as part of the measures undertaken to achieve Solvency II equivalence. The FCR provides, among other things, details of measures governing the business operations, corporate governance framework and solvency and financial performance of the insurer/insurance group. We applied for, and received, approval from the BMA to file a consolidated group FCR, inclusive of our Bermuda-domiciled insurance subsidiaries and Top Layer Re. Our group FCR was filed in advance of the June 30, 2017 deadline and is available on our website.
Bermuda Subsidiaries
Bermuda regulations require BMA approval for any reduction of capital in excess of 15% of statutory capital, as defined in the Insurance Act. The Insurance Act also requires the Bermuda insurance subsidiaries of RenaissanceRe to maintain certain measures of solvency and liquidity. At September 30, 2017, we believe the statutory capital and surplus of our Bermuda insurance subsidiaries exceeded the minimum amount required to be maintained under Bermuda law.
Under the Insurance Act, RenaissanceRe Specialty U.S. is defined as a Class 3B insurer, and Renaissance Reinsurance and DaVinci are classified as Class 4 insurers, and must each maintain capital at a level equal to an ECR which is established by reference to the BSCR model. The 2016 BSCR for Renaissance Reinsurance, RenaissanceRe Specialty U.S. and DaVinci was filed with the BMA before the April 30, 2017 filing deadline; and each company exceeded the minimum amount required to be maintained under Bermuda law. In addition, audited annual financial statements prepared in accordance with GAAP for each of Renaissance Reinsurance, RenaissanceRe Specialty U.S. and DaVinci are filed prior to April 30 of each year with the BMA and are available free of charge on the BMA’s website.
U.K. Subsidiaries
Underwriting capacity, or stamp capacity, of a member of Lloyd’s must be supported by providing a deposit in the form of cash, securities or letters of credit, which are referred to as Funds at Lloyd’s (“FAL”). The amount of FAL is determined by Lloyd’s and is based on Syndicate 1458’s solvency and capital requirement as calculated through its internal model. In addition, if the FAL are not sufficient to cover all losses, the Lloyd’s Central Fund provides an additional level of security for policyholders. At September 30, 2017, the stamp capacity approved by Lloyd’s for Syndicate 1458 was £353.2 million based on its business plan originally approved in November 2016 (December 31, 2016 - £353.2 million based on its business plan originally approved in November 2016).
At September 30, 2017, the FAL required to support the underwriting activities at Lloyd’s through Syndicate 1458 was £381.9 million (December 31, 2016 - £351.7 million). Actual FAL posted for Syndicate 1458 at September 30, 2017 by RenaissanceRe CCL was £381.9 million, supported by a $180.0 million letter of credit and a $316.6 million deposit of cash and fixed maturity securities. Effective May 25, 2017, the then existing FAL letters of credit issued for the account of Renaissance Reinsurance, with stated amounts of $380 million and £90 million, were amended. Pursuant to the amendment, the stated amount of the $380 million letter of credit was reduced to $180 million and the £90 million letter of credit was cancelled. See “Note 7. Debt and Credit Facilities” in our “Notes to the Consolidated Financial Statements” for additional information related to this facility.
U.S. Subsidiaries
Renaissance Reinsurance U.S. is domiciled in Maryland, which has adopted the NAIC's model law that uses a risk-based capital ("RBC") model to monitor and regulate the solvency of licensed life, health, and property and casualty insurance and reinsurance companies. The RBC calculation is used to measure an insurer's capital adequacy with respect to: the risk characteristics of the insurer's premiums written and net claims and claim expenses, rate of growth and quality of assets, among other measures. At September 30, 2017, we believe the statutory capital and surplus of Renaissance Reinsurance U.S. exceeded the minimum capital adequacy level required to be maintained under U.S. law.
Renaissance Reinsurance U.S. is subject to certain restrictions on its ability to pay dividends pursuant to Maryland law, including making appropriate filings with and obtaining certain approvals from its regulator. During 2017, Renaissance Reinsurance U.S. has an ordinary dividend capacity of $25.4 million (2016 - $26.0 million).
Top Layer Re
Renaissance Reinsurance is obligated to make a mandatory capital contribution of up to $50.0 million in the event that a loss reduces Top Layer Re’s capital below a specified level.
Liquidity and Cash Flows
Holding Company Liquidity
As a Bermuda-domiciled holding company, RenaissanceRe has limited operations of its own and its assets consist primarily of investments in subsidiaries, and, to a degree, cash and securities in amounts which fluctuate over time. Accordingly, RenaissanceRe’s future cash flows largely depend on the availability of dividends or other statutorily permissible payments from our subsidiaries. As discussed above, the ability to pay such dividends is limited by the applicable laws and regulations in the various jurisdictions in which our subsidiaries operate.
RenaissanceRe’s principal uses of liquidity are: (1) common share related transactions including dividend payments to our common shareholders and common share repurchases, (2) preference share related transactions including dividend payments to our preference shareholders and preference share redemptions, (3) interest and principal payments on debt, (4) capital investments in our subsidiaries, (5) acquisition of new or existing companies or businesses, such as our acquisition of PlatinumTMR and (6) certain corporate and operating expenses.
We attempt to structure our organization in a way that facilitates efficient capital movements between RenaissanceRe and our operating subsidiaries and to ensure that adequate liquidity is available when required, giving consideration to applicable laws and regulations, and the domiciliary location of sources of liquidity and related obligations.
In the aggregate, our principal operating subsidiaries have historically produced sufficient cash flows to meet their expected claims payments and operational expenses and to provide dividend payments to us. In addition, our subsidiaries maintain a concentration of investments in high quality liquid securities, which management believes will provide additional liquidity for extraordinary claims payments should the need arise. However, in some circumstances, RenaissanceRe may contribute capital to its subsidiaries. For example, during 2018 and 2017 we experienced significant losses from large catastrophe events, and as we would expect following events of this magnitude, it was necessary for RenaissanceRe to contribute capital to certain of our principal operating subsidiaries to ensure they were able to maintain levels of capital adequacy and liquidity in compliance with various laws and regulations, support rating agency capital requirements, pay valid claims quickly and be adequately capitalized to pursue business opportunities as they arise. During 2019, RenaissanceRe contributed capital to RenaissanceRe Specialty Holdings (UK) Limited to fund the acquisition of TMR and made a capital contribution to Renaissance Reinsurance to increase its shareholders’ equity, consistent with past practice following a significant acquisition and to support growth in premiums. In addition, from time to time we invest in new managed joint ventures, increase our investments in certain of our managed joint ventures and contribute cash to investment subsidiaries. In certain instances, we are required to make capital contributions to our subsidiaries, for example, Renaissance Reinsurance is obligated to make a mandatory capital contribution of up to $50.0 million in the event that a loss reduces Top Layer Re’s capital below a specified level.
Sources of Liquidity
Historically, cash receipts from operations, consisting primarily of premiums, investment income and investmentfee income, have provided sufficient funds to pay losses and operating expenses of our subsidiaries and to fund dividends and distributions to RenaissanceRe. Other potential sources of liquidity include borrowings under our credit facilities and issuances of securities. For example, in June 2020, we raised $1.1 billion of net proceeds in an underwritten public offering and concurrent private placement of our common shares.
The premiums received by our operating subsidiaries are generally received months or even years before losses are paid under the policies related to such premiums. Premiums and acquisition expenses generally are received within the first two years of inception of a contract while operating expenses are generally paid within a year of being incurred. It generally takes much longer for claims and claims expenses to be reported and ultimately settled, requiring the establishment of reserves for claims and claim expenses. Therefore, the amount of claims paid in any one year is not necessarily related to the amount of net claims incurred in that year, as reported in the consolidated statement of operations.
While we expect that our liquidity needs will continue to be met by our cash receipts from operations, as a result of the combination of current market conditions, lower than usual investment yields, and the nature of our business where a large portion of the coverages we provide can produce losses of high severity and low frequency, future cash flows from operating activities cannot be accurately predicted and may fluctuate significantly between individual quarters and years. In addition, due to the magnitude and complexity of certain large loss events, meaningful uncertainty remains regarding losses from these events and our actual ultimate net losses from these events may vary materially from preliminary estimates, which would impact our cash flows from operations. Further, we expect historically significant industry losses related to the
COVID-19 pandemic to emerge over time as the full impact of the pandemic and its effects on the global economy are realized, which may impact our cash flows from operations.
Our “shelf” registration statement on Form S-3 under the Securities Act allows for the public offering of various types of securities, including common shares, preference shares and debt securities, and thus provides a source of liquidity. Because we are a “well-known seasoned issuer” as defined by the rules promulgated under the Securities Act, we are also eligible to file additional automatically effective registration statements on Form S-3 in the future for the potential offering and sale of an unlimited amount of debt and equity securities.
Credit Facilities
In addition, we maintain lettercredit facilities that provide liquidity and allow us to satisfy certain collateral requirements. The outstanding amounts drawn under each of our significant credit facilities are set forth below:
| | | | | | | | | | | |
| | | |
| At September 30, 2020 | Issued or Drawn | |
| Revolving Credit Facility (1) | $ | — | | |
| Bilateral Letter of Credit Facilities | | |
| Secured | 330,356 | | |
| Unsecured | 346,459 | | |
| Funds at Lloyd’s Letter of Credit Facility | 290,000 | | |
| | | |
| | | |
| | $ | 966,815 | | |
| | | |
(1) At September 30, 2020, no amounts were issued or drawn under this facility.
During the nine months ended September 30, 2020, the letters of credit and facilities which provide liquidity. Referthat were transferred to “Part II, Item 7. Management’s Discussion and Analysisthe Company in connection with the acquisition of Financial Condition and Results of Operations, Liquidity and Capital Resources, Capital Resources”TMR were terminated. There have been no other material changes to our credit facilities as disclosed in our Form 10-K for the year ended December 31, 20162019.
Refer to “Note 7. Debt and Credit Facilities” in our “Notes to the Consolidated Financial Statements” for detailsadditional information related to our debt and significant credit facilities.
Funds at Lloyd’s
As a member of these facilities.Lloyd’s, the underwriting capacity, or stamp capacity, of Syndicate 1458 must be supported by providing a deposit in the form of cash, securities or letters of credit (referred to as “Funds at Lloyd’s” or “FAL”). At September 30, 2020, the FAL required to support the underwriting activities at Lloyd’s through Syndicate 1458 was £509.0 million (December 31, 2019 - £524.3 million). Actual FAL posted for Syndicate 1458 at September 30, 2020 by RenaissanceRe Corporate Capital (UK) Limited was £561.1 million (December 31, 2019 - £522.5 million), supported by a $290.0 million letter of credit and a $405.7 million deposit of cash and fixed maturity securities (December 31, 2019 - $290.0 million and $385.9 million, respectively).
Multi-Beneficiary Reinsurance Trusts and Multi-Beneficiary Reduced Collateral Reinsurance Trusts
Certain of our insurance subsidiaries use multi-beneficiary reinsurance trusts and multi-beneficiary reduced collateral reinsurance trusts to collateralize reinsurance liabilities. Refer to “Note 18. Statutory Requirements” in our “Notes to the Consolidated Financial Statements” in our Form 10-K for the year ended December 31, 2019 for additional information.
Multi-Beneficiary Reinsurance Trusts
Assets held under trust at September 30, 2020 with respect to our multi-beneficiary reinsurance trusts totaled $1.2 billion and $278.2 million for Renaissance Reinsurance and DaVinci, respectively (December 31, 2019 - $1.3 billion and $336.5 million, respectively), compared to the minimum amount required under U.S. state regulations of $884.1 million and $246.8 million, respectively, at September 30, 2020 (December 31, 2019 - $927.4 million and $249.4 million, respectively).
Multi-Beneficiary Reduced Collateral Reinsurance Trusts
Assets held under trust at September 30, 2020 with respect to our multi-beneficiary reduced collateral reinsurance trusts totaled $55.1 million and $46.8 million for Renaissance Reinsurance and DaVinci, respectively (December 31, 2019 - $51.7 million and $43.8 million, respectively), compared to the minimum amount required under U.S. state regulations of $45.1 million and $48.2 million, respectively (December 31, 2019 - $40.3 million and $40.9 million, respectively).
|
| | | | | | | | | |
| | | | | | |
| | Nine months ended September 30, | 2017 | | 2016 | |
| | (in thousands) | | | | |
| | Net cash provided by operating activities | $ | 621,702 |
| | $ | 380,365 |
| |
| | Net cash (used in) provided by investing activities | (214,857 | ) | | 25,728 |
| |
| | Net cash used in financing activities | (256,022 | ) | | (420,964 | ) | |
| | Effect of exchange rate changes on foreign currency cash | 9,596 |
| | 1,316 |
| |
| | Net increase (decrease) in cash and cash equivalents | 160,419 |
| | (13,555 | ) | |
| | Cash and cash equivalents, beginning of period | 421,157 |
| | 506,885 |
| |
| | Cash and cash equivalents, end of period | $ | 581,576 |
| | $ | 493,330 |
| |
| | | | | | |
| | | | | | | | | | | | | | | | | |
| | | | | |
| Nine months ended September 30, | 2020 | | 2019 | |
| (in thousands) | | | | |
| Net cash provided by operating activities | $ | 1,329,779 | | | $ | 1,264,432 | | |
| Net cash used in investing activities | (2,054,819) | | | (2,338,764) | | |
| Net cash provided by financing activities | 632,307 | | | 833,020 | | |
| Effect of exchange rate changes on foreign currency cash | 1,043 | | | 4,641 | | |
| Net decrease in cash and cash equivalents | (91,690) | | | (236,671) | | |
| | | | | |
| Cash and cash equivalents, beginning of period | 1,379,068 | | | 1,107,922 | | |
| Cash and cash equivalents, end of period | $ | 1,287,378 | | | $ | 871,251 | | |
| | | | | |
20172020
During the first nine months of 2017,ended September 30, 2020, our cash and cash equivalents increased $160.4decreased by $91.7 million, to $581.6 million$1.3 billion at September 30, 2017,2020, compared to $421.2 million$1.4 billion at December 31, 2016.2019.
Cash flows provided by operating activities. Cash flows provided by operating activities during the first nine months of 2017 were $621.7 million, compared to cash flows provided by operating activities of $380.4
million during the first nine months of 2016. Cash flows provided by operating activities during the first nine months of 2017 were primarily the result of certain adjustments to reconcile our net loss of $356.9 million to net cash provided by operating activities, including:
an increase in our reserve for claims and claim expenses of $2.3 billion as a result of claims and claims expenses incurred of $2.9 billion, partially offset by claims payments of $613.3 million, each largely driven by the Q3 2017 Large Loss Events;
an increase in unearned premiums of $481.5 million due to the timing of renewals and a $360.5 million increase in reinsurance balances payable due to the timing of payments of our premiums ceded;
a corresponding increase of $1.3 billion in our reinsurance recoverable given the increase in net claims and claim expenses noted above and recoverables associated with the Q3 2017 Large Loss Events;
decreases in premiums receivable and deferred acquisition costs of $533.9 million and $99.6 million, respectively, due to the timing of payments of our gross premiums written and amortization of of deferred acquisition costs, respectively; and
an increase of $194.5 million in our prepaid reinsurance premiums due to ceded premiums written associated renewals in the first nine months of 2017.
Cash flows used in investing activities. During the first nine months of 2017, our cash flows used in investing activities were $214.9 million, principally reflecting net purchases of fixed maturity investments and short term investments of $135.3 million and $146.3 million, respectively, partially offset by net sales of equity investments trading of $61.6 million.
Cash flows used in financing activities. Our cash flows used in financing activities in the first nine months of 2017 were $256.0 million, and were principally the result of:
the repayment in full at maturity of the aggregate principal amount of $250.0 million of our Series B 7.50% Senior Notes due 2017 assumed in connection with the acquisition of Platinum and originally issued by Platinum Underwriters Finance, Inc.;
the settlement of $188.6 million of common share repurchases;
dividends paid on our common and preferred shares of $38.6 million and $16.8 million, respectively; and
net outflows of $44.2 million related to a net return of capital to third-party shareholders, principally in DaVinciRe and Medici; partially offset by
net inflows of $295.9 million associated with the issuance of $300.0 million of our 3.450% Senior Notes due July 1, 2027, net of underwriting discount.
2016
During the first nine months of 2016, our cash and cash equivalents decreased $13.6 million, to $493.3 million at September 30, 2016, compared to $506.9 million at December 31, 2015.
Cash flows provided by operating activities. Cash flows provided by operating activities during the first nine months of 2016ended September 30, 2020 were $380.4 million.$1.3 billion, compared to $1.3 billion during the nine months ended September 30, 2019. Cash flows provided by operating activities during the first nine months of 2016ended September 30, 2020 were primarily the result of certain adjustments to reconcile our net income of $538.8$801.4 million to net cash provided by operating activities, including:
•an increase in reinsurance balances payable of $1.1 billion principally driven by the issuance of non-voting preference shares to investors in Upsilon RFO, which are accounted for as prospective reinsurance and included in reinsurance balances payable on our consolidated balance sheet. See “Note 9. Variable Interest Entities” in our “Notes to the Consolidated Financial Statements” for additional information related to Upsilon RFO’s non-voting preference shares;
•an increase in unearned premiums of $745.5 million due to the growth in gross premiums written across both our Property and Casualty and Specialty segments;
•an increase in reserve for claims and claim expenses of $675.1 million primarily the result of net claims and claim expenses associated with the 2020 Large Loss Events, partially offset by a reduction in net claims and claim expenses of $155.2 million due to the sale of RenaissanceRe UK; partially offset by
•an increase in premiums receivable and deferred acquisition costs of $403.3$736.1 million and $152.5 million, respectively, due to the timing of receipts and increase in our gross premiums written;
•net realized and unrealized gains on investments of $561.9 million principally driven by higher realized gains generated on the sale of fixed maturity investments trading and higher overall returns in our portfolio of equity investments trading, partially offset by lower overall returns in our portfolio of other investments;
•an increase of $280.8$314.5 million in our prepaid reinsurance premiums due to the timing of payments and increase in ceded premiums written; and
•a decrease in other operating cash flows of $267.4 million primarily reflecting subscriptions received in advance of the issuance of Upsilon RFO’s non-voting preference shares effective January 1, 2020, which were recorded in other liabilities at December 31, 2019. During the nine months ended September 30, 2020, in connection with the issuance of the non-voting preference shares of
Upsilon RFO, other liabilities were reduced by the subscriptions received in advance, and reinsurance balances payable were increased by an offsetting amount, with corresponding impacts to other operating cash flows and the change in reinsurance balances payable, as noted above, on our gross premiums ceded;consolidated statements of cash flows for the nine months ended September 30, 2020. See “Note 9. Variable Interest Entities” in our “Notes to the Consolidated Financial Statements” for additional information related to Upsilon RFO’s non-voting preference shares.
Cash flows used in investing activities. During the nine months ended September 30, 2020, our cash flows used in investing activities were $2.1 billion, principally reflecting net purchases of fixed maturity investments trading, short term investments and other investments of $1.5 billion, $549.2 million and $101.3 million, respectively. The net purchase of fixed maturity investments trading was primarily funded by cash flows provided by operating activities, as described above, and the issuance of RenaissanceRe common shares during the second quarter of 2020, whereas the net purchase of short term investments was primarily associated with capital received from investors in Upsilon RFO during the nine months ended September 30, 2020. The net purchase of other investments during the nine months ended September 30, 2020, was primarily driven by an increased allocation to catastrophe bonds. Partially offsetting these net outflows in our cash flows used in investing activities was net proceeds of $136.7 million from the sale of RenaissanceRe UK during the third quarter of 2020.
Cash flows provided by financing activities. Our cash flows provided by financing activities in the nine months ended September 30, 2020 were $632.3 million, and were principally the result of:
•the issuance of 6,325,000 of our common shares in an underwritten public offering at a public offering price of $166.00 per share, combined with an additional $75.0 million raised through the issuance of 451,807 of our common shares at a price of $166.00 per share to State Farm, one of our existing stockholders, in a private placement. The total net proceeds from the offerings were $1.1 billion;
•net inflows of $59.1 million primarily related to net third-party redeemable noncontrolling interest share transactions in Medici and Vermeer; partially offset by
•the repayment in full at maturity the aggregate principal amount of $250.0 million, plus applicable accrued interest, of our 5.75% Senior Notes due 2020 of RenRe North America Holdings Inc. and RenaissanceRe Finance;
•the redemption of all 5 million of our outstanding Series C 6.08% Preference Shares on March 26, 2020 for $125.0 million plus accrued and unpaid dividends thereon;
•the repurchase of 406 thousand of our common shares in open market transactions at an aggregate cost of $62.6 million and an average price of $154.36 per common share; and
•dividends paid on our common and preference shares of $50.8 million and $23.6 million, respectively.
2019
During the nine months ended September 30, 2019, our cash and cash equivalents decreased by $236.7 million, to $871.3 million at September 30, 2019, compared to $1.1 billion at December 31, 2018.
Cash flows provided by operating activities. Cash flows provided by operating activities during the nine months ended September 30, 2019 were $1.3 billion, compared to $888.5 million during the nine months ended September 30, 2018. Cash flows provided by operating activities during the nine months ended September 30, 2019 were primarily the result of certain adjustments to reconcile our net income of $909.9 million to net cash provided by operating activities, including:
•an increase in reinsurance balances payable of $106.2$738.4 million principally driven by the issuance of non-voting preference shares to investors in Upsilon RFO, which are accounted for as prospective reinsurance and included in reinsurance balances payable on our consolidated balance sheet. See “Note 10. Variable Interest Entities” in our reinsurance recoverable;“Notes to the Consolidated Financial Statements” for additional information related to Upsilon RFO’s non-voting preference shares;
•an increase in unearned premiums of $545.0$487.9 million due to an increasethe growth in our gross premiums written across both our Property and Casualty and Specialty segments;
•a $250.7 million increasenet decrease in reinsurance balances payable duerecoverable of $482.7 million, after taking into account the acquisition of TMR, primarily resulting from the collection of $930.7 million during the nine months ended September 30, 2019, partially offset by increases to reinsurance recoverable principally driven by increases in net claims and claim expenses associated with current accident year losses, combined with the timing of paymentscontinued execution of our gross premiums ceded; andgross-to-net strategy;
•an increase in our reserve for claims and claim expenses of $94.1$118.7 million as a result of claims and claims expenses incurred of $540.7 million,$1.8 billion during the nine months ended September 30, 2019 principally driven by current accident year losses, partially offset by claims payments of $446.6 million.$1.6 billion primarily associated with prior accident years losses; partially offset by
Cash•increases in premiums receivable of $625.0 million due to the timing of receipts of our gross premiums written;
•an increase of $216.1 million in our prepaid reinsurance premiums due to an increase in ceded premiums written;
•a decrease in other operating cash flows provided by investing activities. of $277.1 million primarily reflecting subscriptions received in advance of the issuance of Upsilon RFO’s non-voting preference shares effective January 1, 2019, which were recorded in other liabilities at December 31, 2018. During the first nine months of 2016,2019, in connection with the issuance of the non-voting preference shares of Upsilon RFO, other liabilities were reduced by the subscriptions received in advance, and reinsurance balances payable were increased by an offsetting amount, with corresponding impacts to other operating cash flows and the change in reinsurance balances payable, as noted above, on our consolidated statements of cash flows for the first nine months of 2019. See “Note 9. Variable Interest Entities” in our “Notes to the Consolidated Financial Statements” for additional information related to Upsilon RFO’s non-voting preference shares; and
•net realized and unrealized gains on investments of $395.7 million principally due to improved performances from our fixed maturity, public equity and investments-related derivative portfolios.
Cash flows used in investing activities. During the nine months ended September 30, 2019, our cash flows provided byused in investing activities were $25.7 million,$2.3 billion, principally reflecting net salespurchases of equity investments trading and short term investments, of $183.1 million and $128.9 million, respectively, partially offset by net purchases of fixed maturity investments and other investments of $229.9$1.4 billion, $567.8 million and $56.8$130.5 million, respectively. The net purchase of short term investments was funded in part by the capital received from investors in Upsilon RFO and other net cash flows provided by operating activities. The net purchase of other investments during the nine months ended September 30, 2019, was primarily driven by an increased allocation to catastrophe bonds. In addition, we completed our acquisition of TMR on March 22, 2019, resulting in a net cash outflow of $276.2 million, comprised of cash consideration paid by RenaissanceRe as acquisition consideration of $813.6 million, net of cash acquired from TMR of $537.4 million. Refer to “Note 3. Acquisition of Tokio Millennium Re” in our “Notes to the Consolidated Financial Statements” in our Form 10-K for the year ended December 31, 2019 for additional information related to the acquisition of TMR.
Cash flows used inprovided by financing activities. activities. Our cash flows used inprovided by financing activities in the first nine months of 2016ended September 30, 2019 were $421.0$833.0 million, and were principally the result of:
•net inflows of the settlement of $309.4 million of common share repurchases, net outflows of $45.5$516.0 million related to a net return of capital to third-party shareholders, principallythird party redeemable noncontrolling interest share transactions in DaVinciRe, and Medici and $38.9Vermeer;
•net inflows of $396.4 million and $16.8associated with the April 2, 2019 issuance of $400.0 million of our 3.600% Senior Notes due April 15, 2029; partially offset by
•dividends paid on our common and preferredpreference shares of $44.5 million and $27.6 million, respectively.
Capital Resources
We monitor our capital adequacy on a regular basis and seek to adjust our capital according to the needs of our business. In particular, we require capital sufficient to meet or exceed the capital adequacy ratios established by rating agencies for maintenance of appropriate financial strength ratings, the capital adequacy tests performed by regulatory authorities and the capital requirements under our credit facilities.
We may seek to raise additional capital or return capital to our shareholders through common share repurchases and cash dividends (or a combination of such methods). In the normal course of our operations, we may from time to time evaluate additional share or debt issuances given prevailing market conditions and capital management strategies, including for our operating subsidiaries and joint ventures. In addition, as noted above, we enter into agreements with financial institutions to obtain letter of credit facilities for the benefit of our operating subsidiaries in their reinsurance and insurance business.
Our total shareholders’ equity attributable to RenaissanceRe and debt iswas as follows: |
| | | | | | | | | | | | | |
| | | | | | | | |
| | | At September 30, 2017 | | At December 31, 2016 | | Change | |
| | (in thousands) | | | | | | |
| | Common shareholders’ equity | $ | 4,003,012 |
| | $ | 4,466,577 |
| | $ | (463,565 | ) | |
| | Preference shares | 400,000 |
| | 400,000 |
| | — |
| |
| | Total shareholders’ equity attributable to RenaissanceRe | 4,403,012 |
| | 4,866,577 |
| | (463,565 | ) | |
| | 3.450% Senior Notes due 2027 | 295,179 |
| | — |
| | 295,179 |
| |
| | 3.700% Senior Notes due 2025 | 297,225 |
| | 296,948 |
| | 277 |
| |
| | 5.75% Senior Notes due 2020 | 249,188 |
| | 248,941 |
| | 247 |
| |
| | Series B 7.50% Senior Notes due 2017 | — |
| | 255,352 |
| | (255,352 | ) | |
| | 4.750% Senior Notes due 2025 (DaVinciRe) (1) | 147,653 |
| | 147,422 |
| | 231 |
| |
| | RenaissanceRe revolving credit facility – unborrowed | 250,000 |
| | 250,000 |
| | — |
| |
| | Total debt | $ | 1,239,245 |
| | $ | 1,198,663 |
| | $ | 40,582 |
| |
| | Total shareholders’ equity attributable to RenaissanceRe and debt | $ | 5,642,257 |
| | $ | 6,065,240 |
| | $ | (422,983 | ) | |
| | | | | | | | |
| | | | | | | | | | | | | | | | | | | | | | | | |
| | | | | | | | |
| | At September 30, 2020 | | At December 31, 2019 | | Change | | |
| (in thousands) | | | | | | | |
| Common shareholders’ equity | $ | 6,865,821 | | | $ | 5,321,367 | | | $ | 1,544,454 | | | |
| Preference shares | 525,000 | | | 650,000 | | | (125,000) | | | |
| Total shareholders’ equity attributable to RenaissanceRe | 7,390,821 | | | 5,971,367 | | | 1,419,454 | | | |
| 3.600% Senior Notes due 2029 | 392,161 | | | 391,475 | | | 686 | | | |
| 3.450% Senior Notes due 2027 | 296,662 | | | 296,292 | | | 370 | | | |
| 3.700% Senior Notes due 2025 | 298,335 | | | 298,057 | | | 278 | | | |
| 5.750% Senior Notes due 2020 | — | | | 249,931 | | | (249,931) | | | |
| 4.750% Senior Notes due 2025 (DaVinciRe) (1) | 148,582 | | | 148,350 | | | 232 | | | |
| | | | | | | | |
| Total debt | $ | 1,135,740 | | | $ | 1,384,105 | | | $ | (248,365) | | | |
| Total shareholders’ equity attributable to RenaissanceRe and debt | $ | 8,526,561 | | | $ | 7,355,472 | | | $ | 1,171,089 | | | |
| | | | | | | | |
| |
(1) | RenaissanceRe owns a noncontrolling economic interest in its joint venture DaVinciRe. Because RenaissanceRe controls a majority of DaVinciRe’s outstanding voting rights, the consolidated financial statements of DaVinciRe are included in the consolidated financial statements of RenaissanceRe. However, RenaissanceRe does not guarantee or provide credit support for DaVinciRe and RenaissanceRe’s financial exposure to DaVinciRe is limited to its investment in DaVinciRe’s shares and counterparty credit risk arising from reinsurance transactions. |
(1) RenaissanceRe owns a noncontrolling economic interest in its joint venture DaVinciRe. Because RenaissanceRe controls a majority of DaVinciRe’s outstanding voting rights, the consolidated financial statements of DaVinciRe are included in the consolidated financial statements of RenaissanceRe. However, RenaissanceRe does not guarantee or provide credit support for DaVinciRe and RenaissanceRe’s financial exposure to DaVinciRe is limited to its investment in DaVinciRe’s shares and counterparty credit risk arising from reinsurance transactions.
During the first nine months of 2017,ended September 30, 2020, our total shareholders’ equity attributable to RenaissanceRe and debt decreasedincreased by $423.0 million,$1.2 billion, to $5.6$8.5 billion.
Our shareholders’ equity attributable to RenaissanceRe decreased $463.6 millionincreased $1.4 billion during the first nine months of 2017ended September 30, 2020 principally as a result of:
•the sale of 6,325,000 common shares in an underwritten public offering and the concurrent sale of 451,807 common shares to State Farm, each at a price per share of $166.00, for total aggregate net proceeds of $1.1 billion;
•our comprehensive loss attributableincome available to RenaissanceRe of $225.5$565.2 million; partially offset by
•the redemption of all 5 million;
of our outstanding Series C 6.08% Preference Shares for $125.0 million plus accrued and unpaid dividends thereon;our•the repurchase of 1.3 million406 thousand common shares in open market transactions at an aggregate cost of $188.6$62.6 million and at an average share price of $142.67;$154.36 per common share; and
•$38.650.8 million and $16.8$23.6 million of dividends on our common and preference shares, respectively.
During Our debt decreased $248.4 million during the first nine months ended September 30, 2020 principally as a result of 2017, our debt increased $40.6 million primarily driven by the June 29, 2017 issuance of $300.0 million of our 3.450% Senior Notes due July 1, 2027, partially offset by the June 1, 2017 repayment in full at maturity on March 15, 2020 of our 5.75% Senior Notes due 2020 of RenRe North America Holdings Inc. and RenaissanceRe Finance Inc. for the aggregate principal amount of $250.0 million, of our Series B 7.50% Senior Notes assumed in connection with the acquisition of Platinum and originally issued by Platinum Underwriters Finance, Inc. and the amortization of deferred debt issuance costs and the amortization related to these notes.plus applicable accrued interest.
Credit Facilities
The outstanding amounts drawn under each of our significant credit facilities is set forth below:99
|
| | | | | |
| | | | |
| | At September 30, 2017 | Issued or Drawn | |
| | RenaissanceRe Revolving Credit Facility | $ | — |
| |
| | Uncommitted Standby Letter of Credit Facility with Wells Fargo | 99,168 |
| |
| | Uncommitted Standby Letter of Credit Facility with NAB | 4,356 |
| |
| | Bilateral Letter of Credit Facility with Citibank Europe | 192,715 |
| |
| | Funds at Lloyd’s Letter of Credit Facilities | | |
| | Renaissance Reinsurance FAL Facility | 180,000 |
| |
| | Total credit facilities in U.S. dollars | $ | 476,239 |
| |
| | | | |
| | Funds at Lloyd’s Letter of Credit Facilities | | |
| | Specialty Risks FAL Facility | £ | 10,000 |
| |
| | Total credit facilities in pound sterling | £ | 10,000 |
| |
| | | | |
Effective May 25, 2017, the Renaissance Reinsurance FAL Facility, pursuant to which two Funds at Lloyd’s letters of credit with stated amounts of $380.0 million and £90.0 million had been issued, was amended. Pursuant to the amendment, the stated amount of the $380.0 million letter of credit was reduced to $180.0 million and the £90.0 million letter of credit was cancelled. In addition, pursuant to the amendment, we may request that the Renaissance Reinsurance FAL Facility be amended to increase the stated amount of the letter of credit, or issue a new letter or credit denominated in Pounds, in an aggregate amount for all such increases or issuances not to exceed $75.0 million or the equivalent thereof.
There have been no other material changes to our credit facilities as disclosed in our Form 10-K for the year ended December 31, 2016.
For additional information related to the terms of our debt and significant credit facilities, see “Note 7. Debt and Credit Facilities” in our “Notes to the Consolidated Financial Statements” in this Form 10-Q and “Note 9. Debt and Credit Facilities” in our “Notes to the Consolidated Financial Statements” in our Form 10-K for the year ended December 31, 2016. Refer2019. See “Note 10. Shareholders’ Equity” in our “Notes to the Consolidated Financial Statements” in this Form 10-Q and “Note 12. Shareholders’ Equity” in our “Notes to the Consolidated Financial Statements” in our Form 10-K for the year ended December 31, 2019 for additional information related to our common and preference shares.
Multi-Beneficiary Reinsurance Trusts
Effective October 19, 2017, assets held under trust with respect to our multi-beneficiary reinsurance trusts totaled $1,074.3 million and $307.3 million for Renaissance Reinsurance and DaVinci, respectively, compared to the minimum amount required under U.S. state regulations of $1,071.2 million and $306.3 million, respectively, at September 30, 2017.
Multi-Beneficiary Reduced Collateral Reinsurance Trusts
Assets held under trust at September 30, 2017 with respect to our multi-beneficiary reduced collateral reinsurance trusts totaled $49.5 million and $62.2 million for Renaissance Reinsurance and DaVinci, respectively, compared to the minimum amount required under U.S. state regulations of $48.6 million and $61.7 million, respectively.
Redeemable Noncontrolling Interest – DaVinciRe
Our noncontrolling economic ownership in DaVinciRe was 23.5% at September 30, 2017 (December 31, 2016 - 24.0%). See “Note 8. Noncontrolling Interests” and “Note 16. Subsequent Events” in our “Notes to the Consolidated Financial Statements” for additional information regarding DaVinciRe.
Ratings
Financial strength ratings are important to the competitive position of reinsurance and insurance companies. We have received high claims-paying and financial strength ratings from A.M. Best Company, Inc. (“A.M. Best”), Standard and Poor’s Rating Services (“S&P”), Moody’s Investors Service (“Moody’s”) and Fitch Ratings Ltd. (“Fitch”). These ratings represent independent opinions of an insurer’s financial strength, operating performance and ability to meet policyholder obligations, and are not an evaluation directed toward the protection of investors or a recommendation to buy, sell or hold any of our securities. Rating organizations continually review the financial positions of our principal operating subsidiaries and joint ventures and ratings may be revised or revoked by the agencies which issue them.
The ratings of our principal operating subsidiaries and joint ventures and the Enterprise Risk Management rating of RenaissanceRe as of October 27, 2017 are presented below. |
| | | | | | | | | |
| | | | | | | | | |
| | A.M. Best | | S&P | | Moody’s | | Fitch | |
| | | | | | | | | |
| Renaissance Reinsurance (1) | A+ | | AA- | | A1 | | A+ | |
| DaVinci (1) | A | | AA- | | A3 | | — | |
| Renaissance Reinsurance U.S. (1) | A | | AA- | | — | | — | |
| RenaissanceRe Specialty U.S. (1) | A | | AA- | | — | | — | |
| Renaissance Reinsurance of Europe (1) | A+ | | AA- | | — | | — | |
| Top Layer Re (1) | A+ | | AA | | — | | — | |
| | | | | | | | | |
| Syndicate 1458 | — | | — | | — | | — | |
| Lloyd’s Overall Market Rating (2) | A | | A+ | | — | | AA- | |
| | | | | | | | | |
| RenaissanceRe (3) | — | | Very Strong | | — | | — | |
| | | | | | | | | |
(1) The A.M. Best, S&P, Moody's and Fitch ratings for these companies set forth in the table above reflect the insurer's financial strength rating and, in addition to the insurer's financial strength rating, the S&P ratings reflect the insurer's issuer credit rating.
(2) The A.M. Best, S&P and Fitch ratings for the Lloyd's Overall Market Rating represent its financial strength rating.
(3) The S&P rating for RenaissanceRe represents the rating on its Enterprise Risk Management practices.
Reserve for Claims and Claim Expenses
We believe the most significant accounting judgment made by management is our estimate of claims and claim expense reserves. Claims and claim expense reserves represent estimates, including actuarial and statistical projections at a given point in time, of the ultimate settlement and administration costs for unpaid claims and claim expenses arising from the insurance and reinsurance contracts we sell. We establish our claims and claim expense reserves by taking claims reported to us by insureds and ceding companies, but which have not yet been paid (“case reserves”), adding IBNR and, if deemed necessary, adding costs for additional case reserves. Additional case reserves represent our estimates for claims related to specific contracts previously reported to us which we believe may not be adequately estimated by the client as of that date, or adequately covered in the application of IBNR.
Our reserving techniques, assumptions and processes differ among our Property and Casualty and Specialty segments. Refer to “Note 6. Reserve for Claims and Claim Expenses” in our “Notes to Consolidated Financial Statements” included herein for more information on prior year development of the reserve foractual net claims and claim expenses paid will differ, perhaps materially, from the estimates reflected in our financial statements, which may adversely impact our financial condition, liquidity and analysis of our incurred and paid claims development for each of our Property and Casualty and Specialty segments. capital resources.
Refer to “Note 8. Reserve for Claims and Claim Expenses” in our “Notes to the Consolidated Financial Statements” in our Form 10-K for the year ended December 31, 20162019 for more information on the risks we insure and reinsure, the reserving techniques,
assumptions and processes we follow to estimate our claims and claim expense reserves, prior year development of the reserve for claims and claim expenses, analysis of our incurred and paid claims development and claims duration information for each of our Property and Casualty and Specialty segments. In addition, refer to “Part II, Item 7. Management’s Discussion and Analysis of Financial Condition and Results of Operations, Summary of Critical Accounting Estimates, Claims and Claim Expense Reserves” in our Form 10-K for the year ended December 31, 20162019 for more information on the reserving techniques, assumptions and processes we follow to estimate our claims and claim expense reserves, our current estimates versus our initial estimates of our claims reserves, and sensitivity analysis for each of our Property and Casualty and Specialty segments.
Investments
The table below shows our invested assets: |
| | | | | | | | | | | | | | | | | | | |
| | | | | | | | | | | | |
| | | September 30, 2017 | | December 31, 2016 | | Change | |
| | (in thousands, except percentages) | | | | | | | | | | |
| | U.S. treasuries | $ | 2,956,952 |
| | 30.7 | % | | $ | 2,617,894 |
| | 28.1 | % | | $ | 339,058 |
| |
| | Agencies | 41,109 |
| | 0.5 | % | | 90,972 |
| | 1.0 | % | | (49,863 | ) | |
| | Municipal | 521,220 |
| | 5.4 | % | | 519,069 |
| | 5.6 | % | | 2,151 |
| |
| | Non-U.S. government (Sovereign debt) | 177,855 |
| | 1.8 | % | | 333,224 |
| | 3.6 | % | | (155,369 | ) | |
| | Non-U.S. government-backed corporate | 121,892 |
| | 1.3 | % | | 133,300 |
| | 1.4 | % | | (11,408 | ) | |
| | Corporate | 2,028,750 |
| | 21.0 | % | | 1,877,243 |
| | 20.2 | % | | 151,507 |
| |
| | Agency mortgage-backed | 499,310 |
| | 5.2 | % | | 462,493 |
| | 5.0 | % | | 36,817 |
| |
| | Non-agency mortgage-backed | 299,530 |
| | 3.1 | % | | 258,944 |
| | 2.7 | % | | 40,586 |
| |
| | Commercial mortgage-backed | 263,029 |
| | 2.7 | % | | 409,747 |
| | 4.4 | % | | (146,718 | ) | |
| | Asset-backed | 183,322 |
| | 1.9 | % | | 188,358 |
| | 2.0 | % | | (5,036 | ) | |
| | Total fixed maturity investments, at fair value | 7,092,969 |
| | 73.6 | % | | 6,891,244 |
| | 74.0 | % | | 201,725 |
| |
| | Short term investments, at fair value | 1,497,262 |
| | 15.5 | % | | 1,368,379 |
| | 14.7 | % | | 128,883 |
| |
| | Equity investments trading, at fair value | 402,035 |
| | 4.2 | % | | 383,313 |
| | 4.1 | % | | 18,722 |
| |
| | Other investments, at fair value | 548,492 |
| | 5.6 | % | | 549,805 |
| | 5.9 | % | | (1,313 | ) | |
| | Total managed investment portfolio | 9,540,758 |
| | 98.9 | % | | 9,192,741 |
| | 98.7 | % | | 348,017 |
| |
| | Investments in other ventures, under equity method | 101,420 |
| | 1.1 | % | | 124,227 |
| | 1.3 | % | | (22,807 | ) | |
| | Total investments | $ | 9,642,178 |
| | 100.0 | % | | $ | 9,316,968 |
| | 100.0 | % | | $ | 325,210 |
| |
| | | | | | | | | | | | |
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
| | | | | | | | | | | |
| | September 30, 2020 | | December 31, 2019 | | Change | |
| (in thousands, except percentages) | | | | | | | | | | |
| U.S. treasuries | $ | 4,350,971 | | | 21.4 | % | | $ | 4,467,345 | | | 25.7 | % | | $ | (116,374) | | |
| Agencies | 437,681 | | | 2.1 | % | | 343,031 | | | 1.9 | % | | 94,650 | | |
| | | | | | | | | | | |
| Non-U.S. government | 568,960 | | | 2.8 | % | | 497,392 | | | 2.9 | % | | 71,568 | | |
| | | | | | | | | | | |
| Non-U.S. government-backed corporate | 401,449 | | | 2.0 | % | | 321,356 | | | 1.9 | % | | 80,093 | | |
| Corporate | 4,655,765 | | | 22.9 | % | | 3,075,660 | | | 17.7 | % | | 1,580,105 | | |
| Agency mortgage-backed | 1,086,474 | | | 5.3 | % | | 1,148,499 | | | 6.6 | % | | (62,025) | | |
| Non-agency mortgage-backed | 293,953 | | | 1.4 | % | | 294,604 | | | 1.7 | % | | (651) | | |
| Commercial mortgage-backed | 788,995 | | | 3.9 | % | | 468,698 | | | 2.7 | % | | 320,297 | | |
| Asset-backed | 807,070 | | | 4.0 | % | | 555,070 | | | 3.2 | % | | 252,000 | | |
| Total fixed maturity investments, at fair value | 13,391,318 | | | 65.8 | % | | 11,171,655 | | | 64.3 | % | | 2,219,663 | | |
| Short term investments, at fair value | 5,158,961 | | | 25.4 | % | | 4,566,277 | | | 26.3 | % | | 592,684 | | |
| Equity investments trading, at fair value | 547,381 | | | 2.7 | % | | 436,931 | | | 2.5 | % | | 110,450 | | |
| Other investments, at fair value | 1,122,683 | | | 5.5 | % | | 1,087,377 | | | 6.3 | % | | 35,306 | | |
| Total managed investment portfolio | 20,220,343 | | | 99.4 | % | | 17,262,240 | | | 99.4 | % | | 2,958,103 | | |
| Investments in other ventures, under equity method | 98,990 | | | 0.6 | % | | 106,549 | | | 0.6 | % | | (7,559) | | |
| Total investments | $ | 20,319,333 | | | 100.0 | % | | $ | 17,368,789 | | | 100.0 | % | | $ | 2,950,544 | | |
| | | | | | | | | | | |
At September 30, 2017,2020, we held investments totaling $9.6$20.3 billion,, compared to $9.3$17.4 billion at December 31, 2016.2019. In connection with the acquisition of TMR, we acquired total investments with a fair market value of $2.3 billion on March 22, 2019, the date of acquisition. Our investment guidelines stress preservation of capital, market liquidity, and diversification of risk. Notwithstanding the foregoing, our investments are subject to market-wide risks and fluctuations, as well as to risks inherent in particular securities. In addition to the information presented above and below, refer tosee “Note 3. Investments” and “Note 4.4. Fair Value Measurements” in our “Notes to the Consolidated Financial Statements” for additional information regarding our investments and the fair value of measurement of our investments, respectively.
As the reinsurance coverages we sell include substantial protection for damages resulting from natural and man-made catastrophes, as well as for potentially large casualty and specialty exposures, we expect from time to time to become liable for substantial claim payments on short notice. Accordingly, our investment portfolio as a whole is structured to seek to preserve capital and provide a high level of liquidity, which means that the large majority of our investment portfolio consists of highly rated fixed income securities, including U.S. treasuries, agencies, municipals, highly rated sovereign and supranational securities, high-grade corporate securities and mortgage-backed and asset-backed securities. We also have an allocation to publicly traded equities reflected on our consolidated balance sheet as equity investments trading and an allocation to other investments (including catastrophe bonds, private equity partnerships,investments, senior secured bank loan funds and hedge funds, and other investments)funds). At September 30, 2017, our portfolio of equity investments trading totaled $402.0 million, or 4.2%, of our total investments (December 31, 2016 - $383.3 million or 4.1%). Our portfolio of other investments totaled $548.5 million, or 5.6%, of our total investments at September 30, 2017 (December 31, 2016 - $549.8 million or 5.9%).
Other Investments
The table below shows our portfolio of other investments:
| | | | | | | | | | | | | | | | | | | | | | | |
| | | | | | | |
| | September 30,
2020 | | December 31,
2019 | | Change | |
| (in thousands) | | | | | | |
| Catastrophe bonds | $ | 816,971 | | | $ | 781,641 | | | $ | 35,330 | | |
| Private equity investments | 274,810 | | | 271,047 | | | 3,763 | | |
| Senior secured bank loan funds | 20,933 | | | 22,598 | | | (1,665) | | |
| Hedge funds | 9,969 | | | 12,091 | | | (2,122) | | |
| | | | | | | |
| Total other investments | $ | 1,122,683 | | | $ | 1,087,377 | | | $ | 35,306 | | |
| | | | | | | |
|
| | | | | | | | | | | | | |
| | | | | | | | |
| | | September 30,
2017 | | December 31,
2016 | | Change | |
| | (in thousands) | | | | | | |
| | Catastrophe bonds | $ | 332,044 |
| | $ | 335,209 |
| | $ | (3,165 | ) | |
| | Private equity partnerships | 196,280 |
| | 191,061 |
| | 5,219 |
| |
| | Senior secured bank loan funds | 19,572 |
| | 22,040 |
| | (2,468 | ) | |
| | Hedge funds | 596 |
| | 1,495 |
| | (899 | ) | |
| | Total other investments | $ | 548,492 |
| | $ | 549,805 |
| | $ | (1,313 | ) | |
| | | | | | | | |
We account for our other investments at fair value in accordance with FASB ASC Topic Financial Instruments. The fair value of certain of our fund investments, which principally include private equity funds, senior secured bank loan funds and hedge funds, is recorded on our consolidated balance sheet in other investments, and is generally established on the basis of the net valuation criteria established by the managers of such investments, if applicable. The net valuation criteria established by the managers of such investments is established in accordance with the governing documents of such investments. Many of our fund investments are subject to restrictions on redemptions and sales which are determined by the governing documents and limit our ability to liquidate these investments in the short term.
Some of our fund managers and fund administrators are unable to provide final fund valuations as of our current reporting date. We typically experience a reporting lag to receive a final net asset value report of one month for our hedge funds and senior secured bank loan funds and three months for private equity funds, although we have occasionally experienced delays of up to six months at year end, as the private equity funds typically complete their year-end audits before releasing their final net asset value statements.
In circumstances where there is a reporting lag between the current period end reporting date and the reporting date of the latest fund valuation, we estimate the fair value of these funds by starting with the prior month or quarter-end fund valuations, adjusting these valuations for actual capital calls, redemptions or distributions, and the impact of changes in foreign currency exchange rates, and then estimating the return for the current period. In circumstances in which we estimate the return for the current period, all information available to us is utilized. This principally includes using preliminary estimates reported to us by our fund managers, obtaining the valuation of underlying portfolio investments where such underlying investments are publicly traded and therefore have a readily observable price, using information that is available to us with respect to the underlying investments, reviewing various indices for similar investments or asset classes, and estimating returns based on the results of similar types of investments for which we have obtained reported results, or other valuation methods, where possible. Actual final fund valuations may differ, perhaps materially so, from our estimates and these differences are recorded in our consolidated statement of operations in the period in which they are reported to us as a change in estimate. Included in net investment incomerealized and unrealized gains (losses) on investments for the first nine months ended September 30, 2020 is a loss of 2017 is income of $1.9$2.4 million (2016 (2019 - loss of $3.4 million)$5.5 million) representing the change in estimate during the period related to the difference between our estimated net investment incomerealized and unrealized gains (losses) due to the lag in reporting discussed above and the actual amount as reported in the final net asset values provided by our fund managers.
Our estimate of the fair value of catastrophe bonds is based on quoted market prices, or when such prices are not available, by reference to broker or underwriter bid indications. Refer toSee “Note 4.4. Fair Value Measurements” in our “Notes to the Consolidated Financial Statements” for additional information regarding the fair value of measurement of our investments.
We have committed capital to private equity partnerships andinvestments, other investments and investments in other ventures of $895.1 million,$1.5 billion, of which $576.1$747.6 million has been contributed at September 30, 2017.2020. Our remaining commitments to these investments at September 30, 20172020 totaled $324.2 million.$745.4 million. In the future, we may enter into additional commitments in respect of private equity partnershipsinvestments or individual portfolio company investment opportunities.
Ratings
Financial strength ratings are important to the competitive position of reinsurance and insurance companies. We have received high long-term issuer credit and financial strength ratings from A.M. Best Company, Inc. (“A.M. Best”), S&P Global Ratings (“S&P”), Moody’s Investors Service (“Moody’s”) and Fitch Ratings Ltd. (“Fitch”), as applicable. These ratings represent independent opinions of an insurer’s financial strength, operating performance and ability to meet policyholder obligations, and are not an evaluation directed toward the protection of investors or a recommendation to buy, sell or hold any of our securities. Rating organizations continually review the financial positions of our principal operating subsidiaries and joint ventures and ratings may be revised or revoked by the agencies which issue them.
The ratings of our principal operating subsidiaries and joint ventures and the Enterprise Risk Management rating of RenaissanceRe as of October 23, 2020 are presented below.
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
| | | | | | | | | |
| | A.M. Best (1) | | S&P (2) | | Moody's (3) | | Fitch (4) | |
| | | | | | | | | |
| Renaissance Reinsurance Ltd. | A+ | | A+ | | A1 | | A+ | |
| DaVinci Reinsurance Ltd. | A | | A+ | | A3 | | — | |
| Renaissance Reinsurance of Europe Unlimited Company | A+ | | A+ | | — | | — | |
| Renaissance Reinsurance U.S. Inc. | A+ | | A+ | | — | | — | |
| RenaissanceRe Europe AG | A+ | | A+ | | — | | — | |
| RenaissanceRe Specialty U.S. | A+ | | A+ | | — | | — | |
| | | | | | | | | |
| Top Layer Reinsurance Ltd. | A+ | | AA | | — | | — | |
| Vermeer Reinsurance Ltd. | A | | — | | — | | — | |
| | | | | | | | | |
| RenaissanceRe Syndicate 1458 | — | | — | | — | | — | |
| Lloyd's Overall Market Rating | A | | A+ | | — | | AA- | |
| | | | | | | | | |
| RenaissanceRe | Very Strong | | Very Strong | | — | | — | |
| | | | | | | | | |
(1) The A.M. Best ratings for our principal operating subsidiaries and joint ventures represent the insurer’s financial strength rating. The Lloyd’s Overall Market Rating represents Syndicate 1458’s financial strength rating. The A.M. Best rating for RenaissanceRe represents our Enterprise Risk Management (“ERM”) score
(2) The S&P ratings for our principal operating subsidiaries and joint ventures represent the insurer’s financial strength rating and the issuer’s long-term issuer credit rating. The Lloyd’s Overall Market Rating represents Syndicate 1458’s financial strength rating. The S&P rating for RenaissanceRe represents the rating on its ERM practices.
(3) The Moody’s ratings represent the insurer’s financial strength rating.
(4) The Fitch rating for Renaissance Reinsurance represents the insurer’s financial strength rating. The Lloyd’s Overall Market Rating represents Syndicate 1458’s financial strength rating.
As of October 23, 2020, there were no other material changes to our ratings as disclosed in our Form 10-K for the year ended December 31, 2019.
EFFECTS OF INFLATION
The potential exists, after a catastrophe loss, for the development of inflationary pressures in a local economy. We consider the anticipated effects on us in our catastrophe loss models. Our estimates of the potential effects of inflation are also considered in pricing and in estimating reserves for unpaid claims and claim expenses. In addition, itIt is possible that the risk of general economic inflation has increased which could, among other things, cause claims and claim expenses to increase and also impact the performance of our investment portfolio. This risk may be exacerbated by the steps taken by governments throughout the world in responding to the COVID-19 pandemic. The actual effects of this potential increase in inflation on our results cannot be accurately known until, among other items, claims are ultimately settled. The onset, duration and severity of an inflationary period cannot be estimated with precision. We consider the anticipated effects of inflation on us in our catastrophe loss models. Our estimates of the potential effects of inflation are also considered in pricing and in estimating reserves for unpaid claims and claim expenses. The potential exists, after a catastrophe loss, for the development of inflationary pressures in a local economy.
OFF-BALANCE SHEET AND SPECIAL PURPOSE ENTITY ARRANGEMENTS
At September 30, 2017,2020, we had not entered into any off-balance sheet arrangements, as defined in Item 303(a)(4) of Regulation S-K.
CONTRACTUAL OBLIGATIONS
In the normal course of business, we are party to a variety of contractual obligations as summarized in our Form 10-K for the year ended December 31, 2016.2019. We consider these contractual obligations when assessing our liquidity requirements. During the nine months endedAs of September 30, 2017, other than as disclosed in “Note 6. Reserve for Claims and Claim Expenses” in our “Notes to Consolidated Financial Statements”, with respect to an increase in our reserve for claims and claim expenses, and “Note 7. Debt and Credit Facilities” in our “Notes to Consolidated Financial Statements” and “Part I, Item 2. Management’s Discussion and Analysis of Financial Condition and Results of Operations, Capital Resources”, with respect to our long term debt obligations,2020, there were no other material changes in our contractual obligations as disclosed in the table of contractual obligations and related footnotes included in our Form 10-K for the year ended December 31, 2016.2019.
CURRENT OUTLOOK
The COVID-19 Pandemic and General Economic Conditions
The global COVID-19 pandemic has had immense impacts on a global scale, including on the insurance and reinsurance industries, where it continues to contribute to an accelerating hard market across property, casualty and specialty lines. Notwithstanding our view of current opportunities available to RenaissanceRe, the COVID-19 pandemic has raised and continues to raise many new questions and challenges for us and our industry. It is not possible to predict precisely all of the potential impacts of the COVID-19 pandemic on RenaissanceRe, or their respective potential timing. Estimating the impact of the COVID-19 pandemic remains complicated and challenging, and its ultimate impact and the extent of losses is highly unpredictable and uncertain at this time. Among the uncertainties that render such estimation unusually challenging are the unknown length and severity of the COVID-19 pandemic, the unknown duration and depth of the economic recession, and the extent and duration of society’s response to the COVID-19 pandemic and economic downturn. From governments’ unprecedented imposition of constraints on economic and social activity, to longer term changes in societal behaviors that may result from people’s reactions to the COVID-19 pandemic, we believe that the COVID-19 pandemic could change demand for (re)insurance products going forward, potentially having significant impacts on the industry. We continue to expect insured losses to emerge over time as primary insurance claims are handled and public sector initiatives develop, and as the full impact of the COVID-19 pandemic and its effects on the global economy are realized. We are closely monitoring COVID-19-related developments, including potential government actions which may impact the insurance and reinsurance sectors.
We expect that stress in the global economy will continue, possibly with a deep recession and severe unemployment, but we are unable to predict the ultimate duration and severity of the economic downturn. We continue to expect increased market volatility as well, impacting the costs of capital formation, business and investment planning, and mark-to-market results from period to period. Given that the demand for insurance is significantly influenced by prevailing economic conditions, continued declining and weak global economic conditions may lead to a suppression of demand for insurance and reinsurance generally, although we believe there will be opportunities for the business we write, including in the remainder of 2020. In addition, this pressure may inordinately affect smaller competitors in the primary insurance, reinsurance and retrocessional markets. In turn, these pressures may lead, among other things, to increased consolidation as larger, better capitalized competitors will be in a stronger position to withstand prolonged periods of economic downturn and sustain their business through the financial volatility. In the current environment, capital and liquidity are extremely important, and we believe our capital and liquidity positions are strong. In furtherance of our strategic plan, in the second quarter of 2020 we raised over $1 billion of new common equity to support our pursuit of successfully executing on future opportunities.
We currently believe that current economic conditions have, and will likely continue to, heighten our counterparty credit risk due to the strain that the COVID-19 pandemic is putting on potentially all companies, including our own customers, agents, brokers, retrocessionaires, and capital providers. If there is a sustained economic downturn resulting from the COVID-19 pandemic, these effects could be magnified or could manifest themselves in ways that we cannot currently predict. We have been closely monitoring the economic impact of COVID-19-related shutdowns and the development of forbearance measures on, among other things, our mortgage book and other aspects of our portfolio. Economic disruption and changing market dynamics may also lead to significant changes and mismatches in the market as different insurance products compete for similar coverages. While we believe that we are well positioned to continue
to execute on our strategic plan and compete for and meet the demand for the protection that we provide, it is difficult to predict all of the potential impacts of the COVID-19 pandemic on the markets in which we participate and our ability to effectively respond to these changing market dynamics.
More broadly, steps taken by governments throughout the world in responding to the COVID-19 pandemic, including the reduction of interest rates in certain jurisdictions in the U.S., could lead to higher inflation over time than we had anticipated, leading to higher costs of claims and claim expenses and the need to increase our reserves. The effects of this trend could be magnified for longer-tail business lines that are more inflation sensitive, particularly our casualty business. At this time, we expect that the low interest rate environment will continue, and that these actions and other dynamics are likely to reduce broadly available realized economic returns on investments.
In addition, market conditions have adversely impacted, and may adversely affect, our investment portfolio in the future. Over the longer term, as the COVID-19 pandemic continues and continues to create volatility in the financial markets, we expect that it is likely that the strain on financial markets will increase. In the near term, it is possible that adverse metrics in respect of the pandemic and the potential for uncertainty in respect of the presidential election in the U.S. will also contribute to volatility in the financial markets. In addition, access to public capital markets and private, third-party capital may become unavailable or constrained, or more expensive than in recent periods, or contain more onerous terms and conditions. Notwithstanding the many uncertainties and challenges that lie ahead, we believe that our track record of responding to industry events, differentiated risk management and client service capabilities, and access to diverse sources of both capital and risk position us favorably in the current environment.
While much of the positive performance in our investment portfolio in the first three quarters of 2020 reflected mark-to-market gains, we expect that it is highly likely that we will realize losses in certain individual positions in our investment portfolio in future periods, particularly in our equity investments trading portfolio and in lower rated corporate credit, as a result of the economic changes from the COVID-19 pandemic. These losses could be significant in respect of a particular financial period, or otherwise. Our ability to derive investment income from our investments may also become more difficult as economic sluggishness, or market volatility, continues. The sustained environment of low interest rates in recent years lowered the yields at which we invest our assets relative to longer-term historical levels. In 2019 and the first three quarters of 2020, decreases in prevailing interest rates contributed significantly to comparably high net realized and unrealized gains from our invested assets. However, as we invest cash from new premiums written or reinvest the proceeds of invested assets, we expect the yield on our portfolio to be adversely impacted by the anticipated period of low interest rates and broader economic uncertainty.
Operationally, as an international company with offices around the globe, the COVID-19 pandemic and restrictions related thereto have presented certain challenges. However, we believe we have adjusted well to date to the work paradigms required by the COVID-19 pandemic, benefiting from prior and enhanced investments in technology, systems and training, which have enabled us to maintain robust oversight of the company. As appropriate, certain of our offices have opened on an optional and limited basis in accordance with applicable rules and regulations in their respective jurisdictions. However, an extended period of remote work arrangements could strain our business continuity plans, introduce additive operational risk, including but not limited to cybersecurity risks such as ransomware attacks, and adversely affect our ability to manage our business.
Reinsurance Market Trends and Developments
Even before the onset of the COVID-19 pandemic, rates were rising across most lines of business. We continue to believe that the COVID-19 pandemic is accelerating the recent rate increases we have seen in many of the lines of business that we write. This has been exacerbated by the natural catastrophe activity in the second half of 2020 to date, which has accelerated the demand for reinsurance and which continues to outpace supply. As an organization, we believe these market conditions have created significant opportunities in the lines of business that we write, and that we are well positioned to deploy capital and grow in this environment given our market leadership and long-term relationships with brokers and customers. Our current expectation is that we will seek to deploy the proceeds from our recent equity offerings into the 2021 market beginning with the January 1 renewal period for general corporate purposes, which may include expanding our existing business lines, entering new business lines, forming new joint ventures, or acquiring books of business from other companies. This capital may be deployed from our holding company to our regulated operating subsidiaries or our joint ventures, and once contributed, our
ability to reallocate such capital may be constrained by regulators or, for our joint ventures, the terms and conditions of our shareholder agreements.
The market has also been impacted by a tightened supply of capital. Among other things, capital in the insurance-linked securities market, which we estimated had already declined to a degree over recent periods, has been further impacted by recent developments, further reducing supply, particularly in respect of certain regions and perils. For example, we believe that the existing and potential impact of the COVID-19 pandemic, along with the high incidence of natural catastrophes in 2020, has contributed to a significant amount of trapped collateral in the insurance-linked securities market. We currently anticipate that this may exacerbate the decline in capital invested in the insurance-linked securities market overall. We believe that this trend magnifies market appreciation of the structural differences between collateralized coverage and traditional reinsurance, and that cedants may increasingly prefer in the near term the certainty of rated balance sheets, providing us with additional opportunities in the lines of business that we write, and putting additional upward pressure on reinsurance rates.
In addition, partly as a result of expected reductions in the availability of retrocessional capacity from third-party investors as third-party capital becomes less abundant, we expect that the trend of increasing rates for retrocessional coverage may accelerate. Accordingly, this trend may affect the amount of such protection we purchase in the future. However, consistent with our strategy of retaining more risk when prices are rising, we expect to manage any potential reductions in the availability of retrocessional reinsurance. We expect that we may also see additional opportunities to be a provider of retrocessional reinsurance as rates increase. This may provide another opportunity for us to profitably deploy available capital, while retaining more net risk on our balance sheet.
Another factor that may contribute to rising rates is that we anticipate reinsurers may be less inclined to write certain classes of business in which we participate that are most impacted by social inflation trends, the risks of climate change, regional or market segment weakness, or other factors, without proper pricing adjustments if other, less risky, opportunities to deploy capital are available to them. Certain classes of business, like Florida homeowners’ coverage and certain forms of casualty coverage, may be impacted by more than one of these factors. Our assessment of these changes in risk exposure will impact our appetite to renew or pursue business we perceive to be adversely impacted, either absolutely or relative to other market opportunities. In particular with regards to our assessment of risks related to climate change, we believe that our proprietary climate-change informed catastrophe models and approach set us apart from many other underwriters or insurance-linked securities managers who often rely on a single vendor model that we believe does not fully capture the impact of climate change.
Property Exposed Market Developments
OverWhile the past several years, notwithstandingimpact of the occurrenceCOVID-19 pandemic may be the most significant driver of a numbermarket dynamics in the near-term, there are other recent trends that have impacted property exposed markets. Prior to the emergence of significant loss events, the globalCOVID-19 pandemic, property catastropheexposed markets were already experiencing constrained supply and elevated demand, resulting in upward pressure on rates. We estimate that the insurance and reinsurance markets have in general manifested growing levels of industry-wide capital held. At the same time, reinsurance demand for many coverages and solutions has not grown at the pace of this growth in available capital. In respectexperienced some of the January 2017 and mid-year 2017 property catastrophe reinsurance renewals, we believe that supply, principallylargest back-to-back years for insured natural disaster losses in history from traditional market participants and increasingly complemented by alternative capital providers, more than offset market demand, resulting in a continued reduction of overall market pricing on a risk-adjusted basis, except for, in general, recent loss impacted treaties and contracts.
The insurance and reinsurance markets were impacted by Hurricanes Harvey, Irma and Maria and the Mexico City Earthquake in the third quarter of 2017 and additional events, most notably the devastating wildfires in many areas of the state of California, in the fourth quarter of 2017 to date. Modeling firms, analysts2019 from multiple hurricanes, typhoons, wildfires and other industry observers have estimated that, in the aggregate, the impact of these events to the industry could approach or potentially exceed $100 billion. Given the nature and breadth of these events,earthquakes. The associated losses haveover this period affected an unusually large number of regions, and, accordingly, insureds, reinsurance lines and reinsurers. In additionaladdition, the ultimate scale of the losses, difficulty of loss estimation, length of payout periods, social inflation risk and other factors have contributed to traditionaluncertainty around these loss events and the market firms,has been impacted by continuing, significant adverse developments from these events. In particular, we estimate basedthat the industry’s reported adverse developments on mediaTyphoon Jebi and on Hurricane Irma would each represent, by themselves, historically large insured loss events. Moreover, to date the 2020 Atlantic storm season has had a record-setting level of storm activity, with an unusual number of named storms forming thus far. The Western portion of the United States has also been impacted by an unprecedented level of wildfire activity. We believe that climate change contributes to making extreme events both more frequent and more severe, and we believe that this level of catastrophe event activity is a result of this trend.
We believe that revised views of risk as a result of these experiences and the potential reduction of capacity or risk appetite from the insurance-linked securities market, have contributed favorably to market conditions, although there can be no assurance that these developments will continue or be sustained. Based on our experience, intermediary reports and public statements by market participants, that retrocessional markets, alternative capital providers, collateralized coverage providers and other non-traditional firms have absorbed a meaningful share of these losses. As a result, we currently believe that the January 2018 renewal markets could be subject to uncertainties relating to factors such as the ability of and speed by which such parties recapitalize, whether new entrants form and at what pace, and uncertainties arising from the commitment of existing collateral.
We currently believe that industry conditions are likely to improvecommentary, in respect of the January 2018 renewal season, and anticipate that bothJune 2020
renewals, rates for retrocessional reinsurance and some lines of primary insurance were up substantially, while rates on other layers of reinsurance, if loss free in expiring periods, were up less markedly. Loss affected transactionsreinsurance programs and lines, such as treaties exposed to the California wildfires, showed more substantially improved terms. In respect of the April 2020 renewal, which includes our Japanese property catastrophe business, the industry saw significant rate improvements in certain lines, such as wind risk, while earthquake-only risk remained flat, but at attractive levels. This momentum continued through the June and other coveragesJuly 1 renewals. With respect to the COVID-19 pandemic, we have been generally able to obtain COVID-19 pandemic exclusions on many of the new deals that we wrote, and only wrote deals without such exclusion that met certain specific criteria.
These developments facilitated our growth in the sector will experience beneficial changes. However, at this time we cannot assess with certainty the degree or breadth of such developments, how long they may be sustained, or the degreegross premiums written, both in our existing operations and by presenting opportunities to which we may benefit from such developments, should they occur.
In addition to pricing, market conditions are increasingly impacted by an erosion of terms and conditions, for which we believe the reinsurance market is being undercompensated or in some instances uncompensated. Notwithstanding the favorable market developments we currently anticipatedeploy additional third-party capital. Nonetheless, in respect of certain regions and perils we continue to assess that prevailing rate increases were not sufficient to offset increases in exposure, continuing risks from social inflation and the coming renewal season, it is possible that,potential for sustained elevation in exposure due to changes in climate conditions and demographics. For example, we continue to carefully monitor ongoing, adverse trends in the Florida market with respect to claims practices, litigation risks, and exposure growth, and are prepared to continue to reduce our exposure to risks and accounts exposed to these trends. Additionally, in 2020, for the first time in several years, the Florida Hurricane Catastrophe Fund did not purchase private reinsurance, citing rising rates as in recent periods, a meaningful portion of the business ceded to the reinsurance market will remain priced below levels we find acceptable, or will be characterized by contractual terms and conditions we do not find to be acceptable, absent the advent of significant new developments. Furthermore, cedants in many of the key markets we serve are large and increasingly sophisticated. They may be able to manage large retentions, access risk transfer capital in expanding forms, and may seek to focus their reinsurance relationships on a core group of well-capitalized, highly-rated reinsurers who can provide a complete product suite as well as value-added service.deciding factor. While we believe we are well positioned to compete for business we find attractive, thesea number of dynamics may limit the degree to which the market improves favorablysustains favorable improvements in the near term,near-term or continue to introduce or exacerbate long-term challenges in our markets.
Casualty and Specialty Exposed Market Developments
InCertain of the markets in which our Casualty and Specialty segment operates,operate experienced generally favorable rate trends in respect of the January 2020 renewals. We have found increasing opportunities to write additional or new business in this segment, contributing to meaningful economic growth in our gross written business, especially when adjusting for the re-underwriting of the portfolio we continuepurchased from TMR. In general, we have seen meaningful improvements in terms and conditions, including broad-based reductions in ceding commissions, from 2019 and into 2020 to expect casualty insurance and reinsurance capacity to remain abundant during 2018, notwithstanding events such asdate. In particular, across that period we have observed favorable conditions for accounts that exhibited elevated loss emergence or underlying rate deterioration, but we also estimate that the Ogden Rate change and the relatively high level of specialty industry loss events in recent periods. In recent periods, the U.S. casualty reinsurancefavorable market overall has continued to reflect a soft pricing environment and we assessed that many programs and treaties did not meet our pricing standards.trends have extended more broadly. In the near term, we now anticipatecontinue to expect that the COVID-19 pandemic will put further pressure on rates and that current pricing trends are likely to continue, with terms and conditions in respectfor loss-affected lines of lines business affected by the large catastrophe events of the third quarter of 2017 should improvecontinuing to show particular improvement and thatcertain other areas of the casualty and specialty may showmarket potentially maintaining less pronounced but positive adjustments. Moreover,
At the same time, we also estimate that underlying loss costs for many casualty and specialty lines of business will continue to believe that pocketsrise, while the costs of niche or specialty casualty lines may provide attractivecapital increases and opportunities for strongerinvestment income decrease. The casualty and specialty markets have continued to broadly exhibit adverse loss development and negative exposure trends, including a meaningful increase in both the incidence and severity of civil jury awards and other social inflation trends.
We plan to continue to seek unique or well-positioned reinsurers anddifferentiated opportunities to provide coverage on large programs open to us on a differentiated basis or to select markets. However, we cannot assure you that positive market trends will continue, that we are well positioned to compete for business we do findwill succeed in identifying and expanding on attractive given our strong ratings, expanded product offerings,programs or obtain potentially attractive new programs, or that future, currently unforeseen, developments will not adversely impact the casualty and increased U.S. market presence. For example, market demand for protection in financial lines, particularly in respect of mortgage reinsurance, has grown in recent periods, contributing to our recent specialty and casualty growth.markets.
However,Relatedly, specific renewal terms vary widely by insured account and our ability to shape our portfolio to improve its estimated risk and return characteristics as estimated by us is subject to a range of competitive and commercial factors. We cannot assure you that these positive dynamics will manifest, that any overall market increase in demand will materializebe sustained, or that we will participate fully in positive changes if they do occur.improving terms. We intend to seek to maintain strong underwriting discipline and, in light of prevailing market conditions, cannot provide assurance that we will succeed in growing or maintaining our current combined in-force book of business.
General Economic ConditionsLegislative and Regulatory Update
Underlying economic conditionsAs a result of the COVID-19 pandemic, we are seeing many legislative and regulatory initiatives that, if enacted, could have a significant adverse effect on our business and results of operations. Legislative,
regulatory, judicial or social influences may seek to impose new obligations on (re)insurers in connection with the COVID-19 pandemic that extend coverage beyond the intended contractual obligations or result in an increase in the frequency or severity of claims beyond expected levels, thereby resulting in unexpected or modeled insurance or reinsurance losses. Certain governments and regulatory bodies are also considering proposals that would retroactively change the terms of existing insurance contracts that generally exclude business interruption losses from pandemics. Litigation in the U.S. is still in the early stages and, accordingly we continue to expect uncertainty regarding coverage for these types of claims and that the outcome may differ by jurisdiction. Internationally, there have also been legal challenges concerning business interruption coverage, including the U.K. Financial Conduct Authority’s business interruption “test case.” Further, a number of legislative proposals have been introduced or proposed to alter the financing of pandemic-related risk in several of the key markets in which we serveoperate, and the impact of these and other proposals on our business is uncertain at this time. For example, at the federal level, following the initial onset of the COVID-19 pandemic, Congress considered legislation that would have retroactively forced insurers to cover pandemic claims in business interruption policies even if specifically excluded. These bills have currently been generally stablewithdrawn, although we cannot assure you that they or similar legislation will not be re-introduced in 2017, with our core markets, includingthe future. At the state level in the U.S., experiencing moderate economic growthat least eight states and increasesthe District of Columbia have considered legislation to require retroactive business interruption coverage, and while none have yet passed legislation, we expect that any such legislation will be challenged in prevailing interest rates. However, manycourt should it become law, however, any legal action challenging such legislation could take years to resolve and there can be no assurance that the outcomes would be favorable. Moreover, a number of stakeholder groups have advocated that, regardless of the key markets we serve may continue to be adversely impacted by the financial and fiscal instability of several European jurisdictions and certain large developing economies, including the impacts of political instability in the Middle East, Ukraine, Russia and other jurisdictions.
We continue to believe that meaningful risk remains for continued uncertainty, economic weakness or adverse disruptions in general economic and financial market conditions. Moreover, any future economic growth may be at a comparatively suppressed rate for a relatively extended period of time. Declining or weak economic conditions could reduce demand for the products sold by us or our customers, impact the risk-adjusted attractiveness and absolute returns and yields of our investment portfolio, or weaken our overall ability to write business at risk-adequate rates. In addition, persistent low levels of economic activity could adversely impact other areas of our financial performance, by contributing to unforeseen premium adjustments, mid-term policy cancellations or commutations or asset devaluation, among other things. Our specialty and casualty reinsurance and Lloyd’s portfolios in particular can be exposed to risks arising from economic weakness or dislocations, including with respect to a potential increase of claims in directors and officers, errors and omissions, surety, casualty clash and other lines of business. In addition, we believe our consolidated credit risk, reflecting our counterparty dealings with customers, agents, brokers,
retrocessionaires, capital providers and parties associated with our investment portfolio, among others, is likely to be higher during a period of economic weakness. Any of the foregoing or other outcomes of a period of economic weakness could adversely impact our financial position or results of operations.
The sustained environment of low interest rates in recent years lowered the yields at which we invest our assets relative to longer-term historical levels. More recently, we have seen increases in interest rates, and as we invest cash from new premiums written or reinvest the proceeds of invested assets that mature or that we choose to sell, the yield on our portfolio may be favorably impacted by the increasing interest rate environment. However, such an increase in prevailing interest rates could contribute to higher realized and unrealized losses associated with our currently invested assets in the near term. While it is possible yields will improve in future periods, we are unable to predict with certainty when conditions will substantially improve, or the pacepassage of any such improvement.legislation, primary insurers voluntarily pay business interruption claims, even if excluded. While we are prepared to engage constructively with our cedants in respect of any such developments, we are also committed to enforcing our own contractual and legal rights, and the outcome of any of these developments is challenging to currently assess.
We continue to monitorCongress is also considering several proposals which, if enacted, would impact the financing of future pandemic exposure and, accordingly, related markets for insurance, reinsurance and other financial products. For example, one such proposal would establish a Pandemic Risk Insurance Act, which would establish a public-private partnership with insurers retaining 5% of the risk that our principal markets will experience increased inflationary conditions, which would cause costs related to our claimsof a future pandemic and claim expenses to increase and impact the performance of our investment portfolio, among other things. The onset, duration and severity of an inflationary period cannot be estimated with precision.
Legislative and Regulatory Update
In June 2016, U.S. House of Representatives leadership released a Tax Reform Task Force Blueprint which, among other things, recommendedfederal government assuming the U.S. move to a consumption or destination-based tax system and adopt corresponding border adjustments taxing imports. During the first half of 2017, the House Ways and Means Committee explored adopting the conceptsremainder of the Tax Reform Task Force Blueprint into law. If adopted, these proposals could materially adversely impactrisk, with businesses charged an “actuarial premium.” Another proposal would create a standing, multi-billion-dollar fund which the federal government would use to pay businesses directly for pandemic losses, rather than through an insurance and reinsurance industry and our own results of operations. In particular, the enactment of such legislation could substantially decrease the exportability of risk and reduce our access to capital and business as a whole. Such legislation may also result in increased prices for our products and services, which could cause a decrease in demand for these products and services. product.
It is also possible that border adjustmentsthe economic uncertainty resulting from the COVID-19 pandemic could resultcause some governments, including cities, counties, states, and national governments, to look at risk transfer as a means to create budgeting certainty. These initiatives could create public entity risk transfer opportunities in retaliatory actions by other countries.
In April 2017, the Trump Administration releasedU.S. and globally. We have been a statementleader in several iterations of principles relating to personalinnovative governmental risk transfer initiatives, at the U.S. federal and corporate tax reform. Among other things, the statementstate level, and in a number of principles called for the adoption of a 15% business tax rate, the imposition of a territorial U.S. tax system, a one-time tax on U.S. assets held in other jurisdictions, across a range of perils. We believe we are well positioned to collaborate on, and participate in, any such new initiatives. However, given the eliminationearly stages of certain tax breaks for specific types of economic activity or transactions. The statement of principles did not address the border adjustment proposals reflected in the Tax Reform Task Force Blueprint.
The House and Senate have both announced that they intend to release specific legislation language for tax rate changes and potential tax reform shortly. Based on media reports, we understand that these proposals, may call for the adoption of a 20% business tax rate, the imposition of a territorial U.S. tax system or components thereof, a one-time tax on U.S. assets held in other jurisdictions, and the elimination or reduction of wide range of deductions or credits. In addition, it has been reported that one or both chambers of Congress may propose changes that would limit or deny U.S. insurers and reinsurers the deduction for reinsurance placed with non-U.S. affiliates. There have also been media reports of other proposed changes that would impact our industry, including reconsideration of past proposals in respect of passive foreign investment company rules. In general, such changes, if adopted as drafted, would increase taxation of certain activities and structures in our industry. However,is difficult to predict at this time material uncertainty remains as to the possibility,impact they may have on our business in the future, and we cannot assure you that we would succeed in participating, or that the terms likelihood and timing of any U.S.such facilities would be attractive.
Across the world, many governments have reacted to COVID-19 pandemic by proposing or enacting stimulus measures which incorporate a variety of strategies, including certain tax relief measures and incentives. In general, we do not expect to participate in, or benefit from, any such initiatives. Accordingly, at this time, we do not anticipate any tax law change. Wechanges or incentives in the jurisdictions where we operate will have a beneficial impact on our results of operations or financial position. Over time, it is possible that many jurisdictions in which we operate, or markets where we provide coverages or services, may consider changes to their tax and revenue systems in light of the unprecedented stimulus, borrowing, and fiscal measures undertaken recently and which may yet be enacted as the COVID-19 pandemic and its impacts continue. It is possible that such measures could increase tax burdens on companies operating in such jurisdictions, or operating multilaterally, or which transact in or with respect to such jurisdictions. At this time, we cannot provide assurance as to likelihood of passageanticipate or precise impactestimate the costs of any of these proposed or other potential changes.such future initiatives.
In prior Congressional sessions, Congress has considered a range of potential legislation which would, if enacted, provide for matters such as the creation of (i) a federal reinsurance catastrophe fund; (ii) a federal consortium to facilitate qualifying state residual markets and catastrophe funds in securing reinsurance; and (iii) a federal bond guarantee program for state catastrophe funds in qualifying state residual markets. In
April 2016, H.R.4947, the Natural Disaster Reinsurance Act of 2016, which would create a federal reinsurance program to cover any losses insured or reinsured by eligible state programs arising from natural catastrophes, including losses from floods, earthquakes, tropical storms, tornadoes, volcanic eruption and winter storms, was introduced. If enacted, this bill, or legislation, similar to any of these proposals, would, we believe, likely contribute to the growth of state entities offering below-market priced
insurance and reinsurance in a manner adverse to us and market participants more generally. Such legislation could also encourage cessation, or even reversal, of reforms and stabilization initiatives that have been enacted in the state of Florida and other catastrophe-exposed states in recent years. While we believe such legislation will continue to be vigorously opposed, if adopted these bills would likely diminish the role of private market catastrophe reinsurers and could adversely impact our financial results, perhaps materially.
In May 2020, the Federal Housing Finance Administration, the regulator and conservator of Fannie Mae and Freddie Mac, issued a proposed capital rule that would significantly reduce the value of credit risk transfer to government sponsored entities (“GSEs”), reinsurers and other capital market participants if enacted. The proposal includes a series of “haircuts” to the GSEs’ credit for risk transfer, meaning they would be expected to require a larger capital reserve even after transferring risk off their balance sheets. Accordingly, this could adversely impact the attractiveness to the GSE’s of investing in private financial protection, including reinsurance, which have been a source of private market demand growth in our sector over recent periods. We cannot assess with precision the probability these changes will be enacted or their exact impact on the markets in which we participate if they are.
In June 2012, Congress passed the Biggert-Waters Bill, which provided for a five-year renewal of the National Flood Insurance Program (the “NFIP”) and, among other things, authorized the Federal Emergency Management Agency (“FEMA”) to carry out initiatives to determine the capacity of private insurers, reinsurers, and financial markets to assume a greater portion of the flood risk exposure in the U.S., and to assess the capacity of the private reinsurance market to assume some of the program’s risk. InCommencing in January 2017, FEMA announced that,has, acting under authority contemplated by the Biggert-Waters Bill, it had secured annual reinsurance protection for the NFIP effectiveNFIP. Most recently, in January 1, 2017 through January 1, 2018. Under the agreement, participating reinsurers agreed2020, FEMA announced that it had renewed its reinsurance program to indemnify FEMAprovide for flood claims on an occurrence basis; the layer is structured to cover 26%$1.33 billion of protection in respect of 2020, covering 10.25% of NFIP’s losses between $4 billion and $6 billion, 34.7% of its losses between $6 billion and $8 billion, and 21.8% of its losses between $8 billion and $10 billion. In addition, NFIP has procured an additional $500 million of private market protection via the FloodSmart Re $500 million Series 2018-1 Notes. It is possible this program will continue and potentially expand in future periods and may encourage other U.S. federal programs to explore private market risk transfer initiatives; however, we cannot assure you that any such developments will in fact occur, or that if they do transpire we will succeed in participating.
The statutory authorization for the operation and continuation of the NFIP was scheduledhas expired and received a series of short-term extensions. The NFIP’s current authorization has now most recently been extended to expire in September 2017, but Congress has extended30, 2021. In January 2019, the authorizationFederal Deposit Insurance Corp. and Office of the Comptroller of the Currency issued rules requiring lenders to December 8, 2017. Legislative language under consideration in the House of Representatives would clarify thataccept private flood insurance providedpolicies that have coverage at least as comprehensive as that offered by private firms satisfies the requirementNFIP, and providing a framework to evaluate alternative flood coverage; these rules went into effect on July 1, 2019. Congress is also considering legislative language that homeowners maintain flood coverage on mortgaged properties that are backed by a federal guarantee and located in a flood zone. Draft language also would direct FEMA to consider policy holderspolicyholders who dropdiscontinue an NFIP policy and then later return to the NFIP as having continuous coverage if they can demonstrate that a flood insurance policy from a private firm was maintained throughout the interim period. If ultimately approved byTo the full Congress, we believe that such legislationextent these laws, rules and regulations are adopted and enforced, they could incrementally contribute to the growth of private residential flood opportunities and the financial stabilization of the NFIP. However, reauthorization of the NFIP remains subject to meaningful uncertainty; and whether a successful reauthorization would continue market-enhancing reforms is significantly uncertain. Wewe cannot assure you that such legislation to reform the NFIP will indeed be enacted or that the private market for residential flood protection will be enhanced if it is.
In recent years, market conditions for insurance in the state of Florida have been significantly impacted by the increasingly prevalent utilization of a practice referred to as “assignment of benefits,” or “AOB”.“AOB.” We currently estimate that the impacts of AOB have contributed adversely and significantly to the ultimate economic losses borne by the insurance market in light of recent large Florida loss events, including Hurricanes Irma and Michael. An AOB is an instrument executed by a primary policyholder that is deemed to permit certain third parties, such as water extraction companies, roofers or plumbers, to “stand in the shoes” of the insured and seek direct payments from the policyholder’s insurance company. According
In April 2019, SB 122: The Insurance Assignment Agreements Act (the “AOB Reform Bill”) became law in Florida, effective July 1, 2019. While we are cautiously optimistic that this law could somewhat mitigate, in respect of losses subsequent to July 2019, some of the more egregious practices that have contributed to adverse industry results in Florida, Office of Insurance Regulation (the “OIR”), while there were 405 AOB lawsuits across Florida in 2006, that number rosewe continue to 28,200 in 2016. Moreover, according to the OIR, claims with an AOB have a much higher degree of severity than claims without one. For example, since 2010 the frequency of water claims has risen by 46% and the severity of water claims has risen by 28%. As a result, we believe that usagethe likely estimated impact to exposed loss in reinsurance treaties and programs will not be material. In addition, the AOB Reform Bill is not intended to remediate the adverse impacts of AOBs is contributing significantlyearlier events, such as the large losses in 2017 and 2018, which continue to exhibit loss development well beyond modeled expectations. In general, we continue to estimate that the dynamics and practices we refer to as “social inflation” will continue to adversely impact loss trends in Florida. Moreover, reforms of social inflation trends in Florida and is having an impact on the profitability and financial condition of certain of the state’s domestic property insurance companies. While both private companies and the OIR are exploring non-statutory means to mitigate these issues, legislative reforms proposed over the last several years haveor other jurisdictions do not been enacted. A continuation of these trends could weaken or potentially impair primary insurance companies, reduce demand for reinsurance and discourage the strengthening of the private insurance market that we believe had otherwise been evident in Florida. Such trends would adversely impact the increased risks attributable to changes in climate, demographics and other factors which we estimate are increasing the probability and severity of meteorologically-driven hazards.
Further, in February 2020, legislation was introduced in the Florida market and manySenate, Bill No. SB 1334, which would, if ultimately adopted, significantly expand the Florida Hurricane Catastrophe Fund for a statutory period of several years. While the companies we seekbill did not attain passage in this year’s session, it could be revisited in a future scheduled or special legislation session. In sum, taken together, these ongoing challenges have impacted our own risk selection criteria with respect to serve.
Florida exposures.
ITEM 3. QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK
We are principally exposed to four types of market risk: interest rate risk,risk; foreign currency risk,risk; credit risk,risk; and equity price risk. Our investment guidelines permit, subject to approval, investments in derivative instruments such as futures, options, foreign currency forward contracts and swap agreements, which may be used to assume risks or for hedging purposes.
There were no material changes to these market risks, as disclosed in “Part II, Item 7A. Quantitative and Qualitative Disclosures about Market Risk,”Risk” in our Form 10-K for the year ended December 31, 2016,2019, during the first nine months of 2017.ended September 30, 2020, except as described below. See “Part II, Item 7A. Quantitative and Qualitative Disclosures about Market Risk,” in our Form 10-K for the year ended December 31, 20162019 for a discussion of our exposure to these risks.
Due to the ongoing and rapidly evolving nature of the COVID-19 pandemic, a longer or more severe recession may increase the probability of credit losses in the Company’s investment portfolio. Volatility in global financial markets, together with low or negative interest rates, reduced liquidity and a continued slowdown in global economic conditions, have adversely affected, and may continue to adversely affect, the Company’s investment portfolio. Additionally, we are exposed to counterparty credit risk, including with respect to reinsurance brokers, customers and retrocessionaires, which may materially increase to the extent the COVID-19 pandemic affects our ability to collect premiums receivable or reinsurance recoverables. ITEM 4. CONTROLS AND PROCEDURES
Evaluation of Disclosure Controls and Procedures:Procedures
Under the supervision and with the participation of our management, including our Chief Executive Officer and Chief Financial Officer, we have evaluated the effectiveness of the design and operation of our disclosure controls and procedures, as defined in Rules 13a-15(b) and 15d-15(b) of the Exchange Act, as of the end of the period covered by this report. Based upon that evaluation, our management, including our Chief Executive Officer and Chief Financial Officer, concluded that, at September 30, 2017,2020, our disclosure controls and procedures were effective to provide reasonable assurance that information required to be disclosed in Company reports filed or submitted under the Exchange Act is (i) recorded, processed, summarized and reported within the time periods specified in the SEC rules and forms and (ii) accumulated and communicated to our management, including our Chief Executive Officer and Chief Financial Officer, as appropriate to allow timely decisions regarding required disclosure.
Changes in Internal Control Over Financial Reporting:Reporting
There were no changes in our internal control over financial reporting during the quarter ended September 30, 2017,2020, which were identified in connection with our evaluation required pursuant to Rules 13a-15 or 15d-15 under the Exchange Act, that have materially affected, or are reasonably likely to materially affect, our internal control over financial reporting.
PART II OTHER INFORMATION
ITEM 1. LEGAL PROCEEDINGS
There have been no material changes to the legal proceedings previously disclosed in our Form 10-K for the year ended December 31, 2016.2019.
ITEM 1A. RISK FACTORS
ThereExcept as previously reported in the “Risk Factors” section of our prospectus supplement filed with the SEC on June 4, 2020, there have been no material changes to the risk factors previously disclosed in our Form 10-K for the fiscal year ended December 31, 2016.2019 and Form 10-Q for the quarter ended March 31, 2020.
ITEM 2. UNREGISTERED SALES OF EQUITY SECURITIES AND USE OF PROCEEDS
Our share repurchase program may be effected from time to time, depending on market conditions and other factors, through open market purchases and privately negotiated transactions. On August 2,November 10, 2017, our Board of Directors approved a renewal of our authorized share repurchase program to an aggregate amount of up to $500.0 million. Unless terminated earlier by our Board of Directors, the program will expire when we have repurchased the full value of the shares authorized. The table below details the repurchases that were made under the program during the third quarter of 2017,2020, and also includes other shares purchased, which represents common shares surrendered by employees in respect of withholding tax obligations on the vesting of restricted stock, or in lieu of cash payments for the exercise price of employee stock options.
|
| | | | | | | | | | | | | | | | | | | | | | | | | | |
| | | | | | | | | | | | | | | | |
| | | Total shares purchased | | Other shares purchased | | Shares purchased under publicly announced repurchase program | | Dollar maximum amount still available under repurchase program | |
| | | Shares purchased | | Average price per share | | Shares purchased | | Average price per share | | Shares purchased | | Average price per share | | |
| | | | | | | | | | | | | | | (in thousands) | |
| | Beginning dollar amount available to be repurchased | | | | | | | | | | | | | $ | 485,145 |
| |
| | July 1 - 31, 2017 | 24,828 |
| | $ | 141.86 |
| | 2,128 |
| | $ | 139.05 |
| | 22,700 |
| | $ | 142.12 |
| | (3,226 | ) | |
| | August 1 - 2, 2017 | 20,602 |
| | $ | 147.85 |
| | — |
| | $ | — |
| | 20,602 |
| | $ | 147.85 |
| | (3,046 | ) | |
| | August 2, 2017 - renewal of authorized share repurchase program of $500.0 million | | | | | | | | | | | | | 21,127 |
| |
| | Dollar amount available to be repurchased | | | | | | | | | | | | | 500,000 |
| |
| | August 3 - 31, 2017 | 187,532 |
| | $ | 145.77 |
| | 2,456 |
| | $ | 148.25 |
| | 185,076 |
| | $ | 145.74 |
| | (26,973 | ) | |
| | September 1 - 30, 2017 | 41,955 |
| | $ | 135.53 |
| | — |
| | $ | — |
| | 41,955 |
| | $ | 135.53 |
| | (5,686 | ) | |
| | Total | 274,917 |
| | $ | 144.01 |
| | 4,584 |
| | $ | 143.98 |
| | 270,333 |
| | $ | 144.01 |
| | $ | 467,341 |
| |
| | | | | | | | | | | | | | | | |
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
| | | | | | | | | | | | | | | |
| | Total shares purchased | | Other shares purchased | | Shares purchased under publicly announced repurchase program | | Dollar maximum amount still available under repurchase program | |
| | Shares
purchased | | Average
price per
share | | Shares
purchased | | Average
price per
share | | Shares
purchased | | Average
price per
share | | |
| | | | | | | | | | | | | | (in thousands) | |
| Beginning dollar amount available to be repurchased | | | | | | | | | | | | | $ | 437,379 | | |
| July 1 - 31, 2020 | 114 | | | $ | 179.37 | | | 114 | | | $ | 179.37 | | | — | | | $ | — | | | — | | |
| August 1 - 31, 2020 | — | | | $ | — | | | — | | | $ | — | | | — | | | $ | — | | | — | | |
| | | | | | | | | | | | | | | |
| | | | | | | | | | | | | | | |
| | | | | | | | | | | | | | | |
| September 1 - 30, 2020 | — | | | $ | — | | | — | | | $ | — | | | — | | | $ | — | | | — | | |
| Total | 114 | | | $ | 179.37 | | | 114 | | | $ | 179.37 | | | — | | | $ | — | | | $ | 437,379 | | |
| | | | | | | | | | | | | | | |
During the first nine months of 2017, pursuant to our publicly announced share repurchase program, weended September 30, 2020, the Company repurchased an aggregate of 1.3 million406 thousand common shares in open market transactions at an aggregate cost of $188.6$62.6 million and an average price of $142.67$154.36 per common share. InGiven the future, we may authorize additional purchase activities undereconomic environment and to preserve capital for both risk and opportunity, the currently authorizedCompany suspended share repurchases in March 2020. The Company did not engage in any share repurchase program, increaseactivity during the amount authorizedsecond and third quarters of 2020. At September 30, 2020, $437.4 million remained available for repurchase under the share repurchase program, or adopt additional trading plans.program. In the near term, the Company intends to prioritize capital for deployment into its business; however, we may resume repurchases at any time when we believe it is prudent to do so and without further notice.
ITEM 3. DEFAULTS UPON SENIOR SECURITIES
None.
ITEM 4. MINE SAFETY DISCLOSURES
Not applicable.
ITEM 5. OTHER INFORMATION
None.
ITEM 6. EXHIBITS
| | | | | |
| 10.1 | |
| 31.1 | |
| 31.2 | |
| 32.1 | |
| 32.2 | |
| 101.INS | XBRL Instance Document |
| - the instance document does not appear in the Interactive Data File because its XBRL tags are embedded within the Inline XBRL document. |
| 101.SCH | Inline XBRL Taxonomy Extension Schema Document |
| Document. |
| 101.CAL | Inline XBRL Taxonomy Extension Calculation Linkbase Document |
| |
| 101.LAB | Inline XBRL Taxonomy Extension Label Linkbase DocumentDocument. |
| 101.DEF | Inline XBRL Taxonomy Extension Definition Linkbase Document. |
| 101.PRE | Inline XBRL Taxonomy Extension Presentation Linkbase Document |
| 104 | Cover Page Interactive Data File (embedded within the Inline XBRL document and included in Exhibit 101). |
| | |
101.DEF | XBRL Taxonomy Extension Definition Linkbase Document |
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.
RENAISSANCERE HOLDINGS LTD.
| |
Date: November 1, 2017 | /s/ Robert QutubDate: October 28, 2020 /s/ Robert Qutub |
Robert Qutub
Executive Vice President and Chief Financial Officer
(Principal Financial Officer and Duly Authorized Officer)
| |
Date: November 1, 2017 | /s/ James C. FraserDate: October 28, 2020 /s/ James C. Fraser |
James C. Fraser
Senior Vice President and Chief Accounting Officer
(Principal Accounting Officer)